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National Program Assessment  
Animal Health 
2000-2004 
 
 
 
National Program Assessments are conducted every five-years through the organization of one or more 
workshop.  Workshops allow the Agricultural Research Service (ARS) to periodically update the vision and 
rationale of each National Program and assess the relevancy, effectiveness, and responsiveness of ARS 
research.  The National Program Staff (NPS) at ARS organizes National Program Workshops to facilitate the 
review and simultaneously provide an opportunity for customers, stakeholders, and partners to assess the 
progress made through the National Program and provide input for future modifications to the National 
Program or the National Program’s research agenda.  A workshop for Animal Health has been scheduled for 
October 2004, Greensboro, North Carolina.  This report provides the accomplishments for the 2000-2004 
National Program Cycle.  You will find detailed information on research objectives, achievements, and impact.  
Results are provided according to location.  Comments and assessments should be addressed to 
mailto:cgg@ars.usda.gov prior to October 2004.     
 
Leading America towards a better future 
through agricultural research and information.
  
 
               
U.S. government work. Not subject to copyright.
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EXECUTIVE SUMMARY 
 
 
 
This report provides the accomplishments of research conducted under the Agricultural Research Services 
(ARS) Animal Health National Program from 2000 to 2004.  The purpose of this report is to assess the impact 
of the program.  An assessment is conducted at the end of each 5-year program cycle to update the vision and 
rationale of the program.  The goal of this assessment is to determine whether the program has had an impact 
on the field of science, animal health, American agriculture, and the U.S. economy. 
 
A summary of the Action Plan prepared at the start of the animal health national program cycle is provided.  
The Action Plan identified seven research components that are the focus of the Animal Health Research 
Program:  Pathogen Detection and Diagnostics; Microbial Genomics; Animal Immunology; Mechanisms of 
Disease; Genetic Resistance to Disease; Epidemiology of Disease; and Strategies to Control Infectious and 
Non-Infectious Diseases.  The Action Plan provides the research direction, goals, and the anticipated outcomes 
and impact.  Research plans with specific objectives wre derived from the Action Plan.  A total of 60 research 
projects were identified, subjected to external peer review, and implemented by 18 Research Units located 
throughout the United States.      
 
Research accomplishments with the greatest impact are summarized for each of the seven research 
components.  The accomplishments are presented relative to their impact on specific diseases.  Many diseases 
affect a single species or are specific to a particular animal industry or management system (e.g., dairy verus 
beef) but many cross host barriers and affect more than one animal segment (e.g., brucellosis).  Thus, the 
impact of accomplishments can only be assessed through a comprehensive understanding of veterinary 
medicine, animal health, and the management systems of the applicable animal industries.  Because of the 
tremendous number of variables associated with animal health and various management systems, this report 
only attempts to assess impact within specific disease areas.  The broader impact on specific commodity 
groups, regulatory and action agencies, American agriculture, the U.S economy, or the field of sciencewill be 
determined by our customers, stakeholders, and partners.  As such, this report will be broadly distributed and 
subject to an external panel review. 
 
Many of the anticipated outcomes and impacts identified at the start of the animal health national program 
cycle have been achieved.  The research component with the greatest success and impact has been in the area 
of diagnostic discovery and development. Several new and improved tests have been discovered by ARS 
scientists. Many of these tests have been commercialized or adopted by animal health officials in the control 
and eradication of diseases.  Many of the diagnostic discoveries have been for zoonotic diseases that impact 
public health and biological threat agents that could cause tremendous harm to our economy and the Nation. 
 
Animal Health program impact has been achieved in all areas of the action plan; 
 
? The goal of research component #1 “Pathogen detection and diagnositics” was to produce a new 
generation of diagnostics tools. Diagnostic tools were produced for detection of Anaplasmosis, avian 
influenza, classical swine fever, chronic wasting disease, Johne’s disease, Listeria moncytogenese, 
Newcastle disease, Poult enteritis mortality syndrome, toxoplasmosis, trichellosis and tuberculosis. 
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? The goal of research component #2 “Microbial Genomics” was to use functional genomic analysis of 
pathogenic microorganisms to solve significant animal disease problems. Microbial genomics was used 
to understand how avian influenza evolves and adaptes to poultry populations; used to study the 
differences in low and high virulence BVD viruses in host cells; used to identify specific regions of 
Johne’s disease and Leptospirosis that can be used as vaccine candidates; used to do a comparative 
assessment of six different pox viruses which will lead to a better understanding of pox viruses 
pathogensis.  
 
? The goal of research component #3 “Animal Immunology” was to understand the early development of 
the immune system allowing scientists to apply new approaches to vaccine delivery and use bio-
therapeutics for disase treatment. In this area ARS scientists created reagents for the assessment of 
immune responses in poultry, “designer” immune reagents to assess swine immune responses and 
immunomodulators that influence coccidiosis in chickens and bovine mastitis.  
 
? The goal of research component #4 “Mechanisms of Disease” was to understand at the molecular level 
how pathogens cause disease. The disease mechanisms that were further understood were those of 
Marek’s disease (genes involved in pathogenicity, replication and cell transformation were identified), 
pine needle abortion (toxins, toxin producers and toxin producing conditions were identified) and 
Porcine Reproduction and Respiratory Syndrome (host cell gene expression patterns were determined).  
 
? The goal of research component #5 “Genetic resistance to disease” was to develop means by which the 
genomes of agricultural species can be utilized to reduce the economic impact of animal diseases. ARS 
scientists developed a genetic test that can determine if a chicken is resistant to Avian Leukosis virus 
infection; developed a genotyping system in cattle that can associate alleles with infection phenotype in 
commercial beef populations; identified several candidate genes in chickens that may confere resistance 
to Marek’s disease; determined a means by which genetics can be used to breed increased resistance in 
sheep to Scrapie infection.  
 
? The goal of research component #6 “Epidemiology of Disease” was to incorporate epidemiological 
analysis into research programs. Molecular epidemiology was used to show that Avian Influenza has 
circulated in live bird markets for years; that wild birds could be a source of Avian Pneumovirus for 
turkeys; allow epidemiological tracebacks of Brucellosis; establish the shedding patterns of Malignant 
Catarrhal Fever virus in sheep; that Neosporosis is a primary cause of abortion in cattle and that dogs 
are an important on-farm risk factor; white-tailed deer were the primary source of Tuberculsis infection 
to cattle; Vesicular Stomatitis infections in the USA often originate from Mexico.  
 
? The goal of research component #7 “Strategies to Control Infectious and Non-Infectious Diseases” was 
to develop and integrate basic research information into applied solution that can be used by farmers 
and ranchers to control animal disease. In this area ARS scientists have determined a means by which 
Foot and Mouth Disease virus infections can be stopped; developed a nutrional solution that will help 
to prevent cows from getting milk fever; developed a method to rapidy and evenly vaccinate laying 
hens against Mycoplasma infection; developed a candidate vaccine against Newcastle disease that can 
easily be differentiated from natural infection; a swine influenza vaccine that can be used in the face of 
maternal antibody. 
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The contributions made to the field of science by ARS scientists cannot be underestimated and the impact can 
easily be assessed by reviewing the list of publications provided in the appendix of this report. 
 
BACKGROUND INFORMATION 
 
 
Agricultural Research Service (ARS) 
Role 
Mission 
National Program Cycle 
National Program Assessment 
Animal Health National Program (NP 103) 
 
 
Agricultural Research Service 
The Agricultural Research Service (ARS) is the principal in-house research agency of the 
U.S. Department of Agriculture (USDA).  ARS is one of four agencies in the Research, 
Education, and Economics (REE) mission area. ARS is charged with extending the 
Nation's scientific knowledge with research projects in agriculture, human nutrition, 
food safety, natural resources, the environment, and other topics affecting the 
American people on a daily basis. ARS supports more than 2,100 scientist years 
organized into approximately 1,050 permanent research projects at over 100 locations 
across the country and five overseas laboratories and more than 150 librarians, technical 
information specialists, and other library specialists. 
 
Role 
ARS conducts innovative research to find solutions to problems of high National priority.  ARS often selects 
high-risk scientific endeavors to make significant breakthroughs in important problem areas but also 
complements the work of State Colleges and Universities, State Agricultural Experiment Stations (SAES), 
other Federal agencies, and the private sector. Mechanisms for addressing State and local issues are already in 
place; therefore, activities within ARS focus on issues having a regional or national scope and where there is a 
clear Federal role. ARS also provides research support to USDA action and regulatory agencies and to several 
other Federal regulatory agencies, including the Food and Drug Administration and the Environmental 
Protection Agency. 
 
Mission 
Our mission is to conduct research to develop and transfer solutions to agricultural problems of high national 
priority and provide information access and dissemination to: 
 
• Ensure high-quality, safe food, and other products 
• Access the nutritional needs of Americans 
• Sustain a competitive agricultural economy 
• Enhance the natural resource base and the environment 
• Provide economic opportunities for rural citizens, communities, and society as a whole 
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National Program Cycle 
The management and execution of all ARS research programs is organized around the five-year National 
Program Cycle, consisting of four sequential phases designed to ensure the relevance, quality, and impact of 
every National Program:  1) Input; 2) Planning; 3) Implementation; and 4) Assessment.  
Input Planning Implementation Assessment
Relevance Quality Impact
National Program Cycle
Action Plan
Prospectus
Project Plan
GPRA 
Workshop
RPES
ARMP
Implementation Memoranda
National Program Assessment
National Program Annual Report
Site Reviews
OSQR Review
 
 
National Program Assessment 
A National Program Assessment is conducted every five-years through the organization of one or more 
workshop.  Workshops allow ARS to periodically update the vision and rationale of each National Program 
and assess the relevancy, effectiveness, and responsiveness of ARS research.  The National Program Staff 
organizes National Program Workshops to facilitate the review and simultaneously provide an opportunity for 
customers, stakeholders, and partners to assess the progress made through the National Program and provide 
input for future modifications to the National Program or the National Program’s research agenda. 
 
Animal Health National Program (NP 103) 
The mission of the Animal Health Program is to conduct basic and applied research on 
selected diseases of economic importance to the United States livestock and poultry 
industries. The goals of the research mission are to produce knowledge and technology to 
reduce economic losses from infectious, genetic, and metabolic diseases of livestock and 
poultry. Dr. Robert A. Heckert, National Program Leader, Animal Health, and Dr. Cyril G. 
Gay, National Program Leader, Animal Health and Safety lead this ARS research program. 
Dr. Gay is lead on domestic disease issues and vaccine and drug discovery projects, and 
Dr. Heckert is lead on projects involving foreign and emerging diseases. The Animal 
Health National Program currently includes 60 research projects supported by 118 
scientists located at 14 research sites throughout the country.  The ARS research budget for 
the Animal Health Program is approximately $54.3 million (NET).   
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ACTION PLAN 
 
 
Introduction 
A workshop for the Animal Health Program was held September 21-23, 1999 in College Park, Maryland. The 
workshop was attended by 127 stakeholders and 50 ARS scientists. Invited stakeholders were encouraged to 
send letters presenting their animal health priorities.  Input received from our stakeholders was used to 
formulate an Action Plan for the Animal Health National Program, consisting of seven research components 
and the anticipated results to be generated from the proposed research.  This process was meant to provide a 
coordinated multi-location plan for research projects conducted by ARS scientists and cooperators that address 
regional and national priorities and result in fundamental advances in agricultural science.  All projects were 
prospectively reviewed by an external panel in 2001, in accordance with Office of Scientific and Quality 
Review (OSQR) policy and procedures. 
 
The following outlines the goals of the action plan for each of the seven research components, including the 
anticipated outcomes and impact identified at the onset of the Animal Health National Program Cycle.  The 
complete action plan can be reviewed on-line at 
http://www.ars.usda.gov/research/programs/programs.htm?np_code=103&docid=288 
 
Research Components 
Research Component 1:  Pathogen Detection and Diagnostics 
 
Goals 
To produce a new generation of diagnostic tools are needed that will facilitate detection and identification of 
known pathogens and diseases, new variants of infectious and non-infectious agents, and emerging organisms 
and diseases. As appropriate, the procedures will be adapted for use in either field or laboratory diagnostic 
situations. These new technologies will be transferred to private organizations for the purpose of 
commercialization, or to state and federal diagnostic laboratories for regulatory or limited field use.  
Techniques that are applicable to national animal disease programs or human health problems will be 
standardized and validated through collaboration with other federal agencies to provide a scientific basis for 
their use in surveillance of animals, animal feeds, animal products, and the environment. Application of these 
techniques will enhance the general health of U.S. livestock, fish, poultry, and wildlife, and provide assurance 
that animals and animal products intended for domestic or international trade are free of infectious and toxic 
agents.  
 
Outcomes 
• Availability of more sensitive and specific techniques for diagnosis of animal disease.  
• Capability for more rapid identification of new or re-emerging diseases.  
• Development of predictive data bases for risk assessment studies. 
• Increased domestic and international trade of animals and animal products.  
• Reduced public health risk from food-borne illness.  
• A safer environment. 
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Impact 
Efficient and profitable animal production systems in which animal well-being is maximized and in which 
disease detection is rapid and causes minimal impact on production, trade, human health and the environment.  
 
Research Component 2:  Microbial Genomics 
 
Goals 
To use functional genomic analysis of pathogenic microorganisms, including bacteria, viruses, protozoa, 
parasites and fungi to solve significant animal disease problems. Specifically to: 1) understand fundamental 
genetic and biological processes underlying microbial pathogenesis and host resistance; 2) facilitate pathogen 
gene discovery for use as disease control targets; 3) provide pathogen gene sequences for development of 
improved gene and protein-based diagnostic tests; and 4) identify pathogen gene targets for development of 
improved vaccines and therapeutics. 
 
Outcomes 
• Improved pathogen detection and diagnosis  
• Improved tools for epidemiological disease investigations  
• Understanding of new metabolic pathways. 
• Improved vaccines and therapeutics  
• Novel disease control strategies  
 
Impact 
Better and faster means to develop diagnostic tests and track microbial pathogens in animal hosts and the 
environment, better vaccines and therapeutics and novel disease control strategies based on a new 
understanding of the molecular mechanism of disease.  
 
Research Component 3:  Animal Immunology 
 
Goals 
Understanding the early development of the immune system in each of our food animals will enable scientists 
to apply new approaches to vaccine delivery and to use novel bio-therapeutics for disease treatments. Adapting 
existing knowledge of rodent and human immunology to domestic animals will speed up the process and cost 
effectiveness of research. Fundamental research is urgently needed in mucosal immunology and the 
mechanisms involved in innate and acquired immunity in order to have a solid foundation to improved 
methods of targeting host/pathogen interactions. Understanding how a host responds to invasion by a pathogen 
will lead to development of a whole new series of methods to prevent primary infection and abrogate the 
development of disease.  
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Outcomes 
• New vaccines, better vaccine delivery, new therapeutic interventions and immunomodulators to control 
or prevent disease.  
• New tools to quantitate a broader range of host immune responses for a better understanding of immune 
function and how to maximize new approaches to vaccine delivery. 
• New methods of disease prevention and control.  
• Novel vaccines and therapeutics, improved food safety, decreased antimicrobial and pesticide 
dependence.  
• Better immuno-diagnostics and improved nutrition to promote disease resistance. 
 
Impact 
New knowledge in animal immunology will enable more rapid progress toward understanding the function of 
immunity in host/pathogen interactions. 
 
Research Component 4:  Mechanisms of Disease 
 
Goals 
Understand how pathogens function at a molecular level, how they invade tissue surfaces, how they evade host 
immune responses and how they interact with higher organisms at a molecular level to cause disease and 
associated lesions.    
Determine which genes encode virulence factors for important pathogens. Identify management practices that 
can exacerbate virulence mechanisms, e.g., antibiotic usage or specific dietary components. Alter host and 
pathogen genes to cause and evaluate predicted changes in pathogen virulence as well as latency to prove the 
relevance of the postulated interactions.  
Define how nutrition and basic physiology and metabolism interface with both infectious and noninfectious 
disease. Define the toxic products of plants and determine how they cause disease in livestock.  
Define which pathogens, and specifically which isolate and which genes in the pathogen, are primary factors in 
disease pathogenesis. In mixed infections determine how each pathogen influences disease pathogenesis. 
Define strategies to ameliorate the results of complex pathogen interactions. Understand the complexities of 
the real world interactions of pathogens with each other and with hosts.  
Outcomes 
• New understanding of complex host/pathogen interactions will lead directly to novel preventative and 
therapeutic interventions.  
• New diagnostic tools and potential intervention strategies that can be tested empirically.  
• New strategies for inhibiting pathogen interactions with hosts.  
• Generation of effective and safe new drugs, vaccines, and perhaps other products that allow industry to 
package modern technology into simple solutions for formerly intractable problems. 
                                                                                      13 
 
Impact 
Understanding mechanisms of disease will enable more rapid progress toward understanding virulence and 
host immunity that influence host/pathogen interactions.  
New knowledge in this area will enable more rapid progress toward understanding virulence of pathogens and 
complex interactions between toxins, physiologic and nutritional interfaces with the many environmental and 
management factors that influence host/pathogen interactions and precipitate disease. 
 
Research Component 5:  Genetic Resistance to Disease 
 
Goals 
The overall goal of studies into genetic resistance to disease are to develop means by which the vast diversity 
present in the genomes of important agricultural species can be utilized in integrated systems to reduce the 
economic impact of important animal diseases. The first step in such a program will be to acquire 
comprehensive data that adequately defines the genotypic and phenotypic compositions of selected test 
populations and of lines and breeds used in production systems. Present limitations include inadequate markers 
for desirable traits, inexact means to precisely measure desirable traits and inadequate tools to delineate 
associations between genetic structure and the desired traits. As markers for desirable traits and accurate means 
to measure the traits are perfected it will then become possible to identify genes or genomic regions within 
genes that are associated with resistance to important diseases of agricultural and public health interest. In 
addition to collection of genomic data and definition of important phenotypes, it will be necessary to develop 
adequate bioinformatics systems to facilitate analyses of the vast number of observations expected when 
measuring complex biologic traits such as disease resistance. As genomic regions are identified as being linked 
to desirable traits, research efforts will focus on the validation in production animals raised in standard 
production.  
 
Outcomes 
• Identification of genes important in disease resistance.  
• Mapping of loci that encode genes important to disease resistance/susceptibility.  
• Use of naturally disease and stress resistant animals in production systems.  
• Lowered use of antibiotics and vaccines. 
 
Impact 
Efficient and profitable animal production systems in which animal well-being is maximized and in which 
disease is controlled through genetic selection of animals most suited to production schemes.  
 
Research Component 6:  Epidemiology of Disease 
 
Goals 
Incorporate hypothesis-driven epidemiologic analysis into selected current and future ARS research programs.  
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Outcome 
• Develop an understanding of animal disease incidence and prevalence in livestock and poultry 
populations.  
• Develop understanding of disease life cycles in nature as a means to interrupt disease transmission 
between livestock and wildlife animals.  
• Devise better disease intervention strategies based on epidemiologic observations.  
• Identify most effective disease management interventions through comparative on-farm studies.  
• Reduce or eradicate key diseases in wildlife that impact livestock production.  
• Reduce the incidence of disease in animal production units through use of better management practices, 
genetics, immune modulation and vaccines.  
 
Impact 
More cost-effective livestock production through promotion of animal health and well-being and protection of 
human health from zoonotic diseases. 
 
Research Component 7:  Strategies to Control Infectious and Non-Infectious Diseases 
 
Goals 
Develop integrated farm management systems that advance animal health and promote economic viability of 
rural America.  
Maximize the return on limited USDA research resources by developing a prioritized list of livestock and 
poultry diseases which need the most urgent research and whose control will have the greatest impact on 
reducing total disease incidence and will provide the maximum economic return.  
Identify the needs and the gaps in our basic and applied knowledge concerning control of the highest priority 
diseases of livestock and poultry.  
Develop and integrate basic research information into applied solutions that can be used by farmers and 
ranchers to control animal diseases in the field. This will include transfer of technology to commercial 
manufacturers, government agencies and university partners.  
Develop comprehensive control strategies that will reduce the incidence and economic losses from endemic, 
emerging and re-emerging diseases. Eradication strategies will be developed to eliminate some diseases from 
individual farms, states, regions or the entire country.  
Develop strategies to prevent introduction of exotic or foreign animal diseases such as foot-and-mouth disease, 
classical swine fever and highly pathogenic avian influenza, and develop eradication strategies for rapid 
elimination of such diseases should they be introduced.  
Outcomes 
• Development of integrated animal health strategies for the application of new and improved disease 
control and prevention methods.  
• Development of vaccines for diseases that currently have no vaccine.  
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• Development of more effective (greater efficacy, easier application, and reduced cost) and safer 
vaccines to replace existing inadequate products.  
• Development of improved pharmaceutical products such as antibiotics, antiviral drugs, antifungal 
compounds, anthelmintics and compounds that kill ectoparasites.  
• Development of compounds that reduce or prevent toxic effects of poison plants and other toxins. 
• Eradication of some animal diseases in US.  
• Healthier and more productive animal agricultural industry.  
• Reduced public health risk from food-borne illness. 
 
Impact 
Implementation of control strategies promotes both animal and human health and well-being. Development 
and maintenance of healthy livestock and poultry populations will provide a low-cost, high quality protein 
source that promotes health and nutrition to all U.S. citizens, including those of low income and from 
economically-disadvantaged backgrounds.  
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PROGRAM IMPACT 
 
 
Introduction 
Pathogen Detection and Diagnostics 
Microbial Genomics 
Animal Immunology 
Mechanisms of Disease 
Genetic Resistance to Disease 
Epidemiology of Disease 
Strategies to Control Infectious and Non-Infectious Diseases 
 
Introduction 
 
The basis for determining whether the Animal Health National Program has been successful is to look at its 
impact.  For the purpose this assessment, impact is defined as research that has or will significantly influence 
the field of science, animal health, American agriculture, and the U.S. economy.  Since this is a qualitative 
assessment that is subject to bias it is critical that a large number of our customers, stakeholders, and partners 
be given the opportunity to independently review and assess the impact of the program.  Accordingly, a survey 
will accompany this report and will be distributed electronically to reach as many customers, stakeholders, and 
partners as possible.   
 
The following summarizes the impact of the research conducted during the 2000-2004 Animal Health National 
Program Cycle.  The information to assess the impact of the Animal Health National Program is provided in 
the appendix of this report.  The appendix identifies the 18 research management units and 60 current research 
information system (CRIS) projects that comprise the Animal Health National Program.  The goals, 
accomplishments, impact, technology transfers, and publications are provided for each of the 60 CRIS projects.   
 
Pathogen Detection and Diagnostics 
 
Anaplasmosis 
Anaplasmosis causes disease in cattle on all six continents, being present in South Africa, Australia, Asia, the 
former USSR, South America, and the United States.  Anaplasmosis causes anemia, weight loss, unthriftiness, 
abortion, and death in affected cattle.  Cattle may not exhibit symptoms until they are stressed, such as when 
calving or when moved to a feedlot.  The competitive inhibition Enzyme Linked Immonosorbent Assay 
(ELISA) test developed by ARS scientists in Pullman, Washington, can be used to detect silent carriers of the 
bloodborne parasite.  This test will allow us to test and ship cattle to Canada and other countries that do not 
have Anaplasmosis. 
 
Avian Influenza (AI) 
A need exists for a rapid and sensitive diagnostic test for the direct detection of both low pathogenic and highly 
pathogenic avian influenza to support control and eradication strategies during an outbreak in poultry.  In 
collaboration with the National Veterinary Services Laboratory (NVSL), Animal and Plant Health Inspection 
Service (APHIS), a real time (RT)-PCR test was developed by ARS scientists at the Southeast Poultry 
Research Laboratory in Athens, GA, which was validated for the detection of any influenza virus and the 
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subsequent sub-typing of the virus.  The test was validated and adopted for clinical use by APHIS and three 
State veterinary laboratories (Virginia, Pennsylvania, and North Carolina).  This diagnostic test has already 
been used to help control the recent H7N2 influenza outbreak in Virginia and will enhance our nation’s ability 
to rapidly control avian influenza in the event of future outbreaks.  
 
Classical Swine Fever Virus (CSFV) 
Rapid identification and diagnosis of a foreign animal disease is critical for successfully controlling and 
eradicating the disease following introduction.  Rapid field-based assays to detect CSFV are not yet available.  
A rapid real-time fluorogenic hydrolysis probe TaqMan assay was developed by ARS scientists at the Plum 
Island Animal Disease Center, New York, and evaluated in pigs experimentally infected with a moderately 
virulent CSF isolate, Haiti-96.  The assay was highly sensitive and specific, detecting infected animals up to 5 
days prior to the appearance of CSF clinical symptoms.  This rapid, real-time RT-PCR assay for CSFV 
provides a new diagnostic tool that will redefine disease management and control strategies for this highly 
significant disease.  
 
Chronic Wasting Disease (CWD) 
Accurate diagnosis of chronic wasting disease is extremely important for control and eradication. ARS 
scientists at the Animal Disease Research Unit in Pullman, WA in collaboration with Colorado State 
University and the Colorado Division of Wildlife, established that the tonsils of deer are a reliable early 
indicator of infection and established a valid method for detecting this marker in live deer.  This test is suitable 
for use in surveillance of deer in highly populated areas, where hunting is not allowed but artificial feeding 
may increase disease prevalence. In addition, scientists have established that the dorsal motor nucleus of the 
vagus nerve is the earliest site of PrP-CWD accumulation in mule deer.  This work identifies the tissue to be 
selected for diagnostic testing in hunter harvest surveys. 
 
Johne’s Disease 
Johne’s disease is a chronic, progressive enteric disease of ruminants caused by Mycobacterium 
paratuberculosis.  Improved diagnostic tools for detection of the disease are urgently needed for early 
detection of subclinically infected animals and reduction of environmental contamination.  Scientists at the 
National Animal Disease Center (NADC), Ames, Iowa, optimized a simple polymerase chain reaction (PCR) 
assay using DNA in blood and fecal samples for detection of M. paratuberculosis.  The new DNA sequence of 
M. paratuberculosis has been transferred to a commercial company for development of the assay.  This assay 
will allow early detection of subclinically infected livestock. 
 
Listeria monocytogenes 
Research was conducted by ARS scientists at the Animal Disease Research Unit in Pullman, WA to design an 
assay that allowed a large number of L. monocytogenes strains to be serotyped rapidly and inexpensively. As 
part of a collaborative project between USDA-ARS, Albany, CA and USDA-ARS-ADRU, Pullman, WA, the 
conventional slide agglutination serotyping assay was converted to an ELISA format. ELISA serotyping of 89 
of 101 L. monocytogenes isolates agreed with slide agglutination serotyping data, and 100 previously 
uncharacterized isolates were serotyped unambiguously using the ELISA method. This ELISA assay greatly 
reduces the time and expense of serotyping L. monocytogenes strains and this will facilitate serotype 
determination by research and public health labs. 
 
Poult Enteritis Mortality Syndrome (PEMS) 
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ARS scientists at the Southeast Poultry Research Laboratory (SEPRL), Athens, GA, identified a novel strain of 
astrovirus isolated from the thymus of turkeys with poult enteritis and mortality syndrome (PEMS) and 
sequenced the entire genome of the nonhuman strain of astrovirus.  ARS researchers then verified that this 
purified astrovirus caused PEMS-like disease in naive turkey poults as characterized by growth depression, 
mortality, enteritis, and immunosuppression.  A new diagnostic test (RT-PCR) was developed to identify 
conserved and divergent regions of the astrovirus genome and this test kit was used to detect astrovirus in 
commercial turkey flocks.  These studies indicate an important role of the new astrovirus in PEMS-associated 
pathology in turkeys.  The RT-PCR test was transferred to scientists at Virginia Polytechnical Institute and 
Texas Veterinary Medical Diagnostic Laboratory and is currently being used to detect astrovirus in commercial 
flocks.  By providing new ways to understand the pathogenesis of astrovirus infection (and PEMS infection) 
the test will ultimately increase basic knowledge on the interactions between the turkey immune system and 
virus infections and enable development of a vaccine against turkey PEMS.  A rapid and sensitive real-time 
reverse transcriptase polymerase chain reaction test (RRT-PCR) was subsequently developed to detect turkey 
astrovirus type-2, one of the major viruses involved in production of PEMS in turkeys.  Real-time RT-PCR is a 
relatively new technology, which offers substantial advantages over the older standard RT-PCR technology, 
including improved accuracy, speed and sensitivity. 
 
Toxoplasmosis 
Toxoplasmosis is the leading cause of blindness in underdeveloped countries.  It is also one of the most 
common causes of parasitic diseases in humans and animals.  Pig products are a major source of Toxoplasma 
gondii infection in the U.S.  ARS scientists at Animal Parasite Diseaase Laboratory in Beltsville, Maryland, 
with funding from the National Pork Producers Council, have developed a sensitive DNA test for the parasite 
in pig or other animal tissues.  The test is very sensitive and specific and will be an important tool for 
protecting America’s food supply and for epidemiological investigations to decrease the numbers of pigs 
infected with this parasite. 
 
Trichinellosis 
The parasitic worm Trichinella spiralis contributes to sporadic outbreaks of trichinellosis of humans.  
Scientists at the Animal Parasite Dsease Laboratory, Beltsville, Maryland, developed a new multiplex PCR test 
to detect all of the different species of Trichinella at the level of a single worm.  This new technique has been 
transferred to the International Trichinella Reference Center and the Danish Center of Experimental 
Parasitology.  Being able to identify Trichinella species will lead to better control strategies for trichinellosis. 
 
Tuberculosis 
In the last seven years, Mycobacterium bovis has been isolated from free ranging white-tailed deer in 12 
counties in the northern part of the lower peninsula of Michigan.  About 5 percent of wild deer, in an area 
identified as the TB core area, have TB.  Tuberculosis has also been found in coyotes, raccoons, a fox, bear, 
feral cat, elk and bobcat and in 16 beef cattle and two dairy cattle herds in northern Michigan.  This is the first 
reservoir of TB in wildlife identified within the United States and presents significant obstacles to the 
eradication effort.  ARS scientists at the Bacterial Diseases of Livestock Research Unit at the National Animal 
Disease Center (NADC), Ames, Iowa, have responded to the challenge by developing an indirect blood test 
that measures nitric oxide induced in mammals in response to Mycobacterium bovis infections.  The test can 
detect human, avium, and bovine TB.  The advantage of this test is that it can be used in most mammals and 
only requires one blood sample, and thus the handling of animals once, as opposed to the official standard skin 
test that requires animals to be handled twice.   
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Microbial Genomics 
 
Avian Influenza (AI) 
ARS scientists at the Southeast Poultry Research Labotaory, Athens, Georgia, have sequenced numerous 
strains of avian influenza from around the world.  They have elucidated the nature and rates of genetic 
variation of avian influenza viruses in various hosts.  We know that the avian influenza viruses are undergoing 
rapid and continuous mutation events as a natural consequence of adaptation to poultry populations.  This rate 
is slower in the natural hosts, wild waterfowl, but even in these hosts evolution continues to generate novel 
strains.  This information has been useful to basic influenza scientists and has contributed to our fundamental 
understanding of influenza.  In addition, ARS scientists have been able to decode what genetic and 
biochemical changes occur to make the influenza virus turn into a highly virulent virus. 
 
Bovine Viral Diarrhea Virus (BVDV) 
There is a wide spectrum of clinical disease that occurs following BVDV (Bovine Virus Diarrhea Virus) 
infections.  The severity of disease depends on the immune and reproductive status of the animal, the presence 
of other pathogens and the strain of BVDV that the animal was exposed to.  In the past ARS scientists have 
identified high and low virulence BVDV.  In the last cycle, scientists at the USDA-ARS-National Animal 
Disease Center (NADC), Ames, IA, in collaboration with scientists at the Hannover School of Veterinary 
Medicine, characterized differences in pathology in vivo, host cell interaction in vitro, and associated genetic 
differences.  They will continue to build on this research as they work to identify the factors that control 
virulence.  They expect that this research will lead to better means of intervention to limit the effects of viral 
infection.  This research has yielded the first published pathogenic studies of high and low virulence BVDV 
and generated tag sequence libraries for sequential analysis of gene expression (SAGE libraries) in infected 
cells in vitro.  This information will be used to study the interaction of high and low virulence viruses with host 
cells. 
 
Brucellosis 
Brucellosis remains a critical zoonotic pathogen with impact on the reproductive health of cattle, swine, sheep, 
and goats, and effects on human health.  ARS scientists were critical partners this year in supporting a multi-
center effort for sequencing the genome of Brucella suis, the cause of swine brucellosis.  Completing the 
sequencing of Brucella suis is a major accomplishment that will lead to comparative genomics studies that 
could provide precise targets for developing vaccines against Brucella strains that are currently affecting 
livestock and wildlife reservoir hosts in the United States. 
 
Johne’s Disease 
ARS scientists at our Bacterial Diseases of Livestock Research Unit at NADC, Ames, Iowa, in collaboration 
with the University of Minnesota completed the sequencing of the entire genome of Mycobacterium avium spp. 
paratuberculosis (M. paratuberculosis), the pathogen responsible for Johne’s Disease.  This bacterium is 
related to the tubercle bacillus and causes a chronic wasting and debilitating enteritis and eventual death in 
cattle, sheep, goats, llamas, deer, and other wild or domestic ruminants.  Public health officials are also 
concerned about recently published medical reports suggesting a link between M. paratuberculosis and Crohn's 
disease, a chronic inflammatory bowel disease in humans.  ARS scientist have identified 19 unique sequences 
that will be the basis for functional genomics studies that may eventually lead to the development of new 
effective diagnostics and preventive and therapeutics tools for the control and eradication of this disease in the 
                                                                                      20 
 
United States.   Seven regions of the DNA of M. paratuberculosis that stimulate protective responses and one 
that exacerbates infection have been identified to date.  Sequencing was completed on two of the protective 
regions and a microarray system of gene pooling is being tested.  Genes from these regions may be useful in 
development of a DNA vaccine for M. paratuberculosis infection. 
 
Leptospirosis 
Little is known about the genetic organization or content of Leptospira borgpetersenii serovar hardjo, the 
major cause of bovine leptospirosis worldwide and an important zoonotic disease.  The genome of this 
bacterium is being sequenced at our Bacterial Diseases of Livestock Research Unit at NADC, Ames, Iowa, to 
identify genes associated with virulence and potential vaccine candidates.  In 2002, a genomic library was 
successfully constructed and our scientists completed the shotgun phase of sequencing, resulting in the 
determination of about 95% of the total sequence.  These data resulted in the identification of several outer 
membrane protein genes and genes associated with virulence factors and will have an impact on future vaccine 
development initiatives. 
 
Marek’s Disease 
ARS scientists at the Avian Diseases and Oncology Laboratory (ADOL), East Lansing, Michigan, sequenced 
175,000 bases of DNA of the GA strain of Marek’s disease virus (MDV), a serotype 1 MDV, thus providing a 
crucial roadmap for understanding viral gene function as an first important step toward better diagnosis of 
MDV in commercial meat-type chickens.  Molecular DNA sequencing of the serotype 1 MDV was transferred 
to academia and the poultry industry to help the global effort to elucidate the function of various viral genes 
and the epidemiology of MDV infection.  Completion of the entire DNA sequence of the GA strain of MDV 
will advance the development of novel molecular vaccines for MDV.  Furthermore, the DNA sequence 
information of MDV will enhance understanding of the immunology of MDV infection, and that may prove 
useful in controlling other types of viruses important to the U.S. poultry industry. 
 
Pox viruses 
ARS scientists at our Plum Island Animal Disease Research Center, New York, have sequenced pox virus 
genes from many different species of animals.  The genes of lumpy skin disease, camel pox, avian pox, sheep 
pox, goat pox and others have been fully sequenced, analyzed and compared.  By comparing the genes of many 
different pox viruses, it has been possible to determine which genes are tightly conserved across the pox virus 
family.  This will enable scientists to learn more about how pox viruses invade the host and cause disease and 
to develop successful intervention strategies for the future. 
 
Animal Immunology 
 
Immunological Reagents 
The accurate assessment of the host immune response to poultry infectious agents such as bacteria, viruses, and 
parasites is critical for monitoring the health of the flocks. ARS scientists at the Animal Parasite Disease 
Laboratory, Beltsville, Maryland, produced several monoclonal antibodies to study host immune responses in 
chickens and have transferred them to diagnostic firms for further development.  Several of these monoclonal 
antibodies can now be used to assess the immune status of chickens vaccinated with different infectious 
agents.  The results to date indicate that these monoclonal antibodies are useful in the identification of 
lymphocyte subpopulations and macrophages in the tissues and the peripheral blood from chickens infected 
with microbial agents or vaccinated with the viral vaccines. 
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Scientists at the Animal Parasitic Diseases Laboratory developed a comprehensive panel of "designer" immune 
reagents to assess swine immune responses for use in analyses of disease and vaccine studies and neonatal pig 
development. These include sensitive gene expression tests for >300 swine immune genes, mAb markers for 
swine cell subsets and immune cytokines, and biotherapeutics. Products from this research will enhance an 
expanding base of scientific knowledge on mucosal and neonatal immunology of swine, techniques and 
reagents for veterinary application, practical outcomes for control of zoonotic pathogens and characterization 
of products with commercial applications. 
 
Coccidiosis 
Avian coccidiosis, an intestinal disease caused by intracellular parasites, is estimated to cost the U.S. poultry 
industry over $600 million annually.  Due to the increasing incidence of drug-resistant parasites, drug-
independent control strategies are warranted.  Scientists at the Animal Parasite Diseases Laboratory, Beltsville, 
Maryland, identified and genetically engineered a recombinant chicken cytokine molecule called interferon 
gamma (IFN-γ), which is secreted by T-lymphocytes, and demonstrated its protective effects against coccidian 
parasites.  A U.S. patent issued to the USDA covering several IFN-γ monoclonal antibodies and a sensitive 
immunoassay to detect chicken IFN-γ is being licensed to a commercial company for worldwide distribution.  
These antibodies and the assay will allow the assessment of poultry cell-mediated immune responses to 
vaccines and diseases, facilitating the development of a new generation of immunological control strategies 
against avian coccidiosis. 
 
Immune Modulators 
Novel vaccination strategies using antigen-encoding DNA plasmids have recently been shown to successfully 
induce protective cellular and humoral immune responses against a variety of infectious diseases. Scientists at 
our Animal Parasite Disease Laboratory in Beltsville, MD, have documented for the first time in chickens that 
immune responses induced by DNA vaccination can be enhanced by co-injecting recombinant cytokines or 
plasmids encoding these cytokines. Administration of recombinant IFN-γ gene decreased coccidia oocyst 
production, enhanced body weight gain, and improved disease resistance following coccidia challenge 
infection. The results of this study clearly document that chicken cytokines can be powerful adjuvants 
providing additional impetus to further investigate their biological activities at the molecular and 
immunological levels. 
 
Mastitis 
Three hundred thousand dairy cows suffer acute endotoxin shock and death annually due to mastitis caused by 
Escherichia coli, which occurs primarily during the early periparturient period.  Scientists at our Bovine 
Functional Genomics Laboratory in Beltsville, Maryland, have identified and characterized the gene for 
soluble CD14, which binds and neutralizes endotoxins responsible for mastitis.  The gene was cloned and 
recombinant bovine (rbo)-CD14 protein was successfully produced and evaluated.  Intraperitoneal injection of 
rboCD14 together with endotoxin reduced fatality in mice.  Preliminary studies indicate that intramammary 
injection of soluble rboCD14 is 100% effective in preventing mastitis by E. coli in lactating dairy cows.  This 
research will potentially lead to a product that for the first time can be used effective to treat and prevent 
mastitis caused by E. coli. 
 
Mechanisms of Disease 
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Marek’s Disease Virus (MDV) 
Marek's disease is a lymphocyte proliferation (a type of cancer) and immune suppressive disease of chickens 
caused by a herpesvirus.  Infections with this virus are nearly universal among commercial chicken flocks 
worldwide.  The virus is relatively stable in the environment and is easily spread through the air.  Despite 
widespread use of vaccines, economic losses from mortality of layers and breeders and condemnation of 
broilers continue to plague producers.  Losses tend to be sporadic and unpredictable.  Moreover, the virus 
continues to mutate to greater virulence, potentially reducing the effectiveness of many existing vaccines and 
causing concerns that vaccines currently considered effective will not protect in the future.  Scientists at our 
Avian Disease and Oncology Laboratory (ADOL) in East Lansing, Michigan, have been conducting functional 
genomics studies of selected Marek's disease viral genes to better understand the mechanism by which the 
virus causes changes in infected chickens.  Several virus preparations with specific deletions or changes in 
selected genes were developed and the effects compared to unaltered virus.  Results to date indicate that the 
132 base pair nucleic acid repeats are nonessential for MDV replication in cell culture and chickens and viruses 
lacking these repeat sequences are still pathogenic.  Furthermore, the putative MDV oncogene called “meq’ 
could be deleted but was found to be essential for the transformation of lymphocytes in infected chickens.  It 
was also found that the pp38 gene in the vaccine virus, Rispens, functions identically to the pp38 gene in the 
very virulent Md5 virus.  Together, these studies are enhancing our knowledge of the mechanisms of virus 
replication and virulence, which is essential for developing a new class of vaccines against this very important 
disease. 
 
Pine Needle Abortion 
Grazing needles of ponderosa pine, lodgepole pine, common juniper or Monterey Cypress by pregnant cattle 
results in abortion/premature parturition, retained placentas and endometritis.  Substantial economic losses to 
cattle producers in the western U.S. and Canada occur annually from ponderosa pine needle-induced abortion. 
A significant accomplishment by ARS scientists has been the isolation and identification of isocupressic acid 
(ICA) as the abortifacient toxin in pine needles.  Furthermore, two ICA derivatives, succinyl and acety ICA 
were also identified in pine needles and were active abortifacient toxins. ELISA’s were developed for ICA and 
it’s sera metabolites using polyclonal antibodies. Using this assay, the absorption into the serum and 
elimination into the urine of three ICA metabolites was measured in a cow dosed orally with common juniper. 
Other accomplishments include screening twenty-three tree and shrub species from throughout the western and 
southern states for abortifacient levels of ICA.  Seasonal changes in ICA levels were monitored in ponderosa 
pine populations in 5 locations. Field and pen studies determined that nutrient status influenced cows to graze 
pine needles.  Similarly, weather patterns had significant impacts on cow’s propensity to graze pine needles.  
This better understanding of what toxins are involved, what species of plant is involved and when the toxin is 
produced will give ranchers better ability to control the poisoning.  
 
Porcine Reproductive and Respiratory Syndrome (PRRS) 
PRRS is a highly infectious disease caused by an RNA virus.  Infections in the United States account for up to 
15-20% of the yearly economic losses in the swine industry.  The vaccines currently on the market have been 
reported to be relatively ineffective.  It is important to understand the reasons for these vaccine failures and the 
impact on the incidence of disease so that better control strategies can be developed.  Scientists at our U.S. 
Meat Animal Research Center (MARC) in Clay Center, Nebraska, have obtained 18 different PRRS virus 
isolates from disease outbreaks in the Midwest and sequenced the NSP2 genes of these viruses to examine 
variations that may correlate with disease expression.  Recombinant antigens have been developed and 
immunity to individual PRRS virus proteins evaluated in sera from naturally infected swine from around the 
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country.  The research team at MARC has conducted kinetic analysis studies of host-cell gene expression in 
response to PRRS virus infection using cDNA microarrays.  Studies to date indicate that there are a number of 
responsive genes that increase in expression while others decrease in expression as a result of PRRS virus 
infection.  In combination with the sequence analysis of a number of PRRS virus isolates, this research project 
will lead to an understanding of the host-virus interactions in the field and identification of viral genes 
responsible for induction of a protective immune response.  
 
Genetic Resistance to Disease 
 
Avian Leukosis Virus (ALV) 
Avian Leukosis is a serious threat to the poultry industry since it induces tumors, decreases egg production, 
and increases mortality in infected chickens. Scientists at the USDA-ARS Avian Disease and Oncology 
Laboratory, East Lansing, MI, developed a DNA-based test for the ALV receptor gene known as TVB. This 
genetic test can distinguish if a chicken carries TVB alleles that confer resistant to ALV subgroups B or E, 
which are some of the most prevalent ALV types in the field. This procedure allows poultry breeders to 
accurately select for chickens for resistance to specific ALVs, which would enhance 
 
Genetic Diversity Panel 
Scientists at our U.S. Meat Animal Research Center (MARC) in Clay Center, Nebraska, have now 
characterized over 180 single nucleotide polymorphisms (SNPs) in more than 50 bovine genes.  These have 
been used to estimate the genetic diversity in beef cattle with automated SNP assays developed for high-
throughput MALDI-TOF MS genotyping.  This is significant because DNA sequence variation provides the 
fundamental material for improving livestock through selection.  Our results indicated that once the halotypes 
for a given gene locus are sufficiently characterized it is possible to correctly assign halotypes to the vast 
majority of the genotypes in commercial populations of cattle.  This allows the evaluation of these alleles as 
risk factors for infection phenotypes in commercial populations of cattle. 
 
Marek’s Disease Virus (MDV) 
With Marek’s disease costing the poultry industry over $160 million a year, developing methods that augment 
current vaccinal control methods is a high priority.  ARS, in collaboration with the University of Delaware, 
screened chickens that were disease resistant and susceptible by the new technology of DNA microarrays, 
which measures expression levels of many genes.  Genetic mapping of the differentially expressed genes 
revealed many positional candidate genes for resistance to Marek’s disease.  This approach of integrating 
global expression studies with mapping shows great promise to rapidly identify disease resistance genes, which 
can be quickly transferred to the poultry industry to enhance disease resistance. 
 
Scrapie 
Scrapie is a member of a group of diseases caused by prions that are called Transmissible Spongiform 
Encephalopathies (TSEs), which includes bovine spongiform encephalopathy (BSE).    Scrapie is efficiently 
transmitted during lambing but other modes of transmission are poorly understood.  Scientists at our Virus and 
Prion Diseases of Livestock Research Unit at NADC, Ames, Iowa, and our Animal Research Unit in Pullman, 
Washington, initiated transmission studies by describing the distribution and biochemical characteristics of the 
prion precursor in placenta and fetal tissues and fluids.  It was discovered that if the fetus is genetically 
resistant to disease, the fetal placental cells do not support prion accumulation and it is therefore probable that 
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transmission by the infected ewe does not occur.  These findings will directly impact control and eradication 
procedures for sheep scrapie in the U.S. 
 
 
Epidemiology of Disease 
 
Avian Influenza (AI) 
Avian influenza, H7N2, has been circulating in the live bird markets (LBMs) of the Northeast since 1994.  This 
virus has the potential for becoming highly pathogenic.  ARS scientists at the Southeast Poultry Research 
Laboratory in Athens, Georgia, in collaboration with the National Veterinary Services Laboratory (NVSL), 
Animal Plant Health Inspection Service (APHIS), and state officials from New York, New Jersey, and 
Pennsylvania, have conducted molecular epidemiology studies of viruses coming from the LBMs and have 
developed a Real Time (RT)-PCR test to rapidly detect birds infected with the influenza virus.  The molecular 
epidemiology studies showed that a single family of viruses has remained in the markets for the last seven 
years.  The RT-PCR test was compared with virus isolations for specificity and sensitivity as part of a 
validation study for deploying this diagnostic test.  The molecular epidemiology data have increased our 
understanding of this virus and the RT-PCR test when validated will support multi-State influenza eradication 
efforts in the LBM system. 
 
Avian Pneumovirus (APV) 
APV, now classified as an avian metapneumovirus, was isolated from commercial turkeys in Colorado in 
1996. The disease was reported in the United Kingdom in 1985 and prior to 1996 the disease was exotic to 
North America. The virus causes a mild, but rapidly spreading, upper respiratory disease and adverse effect on 
weight gain and feed conversion. Last year, APV antibody was demonstrated in wild birds in the Southeast 
U.S. and suggests wild birds could be a source of APV virus transmission to turkeys. Southeast Poultry 
Research Laboratory scientists in Athens, GA collected swabs from the species of wild birds previously found 
to have APV antibodies.  APV was identified from 12 of the sampled wild birds and it was determined through 
sequence analysis of the glycoprotein, matrix and fusion genes that the wild bird viruses are closely related to 
viruses found in domestic poultry. The presence of virus in wild birds and the relatedness to viruses found in 
domestic poultry indicate the potential for wild birds to spread APV infections in areas of the United States 
where the virus is currently not found in poultry. 
 
Brucellosis 
The ability to epidemiologically trace the origin of brucellosis infections is of great importance for regulatory 
personnel.  At the USDA-ARS-National Animal Disease Center (NADC), Ames, IA, the B. abortus genome 
sequencing project was used to identify variable regions in the genome in an effort to differentiate B. abortus 
strains. An assay was developed that allows strains from single origins to be differentiated from other strains 
such that epidemiologic tracebacks to identify the source of brucellosis infections may now be possible.  This 
assay will be valuable in determining the source of a brucellosis infection in a cattle herd (i.e. wildlife or other 
cattle) and help in determining if a brucellosis outbreak is from single or multiple sources. 
 
Chronic Wasting Disease (CWD) 
CWD is another member of a group of diseases called TSEs, which includes BSE and Scrapie.  CWD is 
associated with serious losses to the captive elk industry and the wildlife management industries through loss 
of hunting revenues.  The only choice currently available to animal health officials for controlling this disease 
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is extensive depopulation of captive and free ranging animals exposed to the disease.  Moreover, the 
interspecies transmission barriers of these diseases are not understood. CWD is reported in several areas of the 
U.S. but the true extent of the epidemic is not known because of the considerable cost of diagnostic testing. 
Using samples submitted by cooperating state wildlife management agencies, ARS scientists at the Animal 
Research Unit in Pullman, Washington, developed an inexpensive high throughput diagnostic test for early 
detection of infection in hunter-killed deer.  The test has been transferred to private industry and is being 
evaluated for licensing by the USDA Center for Veterinary Biologics.  The impact of this work will be to 
facilitate increased surveillance within and outside the endemic areas. 
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Malignant Catarrhal Fever (MCF) 
The epidemiology of sheep-associated Malignant catarrhal fever has long remained an area of great 
uncertainty. Scientists at the Animal Disease Research Unit in Pullman, WA, Collaborating with Washington 
State University and the ARS-US Sheep Experiment Station developed a refined picture of the viral shedding 
patterns in both adolescent and adult sheep.  The data indicate that nasal shedding is the major mode of sheep-
associated MCF virus transmission among domestic sheep and that the adolescents are by far the heaviest 
shedders of virus for other species.  The kinetics of the shedding patterns documented in adolescent sheep 
appear to be a unique biological phenomenon without precedent and definition of the virus-host mechanisms 
underlying this behavior should lead to new knowledge of the potential ways viruses can interact with hosts. 
 
Neosporosis 
Neospora caninum has been identified as a major cause of abortion and neonatal mortality in cattle worldwide.  
Losses in California dairies due to neosporosis-associated abortions are estimated to be $35 million annually.  
Epidemiological investigations indicate that up to 45 percent of abortions in dairy cows are caused by N. 
caninum.  ARS scientists discovered that the dog was the definitive host and the source of new infections.  
ARS investigated the prevalence of N. caninum antibodies in dogs and established that levels were 
significantly higher in dogs from beef and dairy cattle farms than dogs from urban areas.  However, recent 
reports suggest that congenital infection from reactivation of the parasite is the main mode of transmission and 
cause of abortions.  Considerable work remains to understand the biology and epidemiology of N. caninum, 
including the survival of oocysts in the environment and elucidating the life-cycle in dogs.  ARS will continue 
to conduct studies that will provide information to help dairy farmers develop biosecurity measures to control 
abortions due to Neosporosis. 
 
 
Tuberculosis 
Bovine tuberculosis is considered a public health threat because humans can become infected with the 
infectious agent, Mycobacterium bovis, through contact with infected animals or contaminated foods.  ARS 
scientists at the National Annimal Disease Center (NADC), Ames, Iowa, demonstrated that white-tailed deer 
populations living in northeastern Michigan were the source of tuberculosis infection of livestock.  These 
results will facilitate development of new eradication control strategies to block the transmission of M. bovis 
from wildlife to domestic livestock and thereby reduce the possibility of human disease. 
 
Vesicular Stomatitis Virus 
Vesicular stomatitis virus (VSV) from an unknown source caused great economic losses to the cattle and horse 
industries in the southwestern United States in 1995, 1997, and 1998.  Using genomic sequencing and analysis, 
ARS scientists at Plum Island, New York, demonstrated that the outbreaks resulted from VSV most similar to 
those circulating in Mexico.  The new molecular test for VSV field strains has been used by a USDA-APHIS-
supported diagnostic laboratory for vesicular disease studies in South American countries. 
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Strategies to Control Infectious and Non-Infectious Disease 
 
Foot-and-Mouth Disease Virus (FMD) 
Current models and simulations have predicted devastating economical and environmental consequences if 
FMDV were introduced in the United States.  Based on recent experiences with FMDV outbreaks in Europe, 
vaccination is now being considered as a first-line intervention tool in the containment of a potential outbreak 
in the U.S., rather than traditional depopulation strategies that would result in destruction of millions of 
animals.  Scientist at our FMDV Research Unit at the Plum Island Animal Disease Center, New York, have 
developed adenoviral based constructs containing the structural proteins of the FMDV capsid and the viral 
protease required to process these protein molecules into empty capsids. Laboratory tests of these viral 
vaccines have demonstrated virus neutralizing activity and protection of animals as early as five days after a 
single inoculation, lasting for at least 42 days.  The same adenoviral vectors have been engineered to contain 
antivirals such as Type I porcine interferon (Ad5-pIFNalpha) and have been shown to confer protection from 
viral challenge as early as 24 hours and for as long as four days after a single inoculation.  The combination of 
empty capsid vaccines and antivirals have been tested in swine and shown to induce complete protection from 
infection in 24 hours and for as long as 42 days upon direct challenge with FMDV. This combined therapy 
provides for the first time a true outbreak response strategy to arrest the spread of FMDV and limit animal 
exposure to this highly contagious disease.  Further work will be needed to research and develop these 
innovative control tools for other animal species, including cattle. 
 
Milk Fever 
Scientists at the Periparturient Diseases of Livestock Research Unit, National Animal Disease Center (NADC), 
Ames, Iowa, fed various sources of chloride and sulfate containing chemicals to dry non-pregnant dairy cows 
and demonstrated that chloride consistently counteracted the effects of dietary potassium by causing a decrease 
in blood acidity which contributes to hypocalcemia (milk fever).  This new information has resulted in the 
development of hydrochloric acid treatment of feeds by at least two feed companies (West Central Corp., 
Ralston, Iowa, and Nutritech, Abbottsford, British Columbia) and allowed farmers, veterinarians, and 
nutritionists to more accurately choose the most effective feeds and chloride sources for balancing transition 
dairy cow rations.  These results will also be applicable to the inability of dairy cows to respond to the high 
demand for calcium at parturition and ultimate development of peri-parturient hypocalcemia.  This research 
has provided a more detailed understanding of the pathogenesis of milk fever.  It has emphasized the 
importance of dietary methods for reversing alkalosis in order to reestablish the target tissue sensitivity to 
parathyroid hormone and to prevent clinical and sub-clinical hypocalcemia in dairy cows.  An enhanced 
understanding of the effects of dietary factors on the overall health of young and adult dairy cattle will benefit 
U.S. producers and consumers. 
 
Scientists at the Periparturient Diseases of Livestock Research Unit have also investigated the utility of 
Solanum glaucophyllum in the prevention of subclinical hypocalcemia in periparturient dairy cows.  Solanum 
glaucophyllum is a plant that contains the active form of vitamin D.  ARS scientists discovered that when used 
in combination with diets high in anions (chloride), we can significantly reduce the incidence of subclinical 
hypocalcemia in dairy cows.  Availability of this plant will offer further opportunities to dairy farmers in 
avoiding complications due to hypocalcemia such as displaced abomasum, retained placenta, and mastitis. 
 
Mycoplasma gallisepticum (MG) 
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Approximately 90% of commercial layer flocks are infected with Mycoplasma gallisepticum (MG); and to 
combat its effects, three live MG vaccines are available for use; however, MG vaccine administration has 
become a major problem from the perspective of uniformity and consistency.  Research into the development 
of a self-propelled vaccinator capable of vaccinating 75,000 chickens in 7½ minutes was conducted at the Mid-
South Area Poultry Research Unit at Mississippi State, MS and involved collaborators from the commercial 
table egg company Cal-Maine Foods, Inc., Jackson, MS.  The research has resulted in a machine which is 
capable of uniformly and consistently delivering MG vaccine to 75,000 chickens in less than 8 minutes as 
compared to 50 minutes while reducing labor by 60%.  The impact of this research is that producers using the 
available commercial vaccines in conjunction with this vaccinator can administer MG vaccines quicker and 
more consistently and uniformly to pullets. 
 
Newcastle Disease 
Newcastle disease is a foreign animal disease that has the potential to devastate the poultry industry. The 
capability to easily differentiate vaccinated from infected birds would enhance current Newcastle Disease 
control programs. At the Southeast Poultry Research Laboratory in Athens, GA, a vaccine was developed that 
is a shell of the whole virus and retains the important surface structures that induce immunity.  The virus used 
in this vaccine cannot infect or be transmitted from bird to bird because the virus genome and internal proteins 
have been removed.  This “virosome” Newcastle disease vaccine was administered intra-nasally and shown to 
protect chickens against a lethal Newcastle disease virus challenge. Because vaccinated birds can be 
differentiated from infected birds, this vaccine may provide an effective tool to control future outbreaks of 
Newcastle disease virus in the United States. 
 
Swine Influenza Virus (SIV) 
SIV is a serious respiratory disease in pigs. Inactivated and/or modified-live vaccines for respiratory pathogens 
do not stimulate protective immunity if given to piglets too early before maternally-derived antibodies have 
decayed.  To overcome this problem, scientists at USDA-ARS-National Animal Disease Center (NADC), 
Ames, IA, used a recombinant human adenovirus (rAd5) vaccine in combination with an inactivated 
commercial vaccine to stimulate protective immunity in piglets that had natural field exposure levels of 
maternally-derived antibodies.  Piglets suckling gilts that were naturally infected with H3N2 influenza virus 
were primed with the rAd5-swine influenza virus (SIV) vaccine or sham-inoculated with a non-expressing 
rAd5 vector at 7 days of age.  The sham-inoculated group and half of the rAd5-SIV vaccinated pigs were 
boosted with a commercial bivalent vaccine when 4 weeks old.  The boosted pigs that had been primed in the 
presence of maternal interfering antibody had strong anamnestic immunity.  But, like the problems 
encountered in the field, the sham-inoculated pigs did not respond to the commercial vaccine because of 
interfering maternal antibodies.  Two weeks after the commercial booster vaccination the pigs were challenged 
with a different, virulent H3N2 influenza virus.  The efficacy of the vaccination protocol was demonstrated by 
abrogation of clinical signs, by clearance of challenge virus from lung lavage fluids, by markedly reduced virus 
shedding in nasal secretions, and by the absence of moderate or severe SIV-induced lung lesions.  These rAd5-
SIV vaccines will be used for priming of the immune system to overcome the effects of maternally-derived 
antibody which interferes with conventional SIV vaccines. 
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CRIS Projects 
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• Publications 
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Greenpoint, NY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Foot and Mouth Disease Research  
Rodriguez, Luis L 
Research Leader 
(631) 323-3364 
P O BOX 848  
Orient Point NY 11944 
 
African Swine Fever Research  
Rock, Daniel L 
Research Leader 
(631) 323-3330 
PLUM ISLAND ANIMAL DISEASE CTR 
P.O. BOX 848 
Orient Point NY 11944 
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PROJECTS 
Foot and Mouth Disease Research  
• Development of Novel Strategies to Control Foot-and-Mouth Disease 
• Determination of the Molecular Basis for Re-Emergence, Pathogenesis,  
 And Host Range of FMDV 
• Pathogenesis and Genomics of Vesicular Stomatitis Viruses and Foot and 
Mouth Disease 
 
African Swine Fever Research 
• High Consequence Pathogen Detection 
• Functional Pathogen Genomics: Virulence and Host Range Genes of 
 Swine Fever Virus 
• Identification and Characterization of African Swine Fever Virus Protective Antigens 
• Detection and Diagnosis of Hog Cholera (CSF) 
• Advanced Animal Vaccines and Diagnostic Applications 
• Advanced Veterinary Vaccines and Diagnostics 
• Program for Prevention of Animal Infections and Advanced Technologies  
for Vaccines and Diagnostics 
• Development of Rapid Real Time PCR-Based Assays for Selected OIE  
Class A Diseases 
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Foot and Mouth Disease Research 
 
Project Title:   Development of Novel Strategies to Control Foot-and-Mouth    
   Disease 
CRIS Number:     1940-32000-034-00D 
Scientists:             Grubman, M.,  Golde, W., Baxt, B., and Gregg, D. 
Location:        Plum Island Animal Disease Center, Office of the Center Director, Foot and Mouth 
Disease research 
Contact:  Grubman, M., Phone: (631) 323-3329, Fax: (631) 323-3006 
mgrubman@piadc.ars.usda.gov 
 
PROJECT OBJECTIVES: 
Foot-and-mouth disease (FMD) is a highly contagious viral disease of livestock. FMD virus (FMDV), the 
causative agent, spreads quickly between animals, and herds, resulting in devastating epizootics and significant 
economic hardship. Normally controlled by slaughter and vaccination with chemically inactivated virus, 
concerns with the effectiveness of this vaccine and the fact that Federal law prohibits its production in the US 
creates a significant need for genetically engineered vaccines as potential alternatives. We are evaluating the 
basis for protective immunity and developing new vaccines that are safer and more effective than 
traditional products. To investigate non-traditional control strategies, we are obtaining detailed knowledge of 
virus-host cell interactions and the immune response to viral infection. Our approach towards these objectives 
includes examining the means by which the virus inhibits the initial host defense response and developing 
subunit vaccine candidates that do not contain infectious material but induce protective immunity. These latter 
products could be produced in the US since they do not contain infectious FMDV. In addition, we are 
developing new knowledge of the immune response to FMDV and FMD vaccines to improve this vaccine. 
 
OVERALL PROJECT ACCOMPLISHMENTS: 
Demonstrated that the FMDV L nonstructural protein is a major virulence factor in viral pathogenesis allowing 
for a better understanding of virus-host interaction.  
 
Developed novel subunit vaccine candidates including naked DNA, and replication-defective human 
adenovirus as vectors for delivery of FMDV capsid antigens. These vaccine candidates have a number of 
advantages over traditional chemically inactivated FMD vaccines including the possibility of producing them 
in the US. 
 
Demonstrated that one inoculation of a replication-defective human adenovirus containing the capsid coding 
region of  FMDV serotype A24 can completely protect swine from direct inoculation challenge as early as 7 
days and as long as 42 days. In preliminary studies in cattle, two doses of the same vaccine can induce 
complete protection from direct inoculation as well as contact challenge. 
  
Developed a model of acute infection in swine for analysis of the initiation of the innate and adaptive immune 
response to viral infection.  
 
Demonstrated immune cell dysfunction during acute phase infection correlates with interruption of specific 
cytokine production.  
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Developed a method to isolate skin derived dendritic cells for analysis of the role of these cells in innate 
immunity and initiation of adaptive immunity. Showed that these cells constitutively express IFNα in situ.  
 
Demonstrated that one inoculation of a recombinant adenovirus vector containing the gene for porcine 
interferon alpha (Ad5-pIFNalpha) can protect swine from FMDV challenge one day post inoculation.  
 
Demonstrated that the combination of IFN alpha administration and vaccination with our Ad5-vectored FMDV 
capsid antigen construct can induce both immediate as well as long term protection.  
 
IMPACT: 
The development of a adenovirus vectored combination vaccine and antiviral against FMDV that provides 
immediate protection in 1 day through its antiviral activity and long-term protection through its FMD empty 
capsid vaccine has had a major impact on the world view of FMD outbreak control. This has resulted in 
recommendations favoring vaccination over mass slaughtering of millions of animals.  The Ad5 vaccine is the 
first genetically engineered vaccine against FMDV shown to induce full protection in swine with one dose as 
early as 7 days post vaccination. Preliminary studies in cattle indicated that two doses of this vaccine can 
induce complete protection and serological data after the first inoculation suggest that protection can be 
induced after only one dose. These vectors can be produced in the US and be part of the US response in the 
event of an FMD outbreak in this country. 
  
 
TECHNOLOGY TRANSFER: 
Our research studies have been published in peer-reviewed scientific journals. Genetically engineered vaccine 
candidates have been produced, and have been proven effective in livestock (swine and bovine) but they have 
not undergone final development.  
 
Patents: 
We have filed a Patent concerning some of our new concepts to control FMD. 
Foot and Mouth Disease Virus Vaccine, Grubman, Marvin J., Chinsangaram, Jarasvech, Koster, Marla, 
Moraes, Mauro, P. Patent, Docket Number:0128.01, Serial Number: 60/286, 345, Date Filed: 4/26/2002. 
 
Cooperative Research Development Agreements (CRADA): 
We have entered into a CRADA with Merial Limited to produce antivirals using poxvirus vectors as a means 
of inducing immediate protection against FMD as well as an SCA with Merial to produce poxvirus vectored 
FMDV empty capsid vaccines. We have entered an SCA with the University of Connecticut at Storrs to study 
the immune response and pathogenesis of FMDV and VSV in swine. We have entered into a second SCA with 
the University of Connecticut at Storrs for testing rapid acting FMDV vaccine formulations in cattle. We have 
a MTA with Qiagen to test their exclusive immune stimulator compounds in combination with commercial 
FMD vaccines. 
 
PUBLICATIONS: 
 
Brown, C.C., Chinsangaram, J., and Grubman, M.J. Type I interferon production in cattle 
infected with 2 strains of foot-and-mouth disease virus, as determined by in situ 
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hybridization. Canadian J. Vet. Res. 64:130-133, 2000. 
 
Grubman, M.J. and Chinsangaram, J. Foot-and-mouth disease virus: The role of the leader proteinase in viral 
pathogenesis. Recent Res. Devel. Virol, 2:123-134, 2000. 
 
Mayr, G.S., O’Donnell, V., Chinsangaram, J., Mason, P.W., and Grubman, M.J. Immune  
responses and protection against foot-and-mouth disease virus (FMDV) challenge in 
swine vaccinated with adenovirus-FMDV constructs. Vaccine 19:2152-2162, 2001. 
 
Chinsangaram, J., Koster, M., and Grubman, M.J. Inhibition of L-deleted foot-and-mouth 
disease virus replication by alpha/beta interferon involves double-stranded RNA 
-dependent protein kinase. J. Virol. 12:5498-5503, 2001.  
 
Mason, P.W. and Grubman, M.J. Controlling FMD with vaccines? Australian Vet. 
J. 79:342-343, 2001. 
 
 Moraes, M.P., Mayr, G.A., and Grubman, M.J. pAd5-Blue: an easy to use, efficient, 
 direct ligation system for engineering recombinant adenovirus constructs. BioTechniques. 
 31:1050-1056. 2001. 
 
Moraes, M.P., Mayr, G.A., Mason, P.W., and Grubman, M.J. Early protection against 
homologous challenge after a single dose of replication-defective human adenovirus type 
5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24. 
Vaccine. 20:1631-1639, 2002. 
 
Grubman, M.J. and Mason, P.W. Prospects, including time frames, for improved foot 
-and-mouth disease vaccines. In Foot and mouth disease: facing the new dilemmas. Rev. 
sci. tech. Off. Int. Epiz. 21:589-600. 2002. 
 
Bautista, E., D. Gregg, and W.T. Golde. Characterization and functional analysis of skin-derived dendritic cells 
from swine without a requirement for in vitro propagation. Veterinary Immunology and Immunopathology. 87: 
137-145, 2002. 
  
Mason, P.W., Grubman, M.J., and Baxt, B. Molecular basis of pathogenesis of FMDV. In 
Foot-and-mouth disease (D. Rowlands ed.). Virus Res. 91:9-32, 2003.  
 
Chinsangaram, J., Moraes, M.P., Koster, M. and Grubman, M.J. A novel viral disease 
control strategy: adenovirus expressing interferon alpha rapidly protects swine from foot 
-and-mouth disease. J. Virol. 77:1621-1625, 2003. 
 
Grubman, M.J., Moraes, M.P., Chinsangaram, J., Mayr, G.A., and Mason, P.W. New 
approaches to control foot-and-mouth disease, p. 337-343. Foot and mouth disease: 
Control strategies. (B. Dodet and M. Vicari eds). Elsevier. 2003. 
 
Mason, P.W., Chinsangaram, J., Moraes, M.P., Mayr, G.A., and Grubman, M.J. 
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Engineering better vaccines for foot-and-mouth disease. Vaccines for OIE List A  and Emerging Animal 
Diseases. Dev. Biol. Basel, Karger (Brown, F, Roth, J eds). 114:79-88, 2003. 
 
Wu, Q., Moraes, M.P., Grubman, M.J. Recombinant adenovirus co-expressing capsid proteins of two serotypes 
of foot-and-mouth disease virus (FMDV): in vitro characterization and induction of neutralizing antibodies 
against FMDV in swine. Virus Research. 2003. v. 93. p. 211-219. 
 
Bautista, E., Ferman, G.S., Golde, W.T. Induction of lymphopenia and inhibition of T cell function during 
acute infection of swine with foot and mouth disease virus (FMDV). Veterinary Immunology and 
Immunopathology. 2003. v. 92. p. 61-73. 
 
Wu, Q., Brum, M.C.S., Caron, L., Koster, M., and Grubman, M.J. Adenovirus-mediated type I interferon 
expression delays and reduces disease signs in cattle challenged with foot-and-mouth disease virus.  J. Int. Cyt. 
Res., 23:371-380, 2003. 
 
Grubman, M.J. New approaches to control foot-and-mouth disease. Proceedings of the International 
Symposium on Foot-and-Mouth Disease, Strasbourg, France, pp. 83-87, 2003.  
 
Moraes, M.P., Chinsangaram, J., Brum, M.C.S., and Grubman, M.J. Immediate protection of swine from foot-
and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease 
virus subunit vaccine. Vaccine. 22:268-279, 2003.  
 
Grubman, M.J. New approaches to rapidly control foot-and-mouth disease outbreaks. Expert Rev. Anti-infect. 
Ther. 1:89-96, 2003. 
 
Rodriguez, L. L., J. Barrera, E. Kramer, J. Lubroth, A. Walfield, F. Brown and W. T. Golde. A synthetic 
peptide containing the consensus sequence of the G-H loop region of FMDV type O VP1 combined with a 
promiscuous T-helper epitope induces peptide-specific antibodies but fails to protect cattle against viral 
challenge. Vaccine 21: 3751-3756, 2003. 
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Foot and Mouth Disease Research 
 
Project Title: Determination of the Molecular Basis for Re-Emergence, Pathogenesis and Host Range 
of FMDV 
CRIS Number:     1940-32000-035-00D 
Scientists:             Baxt, B., Rieder, E., Grubman, M., Golde, W., Gregg, D.  
Location:        Plum Island Animal Disease Center, Office of the Center Director, Foot and Mouth 
Disease Research 
Contact:  Baxt, B., Phone: (631) 323-3354, Fax: (631) 323-3006, bbaxt@piadc.ars.usda.gov 
  
PROJECT OBJECTIVES: 
Foot-and-mouth disease (FMD) is a highly contagious viral disease of livestock. The causative agent, foot-and-
mouth disease virus (FMDV), has been extensively studied due to its economic impact. Recently, FMD has re-
emerged in Europe, South America and Asia with devastating consequences. This re-emergence has 
emphasized how little is known about the detailed virus-host interactions in different susceptible livestock 
species that control the pathogenesis and virulence of the virus. This information is necessary to develop new 
strategies to assist in preventing FMD epizootics. The Plum Island Animal Disease Center (PIADC) 
performs research developing such strategies to assist in preventing the introduction of FMD and to 
control it if it is introduced. As part of this program, this project will determine the virus-host interactions at 
the cellular and molecular levels.  These interactions, critical in the replication cycle and spread of FMDV, 
start with the interaction between the virus and receptor molecules on susceptible cells and follow intracellular 
pathways of viral replication and mechanisms of viral exit. We will use this information to find targets for 
novel anti-viral therapeutics and means to prevent infection of susceptible animals. In addition, knowledge of 
the genetic basis of viral transmission and spread will be obtained to help us better cope with the disease, if it is 
introduced into the United States. 
  
OVERALL PROJECT ACCOMPLISHMENTS: 
• Molecular cloning and characterization of all cell surface molecules from the bovine that serve as 
receptors for FMDV. 
•  Identification of at least one viral (3A protein), and host (ITAF45) factor that play roles in determining 
virulence and species specificity. 
•  Development of models to measure FMDV virulence and spread as it relates to the genetic makeup of 
the virus. 
•  Analysis of the efficiency of utilization of the different receptor molecules by the different viral 
serotypes. 
• Generation of soluble FMDV receptors which can neutralize viral infectivity.  
 
IMPACT: 
The identification of the receptors for FMDV has enhanced our ability to study the pathogenesis of the disease.  
In addition, the cloning of these receptors has allowed us to study new ways of using these molecules in rapid 
diagnosis.  Data showing that soluble receptors can neutralize viral infectivity suggest that receptor 
intervention using antivirals may be a feasible way to interfere with viral replication in susceptible animals.  
The identification of viral and host cell proteins important for FMDV virulence and host specificity has 
identified important new targets for anti-viral therapeutics. 
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TECHNOLOGY TRANSFER: 
Transfer of a genetically improved cell line to APHIS that allows more effective isolation of foot-and-mouth 
disease virus (FMDV).   A hamster cell line (BHK-21) frequently used for the diagnosis of FMDV, was 
engineered to increase its susceptibility to FMDV by expressing the integrin  alphaVbeta3 and alphaVbeta6 
receptors, previously discovered at Plum Island as one of the main cellular receptors for FMDV. 
 
PUBLICATIONS: 
 
Neff, S., Mason, P. W., and Baxt, B.  High efficiency utilization of the bovine integrin αVβ3 as a receptor for 
foot-and-mouth disease virus is dependent on the bovine β3 subunit.  J. Virol.  74:7298-7306. 2000. 
 
Neff, S., and Baxt, B.  The ability of the integrin αVβ3 to function as a receptor for foot-and-mouth disease 
virus is not dependent on the presence of complete subunit cytoplasmic domains.  J. Virol.  75:527-532. 2001. 
 
O'Donnell, V. K., Pacheco, J. M., Henry, T. M., and Mason, P. W.  Subcellular distribution of the foot-and-
mouth disease virus 3A protein in cells infected with viruses encoding wild-type and bovine-attenuated forms 
of 3A. Virology 287:151-162.  2001. 
 
Baxt, B., Neff, S., Rieder, E., and Mason, P. W.  Foot-and-mouth disease virus-receptor interactions:  Role in 
pathogenesis and tissue culture adaptation.  In Semler, B. L., and Wimmer, E. (eds.).  Molecular Biology of 
Picornaviruses.  ASM Press, Washington, DC.  pp. 115-123.  2002. 
 
Van Rensburg, H. G., and Mason, P. W.  Construction and evaluation of a recombinant foot-and-mouth disease 
virus: implications for inactivated vaccine production. Ann. NY Acad. Sci. 969:83-87.  2002. 
 
Mason, P. W., Bezborodova, S.V., and Henry, T. M. Identification and characterization of a cis-acting 
replication element (cre) adjacent to the internal ribosome entry site of foot-and-mouth disease virus. J Virol. 
76: 9686-9694.  2002. 
 
Duque, H., and Baxt, B.  Foot-and-mouth disease virus receptors:  Comparison of bovine alphaV integrin 
utilization by type A and O viruses.  J. Virol.  77:2500-2511.  2003. 
 
Mason, P. W., Grubman, M. J., and Baxt, B.  Molecular basis of pathogenesis of FMDV.  Virus Res.  91:9-32.  
2003. 
 
Zhao, Q., Pacheco, J. M., and Mason, P. W.  Evaluation of genetically engineered derivatives of a Chinese 
strain of foot-and-mouth disease virus reveals a novel cell-binding site which functions in cell culture and in 
animals.  J. Virol.  77:3269-3280.  2003 
 
Mason, P. W., Pacheco, J. M., Zhao, Q. Z., and Knowles, N. J.  Comparison of the complete genomes of 
Asian, African, and European isolates of a recent foot-and-mouth disease virus type O pandemic strain 
(PanAsia).  J. Gen. Virol.  84:1583-1593.  2003. 
 
Mason, P. W., Chinsangaram, J., Moraes, M. P., Mayr, G. A., and Grubman, M. J. Engineering better vaccines 
for foot-and-mouth disease.  Dev. Biol. 114:79-88. 2003. 
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Pacheco, J. M., Henry, T. M., O'Donnell, V. K., Gregory, J. B., and Mason P. W.  Role of nonstructural 
proteins 3A and 3B in host range and pathogenicity of foot-and-mouth disease virus.  J. Virol. 77: 13017-
13027.  2003. 
 
van Rensburg, H. G., Henry, T. M., and Mason, P. W.  Studies of genetically defined chimeras of a European 
type A virus and a South African Territories type 2 virus reveal growth determinants for foot-and-mouth 
disease virus.  J. Gen. Virol. 85: 61-68. 2004. 
 
Grubman, M. J., and Baxt, B.  Foot-and-mouth disease.  Clin. Microb. Rev.  17:465-493. 2004. 
 
Baxt, B., and Rieder, E.  Molecular Aspects of foot-and-mouth disease virus virulence and host range:  Role of 
host cell receptors and viral factors.  In Sobrino, F., and Domingo, E. (eds.).  Foot-and-Mouth Disease: Current 
Perspectives.  Horizon Scientific Press, in press, 2004. 
 
Duque, H., LaRocco, M., Golde, W. T., and Baxt, B.  Interactions of foot-and-mouth disease virus with soluble 
bovine αVβ3 and αVβ6 integrins.  J. Virol., in press, 2004. 
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Foot and Mouth Disease Research 
 
Project Title:   Pathogenesis and Genomics of Vesicular Stomatitis Viruses and Foot and Mouth 
Disease 
CRIS Number::     1940-32000-040-00D 
Scientists:             Rodriguez, L., Golde, W., Gregg, D. 
Location:         Plum Island Animal Disease Center, Office of the Center Director  
                        Foot and Mouth Disease Research 
Contact: Rodriguez, L.,Phone: (631)323-3364, Fax: (631)323-3295, 
lrodriguez@piadc.ars.usda.gov
 
PROJECT OBJECTIVES: 
Vesicular stomatitis (VS) is a viral disease that causes serious economic losses to the cattle and horse industries 
due to decreased animal production and quarantines. The disease is clinically indistinguishable from foot-and-
mouth disease, one of the most devastating exotic diseases in livestock. VS is the most commonly reported 
vesicular disease in livestock in the Americas and is included as a List-A disease by OIE.  Outbreaks of VS 
occur sporadically in the south-western United States. VS virus (VSV) strains causing these outbreaks are 
closely related to those circulating in enzootic areas of Mexico but their means of transmission and 
introduction to the United States remain unclear. Other exotic VS viruses circulate in South America. 
Knowledge about these viruses is limited and rapid sensitive and specific diagnostic tests for VSV are lacking. 
Host and viral factors influencing clinical presentation and mediating protective immune responses to VSV are 
poorly understood. This information is required in order to design appropriate prevention and outbreak control 
methods. This project has two separate components both aimed at minimizing the occurrence of VS in the US:  
Objective 1 utilizes viral genomics for diagnosis and molecular epidemiology, to rapidly detect and track 
the origin of VSV strains causing outbreaks. Objective 2 addresses pathogenesis aspects specifically the 
role of viral and host factors in determining the outcome of viral infections.  This could result in the 
development of therapeutic agents capable of preventing clinical disease during outbreaks.   
 
OVERALL PROJECT ACCOMPLISHMENTS: 
ORIGIN OF VESICULAR STOMATITIS OUTBREAKS IN SOUTH WEST. 
Using genomic analyses, determined that viruses causing the 1995, 1997 and 1998 VS outbreaks were newly 
emerging viruses, they were different from viruses causing previous US outbreaks but similar to viruses 
circulating in enzootic areas of southern Mexico. This information is valuable in focusing our attention on the 
factors influencing the introduction of VSV into the US. 
 
FIRST FULL-LENGTH GENOMIC SEQUENCES OF VSV FIELD STRAINS.  Full length genomic 
sequences were determined for each of the major serotypes and subtypes of VSV. These sequences provided 
crucial information for understanding the genomic basis of viral pathogenesis and allowed the identification of 
genetic signatures for diagnostic assay development, such the VSV rapid real-time RT-PCR. 
 
ROLE OF THE GLYCOPROTEIN IN PATHOGENESIS OF VESICULAR STOMATITIS IN LIVESTOCK.  
Host and viral factors influencing clinical presentation and mediating protective immune responses to VSV are 
poorly understood. This information is required in order to design appropriate prevention and outbreak control 
methods. In collaboration with the University of Alabama-Birmingham, we showed that the VSNJV 
glycoprotein is a determinant of pathogenesis in swine. Furthermore, genetically engineered VSVs containing 
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glycoproteins from both serotypes induced immune responses to both VSNJV and VSIV but could only protect 
against VSIV challenge. This information is valuable for designing effective vaccines.  
 
IMPACT: 
Phylogenetic analyses of VSV strains combined with epidemiological information provided valuable tools for 
understanding the molecular epidemiology of VSV in the United States.  Full-length genomic information 
provide de the basis for the design of rapid detection methods for VSV based on real-time RT-PCR. This rapid 
diagnostic test currently under validation in APHIS, is part of a National strategy for developing real-time 
RT_PCR test for rapid detection of foreign animal disease agents. Identifying the glycoprotein gene as a 
virulence determinant for VSV has had a major impact in understanding the protective immune responses to 
VSV. 
 
TECHNOLOGY TRANSFER:  
Material Transfer Agreement 
ONE-TUBE RAPID DIAGNOSTIC TEST FOR VESICULAR STOMATITIS.  This test based on real-time 
PCR was designed to detect a wide range of vesicular stomatis virus strains from various geographical regions 
of the Americas.  The test has been transferred to APHIS-FADDL for ongoing validation and will be 
transferred to other regional laboratories of the National Animal Health Laboratory Network during 2004. 
 
PUBLICATIONS: 
 
Rodriguez, L L, Bunch T A, Fraire M, and Llewellyn Z. 2000.  Re-emergence of vesicular stomatitis in the 
western United States is associated with distinct viral genetic lineages. Virology 271: 171-181. 
 
Flanagan, E. B., J. M. Zamparo, L. A. Ball, L. L. Rodriguez, and G. W. Wertz. 2001. Rearrangement of the 
genes of vesicular stomatitis virus eliminates clinical disease in the natural host: new strategy for vaccine 
development. Journal of Virology 75: 6107-6114. 
 
Rodriguez L L.  2002.  Emergence and Re-Emergence of Vesicular Stomatitis in The United States.  Virus 
Research 85: 211-219 
 
Rodriguez, L.L., S.J. Pauszek, T. A. Bunch and K.R. Schumann.  2002.  Full-Length Genome Analysis of 
Natural Isolates of Vesicular Stomatitis Virus (Indiana 1 Serotype) from North, Central and South America.  
Journal of General Virology 83: 2475-2483. 
 
Llewellyn, Z., M.D. Salman, S. J. Pauszek, and L.L. Rodriguez. 2002.  Growth and Molecular Evolution of 
Natural Isolates of Vesicular Stomatitis Virus Serotype New Jersey in Insect Cells. Virus Research  89: 65-73. 
 
Meissner F., Maruyama T., Frentsch M., Hessell A. J. Rodriguez L.L., Geisbert T.W., Jahrling P.B., Burton 
D.R., and Parren W.H.I. 2002.  Detection of Antibodies against the Four Subtypes of Ebola Virus in Sera from 
Any Species Using a Novel Antibody-Phage Indicator Assay. Virology  300: 236-243  
 
Martinez I., Rodriguez L.L., Jimenez C., Pauszek S.J. and Wertz G.W. 2003.  Vesicular Stomatitis Virus 
Glycoprotein is a Determinant of Pathogenesis in Swine, a Natural Host.  Journal of Virology 77: 8039-47.  
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Rodriguez L.L., Barrera J.C., Kramer E., Lubroth J., Brown F., and Golde W.T. 2003.  A Synthetic Peptide 
Containing The Consensus Sequence Of The G-H Loop Region Of FMDV Type O VP1 Combined With A 
Promiscuous T-Helper Epitope Induces Peptide-Specific Antibodies But Fails To Protect Cattle Against Viral 
Challenge.  Vaccine 21: 3751-3756. 
 
Magnuson RJ, Triantis J, Rodriguez LL, Perkins A, Meredith CO, Beaty B, McCluskey B, Salman M.  2003.  
A single-tube multiplex reverse transcription-polymerase chain reaction for detection and differentiation of 
vesicular stomatitis Indiana 1 and New Jersey viruses in insects. Journal of Veterinary Diagnostic 
Investigations. v15 p. 561-567 
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African Swine Fever Research 
 
 
Project Title:   High Consequence Pathogen Detection 
CRIS Number::     1940-32000-041-02S 
Scientists:             Rock, D., Huxsoll, D., McKenna, T., Adams, L. 
Location:         Plum Island Animal Disease Center                            
                        Office of the Center Director                    
Contact: Rodriguez, L.,Phone: (631)323-3364, Fax: (631)323-3295, 
lrodriguez@piadc.ars.usda.gov
 
PROJECT OBJECTIVES: 
Although exotic livestock diseases, Foot-and-Mouth Disease Virus (FMDV), Classical Swine Fever (CSF), 
African swine fever (ASF), rinderpest (RP), contagious bovine pleuropneumonia (CBPP) and lumpy skin 
disease (LSD)may enter the United States mainland by various means, the potential for terrorists, seeking 
vulnerable or soft targets in the US, to deliberately introduce foreign animal diseases has added a new 
dimension to livestock diseases as a threat to the national economy.  Foreign animal diseases (FAD) are a 
likely choice for terrorists in that many of the disease agents are easy to acquire, dissemination is not difficult, 
the diseases are readily transmissible, the livestock population is highly susceptible, and the economic impact 
of a major outbreak would be catastrophic. 
 
To counter the new threat concerns the U.S. Department of Agriculture is developing a system of rapid real-
time PCR assays for selected OIE class A animal pathogens to enable rapid detection and identification of 
diseased animals and effective management of disease outbreaks resulting from accidental or intentional 
introduction into the United States. This report serves to document the accomplishments of this project for 
fiscal year 03.   
 
OVERALL PROJECT ACCOMPLISHMENTS: 
The major accomplishments over the life of this project include the design, development, optimization, and 
bench validation of a "dried-down" real-time RT-PCR assay for FMDV and CSFV. The FMDV and CSFV 
assays are ready for field validation. 
 
Work is underway to complete bench validation on real-time PCR assays for other OIE List A diseases such as 
RP, ASF, CBPP and LSD.  The introduction of a foreign animal disease into the United States would have a 
great economic impact upon the agricultural system.  Movement of animals and animal products would be 
interrupted until a clear epidemiological picture could be established.  Therefore, it is essential that a rapid and 
accurate method of diagnosis is available.  These assays will provide the agricultural industry and the US 
government with rapid, deployable assays that are sensitive and capable of detecting the presence of a foreign 
animal disease in the United States.  Real-time PCR will play a critical role in determining the epidemiological 
pattern and management of a foreign animal disease outbreak within the United States.   
 
IMPACT: 
 
TECHNOLOGY TRANSFER: 
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 The CSFV real-time RT-PCR assay was transferred from ARS to APHIS in April 2003.  The FMDV real-time 
assay is scheduled to be transferred to APHIS within the first two weeks of September of 2003 
 
Use of a portable real-time reverse transcriptase-polymerase chain reaction assay for rapid detection of foot-
and-mouth disease virus. 
 
PUBLICATIONS: 
 
Risatti, G.R., Callahan, J.D., Nelson, W.M., Borca, M.V. Rapid detection of classical swine fever virus by a 
portable real-time reverse transcriptase PCR assay.  Journal of Clinical Microbiology. 2003 v. 41(1). p. 500-
505. 
 
Callahan JD, Brown F, Osorio FA, Sur JH, Kramer E, Long GW, Lubroth J, Ellis SJ, Shoulars KS, Gaffney 
KL, Rock DL, Nelson WM.  J Am Vet Med Assoc. 2002 June 1;220(11):1636-42. 
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African Swine Fever Research 
 
 
Project Title:   Functional Pathogen Genomics: Virulence and Host Range Genes of swine Fever Virus 
CRIS Number::     1940-32000-036-00D 
Scientists:             Rock, D., Neilan, J., Zsak, L., Afonso, C., Lu, Z. 
Location:        Plum Island Animal Disease Center, Office of the Center Director, African Swine Fever 
Research 
Contact: Rock, D., Phone: (631) 323-3330, Fax: (631) 323-3044, 
drock@cshore.com 
  
PROJECT OBJECTIVES: 
African swine fever (ASF) is a highly lethal hemorrhagic disease of domestic swine with mortality rates 
approaching 100%. The causative agent, African swine fever virus (ASFV), is a unique and genetically 
complex DNA virus. It is the sole member of a newly named virus family and the only known DNA arbovirus. 
Cycling of virus between soft ticks and the genus Ornithodoros and wild pig populations (wart hogs and bush 
pigs) in sub-Saharan Africa provides a natural reservoir of virus that poses a constant threat to domestic pig 
populations worldwide. There is no vaccine for ASF. Either a vaccine or other novel control methods is needed 
to reduce the threat posed by this highly significant viral disease.  
 
Work here is focused on: 1) Identifying and characterizing viral genes responsible for virulence, viral latency 
and host range in both the swine and tick host; 2) Identifying host cell genes associated with host susceptibility 
and/or resistance;3) Developing vaccines and/or other novel approaches for disease control that exploit 
virulence and host range mechanisms; and 4) Developing genomic based methods to rapidly identify and 
phenotypically characterize viruses. Identification of viral virulence-associated genes will permit the rational 
design and genetic engineering of live attenuated viruses for use as vaccines. Additionally, an understanding of 
these genes and their functions may permit development of novel approaches for disease control that exploit 
aspects of viral host range.  
 
OVERALL PROJECT ACCOMPLISHMENTS: 
Characterization of the ASFV genome - The genome of a pathogenic African ASFV isolate, Malawi Lil-20/1, 
was sequenced and analyzed. Data provided primary structure of all encoded genes and overall genome 
organization. Sequence homologies with other known genes have had great predictive value for proposing and 
examining ASFV gene function and have led to the identification of significant swine virulence and host range 
genes. Additionally, these data have also facilitated the identification of putative immunogenic proteins - viral 
membrane and envelope proteins. 
 
Identification of viral genes function in virulence and host range is difficult and very time consuming, 
especially when the genes are novel - lacking homology with other known genes. Putative ASFV virulence and 
host range genes were identified using a novel comparative genome approach. Analysis of complete genome 
sequences of seven pathogenic field isolates of ASFV identified several highly conserved genes in regions of 
the viral genome known to contain other pathobiologically significant genes. Impact - Comparative genomic 
approaches - facilitated by highly throughput DNA sequencing - may greatly simplify identification of novel 
genes with critical functions in the host. The strategy developed here for ASFV will have broad applicability 
for characterization of other threat agent pathogens.  
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Genetic engineering of the ASFV genome - Techniques were developed to genetically engineer pathogenic 
isolates of ASFV. These techniques which allow the addition or deletion of specific genes have permitted both 
genetic and reverse genetic research approaches for determining viral gene function. Recombinant ASFV gene-
deletion mutants have been used to identify and characterize swine virulence and host range genes. This 
technology has proven critical for engineering live-attenuated ASFV vaccine viruses. 
 
Identification and characterization of ASFV swine virulence and host range genes - Using genetic based 
strategies and ASFV gene-deletion mutants, a number of pathobiologically significant viral genes, many of 
which are novel, have been identified and characterized.  
 
Virulence-associated genes, NL-S and UK were identified in pathogenic European ASFV isolates. Deletion of 
either of these genes from the viral genome resulted in complete attenuation of the virus in swine. A third 
distinct virulence determinant which includes multiple members of the multigene family 530 genes AVAD, 
was identi-fied in the left variable region of the genome. These genes which are required for viral virulence are 
novel, lacking similarity to any other known genes.  
 
ASFV genes involved with the regulation of apoptosis in virus infected cells (bcl-2 and iap homologs) and 
genes with functions involving immune evasion in the swine host (CD2 and IkB homologs) were identified and 
characterized. CD2 and IkB genes had not been previously described in any virus. This is the first example of a 
pathogen using of a CD2-like molecule in immune evasion. 
 
ASFV genes which affect macrophage host range were also identified and 
characterized. The thymidine kinase gene (TK) and a second gene 9-GL are required for efficient replication of 
virus in infected cells; deletion of either gene resulted in a 99% to 99.9% reduction in viral growth and 
virulence attenuation.  
9-GL is a novel gene whose function in virus replication is unknown. A novel macrophage growth-associated 
determinant which includes multiple members of the multigene family 360 genes was identified in the left 
variable region of the ASFV genome. These genes are novel lacking homology to other known genes. 
 
ASFV and CSF infect and replicate in cells of the monocyte-macrophage lineage. Revealing molecular 
mechanisms involved in macrophage responses to infection is important to devise novel disease control 
strategies. A macrophage-specific swine cDNA microarray of 8029 clones was constructed and used to analyze 
the transcriptional profiles of swine macrophages infected with ASFV and gene deleted mutant viruses. 
Infection with virus caused a transcriptional response characterized by changes in the levels of expression of 
multiple macrophage genes. Up-regulated genes included novel and previously known genes, some of these 
involved in leukocyte differentiation, protein trafficking, endosome acidification and modulation of the 
antiviral response by nuclear factor kappa beta. Comparison of wild type and gene-deleted viruses revealed 
that ASFV genes from families 360 and 530 suppress early innate host responses induced by interferon 
alpha/beta. Mutant viruses containing deletion of 360 and 530 genes displayed enhanced expression of 
interferon induced early response genes and chemokines involved in the inflammatory response. Impact: These 
finding contribute to our understanding of swine resistance/susceptibility to viral infection and mechanisms of 
pathogenesis and may lead to early recognition of viral infection, predication of clinical outcome and 
identification of macrophage response genes associated with disease resistance.  
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A novel viral virulence determinant which includes multiple members of the MGF 530 genes has been 
identified in the left variable region of the ASFV genome using in vivo marker rescue. These genes will be an 
important target for engineering liveattenuated ASF vaccine viruses. 
 
An understanding of pathogen-host interactions is critical for  development of traditional and/or novel disease 
control strategies. The yeast two-hybrid system, used for the study of protein-protein interactions, was adapted 
specifically for investigating ASFV - swine macrophage interactions. ASFV infected swine macrophage cDNA 
libraries were constructed in a yeast activation domain GAL4 vector. Library Quality was assessed by 
nucleotide sequence and bio-informatic analysis. Two ASFV genes (5HL and 6FR) screened in this system, 
identified positive host cell interactor proteins. 5HL, an ASFV gene previously found to have a role in the 
modulation of apoptosis, baited host genes predicted to have roles in the regulation of programmed cell death 
pathways and cell cycle modulation. 6FR, a novel gene which has been implicated to have a critical role in 
ASFV infection, baited genes involved in host cell transcriptional regulation.  
 
Overall, the identification of significant virulence and host range genes provides a rational basis for 
development of genetically engineered attenuated or nonreplicating (in the swine host) ASFV viruses for use as 
vaccines. Further, an understanding of how these novel genes function in the swine host will contribute to our 
overall understanding of viral virulence/host range, viral persistence and pathogen-vector-host interactions; 
information that may have broad impact on swine infectious disease in general.  
 
Characterized latent infection with ASFV - Determined ASFV establishes a true latent infection in peripheral 
blood monocytes/macrophages, bone marrow and tonsil all recovered pigs, one in which viral replication does 
not occur. Knowledge of the existence of ASFV carrier animals is of critical importance for developing disease 
control programs in disease endemic regions. 
 
Characterized ASFV-tick host interactions - Our identification of a large number of highly conserved ASFV 
genes with no apparent role in the swine host suggested these genes may be associated with aspects of 
infection in the tick host. Colonies of Ornithodoros ticks for use in investigating virus-tick interactions were 
established at PIADC from wild ticks collected in South Africa. Detailed pathogenesis studies of ASFV 
infection in the tick host revealed important aspects of this virus-host interaction. Recombinant ASF viruses 
containing deletions of putative tick host range genes were constructed and examined in the ticks. The viral TK 
gene has recently been shown to be necessary for viral replication in midgut epithelial cells. And, a second tick 
host range determinant has been mapped to the left variable region of the ASFV genome. Identification of ASF 
viral genes functioning in host range in Ornithodoros porcinus ticks. Viral genes necessary for infecting ticks 
were identified. Multigene family 360 genes are required for efficient virus replication and generalization of 
infection in O.porcinus ticks. Successful identification of tick host range genes will permit the design of live 
attenuated ASFV vaccine viruses that are incapable of infecting or being transmitted by ticks. The functional 
characterization of these genes, will also likely contribute to our understanding of pathogen-arthropod host 
interactions in general. 
 
Functional genomics of cytoplasmic DNA viruses - A viral genomics approach was used to identify putative 
ASFV arthropod host range genes. Two cytoplasmic DNA viruses representing distinct virus families, 
Chlorella virus PBCV-1 (330 Kbp) and the Melanoplus Sanguinipes Entomopoxvirus (236 Kbp) and a 
Baculovirus pathogenic for Culex nigripalpus were completely sequenced and analysed. The Chlorella virus 
genome represents the largest viral genome sequenced to date. These data provided information on the primary 
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structure of all encoded genes, their organization, potential regulatory sequences and their evolutionary 
relationship to one another. In both viruses a number of novel and unexpected genes were identified. Sequence 
homologies with these viruses have led to the identification of ASFV genes with putative functions in virus-
arthropod host interactions. This work has led to ASFV being placed into its own virus family, the 
Asfarviridae, and it has provided the genetic underpinning for all future research aimed at understanding the 
complex biology and evolution of large cytoplasmic DNA viruses.  
 
Development of ASFV diagnostics and reagents - A PCR-based diagnostic assay for ASFV DNA, with a 
sensitivity equal to that of animal inoculation, was developed for use with blood and tissue samples. The assay 
is being used for research and diagnostic applications in the US, Spain, UK, South Africa, and China. Cloned 
genes, protein expression vectors, and both polyclonal and monoclonal antibody reagents have been developed 
and provided to research and diagnostic laboratories in the US, UK, Spain, South Africa, the Netherlands, and 
China.  
 
The genomes of Fowlpox virus, Marek's disease virus, Turkey herpesvirus and Swine pox were completely 
sequenced and analyzed. An understanding of the genetic basis of viral virulence and host range will permit the 
engineering of novel vaccine viruses and expression vectors with enhanced efficacy and greater versatility.  
 
The capripox viruses are responsible for highly significant foreign animal diseases (FAD) found in Africa and 
Central Asia and significantly they can be confused with a disease of sheep present in the United States caused 
by a parapoxvirus (orf virus). To improve diagnostic assays to distinguish between these viruses and to 
improve on existing vaccines for these diseases the genomes of lumpy skin disease-virus (151 kpb, 156 genes), 
sheeppox virus (146 kpb, 150 genes) and goatpox virus (151 kpb and 150 genes) were completely sequenced 
and analyzed. Virus specific gene targets were identified as were genes important for viral virulence and host 
range. Impact: Genomic sequences of these FAD viruses will allow for development of highly sensitive and 
specific diagnostic tests. Additionally, an understanding of the genetic basis of viral virulence and host range 
will permit the engineering of novel vaccine viruses and expression vectors with enhanced efficacy and greater 
versatility and will contribute novel concepts of pathogen-host interactions. This is fundamental information 
that will have broad impact on future strategies for controlling animal infectious diseases in general. 
 
IMPACT: 
The understanding of the genetic basis of ASFV virulence and host range generated here permit development 
of the first safe and efficacious ASF vaccine.  
 
Information generated here on novel mechanisms of viral disease provide fundamental new insights on 
pathogen-host interactions and will have broad impact on future strategies for controlling animal infectious 
disease in general.  
 
TECHNOLOGY TRANSFER: 
Viruses, genomic sequences, cloned viral genes, protein expression vectors, and both polyclonal and 
monoclonal antibody reagents have been provided to research and diagnostic laboratories in the US, UK, 
Spain, the Netherlands, Denmark and China.  
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PUBLICATIONS: 
 
Allende, R., Kutish, G.F., Laegreid, W.W., Lu, Z., Lewis, T.L., Rock, D.L., Friesen, J., Galeota, J.A., Doster, 
A.R. and Osorio, F.A. 2000. Mutations in the genome of porcine reproductive and respireatory syndrome virus 
responsible for the attenuation phenotype. Arch. Virol. 145:1149-1161. 
 
Tulman, E.R., Afonso, C.L., Lu, Z., Zsak, L., Rock, D.L. and Kutish, G.F.  2000.  The Genome of a Very 
Virulent Marek’s Disease Virus.  J. Virol. 74(17):7980-7988. 
 
Afonso, C.L., Tulman, E.R., Lu, Z., Zsak, L., Rock, D.L. and Kutish, G.F.  2001.  The Genome of Turkey 
Herpesvirus.  J. Virol. 75(2):971-978. 
 
Zsak, L., Lu, Z., Burrage, T.G., Neilan, J.G., Kutish, G.F., Moore, D.M. and Rock, D.L. 2001.  African Swine 
Fever Virus Multigene Family 360 and 530 Genes are Novel Macrophage Host Range Determinants.  J. Virol.  
75(7):3066-3076. 
  
Zsak, L., Sur, J-H., Burrage, T.G., Neilan, and Rock, D.L. 2001.  African Swine Fever Virus Multigene 
Families 360 and 530 Genes Promote Infected Macrophage Survival.  Scientific World Journal (1 Suppl 3):97. 
 
Tulman, E.R. and Rock, D.L. 2001.  Novel Virulence and Host Range Genes of African Swine Fever Virus.  
Current Opinion in Microbiology 4:456-461. 
 
Zsak, L. and Neilan, J.G.  2002.  Regulation of Apoptosis in African Swine Fever Virus-Infected Macrophages.  
Scientific World Journal 3(2):1186-11195. 
 
Neilan, J.G., Zsak, L., Lu, Z., Kutish, G.F., Afonso, C.L. and Rock, D.L.  2002. A Novel Swine Virulence 
Determinant in the Left Variable Region of the African Swine Fever Virus Genome.  J. Virol. 76(7):3095-
3104. 
 
Afonso, C.L., Piccone, M.E., Zaffuto, K.M., Neilan, J.G., Kutish, G.F., Lu, Z., Balinsky, C.A., Gibb, T.R., 
Bean, T.J., Zsak, L., and Rock, D.L. 2004.  African Swine Fever Virus Multigene Family 360 and 530 Genes 
Affect Host Interferon Response.  J. Virol. 78(4):1858-1864. 
 
Burrage, T.G., Lu, Z., Neilan, Rock, D.L. and Zsak, L.  2004.  African Swine Fever Virus Multigene Family 
360 Genes Affect Virus Replication and Generalization of Infection in Ornithodoros Porcinus Ticks.  J. Virol. 
78(5):2445-2453. 
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African Swine Fever Research 
 
 
Project Title:   Identification and Characterization of African Swine Fever Virus Protective Antigens 
CRIS Numbe:     1940-32000-037-00D 
Scientists:             Zsak, L., Rock, D., Neilan, J., Afonso, C., Vacant   
Location:        Plum Island Animal Disease Center, Office of the Center Director, African Swine Fever 
Research 
Contact:   Zsak, L., Phone: (631) 323-3023, Fax: (631) 323-3295 
lzsak@piadc.ars.usda.gov 
 
PROJECT OBJECTIVES: 
African swine fever (ASF) is a highly lethal hemorrhagic disease of domestic swine with mortality rates 
approaching 100%. The causative agent, African swine fever virus (ASFV), is a unique and genetically 
complex DNA virus. It is the sole member of a newly named virus family and the only known DNA arbovirus. 
Cycling of virus between soft ticks of the genus Ornithodoros and wild pig populations (wart hogs and bush 
pigs) in sub-Saharan Africa provides a natural reservoir of virus that poses a constant threat to domestic pig 
populations worldwide. There is no vaccine for ASF.  
 
Either a vaccine or other novel control methods is needed to reduce the threat posed by this highly significant 
viral disease. The long term goal of the ASF research group at the Plum Island Animal Disease Center 
(PIADC) is development of an effective control strategy for this viral disease. This research project focuses on 
vaccination as a potential control strategy. Research involves defining the protective immune response to 
ASFV. Specifically to: 1) Evaluate genetically engineered ASFV with deletions of virulence/host range genes 
as vaccines for ASF; 2) Identify and characterize ASF viral proteins that induce a protective immune response 
in swine; 3) Define antigenic variability ASFV strains; 4) Define critical protective host immune responses; 
and 5) Develop new methods for effective vaccine delivery in swine. This research will allow evaluation of 
vaccination as a potential control measure for ASFV and will provide both the theoretical and practical basis 
for subsequent vaccine development. 
 
OVERALL PROJECT ACCOMPLISHMENTS: 
Our recent work in ASFV protective immunity has: 1) Clearly demonstrated the importance of the humoral 
immune response in protective immunity to ASFV infection; 2) Demonstrated the existence of neutralizing 
antibodies in the serum of recovered ASFV infected animals; 3) identified for the first time a specific viral 
protein (p72) involved in mediating virus neutralization and mapped the protein epitope responsible; 4) 
Demonstrated that ASFV neutralizing antibodies are not sufficient for antibody-mediated protection and that 
other antibody-mediated immune mechanisms are responsible for the protective effect; 5) Anti-ASFV 
antibodies mediating a novel anti-viral mechanism, monocyte infection-inhibition (M-II), were identified and 
shown to function in a strain-specific manner, suggesting a role for them in protective immunity; 6) Identified 
additional viral genes with possible significance to a protective immune response including those encoding, 
putative virion and infected cell membrane proteins, highly variable viral proteins and putative secreted viral 
virulence factors; 7) Demonstrated the feasibility of using genetically engineered live attenuated ASF viruses 
as vaccines. A live attenuated ASFV was constructed by deleting the 9GL gene (a gene required for efficient 
growth in swine macrophages). Pig infected (immunized) with this genetically engineered mutant virus were 
completely protected from lethal challenge with homologous and several heterologous virus strains indicating 
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that highly virulent African ASFV field isolates can be attenuated by gene deletion and that these viruses 
induce a protective immune response in swine; 8) Several virulent African strains of ASFV were attenuated by 
deleting virulence associated genes and then used in cross protection studies in pigs. Cross protection was 
observed for all South African viruses examined indicating that protection from heterologous viruses within a 
geographic region can be achieved. These data indicate that ASFV strain variation may not be as great as 
previously thought thus, vaccination with a single virus strain may be a viable option for controlling ASFV 
within a geographic region; and 9) Immune sera to different ASFV isolates were raised and tested in an in vitro 
monocyte infection-inhibition (M-II) assay where homologous and region-specific heterologous protective 
effects were observed. Significant correlation between the specificity of M-II assay and cross protection from 
heterologous viruses was observed. Findings will permit identification of viral proteins mediating M-II. 
 
IMPACT: 
Characterization of protective anti-viral host responses and viral antigens responsible for inducing them permit 
the development of a subunit vectored ASF vaccines that could be used in the U.S. in the event of a disease 
outbreak. 
 
Insight into novel anti-viral host immune responses identified here will have broad impact on future strategies 
for controlling animal infectious disease in general.  
 
TECHNOLOGY TRANSFER: 
Viruses, genomic sequences, cloned viral genes, protein expression vectors, and both polyclonal and 
monoclonal antibody reagents have been provided to research and diagnostic laboratories in the US, UK, 
Spain, South Africa, the Netherlands, Denmark and China. 
 
PUBLICATIONS: 
 
Lewis, T., Zsak, L., Burrage, T.G., Lu, Z., Kutish, G.F.,  Neilan, J.G. and Rock, D.L.  2000. An African Swine 
Fever Virus ERV1-ALR Homologue, 9GL Affects Virion Maturation and Viral Growth in Macrophages and 
Viral Virulence in Swine. J. Virol. 74(3):1275-1285. 
 
Neilan, J.G., Zsak, L., Lu, Z., Burrage, T.G., Kutish, G.F. and Rock, D.L.   2004. Neutralizing Antibodies to 
African Swine Fever Virus Proteins p30, p54 and p72 are not Sufficient for Antibody-Mediated Protection. 
Virology 319(2):337-342 
 
Risatti, G.R., Borca, M.V., Zsak, L., Neilan, J.G., Lu, Z., Kutish, G.F. and Rock, D.L.  2004.  Preclinical 
Diagnosis of African Swine Fever in Contact Exposed Swine by Portable Real-Time PCR Assay.  J. Clin. 
Micro. (Submitted for Publication).  
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 African Swine Fever Research 
 
Project Title:   Detection and Diagnosis of Hog Cholera (CSF) 
CRIS Number::     1940-32000-038-00D 
Scientists:             Vacant, Vacant   
Location:       Plum Island Animal Disease Center, Office of the Center Director, African Swine Fever 
Research 
 
 
PROJECT OBJECTIVES:  
Classical Swine Fever (CSF) is a highly infectious disease of swine. Morbidity and mortality rates in infected 
herds can be high. Infected sows can also transmit the virus to their offspring, creating asymptomatic carriers 
of the virus that shed virus in their feces, thereby contaminating the environment and posing risk to susceptible 
populations. As a foreign animal disease (FAD), an outbreak of CSF would significantly affect the U.S. pork 
industry and export markets. Improved CSF diagnostic tests and a marker live-attenuated CSF vaccine are 
needed to further reduce the risk posed by this FAD. 
 
The goal of this research is directed at: 1) Developing molecular epidemiological capabilities for CSF; 2) 
Developing rapid field diagnostic tests for CSF; 3) Developing laboratory diagnostic tests that will differentiate 
field from marker vaccine strains of CSF; 4) Defining the pathogenesis of moderately virulent CSF viruses in 
pigs; 5) Identifying CSF virulence and host range determinants; and 6) 
Developing a marker live attenuated CSF vaccine. 
 
OVERALL PROJECT ACCOMPLISHMENTS:  
Rapid identification and diagnosis of a FAD is critical for successfully controlling and eradicating the disease 
following introduction. Rapid field-based assays to detect CSFV are not yet available. A rapid real-time 
fluorogenic hydrolysis probe TaqMan assay was developed and evaluated in pigs experimentally infected with 
a moderately virulent CSF isolate, Haiti-96. The assay was highly sensitive and specific, detecting infected 
animals up to 5 days prior to the appearance of CSF clinical symptoms. Impact: This rapid, real-time RT-PCR 
assay for CSFV provides a new diagnostic tool that will redefine disease management and control strategies for 
this highly significant FAD. This is a new project initiated in FY 2001.   
 
Engineering new markered live-attenuated CSF vaccines requires knowledge of viral virulence and host range 
determinants. Currently, little is known about CSFV in this regard. Insertional mutagenesis was used to define 
CSFV virulence and host range determinants. A CSFV genomic region associated with viral virulence was 
identified. Mutant viruses with changes in this region were: 1) completely attenuated in pigs; and 2) capable of 
inducing a protective immune response in pigs. Impact: The mapping of genetic determinants associated with 
viral virulence and host range represents the first step toward rational design of improved markered live-
attenuated CSF vaccines. 
  
IMPACT: 
Rapid real-time PCR test for CSF provides new diagnostic tool that has redefined emergency disease 
management and control strategies for this high consequence disease.  
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Work here on identification and characterization of CSFV virulence and host range determinants permits 
rational design of improved markered live-attenuated CSF vaccines. 
TECHNOLOGY TRANSFER: 
Rapid detection method transferred to APHIS. 
  
PUBLICATIONS: 
 
Risatti, R.G., Callahan, J.D., Nelson, W.M., Boca, M.V. Rapid detection of Classical swine fever virus by a 
portable real-time reverse transcriptase PCR assay.  Journal of Clinical Microbiology. 2003. v. 41(1). p. 500-
505. 
 
Risatti, G.R., Holinka, L.G., Lu, Z., Kutish, G.F., Callahan, J.D., Nelson, W.M., Brea Tio, E. and Borca, M.V.  
2004.  Diagnostic Evaluation of a Portable Real-Time Reverse Transcriptase PCR Assay for the Detection of 
Classical Swine Fever.  J. Clin. Micro. (In Press). 
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African Swine Fever Research 
 
 
Project Title:   Advanced Animal Vaccines and Diagnostic Applications 
CRIS Number::     1940-32000-039-00D 
Scientists:            Rock, D., Neilan, J., Zsak, L., Lu, Z.  
Location:         Plum Island Animal Disease Center                            
                        Office of the Center Director                                
                        African Swine Fever Research 
Contact: Rock, D., Phone: (631) 323-3330, Fax: (631) 323-3044, 
drock@cshore.com 
  
 
PROJECT OBJECTIVES: 
New disease control strategies are needed to reduce the threat posed by high consequence foreign animal 
diseases (FAD). Functional pathogen genomics offers an unprecedented opportunity for addressing this critical 
issue. High throughput pathogen genome sequencing together with detailed genome analysis will be used to 
provide improved tools for pathogen detection, disease diagnosis and epidemiological disease investigations, 
improved vaccines and therapeutics, and in all  likelihood, completely novel disease control strategies with 
increased efficacy and utility. Specifically the goal of this research is to: 1) Develop methods for rapid strain 
identification and epidemiological investigations for key FAD agents; 2) Develop rapid field diagnostic tests 
for key FAD agents; 3) Develop improved vaccines for key FAD; and 4) Develop new methods on strategies 
for efficient and effective 
disease control.  
 
OVERALL PROJECT ACCOMPLISHMENTS: 
Rapid field-based assays to detect foot and mouth disease virus (FMDV) are not yet available. A rapid RT-
PCR assay was developed and evaluated in experimentally infected animals. The assay was both highly 
sensitive and specific and, it detected the virus before the animals showed signs of disease. Impact: A rapid (1 - 
1 ½ hr) field-based diagnostic assay for FMDV provides a new and powerful tool that in all likelihood will 
revolutionize disease management and control strategies for this highly significant viral disease. 
 
Canarypox virus (CPV) is a increasingly important mammalian vaccine vector; however, little information 
regarding the canarypox genome is currently available. The 360 kpb CPV genome was sequenced and 
compared to fowlpox virus, a related avipoxvirus of domestic birds. Analysis revealed 325 genes, including 
those conserved with fowlpox virus, other novel genes in expanded gene families, and virulence and host range 
genes unique to CPV. Impact: Knowledge of the entire coding capacity of CPV has identified specific genes 
which may affect unique aspects of CPV virulence and host range, allowing more directed studies to determine 
gene function in the host. Engineering of improved and more efficacious CPV vaccine vectors will result. 
 
Poxviral infections in wild animal species are increasingly documented, indicating the presence of other, yet to 
be characterized poxviruses circulating in wild animal species. These can be confused with FAD viruses. Two 
deerpox viruses isolated in the western U.S. from free ranging mule deer were sequenced. Both virus genomes 
of 165 kbp shared 95% nucleotide identity. They differed from other known poxviruses both in central 
conserved regions and in terminal genomic regions where they contained a unique complement of virulence 
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and host range genes. Impact: Genomic information will permit design of improved diagnostic assays to 
distinguish between this virus and other exotic poxviruses associated with FAD of domestic animals. 
 
IMPACT: 
Rapid real-time PCR tests for high consequence foreign animal diseases developed here provides new 
diagnostic tools that have redefined emergency disease management and control strategies for these high 
significant diseases. 
 
Pathogen comparative genomics has provided new tools for epidemiological and forensic investigations of 
foreign animal diseases and fundamental information that permit development of safer and more efficacious 
vaccines and vaccine vectors. 
 
TECHNOLOGY TRANSFER: 
Rapid FAD diagnostic tests for FMD, CSF and ASF have been developed. Evaluated and transferred to APHIS 
for use. 
 
PUBLICATIONS: 
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African Swine Fever Research 
 
 
Project Title:   Advanced Veterinary Vaccines and Diagnostics 
CRIS Number::     1940-32000-039-04S 
Scientists:             Rock, D., Geary, S. 
Location:         Plum Island Animal Disease Center                            
                        Office of the Center Director                                
                        African Swine Fever Research 
Contact: Rock, D., Phone: (631) 323-3330, Fax: (631) 323-3044, 
drock@cshore.com 
  
PROJECT OBJECTIVES: 
The US food animal economy has long been threatened by infectious diseases that could devastate the cattle, 
swine and poultry industries. Viral and bacterial infections affecting the airways and other mucosal tissues 
present the major risk to these economically important animal species. Pathogenic microbes are now, and will 
continue to be, the most significant cause of animal disease and economic loss. The easy pathogens have been 
dealt with, the difficult, intractable ones remain. New pathogens are continuously emerging and, in some cases, 
past disease control strategies (vaccines, antibiotics, other drugs and chemicals) are either losing effectiveness 
and/or public support for their use.  Development and administration of new, more effective vaccines to 
counteract these pathogens will increase food safety, quality and production that will strengthen our markets at 
home and abroad.    
 
OVERALL PROJECT ACCOMPLISHMENTS: 
We have identified and characterized numerous virulence determinants in Mycoplasma gallisepticum and 
gained a greater understanding of the regulation of gene expression as well as posttranslational processing 
mechanisms of proteins in this pathogen. We have initiated studies aimed at determining the host response to 
this pathogen and assess how this contributes to the overall pathogenesis. 
 
IMPACT: 
Development of more effective vaccines for significant animal diseases will reduce losses associated with 
disease permitting increased food safety, quality and production and strengthen economic markets at home and 
abroad.  
 
TECHNOLOGY TRANSFER: 
"Use of a Live Attenuated Mycoplasma gallisepticum Strain as a Vaccine and Vector for the Protection of 
Chickens and Turkeys From Respiratory Disease" (Full patent filed 4/19/02). 
 
PUBLICATIONS: 
 
Papazisi,L., Silbart, L.K., Frasca Jr., S., Rood, D., Liao, X., Gladd, M. Javed, M.A. and Geary, S.J. A Modified 
Live Mycoplasma gallisepticum Vaccine to Protect Chickens From Respiratory Disease, Vaccine, 2002, 20(31-
32):3709-3719.  
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African Swine Fever Research 
 
 
Project Title:   Program for Prevention of Animal Infections and Advanced Technologies  
for Vaccines and Diagnostics 
CRIS Number::     1940-32000-039-05S 
Scientists:             Rock, D., Estes, M. 
Location:         Plum Island Animal Disease Center                            
                        Office of the Center Director                                
                        African Swine Fever Research  
Contact: Rock, D., Phone: (631) 323-3330, Fax: (631) 323-3044, 
drock@cshore.com 
  
PROJECT OBJECTIVES: 
The infectious agents under study cause significant production losses to domestic food animals and include 
agents of foreign animal diseases that threaten a key segment of the agricultural economy.  We are developing 
strategies for improved diagnostics and vaccine approaches to meet this challenge. 
 
OVERALL PROJECT ACCOMPLISHMENTS: 
We have begun to establish a comparative framework for genomic investigation of the Mycoplasma mycoides 
cluster of bovine and caprine pathogens that will be mined continually for potential diagnostic and therapeutic 
targets.  This database will underpin new efforts to complete genomic sequences for the remaining species in 
this cluster, other bovine mycoplasma pathogens, and isolated strains of those species correlated with 
worldwide disease outbreaks.  It is anticipated that the now completed genome sequence of M. capricolum 
subspecies capricolum Kid strain will drive the development of a genetic system for analysis of virulence traits 
for this group of organisms, leading to an accelerated understanding of their pathobiology and strategies to 
diagnose and treat these infectious diseases. 
 
IMPACT: 
Rapid diagnostic tests for high consequence foreign animal diseases will provide new diagnostic tools and will 
redefine emergency disease management and control strategies for these high significant diseases. 
 
TECHNOLOGY TRANSFER: 
The project has been underway for three years (since 3-1-00).  Mycoplasmal genomic sequences will be 
deposited in public databases as they are annotated.  Some delays in reaching these objectives occurred during 
the current period, reflecting the need to refine annotation methodology and to acquire the most recent 
comparative data.  Prototype diagnostic applications are anticipated in the next two years.  Vaccine material for 
tuberculosis is anticipated within the next two years.  Adjuvant materials developed in this study show promise 
in tests in chimeric mice and can be applied to several vaccines under study within the consortium.  Constraints 
may apply to the use of commercial materials obtained within the defined conditions of Material Transfer 
Agreements.  New PRRSV infectious clones should be available within the next year and subsequent 
investigation is projected to provide potential vaccine reagents to commercial swine producers and scientists in 
the following several years.  RNAi technology as an anti-parasitic sterilization therapy will be tested 
thoroughly in the coming year.  Its application across the spectrum of animal parasitic diseases will be 
regulated by the pace by which parasite genomic sequence data become available. 
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African Swine Fever Research 
 
 
Project Title:   Development of Rapid Real Time PCR-Based Assays for Selected OIE  
Class A Diseases 
CRIS Number::     1940-32000-041-00X 
Scientists:             Rock, D., Huxsoll, D., Rodriguez, L., McKenna, T.  
Location:         Plum Island Animal Disease Center                            
                        Office of the Center Director 
Contact: Rock, D., Phone: (631) 323-3330, Fax: (631) 323-3044, 
drock@cshore.com 
 
PROJECT OBJECTIVES: 
Although exotic livestock diseases, Foot-and-Mouth Disease Virus (FMDV), Classical Swine Fever (CSF) and 
Vesicular Stomatitis Virus (VSV) may enter the United States mainland by various means, the potential for 
terrorists, seeking vulnerable or soft targets in the US, to deliberately introduce foreign animal diseases has 
added a new dimension to livestock diseases as a threat to the national economy.  Foreign animal diseases are a 
potential choice for terrorists in that many of the disease agents are easy to acquire, dissemination is not 
difficult, the diseases are readily transmissible, the livestock population is highly susceptible, and the economic 
impact of a major outbreak would be catastrophic. 
 
To counter the new threat concerns the U.S. Department of Agriculture is developing a system of rapid real-
time PCR assays for selected OIE class A animal pathogens to enable rapid detection and identification of 
diseased animals and effective management of disease outbreaks resulting from accidental or intentional 
introduction into the United States. This report serves to document the accomplishments of this project for 
fiscal year 2003.   
 
OVERALL PROJECT ACCOMPLISHMENTS: 
The major accomplishments over the life of this project include the design, development, optimization, and 
bench validation of a "dried-down" real-time RT-PCR assay for FMDV and CSFV.  In addition, a real-time 
assay for VSV has been designed and optimized on wet-reagents and is now ready for production as a "dried-
down" assay.  All of the aforementioned assays have been or will be "dried-down" in a format specific for use 
in the SmartCycler (Cepheid, Sunnyvale, CA).  The FMDV and CSFV assays are ready for field validation. 
 
APHIS is finalizing agreements with foreign countries such as Argentina, Bolivia, Afghanistan, and Mexico to 
obtain samples from FMDV and CSFV outbreak areas in order to proceed with field validation of the real-time 
RT-PCR assays.  Likewise, VSV field validation in negative animal cohorts will be initiated in the fall of 2003 
through collaborative projects with Colorado State University and University of California-Davis (see annual 
reports for projects 1940-32000-040 03S and 1940-32000-041 03S) and through ongoing collaborations with 
ARS's Arthropod Borne Disease Research Laboratory (ABDRL). Field validation in positive cohorts for the 
VSV assay will be initiated in the fall of 2003 through collaborative agreements already in place with Mexico's 
Exotic Animal Disease Commission (5410-32000-012-01S  and Costa Rica's School of Veterinary Medicine 
(5410-32000-012-02S). These collaborative agreements were established by ABDRL in FY03. 
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A training and proficiency test system has been put in place in order to have the real-time assays, once field 
validated, transferred to the NAHLN laboratories.  BEI inactivated FMDV and CSFV isolates are currently 
being produced and tested both in vitro and in vivo.  These inactivated viruses will be used in proficiency 
panels and as positive controls in the NAHLN laboratories.   Once trained and tested, the NAHLN laboratory 
personnel will be capable of screening and helping diagnose the introduction of a foreign animal diseases into 
the United States.  In the event of the outbreak, personnel trained to perform the real-time assays in the 
NAHLN laboratories would be available to assist the Foreign Animal Disease Diagnostic Laboratory at Plum 
Island in the diagnosis and management of additional cases. 
 
Work is underway to complete bench validation on real-time PCR assays for other OIE List A diseases such as 
Rinderpest and African Swine Fever. 
 
The introduction of a foreign animal disease into the United States would have a great economic impact upon 
the agricultural system.  Movement of animals and animal products would be interrupted until a clear 
epidemiological picture could be established.  Therefore, it is essential that a rapid and accurate method of 
diagnosis is available.  These assays will provide the agricultural industry and the US government with rapid, 
deployable and sensitive tools to detect the presence of a foreign animal disease in the United States.  Real-
time PCR will play a critical role in determining the epidemiological pattern and management of a foreign 
animal disease outbreak within the United States.   
 
IMPACT: 
Rapid real-time PCR tests for high consequence foreign animal diseases developed here provides new 
diagnostic tools that have redefined emergency disease management and control strategies for these high 
significant diseases. 
 
TECHNOLOGY TRANSFER: 
The CSFV real-time RT-PCR assay was transferred from ARS to APHIS in April 2003.  The FMDV real-time 
assay is scheduled to be transferred to APHIS within the first two weeks of September of 2003.  APHIS will be 
training and proficiency testing NAHLN laboratory personnel on real-time RT-PCR using the Cepheid 
SmartCycler platform in the fall of FY'04.  These two real-time assays will be deployed to the NAHLN 
laboratory network for negative field sample collection and diagnostic specificity testing in December (CSFV) 
and January/February (FMDV), respectively.  Complete deployment of each assay to the end-user (NAHLN) is 
expected by March 2004 (CSFV) and July 1, 2004 (FMDV). 
  
PUBLICATIONS: 
 
Risatti, G.R., Callahan, J.D., Nelson, W.M., Borca, M.V. Rapid detection of classical swine fever virus by a 
portable real-time reverse transcriptase PCR assay. Journal of Clinical Microbiology. 2003. vol. 41(1). p. 500-
505. 
 
Callahan JD, Brown F, Osorio FA, Sur JH, Kramer E, Long GW, Lubroth J, Ellis SJ, Shoulars KS, Gaffney 
KL, Rock DL, Nelson WM.  Use of a portable real-time reverse transcriptase-polymerase chain reaction assay 
for rapid detection of foot-and-mouth disease virus. J Am Vet Med Assoc. 2002 Jun 1;220(11):1636-42. 
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Dairy Processing and Products Research 
 
Project Title:   Biosecurity of Milk from the Farm to the Dairy Processing Plant 
CRIS Number:     1935-41000-062-00D 
Scientists:             Tomasula, P., Rodriguez, L.  
Location:        Eastern Regional Research Center, Dairy Processing and Products Research 
Contact:  Tomasula, P., Phone: (215) 233-6703, x. 6703, Fax: (215) 233-6795 
ptomasula@arserrc.gov 
 
PROJECT OBJECTIVES: 
Foot and-mouth disease (FMD), caused by the foot-and-mouth disease virus (FMDV), is not a public health 
threat but is highly contagious to cloven-footed animals. The virus may be shed into milk up to 33 hrs before 
there are any apparent signs of the disease in dairy cows. Some of the literature on pasteurization of milk 
infected with FMDV reports that the virus survives in milk and milk products pasteurized according to current 
standards. Animals fed these products may then become infected with the virus. 
 
The purpose of this project is to review past experiments and conduct additional relevant experiments to 
determine the thermal resistance of FMDV in milk and milk products and to ensure that current pasteurization 
standards for high temperature short time pasteurization, the method used in most processing plants, provides a 
safety margin for elimination of FMDV in milk and milk products.  In addition, technologies that have been 
developed since the earlier research conducted in the ‘70s and that are currently available for dairy 
applications,  will be applied to solve potential biosecurity problems at the farm, during transport of milk, and 
at the processing plant.   This knowledge is needed for the development of science-based strategies for 
elimination of the virus in the event of an outbreak. The research and approaches are relevant to all pathogens 
that may cause animal safety or food safety concerns.  
 
OVERALL PROJECT ACCOMPLISHMENTS: 
This project was initiated in FY 2002, in collaboration with the Plum Island Animal Disease Center (PIADC) 
to support FMD research priorities. Both research locations are members of the FMD Dairy Research Working 
Group, an industry-driven group comprised of representatives from the dairy marketing cooperatives, milk 
processing groups, cheese processors, dairy farmers, representatives from the FDA – CFSAN and CVM and 
other government groups, and representatives from industry. The purpose of the FMD Dairy Research WG  is 
to develop science-based guidelines that may be used by APHIS and local, state, and federal officials in the 
event of an outbreak to effect a coordinated response.  
    
Methods Review: Examined the methodology  that was used in experiments conducted in the ‘70s and 80’s  to 
determine the thermal resistance of foot-and-mouth disease in milk. This data was and still is used in the 
guidelines issued by APHIS and OIE for treatment of milk infected with FMDV.   Concluded that much of the 
data was obtained using laboratory methods not in use today that do not simulate high temperature short time 
pasteurization. The data may over or under predict the thermal treatment delivered to milk in commercial 
pasteurization.  Also, the data cannot be used to determine exact temperature-time relationships required to 
inactivate the FMD virus in milk as a function of  log reduction of virus in milk. However, the data are useful 
to determine the ultimate effectiveness of a particular temperature in eliminating the virus in milk and past 
research has demonstrated that the difficulty in eliminating the virus in milk is most likely due to encapsulation 
of the virus by fat globule membrane or interaction with protein.  
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Review of guidelines: Current APHIS and OIE guidelines recommend that double pasteurization be used to 
eliminate virus in milk prior to feeding to animals. Determined from a literature review  that these guidelines 
are not based on peer reviewed data but are an apparent extrapolation of data.  
 
Pasteurization of infected milk:  Experiments were conducted at PIADC, NY, to test the efficacy of HTST 
pasteurization for elimination of FMDV in milk using pilot plant scale equipment. This is preferable to use of a 
commercial unit because several thousand gallons of milk naturally infected with FMDV would be necessary 
for processing. In addition, milk containing at least 2log virus is required to measure pasteurization 
effectiveness, a level high enough for kinetic studies.  Results from this study are also being interpreted in 
terms of on-farm destruction of milk.  
 
At ERRC, developed methodology for determination of residence time distribution and fastest moving particle 
determination so that temperature-time relationships may be determined for pathogens in milk using smaller 
scale equipment and applied to commercial pasteurizers.  
 
Milk tanker biosecurity : In preliminary work at ERRC,  demonstrated the parameters for operation of the 
tanker at the farm and the processing plant, if existing tankers are retrofitted with equipment to secure the 
contents of the tanker.  
 
 
IMPACT: Work performed to date has led to the strategies now being implemented by the dairy industry for 
improved biosecurity, in general, and for handling milk infected with FMDV at the farm, in transit, and at the 
processing plant. The strategies developed in this work are sufficiently general that their implementation will 
improve the security and safety of milk and dairy products against most pathogens.    
 
TECHNOLOGY TRANSFER:  
The results of the experiments are regularly discussed with dairy stakeholder groups and APHIS, USDA, and 
the FDA.  The dairy stakeholder groups have shared the knowledge obtained in this study with their users.   
 
PUBLICATIONS: 
 
Tomasula, P.M. and R.P. Konstance. 2004. The survival of foot-and-mouth disease virus in raw and 
pasteurized milk and milk products. J. Dairy Sci. 87: 1115-1121. 
 
Tomasula, P.M. and M.F. Kozempel. 2004. Flow characteristics of a pilot scale high temperature short time 
pasteurizer. Submitted to J. Dairy Science. 
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PROJECTS 
 
Periparturient Diseases of Cattle 
• Molecular, Nutrient and Endocrine Basis for Metabolic Disease in the  
Transition Dairy Cow 
• Identification of Factors Causing Immune Suppression at Parturition 
 
Bacterial Diseases of Livestock 
• Genomic and Immunological Analysis of Spirochetes that Infect Livestock 
• Brucellosis: Vaccines, Immune Responses, Diagnostic Reagents 
• Understanding Host-Pathogen Interactions for the Diagnosis and Control of Paratuberculosis (Johne's) 
• Diagnosis and Control of Tuberculosis in Livestock and Wildlife 
 
Virus and Prion Diseases of Livestock 
• Emerging Viral Diseases of Swine 
• Virus-Induced Respiratory and Reproductive Diseases of Swine 
• Detection and Control of Bovine Viral Diarrhea Viruses 
• Bovine Spongiform Encephalopathy and Other Transmissible  
Spongiform Encephalopathies 
 
Respiratory Diseases of Livestock 
• Respiratory Diseases of Poultry 
• Control of Porcine Respiratory Diseases of Complex Etiology 
• Haemophilus Parasuis Proteomics for Vaccine Design 
• Controlling Losses from Respiratory Disease in Cattle, Sheep, and Goats 
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• Construction of Live Mucosal and Injectable Bacterial Vaccines Against  
Avian and Bovine Respiratory Diseases 
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Periparturient Diseases of Cattle 
 
Project Title:   Molecular, Nutrient and Endocrine Basis for Metabolic Disease in the  
Transition Dairy Cow 
CRIS Number::     3625-32000-058-00D 
Scientists:             Reinhardt, T., Horst, R.  
Location:        Ames, IA, National Animal Disease Center, Periparturient Diseases of Cattle 
Contact: Reinhardt, T., Phone: (515) 663-7540, Fax: (515) 663-7669, treinhar@nadc.ars.usda.gov 
 
PROJECT OBJECTIVES: 
Clinical hypocalcemia (Milk Fever) and subclinical hypocalcemia have an 8% and 75% incidence, 
respectively, in the periparturient dairy cow. Epidemiological studies have shown that metabolic diseases do 
not occur in isolation from each other, and hypocalcemia increases the incidence of other metabolic and 
infectious disorders in cows.  It is clear that hypocalcemias are the initiators of a metabolic and infectious 
disease complex in the periparturient dairy cow.  Hypocalcemia results in a 9-fold increase in ketosis, 6 times 
more dystosia, and a 4-fold increase in left displaced abomasum and retained placenta.  In addition, the 
majority of infectious diseases (mastitis, salmonellosis, bovine viral diarrhea (BVD) and Johnes disease) that 
occur are associated with or increased by hypocalcemia.  We are attempting to resolve this problem with an 
applied and basic research program focusing on understanding the diseases and improving methods we have 
developed to prevent hypocalcemia. 
 
OVERALL PROJECT ACCOMPLISHMENTS: 
Prior to our research, pre-calving diets high in calcium were thought to be the cause of milk fever. We proved 
this is not true in a seminal experiment with milk fever (hypocalcemia)-prone Jersey cows fed a high or low 
calcium diet, with either 1, 2, or 3% dietary potassium.  Dietary calcium was found to have no effect on the 
development of milk fever or hypocalcemia.  However the experiment did demonstrate that milk fever is 
primarily caused by high dietary potassium.  Additional experiments suggest that high dietary potassium 
interferes with the ability of a key calcium regulating hormone – parathyroid hormone- to regulating the cow's 
blood calcium concentration .  
 
We have also found the level of expression of a calcium-pumping gene in the mammary gland is a predictor of 
the metabolic disease complex associated with the stresses of parturition in dairy cows.  We have developed 
reagents that can be used to study mammary gland calcium transport (during milk fever) and have potential as 
indicators of milk and milk protein production. We have contributed to the basic endocrinology/cell biology of 
the periparturient period in cows and model systems.  We have identified factors predisposing cows to 
metabolic disease, such as age and diet, and we have established how these factors contribute to the 
development of the disease at the cellular level.  For example, key hormone receptors involved in the control of 
blood calcium concentration were found to decline with age, the stresses of parturition, and the breed of cow.  
Diets to enhance the function of key hormone receptors have been developed and these are currently being 
applied for prevention of milk fever.   
 
IMPACT: 
These data have resulted in our development of new practical dietary supplements, which are now being used 
to lower the incidence of milk fever.  As an outcome of our research, 50-60% of dairies now control potassium 
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content of diets fed to dry cows and 20-30% of dairies are now adding chloride supplements to adjust dietary 
cation-anion difference in their dry cow feeding programs.  
 
TECHNOLOGY TRANSFER: 
Our discovery that potassium is the cause of milk fever is now being included in every new veterinary medical 
textbook.  The research was published in many of the major lay dairy publications in the U.S.  Nearly all dairy 
nutritionists carefully determine dietary potassium when formulating rations for dairy cattle.  Some are 
beginning to change agronomic practices designed to reduce potassium and increase chloride content of 
forages grown for dairy dry cows.  Summaries of our recent experiments on the use of dietary hydrochloric 
acid as a means of counteracting high dietary potassium have also appeared in nearly every major lay dairy 
publication.  The industry has been very quick to adopt the technology that has arisen from this project.  Within 
months of our presentation of the work on hydrochloric acid at a scientific meeting, a company began 
marketing a feed supplement with hydrochloric acid to aid in prevention of milk fever.  There are two 
companies (West Central Cooperative, Ralston, IA, and Nutritech Solutions, Ltd, Clearbrook, BC, Canada) 
now marketing products with HCl using formulas that are essentially our recipe.  Technology transferred has 
also been scientific knowledge for use by other scientists and us.  The knowledge should be reasonably durable 
but is subject to modification and change as the project's research moves forward.  The probes and reagents 
developed should provide sound scientific tools required for further understanding of mammary function and 
milk production as well as tools for evaluation of practical metabolic disease prevention methods that will 
make it to the farmer. 
 
T. Reinhardt 
 
Invited to speak At the Stu Patten Wilderness Conference on Mammary Biology,  on “Calcium Homeostasis in 
the Mammary Gland”, 2003 
 
Invited to present a seminar at the Dept of Molecular Biology and Biochemistry ISU winter semester seminar 
series, on “Calcium transport in the Mammary Gland”, 2004 
 
Invited to speak at the 18th Brunner Symposium at Michigan State Univ, “Calcium Pumps and Calcium 
Transport in the Mammary Gland”, 2004 
 
R. Horst 
Invited to lecture on “Role of Vitamin D in Calcium Homeostasis and its use in Milk Fever Prevention” at the 
Abildgaard Symposium on Hypocalcemia, Acidosis and Calcium Homeostasis, Copenhagen, Denmark, August 
16-17, 2001. 
 
Invited to lecture on “Troubleshooting Transition Rations for the Dairy Cow” at the 62nd Minnesota Nutrition 
Conference, Bloomington, MN, September 11-12, 2001. 
 
Invited to lecture annual Wisconsin Agriculture Systems Association meeting on “Managing the Close UP 
Transition Cow” Wisconsin Dells, WI Jan 24-25 , 2002 
 
Invited to lecture at the 17th annual Southwest Nutrition and Management Conference, on “Troubleshooting 
Transition Rations for the Dairy Cow” Feb 21-23, 2002, Pheonix,  AZ 
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Invited to lecture to the University of Colorado Veterinary College on “Managing Hypocalcemia in the 
Periparturient Dairy Cow” March 19, 2002. Ft. Collins, CO  
 
Invited to lecture at the annual Iowa Feed and Nutrition Seminar.  Iowa State University, "Management of the 
transition dairy cow" April 23, 2002. 
 
Invited to lecture at the Brown University DeLuca Symposium on Vitamin D on “Rat Cytochrome P450C24 
(Cyp24) does not Metabolize 1,25-Dihydrovitamin D2 to Calcitroic Acid” Taos, NM, June 15-19, 2002. 
 
Invited by Faculty of Veterinary Medicine, Warsaw Agricultural University to give a lecture at the Conference 
on “Prevention of Periparturient Diseases in Dairy  Cows” September 4-5 2003, Warsaw, Poland. 
 
Invited to co-author a review on “Vitamin D Metabolism” for Vitamin D 2nd edition edited by D. Feldman, 
F.H, Glorieux, J.W. Pike, 2004. 
 
PUBLICATIONS: 
 
Cheng YH, Goff JP, Sell JL, Dallorso ME, Gil S, Pawlak SE, Horst RL. Utilizing Solanum glaucophyllum 
alone or with phytase to improve phosphorus utilization in broilers.  Poult Sci. 2004 Mar;83(3):406-13.  
 
Foote MR, Horst RL, Huff-Lonergan EJ, Trenkle AH, Parrish FC Jr, Beitz DC.  The use of vitamin D3 and its 
metabolites to improve beef tenderness.  J Anim Sci. 2004 Jan;82(1):242-9.  
 
Waldron MR, Nonnecke BJ, Nishida T, Horst RL, Overton TR.  Effect of lipopolysaccharide infusion on 
serum macromineral and vitamin D concentrations in dairy cows.  J. Dairy Sci. 2003 Nov;86(11):3440-6.  
 
Waters WR, Palmer MV, Nonnecke BJ, Whipple DL, Horst RL.  Mycobacterium bovis infection of vitamin D-
deficient NOS2-/- mice.  Microb Pathog. 2004 Jan;36(1):11-7.  
 
Goff JP, Horst RL.  Milk fever control in the United States.  Acta Vet Scand Suppl. 2003;97:145-7. Review.  
 
Goff JP, Horst RL.  Role of acid-base physiology on the pathogenesis of parturient hypocalcaemia (milk 
fever)--the DCAD theory in principal and practice.  Acta Vet Scand Suppl. 2003;97:51-6. Review.  
 
Horst RL, Goff JP, Reinhardt TA.  Role of vitamin D in calcium homeostasis and its use in prevention of 
bovine periparturient paresis.  Acta Vet Scand Suppl. 2003;97:35-50. Review.  
 
 
Waters WR, Nonnecke BJ, Foote MR, Maue AC, Rahner TE, Palmer MV, Whipple DL, Horst RL, Estes DM. 
Mycobacterium bovis bacille Calmette-Guerin vaccination of cattle: activation of bovine CD4+ and gamma 
delta TCR+ cells and modulation by 1,25-dihydroxyvitamin D3. Tuberculosis (Edinb). 2003;83(5):287-97.  
 
Reinhardt TA, Horst RL, Waters WR.  Characterization of Cos-7 cells overexpressing the rat secretory 
pathway Ca2+-ATPase. Am J Physiol Cell Physiol. 2004 Jan;286(1):C164-9. Epub 2003 Sep 10.  
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Nonnecke BJ, Waters WR, Foote MR, Horst RL, Fowler MA, Miller BL.  In vitro effects of 1,25-
dihydroxyvitamin D3 on interferon-gamma and tumor necrosis factor-alpha secretion by blood leukocytes 
from young and adult cattle vaccinated with Mycobacterium bovis BCG. 
Int J Vitam Nutr Res. 2003 Jul;73(4):235-44.  
 
Fujiwara I, Aravindan R, Horst RL, Drezner MK. Abnormal regulation of renal 25-hydroxyvitamin D-
1alpha-hydroxylase activity in X-linked hypophosphatemia: a translational or post-translational defect. J Bone 
Miner Res. 2003 Mar;18(3):434-42.  
 
Horst RL, Omdahl JA, Reddy S. Rat cytochrome P450C24 (CYP24) does not metabolize 1,25-
dihydroxyvitamin D2 to calcitroic acid. J Cell Biochem. 2003 Feb 1;88(2):282-5.  
 
Goff JP, Kimura K, Horst RL.Effect of mastectomy on milk fever, energy, and vitamins A, E, and beta-
carotene status at parturition. J Dairy Sci. 2002 Jun;85(6):1427-36.  
 
 Kimura K, Goff JP, Kehrli ME Jr, Reinhardt TA.  Decreased neutrophil function as a cause of retained 
placenta in dairy cattle. J Dairy Sci. 2002 Mar;85(3):544-50. 
 
Zimmerman DR, Reinhardt TA, Kremer R, Beitz DC, Reddy GS, Horst RL. Calcitroic acid is a major catabolic 
metabolite in the metabolism of 1 alpha-dihydroxyvitamin D(2). Arch Biochem Biophys. 2001 Aug 
1;392(1):14-22.  
 
Reinhardt TA, Filoteo AG, Penniston JT, Horst RL. Ca(2+)-ATPase protein expression in mammary tissue. 
Am J Physiol Cell Physiol. 2000 Nov;279(5):C1595-602.  
 
Langub MC, Reinhardt TA, Horst RL, Malluche HH, Koszewski NJ. Characterization of vitamin D receptor 
immunoreactivity in human bone cells. Bone. 2000 Sep;27(3):383-7.  
 
Horst, R.L., Omdahl, J.L., Reddy, S. Rat cytochrome P450C24 (CYP24) does not metabolize 1,25-
dihydroxyvitamin D2 to calcitroic acid. Journal of Cell Biochemistry. 2003. v. 88. p. 282-285. 
 
Montgomery, J.L., Morrow Jr, K.J., Horst, R.L., Blanton, R.L., Galyean, M.L., Miller, M.F. Effect of vitamin 
D3 supplementation level on the postmortem tenderizatin of beef from steers. Journal of Animal Science. 
2002. v. 80. p. 971-981. 
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Periparturient Diseases of Cattle 
 
Project Title:   Identification of Factors Causing Immune Suppression at Parturition 
CRIS Number::     3625-32000-068-00D 
Scientists:             Horst, R., Goff, J., Schmerr, M., Lippolis, J., Harp, J.  
Location:        Ames, IA, National Animal Disease Center, Periparturient Diseases of Cattle 
Contact: Horst, R., Phone: (515) 663-7312, Fax: (515) 663-7669, rhorst@nadc.ars.usda.gov
 
 
PROJECT OBJECTIVES: 
The major portion of health problems in dairy cattle occur at or around the time of calving; i.e., the 
periparturient period.  These problems include mastitis, milk fever, retained placenta, and metabolic disorders 
such as ketosis and fatty liver.  A common thread to many of these disorders may be diminished immune 
function.  Our work will address mechanisms of immunity as they relate to two of the most economically 
important diseases of dairy cattle, mastitis and retained placenta.  We will examine the effects of nutritional 
supplementation, milk production, or hormone treatments on periparturient immunosuppression in cows.  We 
will test the actual activity of the immune system of the animals by intramammary challenge of the animals 
with common mastitis causing organisms such as the coliform and Streptococcus species.   These studies will 
also provide information allowing us to investigate the relationship between immunological parameters we can 
measure in the lab and actual resistance to disease.  These infection models also allow us to examine the 
molecular and cellular basis of the host-pathogen interaction in the bovine mammary gland to each bacterial 
infection.  We are using proteomic analysis, as well as more traditional cytokine and leukocyte function assays 
to identify host proteins that are up or down-regulated during infection.  We are working to determine whether 
bacterial protein expression differs inside the mammary gland from that observed when the bacteria are grown 
in culture media by comparing in vivo to in vitro grown bacterial protein expression.  Ultimately antigens 
expressed in vivo, but not in vitro, could help define antigens necessary for incorporation into vaccines.  We 
are also using the mammary gland infection model to compare the expression of lymphocyte cell surface 
receptors that regulate the migration and activation of immune cells in the mammary gland.  
 
We have recently established an association between immune suppression and the retention of fetal membranes 
after calving (retained placenta).  We continue to examine the immunologic parameters important in the 
etiology of retained placenta by identifying factors affecting neutrophil chemotaxis towards placental 
homogenate and attempting to modulate these interactions. A sensitive fluorescence immunoassay for IL8 
using laser induced fluorescence on a capillary electrophoresis platform is under development.  This assay will 
be able to measure IL8 at physiological levels.   In addition, we are using genomic and proteomic analysis to 
compare protein profiles in placental tissues from cows with and without retained placenta to identify "disease-
specific proteins" that may be critical to the success or failure of placental expulsion.  
 
Completion of these objectives will result in an increased understanding of the mechanisms controlling two of 
the most economically important diseases in dairy cattle, mastitis and retained placenta.  These findings will 
provide insight into rational measures for controlling these diseases. 
 
OVERALL PROJECT ACCOMPLISHMENTS: 
We demonstrated that the presence of the mammary gland affects the degree of immune suppression 
experienced by the cow during the periparturient period, most likely because milk production causes the cow to 
                                                                                      73 
 
experience prolonged periods of negative calcium and energy balance.  These studies suggest that improved 
nutrition to address these two metabolic problems involving energy and calcium balance could have a positive 
impact on immune function and resistance to disease. Studies were then conducted to determine whether 
manipulation of the energy balance of cows at calving would have an impact on immune function.  Cows 
outfitted with rumen cannulas were fed a balanced diet formulated to meet their energy needs.  Control cows 
were allowed to undergo the usual decline in feed intake observed in most cows around the time of calving.  
However, treated cows were force-fed their diet through the rumen cannula so that energy intakes were not 
permitted to decline.  This tactic succeeded in improving the energy balance of the cows but failed to prevent a 
decline in immune function in the cows.  This research does not mean that energy balance is not important to 
the immune system but does suggest that improving energy balance alone will not restore full function to the 
immune system. The periparturient cow model we have developed permits assessment of the effects of a 
variety of nutritional factors on immune function around the time of calving.  
 
The discovery of a role for the immune system in the etiology of retained placenta has redirected research 
focused on prevention of retained placenta into a whole new direction.  Scientists now understand why the 
search for a link between the hormones associated with the act of parturition and retained placenta was so 
frustrating.   Immune dysfunction is more likely at the heart of the retained placenta problem.   We have 
discovered that cows developing retained placenta have lower levels of a cytokine, interleukin-8, in their blood 
than do cows that expel the placenta normally.  Since interleukin-8 is considered the primary factor involved in 
neutrophil recruitment, a reason for the lack of production of this cytokine is our current focus. 
  
IMPACT: 
Demonstrating that all cows are immune suppressed for 1-2 weeks before and after calving has been 
instrumental in changing certain farm practices.  For instance vaccination of cows on the day of calving was 
common because it was a convenient time to handle the cow.  We are slowly convincing the industry that the 
cow will not respond to vaccinations administered at this time.  We have clearly demonstrated that metabolic 
disease can worsen the degree of immune suppression experienced by the cow around the time of calving.  
Unfortunately we have not determined a way to fix damaged cows and our current focus is on understanding 
how to prevent the metabolic diseases from impacting the immune system through improved nutrition and 
management. 
 
TECHNOLOGY TRANSFER: 
Producers and veterinarians are excited about the implications of this research as it explains why vaccination 
protocols for periparturient cows often fail to provide protetion.  Our work has clearly defined the major causes 
of the immune system shutdown.  Producers are very familiar with the veterinary costs incurred during the first 
weeks of lactation in dairy cows from masitits and other infectious disease, and have been anxious to learn 
more about the factors that contribute to immune suppression in the newly calved cow.  Scientists within this 
unit have been invited to many National and International meetings in the last two-three years to provide 
information on immune function in the periparturient cow and its implications to veterinarians, producers and 
allied industry personnel.   
 
J. Goff 
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Invited to present a lecture on “Periparturient Immune Suppression and Nutrition” at the University of 
California-Davis Veterinary Continuing Education Program at the Tulare Farm Progress Show, Tulare, CA, 
February 10, 2001. 
 
Invited to speak on “Milk Fever and Its Association with Metabolic Disease in Dairy Cows” at the Empire 
State Corn Days, Miner Institute, Chazy, NY, February 27, 2001. 
 
Invited to speak on “Physiologic Factors to Consider in the Transition Dairy Cow” at the Western Dairy 
Management Conference, Las Vegas, NV, April 5, 2001. 
 
Invited to speak at the Guelph University Continuing Education Conference for Dairy Practitioners on “New 
Research on Transition Cows”, Guelph, Ontario, Canada May 30, 2001. 
 
Invited to speak at the Feed Additives Update Conference for Dairy Nutritionists on “Adjusting DCAD and 
Minerals to Improve Transition Cow Health,” East Lansing, MI, June 5, 2001. 
 
Invited to speak on “The Role of Acid-base Physiology in Control of Hypocalcemia” and “Strategies for 
Prevention of Milk Fever” at the Abildegaard Veterinary Conference, Royal Veterinary College, 
Fredericksburg, Denmark, August 16, 2001. 
 
Invited to present a seminar on “Mineral and DCAD Adjustments to Prevent Metabolic Disease” for the 
ZinPro-Balchem-Kemin joint Ohio Nutrition Conference, Akron, OH, August 28, 2001. 
 
Invited to present a full-day pre-convention seminar on “Dry Cow Nutrition” at the Americasn Association of 
Bovine Practitioners Conference, VanCouver, British Columbia, Canada, September 12, 2001.  (Unable to 
participate due to the tragedy of 09/11/01). 
 
Invited to speak at the Nutritionist Conference for Dairy Consultants on “Dry Cow Physiology and Nutrition,” 
Albuquerque, NM, September 26, 2001. 
 
Invited to speak at the Idaho Feed Industry Consortium of Dairy Nutritionists on “Dry Cow Nutrition,” Boise, 
ID, September 28, 2001. 
 
Invited to present a Dairy Science departmental seminar on “Physiology of the Transitin Cow” at Penn State 
University, State College, PA, November 16, 2001. 
 
Invited to speak at the Colorado Nutrition Conference on “Mineral Management of the Dry Cow, Including 
Oral Drenching,” Greeley, CO, January 29, 2002. 
 
Invited to give a lecture in the Plenary Session of the National Mastitis Council meeting on “Mechanisms by 
Which Metabolic Diseases Predispose Cows to Infectious Disease,” Orlando, FL, February 5, 2002. 
 
Presented an invited paper  on “Management and feeding of the transition cow “ at the Central Wisconsin 
Nutrition Meeting, July 23, 2003 in Eau Claire, WI.  (75 dairy nutritionists) 
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Taught section of a course on dairy herd management and troubleshooting to senior veterinary students at the 
Iowa State University Veterinary College from August 11-15 2003. ( 30 veterinary students) 
 
Taught 2 day seminar on nutrition and management of the transition cow at the American Association of 
Bovine Practitioners Meeting in Columbus Ohio on September 16 and 17, 2003. 
 
 
Presented a series of dairy extension talks  on “Metabolic disease control  and mastitis resistance”  to dairy 
producers and veterinarians in Valdosta, Ga September 17, 2003,; Chiefland, FL on September 18, 2003; and 
Okeechobee, FL on September  19, 2003.   
 
Presented a paper on “Effect of the presence of the mammary gland on periparturient immune function” at the 
USDA-ARS Immunology Conference in Bethesda MD on December 2, 2003. 
 
Presented talks on “Macromineral nutrition” and “Factors affecting trace mineral requirements of cattle” at the 
Shur-gain Nutrition Conference in Stratford, Ontario, Canada on December 4, 2003. 
 
Served on Committee on Animal Nutrition for the National Research Council of the National Academies of 
Science. 
 
Serving on the subcommittee of the Board on Agriculture of the National Academy of Science to revise the 
book “Mineral Tolerances of Domestic Animals”. 
 
Section Editor of the Digestive Physiology and Metabolism portion of the revised edtition of the book “Duke’s 
Physiology of Domestic Animals” which is a primary textbook for veterinary students. 
 
M. Schmerr 
 
Presented paper “Isolation of the Cytokine IL8 from Bovine Pla sma”  HPCE2003 in San Diego, CA January 
2003. Mary Jo Schmerr and Kayoko Kimura 
 
Presented paper “Analysis of a Fluorescence Immunoassay for the Cytokine IL-8 by Capillary Electrophoresis” 
at HPCE2004 in Salzburg, Austria February 2004  
Mary Jo Schmerr and Kayoko Kimura 
 
J. Harp 
 
Chaired Immunology Section at 2002 (St. Louis) and 2003 (Chicago) Annual Meetings of Conference of 
Research Workers in Animal Diseases. 
 
PUBLICATIONS: 
 
Cheng YH, Goff JP, Sell JL, Dallorso ME, Gil S, Pawlak SE, Horst RL. Utilizing Solanum glaucophyllum 
alone or with phytase to improve phosphorus utilization in broilers. 
Poult Sci. 2004 Mar;83(3):406-13.  
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Harp, J.A., Stabel, J.R., Pesch, B.A. and Goff, J.P.  Expression of adhesion molecules on milk and blood 
leukocytes from periparturient dairy cattle with Johne’s disease.  Vet. Immunol. Immunopathol.  98:69-76. 
2004. 
 
Stabel JR, Goff JP, Kimura K. Effects of supplemental energy on metabolic and immune measurements in 
periparturient dairy cows with Johne's disease. 
J Dairy Sci. 2003 Nov;86(11):3527-35.  
 
Goff JP, Horst RL. Milk fever control in the United States. Acta Vet Scand Suppl. 2003;97:145-7. Review.  
 
Harp JA. Cryptosporidium and host resistance: historical perspective and some novel approaches. Anim Health 
Res Rev. 2003 Jun;4(1):53-62. Review.  
 
Chen W, Harp JA, Harmsen AG. Cryptosporidium parvum infection in gene-targeted B cell-deficient mice. J 
Parasitol. 2003 Apr;89(2):391-3.  
 
Goff JP, Horst RL. Role of acid-base physiology on the pathogenesis of parturient hypocalcaemia (milk fever)-
-the DCAD theory in principal and practice. 
Acta Vet Scand Suppl. 2003;97:51-6. Review.  
 
Horst RL, Goff JP, Reinhardt TA. Role of vitamin D in calcium homeostasis and its use in prevention of 
bovine periparturient paresis. Acta Vet Scand Suppl. 2003;97:35-50. Review.  
 
Melendez P, Donovan GA, Risco CA, Littell R, Goff JP.    Effect of calcium-energy supplements on calving-
related disorders, fertility and milk yield during the transition period in cows fed anionic diets. 
Theriogenology. 2003 Sep 15;60(5):843-54.  
 
Nonnecke BJ, Kimura K, Goff JP, Kehrli ME Jr. Effects of the mammary gland on functional capacities of 
blood mononuclear leukocyte populations from periparturient cows. 
J Dairy Sci. 2003 Jul;86(7):2359-68.  
 
Trott DJ, Moeller MR, Zuerner RL, Goff JP, Waters WR, Alt DP, Walker RL, Wannemuehler MJ.  
Characterization of Treponema phagedenis-like spirochetes isolated from papillomatous digital dermatitis 
lesions in dairy cattle. J Clin Microbiol. 2003 Jun;41(6):2522-9.  
 
Harp, J.A.  Parasitic infections of the gastrointestinal tract.  Curr. Opin. Gastroenterol.  19:31-36. 2003. 
 
Kimura K, Goff JP, Kehrli ME Jr, Harp JA, Nonnecke BJ. Effects of mastectomy on composition of peripheral 
blood mononuclear cell populations in periparturient dairy cows. 
J Dairy Sci. 2002 Jun;85(6):1437-44.  
 
Goff JP, Kimura K, Horst RL. Effect of mastectomy on milk fever, energy, and vitamins A, E, and beta-
carotene status at parturition. J Dairy Sci. 2002 Jun;85(6):1427-36.  
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Kimura K, Goff JP, Kehrli ME Jr, Reinhardt TA. Decreased neutrophil function as a cause of retained placenta 
in dairy cattle. J Dairy Sci. 2002 Mar;85(3):544-50.  
 
El-Samad H, Goff JP, Khammash M. Calcium homeostasis and parturient hypocalcemia: an integral feedback 
perspective. J Theor Biol. 2002 Jan 7;214(1):17-29.  
 
Lippolis JD, White FM, Marto JA, Luckey CJ, Bullock TN, Shabanowitz J, Hunt DF, Engelhard VH. Analysis 
of MHC class II antigen processing by quantitation of peptides that constitute nested sets. J Immunol. 2002 
Nov 1;169(9):5089-97.  
 
Tang M, Harp JA, Wesley RD. Recombinant adenovirus encoding the HA gene from swine H3N2 influenza 
virus partially protects mice from challenge with heterologous virus: A/HK/1/68 (H3N2). Arch Virol. 2002 
Nov;147(11):2125-41.  
 
Sonea IM, Palmer MV, Akili D, Harp JA. Treatment with neurokinin-1 receptor antagonist reduces severity of 
inflammatory bowel disease induced by Cryptosporidium parvum. 
Clin Diagn Lab Immunol. 2002 Mar;9(2):333-40.  
 
Waters WR, Nonnecke BJ, Rahner TE, Palmer MV, Whipple DL, Horst RL.   
Modulation of Mycobacterium bovis-specific responses of bovine peripheral blood mononuclear cells by 1,25-
dihydroxyvitamin D(3). Clin Diagn Lab Immunol. 2001 Nov;8(6):1204-12.  
 
Sunita Rao D, Balkundi D, Uskokovic MR, Tserng K, Clark JW, Horst RL, Satyanarayana Reddy G. Double 
bond in the side chain of 1alpha,25-dihydroxy-22-ene-vitamin D(3) is reduced during its metabolism: studies 
in chronic myeloid leukemia (RWLeu-4) cells and rat kidney. 
J Steroid Biochem Mol Biol. 2001 Aug;78(2):167-76.  
 
Luckey CJ, Marto JA, Partridge M, Hall E, White FM, Lippolis JD, Shabanowitz J, Hunt DF, Engelhard VH. 
Differences in the expression of human class I MHC alleles and their associated peptides in the presence of 
proteasome inhibitors. J Immunol. 2001 Aug 1;167(3):1212-21.  
 
Schell TD, Lippolis JD, Tevethia SS.  Cytotoxic T lymphocytes from HLA-A2.1 transgenic mice define a 
potential human epitope from simian virus 40 large T antigen. 
Cancer Res. 2001 Feb 1;61(3):873-9.  
 
Chen, W., Chadwick, V.S., Tie, A., and Harp, J.A.  Cryptosporidium parvum in intestinal mucosal biopsies 
from patients with inflammatory bowel disease.  Am. J. Gastroenterol.  96:3463-3464. 2001. 
 
Purdy, C.W., Straus, D.C., Harp, J.A., Mock, R., and Popham, T.W.  Microbial pathogen survival in a high 
plains feedyard playa.  Texas J. Sci. 53:247-266. 2001 
 
Kehrli ME Jr, Harp JA. Immunity in the mammary gland. Vet Clin North Am Food Anim Pract. 2001 
Nov;17(3):495-516, vi. Review.  
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Heidari M, Harp JA, Kehrli ME Jr. Expression, purification, and in vitro biological activities of recombinant 
bovine granulocyte-colony stimulating factor. Vet Immunol Immunopathol. 2001 Aug 30;81(1-2):45-57.  
 
Moore D, Waters WR, Wannemuehler MJ, Harp JA. Treatment with agmatine inhibits Cryptosporidium 
parvum infection in infant mice. J Parasitol. 2001 Feb;87(1):211-3.  
 
Nepom GT, Lippolis JD, White FM, Masewicz S, Marto JA, Herman A, Luckey CJ, Falk B, Shabanowitz J, 
Hunt DF, Engelhard VH, Nepom BS.  Identification and modulation of a naturally processed T cell epitope 
from the diabetes-associated autoantigen human glutamic acid decarboxylase 65 (hGAD65). Proc Natl Acad 
Sci U S A. 2001 Feb 13;98(4):1763-8.  
 
Lippolis JD, Denis-Mize KS, Brinckerhoff LH, Slingluff CL Jr, Galloway DR, Engelhard VH.   
Pseudomonas exotoxin-mediated delivery of exogenous antigens to MHC class I and class II processing 
pathways. Cell Immunol. 2000 Aug 1;203(2):75-83.  
 
Pelan-Mattocks LS, Kehrli ME Jr, Casey TA, Goff JP. Fecal shedding of coliform bacteria during the 
periparturient period in dairy cows. Am J Vet Res. 2000 Dec;61(12):1636-8.  
 
Hagemoser WA, Goff JP, Sanderson TP, Haynes JS. Osteopenic disease in growing pigs: diagnostic methods 
using serum and urine calcium and phosphorus values, parathoromone assay, and bone analysis. J Vet Diagn 
Invest. 2000 Nov;12(6):525-34.  
 
Goff JP. Pathophysiology of calcium and phosphorus disorders. Vet Clin North Am Food Anim Pract. 2000 
Jul;16(2):319-37, vii. Review.  
 
Moore SJ, VandeHaar MJ, Sharma BK, Pilbeam TE, Beede DK, Bucholtz HF, Liesman JS, Horst RL, Goff JP. 
Effects of altering dietary cation-anion difference on calcium and energy metabolism in peripartum cows. J 
Dairy Sci. 2000 Sep;83(9):2095-104.  
 
Akili D, Harp JA. A factor derived from adult rat and cow small intestine reduces Cryptosporidium parvum 
infection in infant rats. J Parasitol. 2000 Oct;86(5):979-82.  
Waters WR, Palmer MV, Wannemuehler MJ, Sacco RE, Harp JA. B cells are required for the induction of 
intestinal inflammatory lesions in TCRalpha-deficient mice persistently infected with Cryptosporidium 
parvum. J Parasitol. 2000 Oct;86(5):1073-7.  
 
Waters WR, Frydman B, Marton LJ, Valasinas A, Reddy VK, Harp JA, Wannemuehler MJ, Yarlett N. 
[(1)N,(12)N]Bis(Ethyl)-cis-6,7-dehydrospermine: a new drug for treatment and prevention of Cryptosporidium 
parvum infection of mice deficient in T-cell receptor alpha. 
Antimicrob Agents Chemother. 2000 Oct;44(10):2891-4. 
 
Jackman R, Schmerr MJ. Analysis of the performance of antibody capture methods using fluorescent peptides 
with capillary zone electrophoresis with laser-induced fluorescence. 
Electrophoresis. 2003 Mar;24(5):892-6.  
 
                                                                                      79 
 
Hamir AN, Miller JM, Schmerr MJ, Stack MJ, Chaplin MJ, Cutlip RC. Diagnosis of preclinical and subclinical 
scrapie in a naturally infected sheep flock utilizing currently available postmortem diagnostic techniques. J Vet 
Diagn Invest. 2001 Mar;13(2):152-4. 
                                                                                      80 
 
Bacterial Diseases of Livestock 
 
 
Project Title:   Genomic and Immunological Analysis of Spirochetes that Infect    
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PROJECT OBJECTIVES: 
Spirochetes are bacteria that cause a variety of diseases in animals and humans. Our project studies spirochete 
diseases of livestock caused by Leptospira, Brachyspira, and Treponema. Leptospirosis, caused by Leptospira, 
is a common cause of reproductive failure (abortion, stillbirth, and production of weak offspring) in livestock. 
Diagnosis or isolation of these bacteria in culture is difficult, but essential for controlling the spread of disease. 
Leptospirosis can be resolved through the use of antibiotics, and vaccines provide some protection. However, 
the effectiveness of vaccination varies among animal species. Furthermore, Leptospira strains are diverse, and 
vaccination produces specific immunity with little cross protection against different strains. The Spirochete 
Diseases Research Project, Genomic and Immunological Analysis of Spirochetes That Infect Livestock, at the 
USDA-ARS National Animal Disease Center (NADC), Ames, IA, is developing novel and sensitive methods 
for diagnosis of spirochetes in livestock, conducting genetic and pathogenesis studies to determine how these 
bacteria cause disease, and identifying new targets for vaccine development. Brachyspira are intestinal 
spirochetes that cause swine dysentery and porcine intestinal spirochetosis. These diseases can cause 
significant losses in swine production. Porcine intestinal spirochetosis is difficult to diagnose. Therefore, we 
are developing tools for serological diagnosis of infection. Brachyspira are also the only spirochetes with a 
known mechanism of genetic exchange. The process by which these bacteria exchange DNA is unusual, and 
we are characterizing the process to determine its usefulness for genetic manipulation of spirochetes. Members 
of the genus Treponema are associated with papillomatous digital dermatitis (PDD), the primary cause of 
lameness in dairy cattle. We are characterizing the bacteria associated with this disease to develop diagnostic 
probes and study how these bacteria contribute to the disease. 
 
OVERALL PROJECT ACCOMPLISHMENTS: 
Leptospiral vaccines for cattle have been available for years, but field data suggested that effectiveness for 
protection against certain types of bovine leptospirosis was not adequate.  A new vaccine that was 
commercially available in Australia, New Zealand, Ireland and the United Kingdom was evaluated to 
determine if it would protect cattle challenged with a United States strain of Leptospira.  The vaccine 
prevented colonization and shedding of the organism and protected animals against infection. This was in 
contrast to poor protection that resulted when cattle were vaccinated with other commercially available 
leptospiral vaccines.   
 
Immune responses stimulated by the effective vaccine were characterized to determine why this vaccine was 
effective when others were not.  Results of this research demonstrated that a potent cell mediated response was 
important for protection.  This information is important for understanding how to design other effective 
vaccines against leptospirosis and other diseases.  
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The composition of the Leptospira outer membrane was characterized with the discovery of several major 
surface exposed proteins.  These proteins are the subjects of studies being done in conjunction with academic 
collaborators aimed at developing subunit vaccines for leptospirosis.  The major outer membrane protein, 
LipL32, was characterized and is well conserved among pathogenic leptospira species. This protein is highly 
antigenic and is potentially useful for both diagnosis and vaccine development. 
 
Cattle infected with Leptospira were treated with streptomycin until its withdrawal from the U.S. market.  
Alternative antibiotic treatments were tested for efficacious treatment of bovine leptospirosis. This work 
provides essential benchmark data that can be used in negotiating export-import restrictions designed to limit 
the spread of leptospirosis.   
 
The genome of Leptospira borgpetersenii serovar hardjo, the primary cause of bovine leptospirosis, is being 
sequenced.  Analysis of genome sequence data led to identification of a surface exposed protein conserved 
among pathogenic spirochetes.  Conserved and variable regions of other outer membrane proteins were 
identified and characterized.  Combined, these data will form the basis for subunit vaccine development for 
leptospirosis.   
 
Bacteria were isolated from PDD lesions and characterized. These Treponema phagedenis-like bacteria are 
similar to bacteria detected in PDD lesions from cattle around the world, and their isolation in pure culture is a 
key step in identifying the cause of this disease and developing strategies to control the development of PDD.  
Cattle with PDD developed antibody to these bacteria and also developed a cellular immune response to 
bacterial antigens.  Using a technique called Serial Analysis of Gene Expression (SAGE), the global response 
of bovine macrophages to a Treponema phagedenis-like bacterium isolated from a PDD lesion was 
characterized.  This study is the first description of global host response to any spirochete, and therefore is 
breaking new ground in the field.  The results of these studies are providing key information on how these 
spirochete bacteria affect the host, and thereby establish infection.   
 
Methods were developed to isolate the outer membrane of Brachyspira, leading to identification of outer 
membrane proteins.  Outer membrane proteins are ideal targets for vaccine development, and may be useful for 
sensitive diagnostic assays.  These studies established an essential framework for analysis of porcine intestinal 
spirochetosis. 
 
IMPACT:  
Understanding host immune responses stimulated by effective vaccines will lead to development of improved 
vaccines for leptospirosis as well as other diseases.  Identification and characterization of specific proteins and 
genes of Leptospira could lead to development of efficacious subunit vaccines.  Improved vaccines to prevent 
disease will result in decreased economic losses to the livestock industry.  
Characterizing the organisms that cause PPD is important for developing tools to treat and prevent the disease, 
which is a leading cause of lameness in dairy cattle and results in significant economic loss.   
 
Determining the whole genomic sequence of Leptospira borgpetersenii serovar hardjo will lead to 
identification of genes and proteins that are associated with virulence of the organism and clues to how the 
organism causes disease.  This information can be used to develop improved diagnostic tests, vaccines, and 
other intervention strategies.  
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TECHNOLOGY TRANSFER: 
Methods and reagents were provided to diagnostic laboratories to aid in diagnosis of leptospirosis in livestock, 
and to assist in isolation of these bacteria in pure culture. Leptospira challenge strains for testing the efficacy of 
vaccines were provided to biologics firms, academic laboratories, and to the Center for Veterinary Biologics. 
ARS scientists have assisted in evaluation of leptospiral vaccines in collaboration with biologics firms. 
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PROJECT OBJECTIVES: 
Brucellosis is a disease of cattle that causes abortion and associated economic losses and has been nearly 
eradicated from cattle in the U.S. after 60 years of regulatory efforts. However, a high percentage of feral 
swine, and elk and bison in Yellowstone National Park and surrounding areas have brucellosis and have the 
potential to transmit the disease to cattle. During the winter months, elk may share feed grounds with cattle, 
and bison may migrate from Yellowstone National Park to areas where they may have direct contact with 
cattle. We have identified Brucella abortus strain RB51 as an efficacious vaccine for bison and cattle that does 
not interfere with identification of Brucella-infected cattle. However, recent data suggest that the strain RB51 
vaccine does not protect elk against brucellosis. Through studies at the USDA-ARS-National Animal Disease 
Center (NADC), Ames, IA, and collaborative work with scientists from other agencies, we are working to 
develop new vaccines that are safe and efficacious and vaccine delivery systems that would protect wildlife 
and domestic livestock against brucellosis. This will facilitate the completion of the Brucellosis Eradication 
program and assist in reducing or eradicating the disease from wildlife. ARS is also conducting research to 
determine the duration of immunity when cattle are vaccinated as calves with B. abortus strain RB51. This is 
important to determine how long cattle are protected against brucellosis. Several feral swine populations in the 
US are infected with B. suis and pose a potential threat to the livestock industry.  ARS scientists are conducting 
research to develop efficacious vaccines to protect feral swine against B. suis infection and prevent 
transmission of the organisms to domestic livestock. In addition, the whole genome of a field strain of B. 
abortus is being sequenced to identify potential vaccine candidates and tools for molecular epidemiology.  
 
OVERALL PROJECT ACCOMPLISHMENTS: 
As a result of work first initiated in 1991, the B. abortus strain RB51 vaccine received full licensure from the 
USDA-Animal and Plant Health Inspection Service (APHIS) in 2003 as the first new brucellosis vaccine for 
cattle in over 50 years.  Strain RB51 has replaced the strain 19 vaccine throughout the U.S. and is being used, 
or considered for use, in numerous other countries. The strain RB51 vaccine induces similar protection in cattle 
against brucellosis as the previously used strain 19 vaccine, and also has a significant advantage over strain 19 
in that cattle vaccinated with strain RB51 do not have antibody responses that cause positive reactions on 
brucellosis surveillance tests. This has eliminated countless vaccine-induced, false-positive serologic responses 
that previously would have required investigation by regulatory personnel. Our studies have demonstrated that 
strain RB51 is safe in cattle or bison as a calfhood vaccine, is safe in adult bison bulls, and can be safely 
administered at a reduced dosage to pregnant cattle. Our data also demonstrate that calfhood vaccination of 
bison with strain RB51 protects against Brucella-induced abortion or fetal infection. With the completion of 
appropriate safety and efficacy studies in target and nontarget species, it is anticipated that strain RB51 will be 
utilized in bison in the Greater Yellowstone Area.  Our studies have also suggested that antigens that stimulate 
protective cell-mediated immunity may be conserved across Brucella species. These data suggest that genes or 
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gene products which mediate protection against B. abortus will have efficacy in protection against other strains 
of brucellosis which are more prevalent in other countries. 
 
A new method to determine and compare the DNA fingerprint of Brucella isolates was developed using 
information generated from the project to sequence the whole genome of B. abortus.  This method has been 
used to help identify potential sources of infection and aid in epidemiological investigations of outbreaks of 
brucellosis in cattle.   
 
IMPACT: 
Results of ARS research were used to support granting full licensure for use of B. abortus strain RB51 as the 
first new brucellosis vaccine for cattle in 50 years.  The vaccine is now used throughout the US and other parts 
of the world.  The safety and efficacy of B. abortus strain RB51 is now being evaluated in bison for possible 
use in Yellowstone National Park.  
 
The DNA fingerprinting method developed by ARS scientists is being used to aid state and federal regulatory 
officials in their investigations of outbreaks of brucellosis.  This is the first method that can be used to reliably 
determine the fingerprint of Brucella strains beyond species and biovar level and represents an important 
advance in the field of science.   
 
Research conducted by ARS scientists has led to the discovery of B. abortus infection in a population of feral 
swine that is also infected with B. suis.  This is an important discovery and suggests that feral swine my pose a 
threat for transmission of both organisms to domestic livestock.  Additional research is being conducted to 
determine the extent of the problem and to develop vaccines to protect feral swine against infection with 
Brucella.   
  
TECHNOLOGY TRANSFER: 
The Brucella abortus strain RB51 vaccine has been transferred to a company that is producing a commercial 
strain RB51 product which is approved by the Animal and Plant Health Inspection Service (APHIS). The 
RB51 vaccine is being universally utilized by producers throughout the U.S. and in a number of other 
countries. Through attendance and presentations at international meetings, national meetings, symposia, the 
Greater Yellowstone Interagency Brucellosis Committee, and local presentations, the results from our research 
have been presented to scientists, regulatory personnel and producers for field application. Knowledge on 
development of brucellosis vaccines and characterization of immunologic responses has also been transferred 
to Russian scientists through a cooperative program in the Department of Defense. Scientists are continuing to 
assist APHIS in completion of an environmental assessment of RB51. Knowledge gained by ARS scientists in 
regards to the use of the strain RB51 vaccine in cattle, bison, and elk has been transferred to state and federal 
regulatory personnel and is being incorporated into brucellosis management programs.  
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PROJECT OBJECTIVES: 
Paratuberculosis (Johne's disease) is a chronic, progressive enteric disease of ruminants caused by infection 
with Mycobacterium paratuberculosis. Economic losses are estimated to be $200/infected cow/year and are the 
result of animal culling, reduced milk production, poor reproductive performance, and reduced carcass value. 
 
Research in improved diagnostic tests for detection of this disease will provide tools for reducing 
contamination of the environment with M. paratuberculosis and the spread of infection in a herd. Research on 
the pathogenesis and immunology of M. paratuberculosis infections of cattle is conducted to allow design of 
more rational diagnostic and control procedures. Sequencing the genome of M. paratuberculosis will lead to 
identification of specific antigens for M. paratuberculosis and will result in better diagnostic tests to allow 
early detection of subclinically infected animals and reduce the incidence of disease in herds. 
 
OVERALL PROJECT ACCOMPLISHMENTS: 
Significant progress has been made in the development and/or optimization of new diagnostic tools for the 
detection of Johne's disease. Fecal culture methodology has been improved and diagnostic laboratories 
throughout the U.S. are using this technique. Optimization of the gamma-interferon test for detection of 
subclinically infected animals has been achieved through incorporation of our antigen preparations in the test, 
allowing for detection of infected animals less than 6 months of age. The ability to accurately identify animals 
in the early stages of disease is a critical control point. Development of the fecal polymerase chain reaction 
(PCR) test may yield more timely and sensitive detection of infected animals that are shedding the bacteria in 
their feces. 
 
Little information is available on host immune responses to M. paratuberculosis infection in cattle and other 
species of ruminants. Host immune responses in the subclinical and clinical stages of disease have been 
evaluated using cattle, bison, and a mouse model. Our work has shown that secretion of proteins (cytokines, 
IFN-g, IL-10, TGF-b) by immune cells and activation of immune cells is affected by the different stages of 
infection. This information is helpful in developing diagnostic tools for Johne's disease as well as treatment 
strategies. 
 
M. paratuberculosis has been implicated as a causative factor in Crohn's disease, an inflammatory bowel 
disease, in humans. A proposed method of infection is via contaminated dairy products from cows with Johne's 
disease. Experiments were conducted to evaluate current pasteurization standards set by the dairy industry on 
the destruction of M. paratuberculosis in raw milk using state-of-the-art technology. Our work has 
demonstrated that continuous flow pasteurization of milk effectively destroys M. paratuberculosis. This work 
is critical in ensuring a safe, clean product for U.S. consumers. 
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Improvement of diagnostic tools and development of vaccines is dependent upon the identification of specific 
antigens for M. paratuberculosis. A genomic library for M. paratuberculosis was screened and several clones 
specific to M. paratuberculosis were recovered. One clone, HspX, has been characterized in our laboratory and 
has been patented. Thirty additional genes have been cloned and expressed and are being evaluated for use in 
diagnostic tests. Further characterization of additional clones and expression of proteins from them will aid in 
the development of more sensitive diagnostic tests. 
  
IMPACT: 
Results of ARS research showed that M. paratuberculosis is effectively killed at high concentrations in milk 
during pasteurization.  In the study, several heat treatment regimes were evaluated using three different strains 
of M. paratuberculosis. Evaluation of current pasteurization methods used by the U.S dairy industry 
significantly impacted the recommendation that pasteurized milk is safe for human consumption. 
 
Identification of new unique genes for M. paratuberculosis will have significant impact on development of 
diagnostic tools for detection of Johne’s disease in ruminants.  Currently, cross-reactivity with other 
mycobacterial species in serologic tests can result in false positive test results for Johne’s disease, which causes 
economic loss for livestock producers.  In addition, sensitivity of detection is a significant problem in most 
diagnostic tests for Johne’s disease.  Developing and optimizing improved diagnostic tests for identification of 
infected animals is important for controlling the spread of this disease.  Furthermore, these antigens can be 
evaluated as vaccine candidates in the calves to either prevent infection or decrease clinical signs. 
 
Continued work on host immune responses in different stages of disease (subclinical and clinical) will provide 
information on how the disease progresses and what causes the progression from the latent state to clinical 
stages of disease.  This information can be used to develop new management strategies to prevent escalation of 
disease within a herd or treatment options that may be cost-effective for the producer.   
 
TECHNOLOGY TRANSFER: 
Polyclonal antibodies to preparations of M. paratuberculosis developed in our laboratory have been transferred 
to several companies (Cooperative Research and Development Agreements or MTAs) in collaborative efforts 
to develop new diagnostic tools for Johne's disease. Commercial availability of the new diagnostic tools is 
dependent upon the companies involved and successful use of these tools. 
 
Invitations to speak about effects of pasteurization on destruction of M. paratuberculosis have resulted in the 
transfer of this information to the dairy industry and producers. 
 
ARS scientists have transferred technology by giving numerous presentations on various aspects of Johne’s 
disease research to scientific organizations and livestock industry groups.  Groups have been particularly 
interested in research on pasteurization of milk, development of improved diagnostic tests, and application of 
the project to sequence the genome of M. paratuberculosis.  
 
PUBLICATIONS: 
 
Khalifeh MS, Stabel JR.  Effects of Gamma Interferon, Interleukin-10, and Transforming Growth Factor beta 
on the Survival of Mycobacterium avium subsp. paratuberculosis in Monocyte-Derived Macrophages from 
Naturally Infected Cattle. Infect Immun. 2004; 72(4):1974-82.  
                                                                                      90 
 
 
Amonsin A, Li LL, Zhang Q, Bannantine JP, Motiwala AS, Sreevatsan S, Kapur V.  Multilocus short sequence 
repeat sequencing approach for differentiating among Mycobacterium avium subsp. paratuberculosis strains. J 
Clin Microbiol. 2004; 42(4):1694-702.  
 
Stabel JR, Bosworth TL, Kirkbride TA, Forde RL, Whitlock RH.  A simple, rapid, and effective method for the 
extraction of Mycobacterium paratuberculosis DNA from fecal samples for polymerase chain reaction. J Vet 
Diagn Invest. 2004; 16(1):22-30.  
 
Bannantine JP, Hansen JK, Paustian ML, Amonsin A, Li LL, Stabel JR, Kapur V.  Expression and 
immunogenicity of proteins encoded by sequences specific to Mycobacterium avium subsp. paratuberculosis. J 
Clin Microbiol. 2004; 42(1):106-14.  
 
Bannantine JP, Zhang Q, Li LL, Kapur V. Genomic homogeneity between Mycobacterium avium subsp. avium 
and Mycobacterium avium subsp. paratuberculosis belies their divergent growth rates. BMC Microbiol. 2003; 
3(1):10.  
 
Stabel JR, Goff JP, Kimura K. Effects of supplemental energy on metabolic and immune measurements in 
periparturient dairy cows with Johne's disease. J Dairy Sci. 2003; 86(11):3527-35.  
 
Stabel JR, Palmer MV, Whitlock RH. Immune responses after oral inoculation of weanling bison or beef 
calves with a bison or cattle isolate of Mycobacterium avium subsp. paratuberculosis. J Wildl Dis. 2003; 
39(3):545-55.  
 
Waters WR, Miller JM, Palmer MV, Stabel JR, Jones DE, Koistinen KA, Steadham EM, Hamilton MJ, Davis 
WC, Bannantine JP. Early induction of humoral and cellular immune responses during experimental 
Mycobacterium avium subsp. paratuberculosis infection of calves. Infect Immun. 2003; 71(9):5130-8.  
 
Bannantine JP, Huntley JF, Miltner E, Stabel JR, Bermudez LE. The Mycobacterium avium subsp. 
paratuberculosis 35 kDa protein plays a role in invasion of bovine epithelial cells. Microbiology. 2003; 149(Pt 
8):2061-9.  
 
Motiwala AS, Strother M, Amonsin A, Byrum B, Naser SA, Stabel JR, Shulaw WP, 
Bannantine JP, Kapur V, Sreevatsan S. Molecular epidemiology of Mycobacterium avium subsp. 
paratuberculosis: evidence for limited strain diversity, strain sharing, and identification of unique targets for 
diagnosis. J Clin Microbiol. 2003; 41(5):2015-26.  
 
Stabel JR, Ackermann MR. Temporal Mycobacterium paratuberculosis infection in T-cell receptor (TCR)-
alpha and TCR-delta-deficient mice. Vet Immunol Immunopathol. 2002; 89(3-4):127-32.  
 
Thornton CG, MacLellan KM, Stabel JR, Carothers C, Whitlock RH, Passen S. Application of the C (18)-
carboxypropylbetaine specimen processing method to recovery of Mycobacterium avium subsp. 
paratuberculosis from ruminant tissue specimens. J Clin Microbiol. 2002; 40(5):1783-90.  
 
                                                                                      91 
 
Stabel JR, Wells SJ, Wagner BA. Relationships between fecal culture, ELISA, and bulk tank milk test results 
for Johne's disease in US dairy herds. J Dairy Sci. 2002; 85(3):525-31.  
 
Bannantine JP, Stabel JR. Killing of Mycobacterium avium subspecies paratuberculosis within macrophages. 
BMC Microbiol. 2002; 2(1):2.  
 
Lee H, Stabel JR, Kehrli ME Jr. Cytokine gene expression in ileal tissues of cattle infected with 
Mycobacterium paratuberculosis. Vet Immunol Immunopathol. 2001; 82(1-2):73-85.  
 
Bannantine JP, Baechler E, Zhang Q, Li L, Kapur V. Genome scale comparison of Mycobacterium avium 
subsp. paratuberculosis with Mycobacterium avium subsp. avium reveals potential diagnostic sequences. J Clin 
Microbiol. 2002; 40(4):1303-10.  
 
Bannantine JP, Stabel JR. Identification of two Mycobacterium avium subspecies paratuberculosis gene 
products differentially recognized by sera from rabbits immunized with live mycobacteria but not heat-killed 
mycobacteria. J Med Microbiol. 2001; 50(9):795-804.  
 
Stabel JR, Whitlock RH. An evaluation of a modified interferon-gamma assay for the detection of 
paratuberculosis in dairy herds. Vet Immunol Immunopathol. 2001; 79(1-2):69-81.  
 
Dargatz DA, Byrum BA, Barber LK, Sweeney RW, Whitlock RH, Shulaw WP, Jacobson RH, Stabel JR. 
Evaluation of a commercial ELISA for diagnosis of paratuberculosis in cattle. J Am Vet Med Assoc. 2001; 
218(7):1163-6.  
 
Pillai SR, Jayarao BM, Gummo JD, Hue EC, Tiwari D, Stabel JR, Whitlock RH.   Identification and sub-
typing of Mycobacterium avium subsp. paratuberculosis and Mycobacterium avium subsp. avium by randomly 
amplified polymorphic DNA. 
Vet Microbiol. 2001; 79(3):275-84.  
 
Stabel JR. On-farm batch pasteurization destroys Mycobacterium paratuberculosis in wastemilk. J Dairy Sci. 
2001 Feb; 84(2):524-7.  
 
Motiwala, A.S., Strother, M., Amonsin, A., Byrum, B., Naser, S.A., Stabel, J.R., Shulaw, W.P., Bannantine, 
J.P., Kapur, V., Sreevatsan, S. Molecular epidemiology of Mycobacterium avium subsp. Paratuberculosis: 
evidence for limited strain diversity, strain sharing, and identification of unique targets for diagnosis. Journal 
of Clinical Microbiology. 2003. v. 41. p. 2015-26. 
 
Bannantine, J.P., Zhang, Q., Li, L.L., Kapur, V. Genomic homogeneity between Mycobacterium avium subsp, 
avium and Mycobacterium avium subsp. Paratuberculosis belies their divergent growth. BMC Microbiology. 
2003. v. 3. 
 
Bannantine, J.P., Huntley, J.F., Miltner, E., Stabel, J.R., Bermudez, L.E. The Mycobacterium avium subsp. 
Paratuberculosis 35 kDa protein plays a role in the invasion of bovine epithelial cells. Microbiology. 2003. v. 
149. p. 2061-9. 
 
                                                                                      92 
 
Stabel JR.Transitions in immune responses to Mycobacterium paratuberculosis. Vet Microbiol. 2000 Dec 
20;77(3-4):465-73. 
 
Bannantine JP, Stabel JR.HspX is present within Mycobacterium paratuberculosis-infectedmacrophages and is 
recognized by sera from some infected cattle.Vet Microbiol. 2000 Oct 20;76(4):343-58.  
 
Stabel JR.Johne's disease and milk: do consumers need to worry?J Dairy Sci. 2000 Jul;83(7):1659-63.  
 
Stabel JR.Cytokine secretion by peripheral blood mononuclear cells from cowsinfected with Mycobacterium 
paratuberculosis.Am J Vet Res. 2000 Jul;61(7):754-60.  
 
Bannantine JP, Griffiths RS, Viratyosin W, Brown WJ, RockeyDD.A secondary structure motif predictive of 
protein localization to the chlamydial inclusion membrane. Cell Microbiol. 2000 Feb;2(1):35-47.  
 
Suchland RJ, Rockey DD, Bannantine JP, Stamm WE. Isolates of Chlamydia trachomatis that occupy 
nonfusogenic inclusions lack IncA, a protein localized to the inclusion membrane. Infect Immun. 2000 
Jan;68(1):360-7. 
 
Ellingson, J. L. E., Stabel, J. R., Bishai, W. R., Frothingham, R., and Miller, J. M.  2000.    Evaluation of the 
Accuracy and Reproducibilityof a Practical PCR Panel Assay for Rapid Detection and Differentiationof 
Mycobacterium avium subsp. paratuberculosis.  Mol. Cell. Probes 14:153-161. 
 
Mwangi SM, Stabel J, Lee E, Kehrli ME, Taylor MJ.Expression and characterization of a recombinant soluble 
form of bovine tumor necrosis factor receptor type I.Vet Immunol Immunopathol. 2000 Dec 29;77(3-4):233-
41.   
 
 
                                                                                      93 
 
Bacterial Diseases of Livestock 
 
Project Title:   Diagnosis and Control of Tuberculosis in Livestock and Wildlife 
CRIS Number:     3625-32000-063-00D 
Scientists:             Palmer, M., Waters, W., Whipple, D.  
Location:        Ames, IA, National Animal Disease Center, Bacterial Diseases of Livestock 
Contact: Palmer, M. Phone: (515) 663-7474, Fax: (515) 663-7458, mpalmer@nadc.ars.usda.gov 
  
 
PROJECT OBJECTIVES: 
Bovine tuberculosis, which is caused by Mycobacterium bovis, is an infectious disease that affects many 
species of animals as well as human beings. Animals infected with M. bovis can shed organisms as they exhale 
or cough and in various secretions including saliva, milk, and urine. Elimination of animals infected with M. 
bovis is important to prevent the spread of disease among animals and to human beings. The U.S. initiated a 
program to eradicate tuberculosis from cattle in 1917 when the prevalence of disease was approximately 5%. 
In general, the eradication program has been successful and today, less than 0.002% of cattle are infected with 
M. bovis. However, a low prevalence of disease has persisted over the last 10-15 years and it has not been 
possible to eradicate bovine tuberculosis from the U.S. using available technology. Improved diagnostic tests 
and control measures are needed to detect and eliminate the few remaining cattle herds that have bovine 
tuberculosis. In addition, tuberculosis has been detected in captive deer and elk and in wild white-tailed deer, 
coyotes, raccoons, bear, bobcat, opossum, and fox. There is epidemiological and experimental evidence to 
suggest that tuberculosis has been transmitted from deer to cattle. The presence of tuberculosis in wildlife 
poses a serious threat to the national eradication program. Other countries with tuberculosis in wildlife species 
have been unable to eradicate the disease from the domestic livestock population. The Bovine Tuberculosis 
Research Project at the USDA-ARS-National Animal Disease Center (NADC), Ames, IA, is conducting 
research to develop a better understanding of the interactions between various host species and M. bovis, 
including immune response, antemortem diagnosis, prevention through vaccination, disease progression and 
interspecies transmission.  
 
OVERALL PROJECT ACCOMPLISHMENTS: 
A new test, the polymerase chain reaction (PCR) for detection and identification of M. bovis in tissue samples 
collected for microscopic examination was developed. When animals are slaughtered, meat inspectors collect 
tissue samples from animals that are suspected of having tuberculosis. Tissue samples are examined for 
microscopic evidence of tuberculosis and for the presence of organisms. Stains used to detect M. bovis in a 
tissue sample also stain other organisms making it impossible to identify the organism in the sample. The new 
test detects a specific piece of DNA that is present only in organisms that cause tuberculosis. The new test 
permits more accurate and rapid identification of animals with tuberculosis than was previously possible. The 
test is used extensively at the request of state and federal regulatory officials to confirm suspected cases of 
tuberculosis in animals. This technology has been transferred to USDA, APHIS. 
 
A method differentiate strains of M. bovis was developed. Differences among various strains of M. bovis can 
be identified by using specific genetic markers. Using these markers, it is possible to determine if different 
animals are infected with a common strain or different strains of M. bovis. This information is used by 
epidemiologists to determine possible sources of infection in outbreaks of tuberculosis in animals. This 
technology has been transferred to USDA, APHIS. 
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An interferon gamma blood based assay for the diagnosis of tuberculosis in cattle is currently available. NADC 
scientists, in cooperation with USDA, APHIS and various state agencies evaluated the accuracy of this assay 
compared to traditional skin testing. Such research allowed the approval of the interferon gamma assay for use 
in cattle.  
 
An experimental model of tuberculosis in white-tailed deer was developed using intratonsilar inoculation. The 
resulting disease is very similar to that observed in naturally infected deer. This model has been used 
extensively by NADC scientists to study the transmission of tuberculosis among deer and between deer and 
cattle and has demonstrated that deer can transmit M. bovis to other deer or cattle through indirect contact such 
as the sharing of feed. This model has also been used to develop and evaluate improved tests for diagnosis of 
tuberculosis in deer and to determine the effectiveness of vaccines to prevent infection.  
 
Current surveys to determine the prevalence of tuberculosis in wild white-tailed deer are based on examination 
of tissues in the head to detect lesions. In a study that involved detailed examination of the entire deer carcass, 
we determined that about 35-50% of the infected deer did not have lesions in the head. This underestimation of 
disease prevalence should be considered when estimating prevalence through surveillance efforts that focus on 
examination of the head only. 
 
A safe, reliable, and reproducible method of aerosol delivery of Mycobacterium bovis to cattle, or other large 
ruminants was developed and validated by scientists at NADC. Aerosol exposure is believed to be a primary 
means of M. bovis transmission between cattle. NADC scientists conducted the first and only studies on 
aerosol exposure of M. bovis in cattle. These studies have shown that this method of exposure results in lesions 
similar to those seen in naturally infected cattle. Such a delivery method is being used at NADC to investigate 
disease pathogenesis, transmission, immune responses, and vaccine efficacy and could be used to deliver other 
pathogens of cattle where aerosol delivery is critical. Aerosol exposure of deer to M. bovis did not result in 
disease similar to that seen in naturally infected deer, further supporting the hypothesis that transmission of M. 
bovis between deer involves routes such as sharing of feed. 
 
The outbreak of tuberculosis in white-tailed deer in Michigan, identified in 1995, represents the first wildlife 
reservoir of M. bovis in North America and a serious threat to the federal bovine tuberculosis eradication effort. 
ARS scientists at NADC demonstrated that M. bovis can be transmitted between deer in close contact, through 
the sharing of feed and to deer fawns through oral infection with milk containing M. bovis. These results 
document that contaminated milk, in addition to saliva, nasal secretions, urine and feces may be involved in 
transmission of M. bovis between deer. Such information is vital for state and federal officials to make 
educated decisions concerning disease control strategies. 
 
Currently, tuberculin skin testing is the most common method of antemortem testing of deer for tuberculosis; 
however, tuberculin skin testing of deer lacks specificity and requires the capture and handling of animals at 
least twice for testing. ARS scientists at NADC have investigated various blood-based assays for the diagnosis 
of tuberculosis in deer species common in North America. ARS scientists have shown that a commercially 
available assay for interferon gamma may be useful in white-tailed deer, reindeer, and possibly elk. After 
further work, this assay could potentially supplement or replace skin testing in captive Cervidae, decreasing 
animal handling and testing time. Such tests would decrease overall cost to producers, animal stress and time to 
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diagnosis. Serological assays have also been investigated and may be useful for screening animals in field 
situations. 
 
IMPACT: 
The technology for PCR testing of formalin fixed tissues has been transferred to major stakeholders, USDA, 
APHIS, NVSL. This testing has allowed more rapid confirmation of tuberculosis, allowing epidemiologic 
investigation to start much earlier than was previously possible. Quarantine times for producers are reduced 
and continued spread of disease through animal movements is minimized. 
 
Methods for differentiation of M. bovis strains has been transferred to USDA, APHIS, NVSL and are used to 
aid in identification of the source of herd infections and trace movements of infected animals. 
 
The experimental model of infection in white-tailed deer has been used extensively by ARS scientists to study 
disease pathogenesis, evaluation of diagnostic tests, vaccine efficacy and interspecies transmission. This model 
is currently being used by investigators in other countries (Canada) to examine tuberculosis in red deer and elk. 
Utilizing this model, NADC scientists have demonstrated the ability of deer to transmit M. bovis to other deer 
and cattle through indirect contact such as the sharing of feed. This information has been extensively used by 
Michigan wildlife and agricultural officials to lobby for the banning of supplemental feeding of wildlife to 
control the tuberculosis outbreak in northern Michigan. Subsequent epidemiological investigations have 
supported these findings and shown an association between supplemental feeding and disease prevalence.   
 
Aerosol methods of infection with M. bovis have been used by ARS scientists to evaluate vaccine efficacy in 
cattle. These are the first studies to examine aerosol infection in cattle, the method considered to be the most 
likely means of transmission between cattle. Aerosol infection studies in deer conducted by ARS have 
demonstrated that white-tailed deer infected by aerosol inoculation do not develop disease similar to that seen 
in naturally infected deer. This information further supports the hypothesis that supplemental feeding and 
shared feed are primary means of disease transmission and supports state and federal efforts to discontinue the 
practice of supplemental feeding of wildlife. 
 
Research on improved diagnosis of tuberculosis in Cervidae has resulted in a change in the interpretation of 
tuberculin skin testing results in reindeer by state and federal veterinarians. Based on ARS research a new 
scattergram was adopted by USDA, APHIS for interpretation of skin tests results in reindeer that results in 
decreased numbers of false positive results, decreased needles destruction of animals, and decreased cost to 
USDA. Research on blood based diagnostic assays has resulted in the recommendation by the USAHA in 2003 
that the gamma interferon assay for deer be evaluated side by side with skin testing to determine if this blood 
based assay may be a suitable replacement for skin testing. Serological assays developed or evaluated by 
NADC scientists have been used to assist Michigan wildlife officials in screening of large numbers of trapped 
wild deer as an approach to selectively remove tuberculous deer. 
 
Research by NADC scientists comparing traditional tuberculin skin testing and the gamma interferon test for 
cattle resulted in the adoption of the gamma interferon test as an officially approved test by USDA for the 
diagnosis of tuberculosis in cattle. Furthermore, the gamma interferon test can be used in place of the 
comparative cervical skin test. This test is now being widely used in states such as Michigan and Texas.  
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Research on an assay to detect nitric oxide as a means of antemortem diagnosis of tuberculosis was patented by 
ARS. Patent # 6,673,566. PC 0152.01. Another patent on the use of a recombinant protein for tuberculosis 
diagnosis is in the process of being filed. 
 
Diseases at the interface of wildlife and domestic animals have become increasingly important. The study of 
infectious diseases in wildlife is costly and challenging and very few institutions are involved in such research 
involving agents requiring bio-containment. NADC has been visited by scientists from Plum Island, Winnipeg 
and other laboratories to observe how NADC scientists conduct such research. The impact of the overall 
wildlife research at NADC has been that NADC scientists are consulted regularly on research in wildlife in 
bio-containment involving BL-3 agents and foreign animal diseases. 
 
TECHNOLOGY TRANSFER: 
PCR of formalin fixed tissues transferred to USDA, APHIS, NVSL. 
 
Technology to differentiate strains of M. bovis transferred to USDA, APHIS, NVSL. 
 
The gamma interferon assay as well as serological assays have been used on numerous occasions to assist state 
and federal animal health officials to more rapidly and accurately diagnose M. bovis infection in deer and 
cattle. 
 
NADC scientists have presented research findings on improved diagnostic tests for Cervidae to producer 
groups such as the North American Deer Farmers Association and the Reindeer Owner’s and Breeders 
Association at their annual meetings. 
 
NADC scientists have presented research findings on improved diagnosis of tuberculosis through use of the 
interferon gamma assay in cattle and deer to the United States Animal Health Association on various 
occasions.  
 
NADC scientists have presented research findings on the transmission of M. bovis between deer and from deer 
to cattle at various meetings of Michigan wildlife and agricultural officials, the United States Animal Health 
Association and USDA, APHIS. These officials have used such findings to implement a ban on supplemental 
feeding of wildlife to control the tuberculosis outbreak in Michigan. 
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Virus and Prion Diseases of Livestock 
 
Project Title:   Emerging Viral Diseases of Swine 
CRIS Number:     3625-32000-071-00D 
Scientists:             Lager, K., Cheung, A., Kehrli, M., Vacant    
Location:       Ames, IA, National Animal Disease Center, Virus and Prion Diseases of Livestock 
Contact:  Lager, K., Phone: (515) 663-7371, Fax: (515) 663-7458, klager@nadc.ars.usda.gov 
  
 
PROJECT OBJECTIVES: 
Recently, swine influenza virus (SIV) has changed or mutated into different strains or subtypes that have 
caused significant losses for the swine industry.  There are at least several SIV subtypes circulating in U.S. 
swine and currently available vaccines may not protect against all of the subtypes. In addition to the SIV 
concerns there has emerged a new swine virus, porcine circovirus type 2 (PCV2), that is associated with a 
newly recognized disease syndrome that causes significant losses for the industry, especially in young pigs.  
The overall goal of this project is to better understand how SIV and PCV2 cause disease in swine and then 
apply this knowledge to develop strategies that can protect swine from these viruses and control the disease 
that they cause.        
 
OVERALL PROJECT ACCOMPLISHMENTS: 
An inactivated swine influenza virus (SIV) vaccine was developed and this technology was transferred to a 
biologics company that is now marketing the vaccine to reduce the economic impact of swine flu.  Rapid 
diagnostic tests have been developed for the detection of SIV, PCV2, and porcine reproductive and respiratory 
syndrome virus (PRRSV) and validation of these assays is underway.  Recent studies have demonstrated 
Adenovirus-vectored SIV vaccines in young pigs may be used to circumvent the inhibitory effect of passively 
acquired SIV maternal antibody, and a potential attenuated SIV virus vaccine has been developed.  Porcine 
circovirus studies have characterized the molecular biology of the virus resulting in a better understanding of 
how this virus replicates and future experiments will apply this knowledge towards understanding how the 
virus infects swine and causes disease.   
 
IMPACT: 
Use of the inactivated vaccine by pork producers has aided in the prevention and control of swine influenza.  
The rapid diagnostic tests can increase the efficincy of diagnostics and may decrease the cost of diagnostic 
work.  Pathogenesis studies have indicated that even within the same SIV subtype (H3 subtype) there are 
antigenically distinct groups of virus and a single H3 vaccine strain may not cross-protect against all H3 SIV 
subtypes.  This finding may explain potential vaccine failures and it indicates a potential need for continually 
evaluating SIV vaccine strains.  Understanding the replication of porcine circovirus will provide a means to 
evaluate how this virus can cause disease and insight into possible ways the virus could be changed to produce 
a vaccine for prevention of disease.    
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TECHNOLOGY TRANSFER: 
Transfer of SIV vaccine to a biologics company that licensed the vaccine and is currently selling it.  Transfer 
PRRSV and SIV real-time reverse transcription-polymerase chain reaction (RT-PCR) assays to North Carolina 
State, Iowa State, and Oregon State Veterinary Diagnostic Laboratories for use in routine diagnostics. 
  
PUBLICATIONS: 
 
Richt, J.A., Lager, K.M., Clouser, D., Spackman, E., Suarez, D.L., Yoon, K-J. 2004. Real-time RT-PCR assays 
for the detection and differentiation of North American swine influenza viruses. J. Vet. Diagn. Invest., in press 
 
Cheung, A.K. Comparative analysis of the transcriptional patterns of pathogenic and nonpathogenic porcine 
circoviruses. Virology. 2003. v. 310. p. 41-49. 
 
Richt, J.A., Lager, K.M., Janke, B.H., Woods, R.D., Webster, R.G. Webby, R.J. Pathogenic and antigenic 
properties of phylogenetically distinct reassortant H3N2 swine influenza viruses cocirculating in the United 
States. Journal of Clinical Microbiology. 2003. v. 41. p. 3198-3205. 
 
Tang, M, Harp, J.A., Wesley, R.D. Recombinant adenovirus encoding the HA gene from swine H3N2 
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Virus and Prion Diseases of Livestock 
 
Project Title:   Virus-Induced Respiratory and Reproductive Diseases of Swine 
CRIS Number::     3625-32000-057-00D 
Scientists:             Wesley, R., Lager, K., Kehrli, M. 
Location:        Ames, IA, National Animal Disease Center, Virus and Prion Diseases of Livestock 
Contact:  Wesley, R., Phone: (515) 663-7358, Fax: (515) 663-7384, rwesley@nadc.ars.usda.gov 
 
PROJECT OBJECTIVES: 
Porcine reproductive and respiratory syndrome (PRRS) is a virus-induced disease of swine that is characterized 
clinically by reproductive failure of gilts and sows and a respiratory tract illness that is especially severe in 
young pigs. It was discovered first in the U.S. in 1987 and soon spread worldwide. The sudden emergence of 
PRRS virus in the swine population has led to speculation that it may have arisen by mutation of a similar virus 
of another species. However, as of today the origin of PRRS virus is still in question. Our current research is 
focused on developing methods for diagnosing, preventing, controlling, and eventually eradicating this costly 
disease. 
 
OVERALL PROJECT ACCOMPLISHMENTS: 
Accomplishments over the life of the project include: 1) developing better methods of diagnosing PRRS; 2) 
developing, evaluating and licensing a laboratory procedure for identifying strains of PRRS virus; 3) 
developing, evaluating and licensing a new vaccine for the prevention of atypical PRRS; 4) defining when and 
how PRRS virus causes disease; and 5) providing service and consultation to industry representatives, swine 
practitioners, other researchers, and swine producers in their efforts to prevent and control PRRS. 
  
IMPACT: 
The vaccine is being used by pork producers to prevent and control PRRS.  The diagnostic assay has been used 
extensively by diagnosticians and field veterinarians for differentiating PRRSV isolates.  The animal studies 
have provided insight into the pathogenesis of the virus and this knowledge is being used to develope and 
improve PRRS control and prevention strategies. 
 
TECHNOLOGY TRANSFER:  
A unique PRRSV isolate was developed into an attenuated vaccine and transferred to a biologics company for 
liscensing and marketing.  Likewise a unique diagnostic assay was developed that can be used to differentiate 
PRRSV isolates by a simple code, this technology is used daily by veterinarians and pork producers.  Formal 
collaborations between ARS and industry has provided information about the safety and efficacy of PRRSV 
vaccines and this information has been applied by veterinarians in the development of PRRS control and 
prevention strategies. Information concerning the use of replication defective human adenovirus-5 vaccines to 
overcome maternal antibody interference was provided to the National Pork Board and the International Pig 
Veterinary Society for use by their members.  A Cooperative Research and Development Agreement with an 
international veterinary biologics company is being initiated to investigate these vectors or others to overcome 
this vaccine interference problem. 
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Lager, K.M., Mengeling, W.L., Wesley, R.D. Strain predominance following exposure of vaccinated and naive 
pregnant gilts to multiple strains of porcine reproductive and respiratory syndrome virus. Canadian Journal of 
Veterinary Research. 2003. v. 67. p. 121-127. 
 
Mengeling, W.L., Lager, K.M., Vorwald, A.C., Clouser, D.F. Comparative safety and efficacy of attenuated 
single-strain and multi-strain vaccines for porcine reproductive and respiratory syndrome. Veterinary 
Microbiology. 2003. v. 93. p. 25-38. 
 
Mengeling, W.L., Lager, K.M., Vorwald, A.C., Koehler, K.J. Strain specificity of the immune response of pigs 
following vaccination with various strains of porcine reproductive and respiratory syndrome virus. Veterinary 
Microbiology. 2003. v. 93. p. 13-24. 
 
Brockmeier, S.L., Lager, K.M. Experimental airborne transmission of porcine reproductive and respiratory 
syndrome virus and Bordetella bronchiseptica. Veterinary Microbiology. 2002. v. 89. p. 267-75. 
 
Butler, J.E., Sun, J., Weber, P., Ford, S.P., Rehakova, Z., Sinkora, J., Francis, D., Lager, K. Switch 
recombination in fetal porcine thymus is uncoupled from somatic mutation. Veterinary Immunology and 
Immunopathology. 2002. v. 87. p. 307-319. 
 
Wesley, R.D., and Lager, K.M.  Increased litter survival rates, reduced clinical illness and better lactogenic 
immunity against TGEV in gilts that were primed as neonates with porcine respiratory coronavirus. Veterinary 
Microbiology. 2003. v. 95. pp. 175-186. 
 
Lager K., Mengeling W., Wesley R.  Evidence for local spread of porcine reproductive and respiratory 
syndrome virus.  J. Swine Health Prod. 10:167-170 (2003). 
 
Mengeling, W. L., Wesley, R. D., Lager, K. M., and Vorwald, A. C.  Effect of concurrent infections on 
persistence and shedding of porcine reproductive and respiratory syndrome virus and transmissible 
gastroenteritis virus.  J. Swine Health Prod. 2002. v. 10. pp. 67-73. 
 
Mengeling, W. L., Boilin, S. R., Lager, K. M., Vorwald, A. C., and Wesley, R. D.  Immunology and 
epidemiology of porcine reproductive and respiratory syndrome, pseudorabies and postweaning multisystemic 
wasting syndrome.  Magazyny Weterynaryjny. 2002. supplement pigs, pp. 27-33. 
 
                                                                                      104 
 
Lager, K. M., Mengeling, W. L., and  Wesley, R. D.  Evidence for local spread of porcine reproductive and 
respiratory syndrome virus.  J. Swine Health Prod. 2002. v. 10. pp. 167-170. 
 
Benson, J. E., Yaeger, M. J., Christopher-Hennings, J., Lager, K., Yoon, K-J.  A comparison of virus isolation, 
immunohistochemistry, fetal serology, and reverse-transcription polymerase chain reaction for the 
identification of porcine reproductive and respiratory syndrome virus transplacental infection in the fetus.  J. 
Vet. Diagn. Invest. 14:8-14. (2002). 
 
Mengeling, W.L., Lager, K.M., Burkhart, K, Vorwald, A.C., Roof, M.B., Gorcyca, D.E. Porcine reproductive 
and respiratory syndrome virus vaccine based on isolate JA-142. U.S. Patent Application S/N 09/298,110. 
 
Brockmeier, S.L., Palmer, M.V., Bolin, S.R., Rimler, R.B. Effects of intranasal inoculation with Bordetella 
bronchiseptica, porcine reproductive and respiratory syndrome virus, or a combination of both organisms on 
subsequent infection with Pasteurella multocida in pigs. American Journal of Veterinary Research. 2001. v. 
62(4). p. 521-525. 
 
Brockmeier, S.L., Palmer, M.V., Bolin, S.R. Effects of intranasal inoculation of porcine reproductive and 
respiratory syndrome virus, Bordetella bronchiseptica, or a combination of both organisms in pigs. American 
Journal of Veterinary Research. 2000. v. 61(8). p. 892-899. 
 
 Mengeling, W.L., Vorwald, A.C., Cornick, N.A., Lager, K.M., Moon, H.W. In vitro detection of Shiga toxin 
using porcine alveolar macrophages. Journal of Veterinary Diagnostic Investigation. 2001. v. 13. p. 421-424. 
 
Harms, P.A., Sorden, S.D., Halbur, P.G., Bolin, S.R., Lager, K.M., Morozov, I., Paul, P.S. Experimental 
reproduction of severe disease in CD/CD pigs concurrently infected with type 2 porcine circovirus and porcine 
reproductive and respiratory syndrome virus. Veterinary Pathology. 2001. v. 38. p. 528-539. 
 
Mengeling, W. L., Lager, K. M., Vorwald, A. C., Wesley, R. D. and Prieto, C.  Porcine reproductive and 
respiratory syndrome: vaccines and immunity.  Animal Reprod. Sci. 2000. v. 60-61. pp.199-210. 
 
Mengeling, W. L., Lager, K. M. A brief review of procedures and potential problems associated with the 
diagnosis of porcine reproductive and respiratory syndrome. 2000. Veterinary Research. v. 31(1). p. 61-69. 
 
Mengeling, W. L., and Lager, K. M.  A brief review of procedures and potential problems associated with the 
diagnosis of porcine reproductive and respiratory syndrome.  Vet. Res. 31:61-69. (2000). 
 
Lager, K.M., Mengeling, W. L.  Diagnosing acute infections of porcine reproductive and respiratory disease 
syndrome in swine.  Vet. Res. 31:70. (2000). 
 
Mengeling, W. L., Lager, K. M., Vorwald, A. C. The effect of porcine parvovirus and porcine reproductive and 
respiratory syndrome virus on porcine reproductive performance. Jul 2000. Animal Reproduction Science. v. 
60-61. p. 199-210. 
 
                                                                                      105 
 
Wesley, R. D., Clouser, D. F., Mengeling, W. L., Andreyev, V. G., Vorwald, A. C., Lager, K. M. Restriction 
enzyme screen for differentiating porcine reproductive and respiratory syndrome virus strains. Jan 2000. U.S. 
Patent 6,015,663. 
 
--------------- Additional publications by scientist in this project. --------------- 
 
Soucie, J. M., Erdman, D. D., Evatt, B. L., Anderson, L. J., Torok, T. J., El-Jamil, M. Barnhart, E. Tepper, M. 
Burrill, H. N., Pickett, A. M., Mengeling, W. L. Investigation of porcine parvovirus among persons with 
hemophilia receiving Hyate:C porcine factor VIII concentrate. Jun 2000. Transfusion. v. 40(6). p. 708-711. 
 
Cheung, A.K., Chen, Z., Sun, Z., McCullough, D. Pseudorabies virus induces apoptosis in tissue culture cells. 
Archives of Virology. 2000. v. 145. p. 2193-2200. 
                                                                                      106 
 
Virus and Prion Diseases of Livestock 
 
Project Title:   Detection and Control of Bovine Viral Diarrhea Viruses 
CRIS Number:     3625-32000-065-00D 
Scientists:             Ridpath, J., Neill, J., Vacant 
Location:        Ames, IA, National Animal Disease Center, Virus and Prion Diseases of Livestock 
Contact:  Ridpath, J., Phone: (515) 663-7586, Fax: (515) 663-7458, jridpath@nadc.ars.usda.gov 
  
PROJECT OBJECTIVES: 
Bovine viral diarrhea viruses (BVDV) acting alone or in conjunction with other pathogens are a source of 
major economic loss to the U.S. farm economy. Pathogenesis varies from strain to strain and appears to be the 
result of a very complex interaction between virus and host. Variation in virulence is not correlated with 
replication rates or cytopathology in vitro. Pathogenesis appears to be due in part to the host's response to viral 
replication rather than viral replication itself. The goals of this project are to improve the industry's ability to 
limit and control infections. Our approach is to correlate variations among BVDV with differences in immune 
response and pathogenesis. 
  
OVERALL PROJECT ACCOMPLISHMENTS: 
This is a project based on a Project Plan certified by the OSQR February 2, 2002. Current research activity 
follows from the previous project.  Major accomplishments for the proceeding project include the recognition 
of a new type of BVDV (genotype BVDV2). BVDV2 strains differ from previously described BVDV strains 
(genotype BVDV1) in the way they are recognized by the immune system, in the makeup of their genetic 
information and in the diseases they cause. It was shown that differences between BVDV2 and BVDV1 strains 
result in diagnostic and vaccine failure. Further, it was shown that viruses, which cause the most severe form of 
acute BVDV infection, belong to the BVDV2 genotype. The first complete characterization of the genetic 
makeup of BVDV2 strains was performed. In response to suggestions that BVDV2 strains represented a 
variation of the bovine border disease virus (BDV) the first complete characterization of a BDV genome was 
done. Comparison of the genetic makeup of BVDV1, BVDV2 and BDV viruses demonstrated that BVDV2 
strains were more closely related to BVDV1 strains than BDV strains. Tests based on these comparisons were 
developed that differentiated BVDV2 strains from BVDV1 and BDV strains. These tests are now standard 
protocol at numerous state diagnostic laboratories and the USDA-Animal and Plant Health Inspection Services 
(APHIS), National Veterinary Services Laboratory (NVSL) Diagnostic Virology Laboratory (DVL), Ames, IA.  
Two new BVDV vaccines, that are the result of collaboration between NADC and commercial biologics 
companies, were recently released. These vaccines offer a wider spectrum of protection compared to previous 
vaccines. 
 
IMPACT: 
Research done in this project has resulted in a new generation of diagnostics and vaccine that do a better job of 
detecting and controlling BVDV infections.  
 
TECHNOLOGY TRANSFER: 
Both scientist were on the organizing committee for the meeting “Detecting and Controlling BVDV Infections 
held in Ames, IA April 4-5, 2002.  The purpose of this meeting was to foster discussion and interaction 
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between researchers, diagnosticians, practitioners and biologics company employees regarding strategies 
aimed at reducing BVDV losses. 
 
Both scientists acted as editors and contributed articles for a special volume of the journal Biologicals that was 
devoted to issues involved with detecting, limiting and preventing BVDV infections.  The target audience for 
this volume was diagnosticians and field veterinarians. 
 
In conjunction with Agrilabs produced a compact disk that included information on the significance of BVDV 
genotypes and biotypes to BVDV management programs.  This CD was generated for distribution to producers 
and field veterinarians. 
  
Attended meeting and contributed to proceeding of meeting (Paris, March 30, 2001) hosted by Office 
International des Epizooties (OIE) called to discuss international standards for purity of reagents used in 
biologics production.  Asked to speak on BVDV contamination of fetal calf serum. 
 
Conducted classes for veterinarians and producers on the basic biology of BVDV, impact of BVDV and 
development of BVDV vaccines for producers and veterinarians (classes qualified as 2 to 3 hours of continuing 
education credits for attending veterinarians):  Breckenridge, Colorado – July 10, 2002; Reno, Nevada - 
February 28, 2003; Yerington, Nevada - March 1, 2003; Breckenridge, Colorado - July 9, 2003; Hot Springs, 
Arkansas – Nov. 21, 2003; Scottsdale, Arizona – January 27, 2004; Oscoela, Iowa  – April 7, 2004. 
 
Contacted authors and reviewed manuscripts for a 4 part series on BVDV published in Hoard’s Dairyman in 
2002- 2003.  Authored one article entitled BVDV: The Basics and co-authored another entitled “To Get Ahead 
of BVD:  find out what strains you have, keep careful records, and take measures to prevent spread of all 
diseases”.   
 
Served as presenters at two “miniconferences” on BVDV held in conjunction with the National Cattlemen’s 
Beef Association meeting (Cattlemen’s College, Phoenix, Arizona - 1/28/04) and the Western Veterinary 
Conference (BVDV Control, Las Vegas, Nevada – 2/15/04). 
 
Researchers in this project have provided numerous groups with one or more of the following:  protocols, 
virus, antibodies, virus characterization, SAGE techniques and tag IDs, PCR primer sequences, genomic 
sequences and/or sequence analysis.  These groups include:  Biocor Animal Health; Centers for Disease 
Control and Prevention; Center for Veterinary Biologics and Product Development; Colorado Serum 
Company; Colorado State University; Cornell College of Veterinary Medicine; Fort Dodge Animal Health; 
Intervet, Inc.; Iowa State University; National Veterinary Services Laboratory; OIC Virology Laboratory, 
NSW, Australia; Oklahoma State University; University of California at Davis; University of Nebraska; 
University of North Dakota; Washington State University; and other research projects at NADC. 
 
In addition, researchers in this group have participated in 3 Cooperative Research and Development Agreement 
(CRADA) with industry; 2 USDA-CSREES-NRI-CGP grant; attended and presented data at 4 international 
meetings, 11 national meetings and 5 regional meetings; acted as outside reviewers for the Office International 
des Epizooties (OIE) Manual on BVDV; and acted as scientific reviewers for the following journals: 
Biologicals; Archives of Virology Comparative Immunology; Microbiology and Infectious Diseases; Journal 
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of Clinical Microbiology; Journal of Virology; Veterinary Microbiology; and Virus Research, Virology and 
served on the editorial board of Virus Research and Veterinary Research Communications. 
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Virus and Prion Diseases of Livestock 
 
Project Title:   Bovine Spongiform Encephalopathy and Other Transmissible  
Spongiform Encephalopathies 
CRIS Number:     3625-32000-066-00D 
Scientists:             Hamir, A., Kunkle, R., Richt, J., Kehrli, M., Vacant, Vacant  
Location:        Ames, IA, National Animal Disease Center, Virus and Prion Diseases of Livestock 
Contact:  Kehrli, M., Phone: (515) 663-7254, Fax: (515) 663-7458 
mkehrli@nadc.ars.usda.gov 
  
 
PROJECT OBJECTIVES: 
This project was expanded in January 2002 from the original TSE project that investigated scrapie.  Today the 
project focuses on investigations of various Transmissible Spongiform Encephalopathies (TSE), which are 
fatal degenerative diseases of the central nervous system that can affect several animal species, including 
humans.  The causal agent is believed to be a natural tissue protein, the prion protein, that has assumed an 
unnatural form. Because the altered protein is resistant to enzyme degradation, it accumulates in nervous tissue 
and the resulting dysfunction ultimately leads to death. The specific TSEs being investigated in this project are 
scrapie in sheep, chronic wasting disease (CWD) in deer and elk, and transmissible mink encephalopathy 
(TME) in mink.  The major concern about these diseases is that another TSE, bovine spongiform 
encephalopathy (BSE), has been shown to cross the species barrier to cause a unique TSE in human beings.  
Although there has not been a similar demonstration that scrapie, CWD or TME could present any risk to 
human health, the BSE experience has raised many questions about the potential hazard these TSEs present for 
transmission to other animal species, especially domesticated livestock and wildlife. The major objectives are 
to assess transmissibility of the TSEs that affect livestock and wildlife species, to develop methods for 
differentiation of TSE strains, and to determine the pathobiology of these diseases in the natural host and after 
cross-species transmission. Results of animal inoculation studies are then compared to results obtained with a 
variety of laboratory procedures to determine if they can be used as predictive models for future risk 
assessments. These studies also provide information about the clinical and pathological disease characteristics 
that can be expected if a TSE crosses the species barrier, thus enabling animal health specialists to recognize 
such situations should they occur. Additional transmission studies in the natural host will focus on determining 
the modes of transmission and disease development in scrapie and CWD so that appropriate intervention 
strategies can be devised that will control the spread of these diseases. Studies, in collaboration with APHIS, 
are underway to determine the role of genetics in the susceptibility of elk to CWD.  The scrapie, CWD and 
TME agents will be used in experiments to further assess the risk that these TSEs might pose to cattle, sheep, 
and swine.  These experiments will also provide information and tissues that can be used to evaluate the 
effectiveness of current diagnostic protocols for animal TSEs.  Cooperative research with the United Kingdom 
includes strain typing of CWD isolated from cases in the U.S.A. utilizing the mouse bioassay, use of 
recombinant prion proteins to develop or improve existing in vitro conversion strain-typing assays, use of 
immunohistochemistry to improve the standard pathology-oriented mouse strain-typing bioassay, and 
development of in vitro assays to predict infective titer of tissues derived from TSE-affected animals.  Sheep 
scrapie studies are underway to determine influences of strain source and host genetics in disease progression.  
Current experiments are in progress to determine transmissibility of CWD from mule deer into cattle and 
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sheep. White-tailed deer have been inoculated with CWD from elk, mule deer and white-tailed deer to 
determine if there are strain differences in the agent that depend on host origin. 
 
OVERALL PROJECT ACCOMPLISHMENTS: 
Scientists on this project have demonstrated the transmissibility of scrapie to cattle by intracerebral inoculation 
and that the pathology of scrapie-affected cattle differed from BSE; importantly, cattle were shown to be 
resistant to challenge with scrapie by the oral route.  Another significant accomplishment was the development 
and ongoing verification of the immunohistochemistry (IHC) test used by APHIS in the BSE surveillance 
program.  A recent contribution of this project was the development of a method to conduct genotyping of the 
sheep prion gene using formalin-fixed and paraffin-embedded tissues as the DNA source material.  Most 
recently, several of our research capabilities were utilized when project scientists contributed critical research 
in support of the 2003 BSE diagnosis.  Western blot analyses and prion allele sequencing from the index case 
verified the accuracy of the APHIS IHC test and the species origin of the tissues as bovine.  Current studies of 
CWD transmissibility to cattle indicate a relative resistance to infection and a pathology profile which differs 
from BSE.  Another significant accomplishment was the demonstration that abnormal prions are not detectable 
by IHC in striated muscle tissues from animals experimentally inoculated with agents of TSEs.  The current 
project has also demonstrated the utility of raccoons as a model for strain-typing TSEs; raccoons are very 
susceptible to TME, moderately so to scrapie, and resistant to CWD.  In FY 2003 a mouse facility, dedicated 
for TSE strain typing of U.S. TSE isolates was built.  This is a critical advance in our research capabilities to 
conduct the gold standard mouse bioassay for the differentiation of TSE strains (“strain-typing”).  The mouse 
bioassay uses 4 inbred mouse strains with different prion protein genotypes. The new facility is essential for 
rearing these mice and is now operational.  Mice from different PrP genotypes are being raised for future 
inoculation with defined U.S. scrapie and CWD isolates.  Concurrently, in vitro strain typing efforts which rely 
on biochemical analysis of the pathological form of the prion protein (PrPd) were started because the animal 
bioassay is relatively slow and expensive.  This methodology involves determination of molecular mass and 
glycoform profile by Western Blot analysis. Preliminary results indicate CWD isolates from mule deer and 
white-tailed deer differ in molecular size when compared to CWD isolates from elk.  Recently, completed 
work has determined that scrapie can be transmitted to elk and the resulting disease is indistinguishable from 
CWD in that species.  
 
IMPACT: 
Ongoing research verification of the IHC test used by APHIS has ensured the sensitivity and specificity of the 
test for BSE.  Research support of the 2003 BSE case provided APHIS diagnostic pathologists with research 
verification of the IHC results and assurance the brain tissue was accurately identified as bovine in origin.  A 
critical question for consumers is whether abnormal prion protein is present in meat, our research has shown 
that abnormal prion protein is not detectable by IHC in skeletal muscle tissues of animals experimentally 
inoculated with scrapie, CWD or TME.  The demonstration that cattle and sheep are relatively resistant to 
experimental inoculation with CWD suggests that transmission of CWD to cattle or sheep in nature is not 
likely to occur easily.  In addition, raccoons were shown to be a potential model for in vivo differentiation of 
the 3 animal prion diseases found in the United States (scrapie, CWD, and TME). 
 
TECHNOLOGY TRANSFER: 
The current and past cross-species-transmission TSE studies have generated a unique set of tissue reagents that 
have been shared with others for research and diagnostic purposes.  This transfer of technology, along with the 
immunohistochemistry test developed by Dr. Miller at NADC (used around the world), has provided 
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diagnostic tools to many laboratories.  Application of in vitro research techniques provided critical information 
to APHIS during the December 2003 diagnosis of BSE in a bovine from Washington State. 
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PROJECT OBJECTIVES: 
Fowl cholera (caused by Pasteurella multocida) and bordetellosis (caused by Bordetella avium) are bacterial 
diseases responsible for major economic losses to the poultry industry, especially the turkey industry.  
Bordetellosis usually affects young turkeys, 1 day to 6 weeks of age, while fowl cholera usually affects turkeys 
at 8 weeks of age and older.  Often turkeys may experience both diseases, i.e., bordetellosis followed by fowl 
cholera.  Live-attenuated vaccines against fowl cholera often fail to protect turkeys after the birds have 
experienced bordetellosis, and killed vaccines against fowl cholera do not protect poultry against different 
types of P. multocida.  The bacterial components and host conditions responsible for these actions have not 
been identified.  The components of P. multocida that produce immunity to the same and different types of the 
bacteria are being purified and evaluated for use as protective vaccines against fowl cholera and for use in 
developing tests of immunity in vaccinated flocks.  The components of B. avium responsible for immune 
suppression are being identified and their mechanisms of action on the turkey and its immune system are being 
characterized. 
 
OVERALL PROJECT ACCOMPLISHMENTS: 
Hyaluronic acid, a component of host tissues and the capsule of P. multocida, was found to be responsible for 
attachment of the bacteria to turkey air sac macrophages, but not to blood monocytes.  Growth of monocytes in 
tissue culture resulted in upregulation of a glycoprotein receptor.  Because bacterial invasion of the host 
initially involves attachment to a host receptor, this glycoprotein may be involved in invasion by P. multocida.  
Methods or materials, which inhibit bacterial attachment to this receptor, may provide a means to protect 
against fowl cholera. 
 
Turkeys infected with B. avium respond poorly to vaccination with live-attenuated vaccines against fowl 
cholera.  Research has shown that B. avium infection did not result in a poor immune response to vaccination 
when bacterins are used to control fowl cholera.  These findings imply that strategies can be developed 
whereby immunization of breeder hens to B. avium and vaccination of their offspring with P. multocida 
bacterins will control fowl cholera in turkeys when vaccination with live-attenuated vaccines of P. multocida is 
not feasible. 
 
The antigen in P. multocida that produces protection against different serotypes of the bacteria was identified 
and purified.  This antigen is most likely responsible for the protection against different serotypes of P. 
multocida conferred by live-attenuated vaccines.  With identification and further characterization of the 
protective determinant, it may be possible to develop reagents and tests to predict flock immunity produced by 
live-attenuated vaccines. 
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A method for DNA fingerprinting R. anatipestifer was developed.  This molecular method can be used to 
determine the epidemiology of R. anatipestifer in turkeys and ducks.   
 
A method for DNA fingerprinting B. avium was developed.  This molecular method can differentiate B. avium 
from the non-pathogenic B. hinzii, which often occurs in turkeys and can be used to determine the 
epidemiology of B. avium. 
 
Monoclonal antibodies to the type specific antigen of serotypes 1, 2, and 3 P. multocida were developed and 
will be used to develop new and simpler tests for serologic typing of P. multocida. 
 
Little is known about the transmission or prevalence of B. avium in wild birds or whether wild birds may act as 
a reservoir for domesticated poultry.  We surveyed 237 birds, representing 61 wild bird species, for evidence of 
past or present B. avium infection.  Approximately 42% of the birds sampled, representing 41 species, were 
identified as having been infected with B. avium.  DNA analysis of B. avium isolates from wild birds showed 
that at least some were indistinguishable from clinical isolates from domesticated turkeys.  These results 
suggest that transmission of B. avium from free-living avian populations may be possible and should be of 
concern to producers. 
 
Two genetic lines of turkeys were infected with B. avium to determine whether there might be genetic variation 
in resistance to bordetellosis.  No differences were found in the time of onset, incidence, or severity of clinical 
signs of bordetellosis between the two lines of poults infected with B. avium.  However, there was a significant 
depression (12%) in body weight of one line of poults selected for rapid growth rate.  This study is the first to 
show genetic variation in response of poults to experimental infection with B. avium and suggests that disease 
resistance to bordetellosis may be further improved by genetic selection. 
 
With researchers at the UCLA School of Medicine, two new avian epithelial antimicrobial peptides, 
Gallinacin3 and gallopavin1, were identified in tissues from chickens and turkeys, respectively.  Expression of 
Gallinacin3 was especially prominent in the tongue, bursa of Fabricius, and trachea of chickens.  Tracheal 
expression of Gallinacin3 was significantly increased following infection with Hemophilus paragallinarum, 
whereas its expression in tongue, oesophagus, and bursa of Fabricius was unaffected.  These peptides may be 
important in the host innate immune defense mechanism to respiratory tract infection. 
 
With researchers at Ohio State University, Beltsville Small White turkeys were found to represent a unique 
source of variation in major histocompatibility complex (MHC) class II genes and could be useful for 
immunological experiments that require syngeneic (MHC-matched) cells.  The MHC is a chromosomal region 
containing a family of genes that encode a group of proteins involved in regulating a number of cellular 
processes of importance to the immune response. 
 
The research that was accomplished will assist in efforts to use the Pasteurella lipoprotein B protein for 
cloning, expressing and utilization in challenge studies for development of a new vaccine for fowl cholera.  
This progress report addresses Objective 1 of the research plan to determine the mechanisms of pathogenesis 
of P. multocida.  
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IMPACT: 
The work described to date reflects activities that were instrumental to developing new objectives outlined in 
the recent OSQR Project Plan (submitted for review 9/5/03). The new objectives focus on bacterial respiratory 
diseases of poultry and are as follows:  (1) Define virulence mechanisms of Ornithobacterium rhinotracheale 
(ORT) infection in poultry in order to optimize control strategies and diagnostic methodologies.  (2) Determine 
the mechanisms of pathogenesis of Bordetella avium associated with tracheal colonization and 
immunosuppression in turkeys.  (3) Identify and characterize virulence factors and or immunogens of 
Pasteurella multocida related to colonization and the development of immunity in poultry.  The impact of the 
work has created the foundation to (1) develop DNA-based diagnostic tests for accurate bacterial identification 
and strain differentiation among isolates; (2) utilize mutant strains of bacteria to examine the pathogenesis 
related to toxin production and examine the genes involved in colonization; (3) express outer membrane 
proteins of the bacteria which could provide heterologous immunity to multiple serotypes and become 
effective vaccine candidates.  This information will be useful in defining new methods for inhibiting infection 
in poultry.
 
TECHNOLOGY TRANSFER: 
Conducted serotyping analysis of P. multocida strains for diagnostic laboratories and industry. 
 
Conducted DNA fingerprinting on R. anatipestifer for The Michigan State University Diagnostic laboratory to 
determine vaccine efficacy. 
 
Provided cultures of P. multocida and H. gallinarum to biologic companies, university laboratories and the 
NVI (Bucharest, Romania) for research, diagnostics and vaccine development. 
 
Provided information pertaining to nucleic acid-based detection methods for Bordetella and Pasteurella to an 
international online news and information provider specific to animal health industries. 
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PROJECT OBJECTIVES: 
Respiratory disease in swine is complex due to interactions between different kinds of bacteria or between 
viruses and bacteria, including Bordetella bronchiseptica, Pasteurella multocida, and Haemophilus parasuis.  
They often act as secondary lung pathogens following viral infections.  Vaccines containing killed B. 
bronchiseptica and P. multocida do provide at least some benefit in reducing the economic impact of these 
diseases.  However, surveys reveal that the majority of U.S. producers find the efficacy of these vaccines to be 
low.  A major impediment to the development of improved vaccines is a gap in our understanding of the 
identity and function of those products of B. bronchiseptica, P. multocida, and H. parasuis that permit the 
bacteria to colonize swine and that cause disease.  Understanding bacterial and host mechanisms involved in 
the pathogenesis of porcine respiratory disease will permit more effective preventive measures and control 
strategies to be developed.  Models for respiratory diseases in swine caused by B. bronchiseptica and P. 
multocida alone, together, and in combination with H. parasuis and viruses such as Porcine Reproductive and 
Respiratory Syndrome Virus (PRRSV) are being developed.  Products of B. bronchiseptica, P. multocida, or 
H. parasuis suspected to have a role in development of disease or inducing immune protection are being 
evaluated in laboratory culture systems or in animal models to determine their actual functions.  Additionally, 
both B. bronchiseptica and P. multocida are difficult to detect using standard laboratory procedures and, as a 
result, their impact in disease is probably underestimated.  New, more sensitive nucleic acid-based tests are 
being developed for their identification and for use in distinguishing different strains. 
 
OVERALL PROJECT ACCOMPLISHMENTS: 
DNA vaccines designed to induce cell-mediated and/or antibody responses to the P. multocida toxin (PMT) 
have been constructed.  The vaccines consist of 2 slightly different eukaryotic expression vectors into which 
we have cloned either a truncated PMT gene that retains all known immunogenic epitopes or the full-length 
PMT gene, but with a single point mutation that results in genetic detoxification.  Immunization of mice with 
the recombinant plasmids demonstrated no toxic effects from any of the constructs.  However, only one of the 
constructs containing the entire PMT gene appears to be immunogenic in mice. 
 
We identified two colonization factors for H. parasuis, a P-5 protein and a P-2 protein based on homologies to 
H. influenzae proteins.  Using monoclonal antibodies we determined that the avirulent reference strains contain 
the P-2 protein as a 55 kDa protein with the exception of serovar 7 and that all virulent strains contain the P-2 
protein as a 48 kDa protein with the exception of serovar 4.  The P-5 protein was purified, characterized and 
the gene for the P-5 protein has been cloned.  Field strains will be tested for the presence of P-2 and the P-5 
proteins.  
 
Whether or not aerosol spread of respiratory pathogens occurs is of importance for determining methods for 
breaking the transmission cycle.  We determined that aerosol transmission of both PRRSV and B. 
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bronchiseptica occurs, at least over short distances.  Thus animals do not necessarily have to be in direct 
contact to transmit these diseases among the herd. 
 
Although vaccines for B. bronchiseptica have been widely utilized for many years, improvements are needed 
since a majority of swine veterinary specialists report dissatisfaction with their protective efficacy.  The protein 
pertactin that is produced by B. bronchiseptica has been implicated as an adhesin and protective immunogen in 
swine.  The DNA and predicted amino acid sequences of the pertactin repeat regions from 81 recent field 
isolates and 5 vaccine strains from the United States were determined, and 4 unique pertactin types were 
identified.  Interestingly, only 2 vaccines possess the most commonly identified pertactin type found in the 
swine isolates.  If immune protection to B. bronchiseptica correlates with the presence of pertactin, then 
vaccine efficacy could be improved by including pertactin types matching those commonly circulating in the 
field. 
 
The protein filamentous hemagglutinin (FHA) may also be an important protective antigen for Bordetella 
species.  Analysis of the FHA genes from different B. bronchiseptica isolates revealed differences in the DNA 
sequence and protein structure.  Heterogeneity in this gene was not previously known to exist.  It may be 
possible to improve the efficacy of swine vaccines by ensuring they contain forms of FHA identical to those 
found in swine isolates.   
 
P. multocida toxin (PMT), known to cause loss of bone density, also causes alterations in the cells involved in 
bone remodelling.  B lymphocytes in the bone marrow may interact with these bone cells during their 
development. We have developed an in vitro porcine bone marrow culture system in order to examine whether 
changes in bone cells induced by treatment with PMT influence the development of B cells in bone marrow.  
Modulation of B cell development could influence the host response to secondary infections. 
 
Haemophilus parasuis is a re-emerging pathogen of high-health status swine.  We have performed a cluster 
analysis of the one-dimensional gel protein profiles of all serovars.  Fifteen serovars have been identified of 
which six are highly virulent (cause death), four are less virulent (cause no death), and five are completely 
avirulent.  The results revealed that there are two main groups consisting of the highly virulent and less virulent 
strains and six sub groups consisting of similar protein profiles.   
 
Secondary pathogens such as P. multocida and H. parasuis have difficulty establishing infection on their own.  
We have shown that prior infection with B. bronchiseptica enhances colonization of both P. multocida and H. 
parasuis in the swine upper respiratory tract.  Thus, reduction of B. bronchiseptica infection should decrease 
the incidence of secondary respiratory infections. 
 
Infection with Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) is thought to predispose to 
pneumonia with bacterial pathogens.  We have shown that PRRSV predisposes to bronchopneumonia with B. 
bronchiseptica but not P. multocida.  Unlike B. bronchiseptica, P. multocida does not colonize the respiratory 
tract well on its own.  Enhancing the colonization of P. multocida through prior infection with B. 
bronchiseptica resulted in increased incidence of bronchopneumonia with P. multocida when the pigs were 
coinfected with PRRSV.  Producers should minimize this combination of organisms in their herds since more 
severe disease, and possibly further infection with opportunistic bacteria, may occur in co-infected herds. 
 
A B. bronchiseptica mutant unable to produce the dermonecrotic toxin, believed to be its primary virulence 
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factor, was produced and subsequently evaluated in swine.  The results demonstrated that the toxin is important 
for much of the disease manifestations, but that other virulence factors appear responsible for establishing 
infection as the mutant was still able to colonize well.  Subsequently, experiments were conducted to determine 
whether colonization despite the attenuation of disease would be able to predispose to secondary infections.  It 
was found that infection with the dermonecrotic toxin mutant of B. bronchiseptica was still able to enhance 
colonization with P. multocida resulting in lesions of atrophic rhinitis. 
 
Swine isolates of B. bronchiseptica were found to be resistant to killing by sera.  Although the genetic locus 
conferring serum resistance for other Bordetella species (brkAB) was demonstrated to be present in B. 
bronchiseptica, construction and analysis of a mutant strain revealed that some other mechanism must underlie 
serum resistance in this species.  Therefore, the products of the brkAB genes are not likely to be beneficial as 
components of a vaccine. 
 
Ribotyping was developed as a molecular method to discriminate among strains of B. bronchiseptica and was 
found to be useful as a tool for investigating outbreaks.  Restriction enzyme analysis was developed as a 
molecular method to distinguish among Bordetella bronchiseptica isolates. 
 
A sensitive and specific diagnostic test was developed to simultaneously identify B. bronchiseptica and 
toxigenic P. multocida in cultures from swine with respiratory disease.  The test should eliminate many false 
negative results obtained with conventional methods currently in use in clinical laboratories. 
 
A B. bronchiseptica mutant deficient in a major pathway for iron acquisition was constructed and evaluated in 
swine.  The mutation significantly decreased the bacteria’s virulence, though not sufficiently to be useful as an 
attenuated vaccine.  However, the results demonstrated that disruption of iron acquisition may provide a means 
to control infection.   
 
B. bronchiseptica was found to be capable of invading and surviving within swine alveolar macrophages, 
which are a primary host defence mechanism in the lung.  Furthermore, B. bronchiseptica was demonstrated to 
be cytotoxic for these cells.  These observations may explain, in part, the ability of this organism to establish 
infection in an otherwise healthy animal and to predispose infected swine to secondary respiratory pathogens. 
 
We demonstrated in vivo and in vitro that greater numbers of bacteria adhere to cells when B. bronchiseptica is 
grown at room temperature compared to body temperature, indicating a potential environmental phase in 
transmission.  B. bronchiseptica was found to attach to swine ciliated nasal epithelial cells through a novel 
mechanism that has not been previously described.  The attachment factor(s) involved is not produced under 
conditions typically used for the growth of bacteria included in bacterin vaccines.  Vaccine efficacy may be 
improved by changes in growth conditions that would permit production of this attachment factor.  
 
We have established a protein expression map of each of the 15 serovars of H. parasuis under an iron-
sufficient growth condition.  This map in addition to others which will be prepared under other nutrient 
limitation or environmental stress will allow us to identify unique proteins of the virulent reference strains 
compared to the avirulent reference strains.  
 
We identified two unique and two common proteins by comparing the composites of two virulent reference 
strains and two avirulent reference strains grown under iron-sufficient growth conditions.  The four proteins 
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were characterized by mass spectrometry.  One of the unique proteins is a homolog of the H. influenzae 
“protective antigen.”  The gene encoding this protein will be cloned, expressed, and purified for preliminary 
vaccine trials in Caesarean-derived, colostrum-deprived (CDCD) nursery pigs. 
 
We identified a virulence factor and colonization factor of H. parasuis by homology to H. influenzae using H. 
influenza primers and PCR.  This colonization factor was cloned and expressed in E. coli.  The recombinant 
adhesion protein P5 will be purified by affinity chromatography and tested in CDCD pigs for its ability to 
prevent colonization of the upper and lower respiratory tract. 
 
 
IMPACT: 
The work addresses these objectives in our OSQR Project Plan:  to determine the ability of these organisms 
and their products to act in concert with other respiratory pathogens to exacerbate disease; to identify, through 
genomic and proteomic analysis, changes in gene expression of the host and infectious agents during the 
infectious process; and to evaluate intervention strategies to control porcine respiratory disease, including 
vaccination.  The accumulating amount of evidence indicates that B. bronchiseptica is important in 
predisposing to a broad spectrum of respiratory diseases in swine and control of this pathogen will be 
important for overall respiratory health of swine.  Identification of proteins unique to virulent strains of H. 
parasuis will impact vaccine development and diagnostics. 
 
 
TECHNOLOGY TRANSFER: 
Provide consultation to veterinary biologics companies, swine production management companies and 
producers. 
 
Have material transfer agreements with several veterinary biologics companies. 
 
Have CRADA 58-3K95-2-921 with BRDC (Effects of PRRSV infection on gene expression in swine). 
 
Have provided ISU diagnostic lab with Pasteurella multocida toxin testing via colony lift assay and PCR 
methods and transferred the PCR technology for them to use. 
 
Used ribotyping to investigate the epidemiology of outbreaks of Bordetella bronchiseptica for several swine 
production management companies. 
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Respiratory Diseases of Livestock  
 
Project Title: Controlling Losses from Respiratory Disease in Cattle, Sheep, and Goats 
CRIS Number: 3625-32000-067 
Scientists:  Briggs RE, Vacant1, Lehmkuhl HD, Tatum FM, Vacant2
Location:  Respiratory Diseases of Livestock Research Unit, NADC, Ames, IA 
Contacts:  515-663-7762 (P); 515-663-7458 (F); bbriggs@nadc.ars.usda.gov
 
PROJECT OBJECTIVES: 
Respiratory tract diseases are the leading cause of loss from disease in the cattle, sheep, and goat industries.  
Annual loss in the United States is estimated to exceed one billion dollars for cattle alone.  Viral agents are 
well recognized as primary pathogens and even uncomplicated infections can cause substantial economic loss.  
Infectious Bovine Rhinotracheitis Virus (IBRV), Respiratory Syncytial Virus (RSV), Parainfluenza Type 3 
Virus (PI3V), and Bovine Viral Diarrhea Virus (BVDV) are generally considered the most economically 
important viruses against which exist numerous commercially-available multivalent vaccines.  Yet the 
magnitude and complexity of the problem still exists.  A portion of this problem is attributable to Respiratory 
Coronavirus and Adenoviruses, which have not been extensively evaluated.  Respiratory viruses also 
predispose animals to costly bacterial pneumonia caused by Mannheimia haemolytica, Pasteurella multocida, 
Haemophilus somnus, and Mycoplasma bovis which commonly affect beef cattle.  P. multocida and M. 
haemolytica commonly affect dairy cattle.  These bacteria remain the major cause of loss from mortality, 
reduced feed efficiency, treatment costs, and reduced product quality.  Commercial vaccines are available for 
bacterial respiratory disease, but their efficacy in the field is questionable.  An underlying problem is the 
current beef cattle marketing system, which does not allow timely vaccination before the peak period of 
disease occurring soon after shipping.  Antibiotic usage at this time is prevalent, costly, but beneficial.  
Vaccination in sheep and goats is complicated by the broad number of M. haemolytica serovars against which 
protection is necessary.  The role of Adenovirus in causing or contributing to respiratory disease is being 
evaluated using serologic and virus isolation methods.  The molecular mechanisms of respiratory tract 
colonization and disease progression are being elucidated by construction and testing of non-polar bacterial 
mutants.  New modified-live vaccine candidates for rapid natural induction of disease resistance are being 
constructed and evaluated.  Finally, innate mechanisms of respiratory tract resistance to bacterial infection are 
being characterized as a new potential point for disease intervention. 
 
OVERALL PROJECT ACCOMPLISHMENTS: 
To better understand disease progression and to produce better vaccines, techniques were developed to 
genetically manipulate M. haemolytica, P. multocida, and H. somnus.  Many of these techniques now are 
patented, and four organisms so produced are currently licensed for use in veterinary vaccines.  A combination 
M. haemolytica/P. multocida single-dose oral vaccine was formulated to address the need for rapid immunity 
and reduction of injection-site reactions.  Evaluation in laboratory and field experiments show that the vaccine 
reduces nasal colonization by M. haemolytica, pneumonic lung lesions, and mortality from respiratory disease.  
Vaccination with the new vaccine significantly improves the performance of calves in the feedlot, a benefit not 
reported for any currently available respiratory disease vaccine.  A live vaccine strain was constructed for 
protection of wild Bighorn sheep, which may prove effective following application on hay in the winter.  These 
studies involve the Pathogen Detection and Diagnostics, Mechanisms of Disease, Epidemiology of Disease, 
and Strategies to Control Infectious and Non-Infectious Disease Components of the Animal Health Program. 
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High-quality reagents to characterize adenoviruses from ruminants have been lacking in the United States.  
Plaque-purified clones and antibodies for prototype cattle, sheep, and goat adenoviruses were produced and 
tested for purity.  The adenoviruses and antiserum are being used as reference reagents to serotype newly-
isolated adenoviruses from ruminants and to determine the prevalence of this group of viruses in the ruminant 
population.  Two new species of adenovirus were isolated and characterized from goats, and one was isolated 
from deer.  Two species of bovine adenovirus were isolated and characterized for the first time from U.S. 
cattle.  Bovine adenovirus 10 has been shown to produce clinical disease and lesions in calves.  Knowledge 
gained will allow for the determination of importance of specific serotypes of adenovirus in the respiratory 
disease complex so that methods of control and diagnosis can be developed.  These studies involve the 
Pathogen Detection and Diagnostics, Mechanisms of Disease, Epidemiology of Disease, and Strategies to 
Control Infectious and Non-Infectious Disease Components of the Animal Health Program. 
 
Not all animals exposed to M. haemolytica develop pneumonia, and these differences may be related to innate 
pulmonary defense mechanisms.  Three antimicrobial anionic peptides were isolated from pulmonary 
surfactant of cattle and sheep.  These peptides were small (721.6 – 823.7 Da), hydrophilic, and contained 
repeats of aspartic acid residues.  Minimal inhibitory concentrations of anionic peptides and similar analogs 
were comparable to those of other vertebrate antimicrobial peptides.  Other antimicrobial peptides have also 
been found in ruminants that are also efficacious.  These include proline-rich antimicrobial peptides from 
sheep and goat leukocytes and beta defensins.  Further study of these innate immune mechanisms may allow 
the elucidation of new potential points for disease intervention.  These studies involve the Animal 
Immunology, Genetic Resistance to Disease, and Strategies to Control Infectious and Non-Infectious Disease 
Components of the Animal Health Program. 
 
IMPACT: 
Novel delivery of new bacterial respiratory disease vaccines has reduced nasal colonization, reduced re-
treatment morbidity costs, reduced mortality losses, and repeatedly improved the performance of cattle placed 
into feedlots, addressing OSQR Objectives 1 and 2.  Commercial veterinary biologics manufacturers are 
interested in marketing vaccines based on this technology.  Improvements in diagnostic capabilities for 
Adenovirus have allowed us to identify type 7 as a prevalent problem among cattle.  These improvements 
directly address OSQR Objective 3 as we seek to determine the importance of Adenovirus in bovine 
respiratory disease.  
 
TECHNOLOGY TRANSFER: 
Presented research progress and updates regarding modified-live mucosal vaccination of cattle against bacterial 
bovine respiratory disease at National Cattlemen’s Beef Association Annual Conventions and United States 
Animal Health Association meetings. 
 
Invited to numerous veterinary biologics firms to present research progress on construction and use of 
modified-live vaccine organisms. 
 
Transferred plasmid constructs, recombinant organisms, and technical assistance to veterinary biologics firms 
and university projects, including one studying human gingivitis and two working with bighorn sheep. 
 
Consulted and assisted commercial veterinary biologics firms regarding design, construction, and evaluation of 
vaccine candidates. 
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Provided extensive field support for multiple university projects examining the impact of respiratory 
coronavirus, bovine viral diarrhea, and specific vaccination, on calves under typical field conditions.   
 
Provided Mannheimia diagnostic assistance, reagents, and bacterial strains to scientists in domestic and foreign 
laboratories.   
 
Participated in and presented “Workshop on Animal Health Research of Common Interest to Mexico and 
USA” in Mexico City, where several international cooperative research projects on bovine respiratory disease 
were planned, April 2003. 
 
Participated and presented in NCBA Animal Production Research Committee meeting at NADC October 2003. 
 
Provided adenovirus diagnostic assistance (isolation of the virus, serotyping, serologic testing and antiserum to 
the prototype ovine and bovine adenoviruses) to scientists in domestic and foreign diagnostic laboratories. 
 
Provided technical assistance on deer adenovirus hemorrhagic disease to several state Departments of Fish and 
Game. 
 
Provided technical assistance on parainfluenza virus type 3 and bovine respiratory syncytial virus to scientists 
at a state university to study immune reaction to virus infection in the lung of small ruminants. 
 
Served as reviewers for manuscripts submitted to refereed national and international scientific publications. 
 
Corresponded with scientists (Veterinary Medical Research Institute, Hungarian Academy of Sciences) in 
Budapest, Hungary, on the Adenovirus Study Group of the International Committee on Taxonomy of Viruses 
on adenovirus taxonomy and classification.  Results from our laboratory have helped to establish a new genus 
Atadenovirus in the Adenoviridae family.   
 
Attended the joint meetings of the American Association of Veterinary Laboratory Diagnosticians and United 
States Animal Health Association and participated as a member of the Diagnostic Virology Committee 
(AAVLD) and the Committee on Infectious Diseases of Cattle, Bison and Lama (Vice Chair of Committee) 
and Committee on Sheep and Goats (USAHA).   
 
Participate and organize the Meeting of the United States-Japan Cooperative Program in Natural Resources 
Panel of Animal and Avian Health Meeting held in Ames, IA and Tsukuba Japan alternate years to discuss 
research common to the National Animal Disease Center and the National Institute for Animal Health.   
 
Participated in organizing and conducting the meeting on “Diseases at the Interface Between Domestic 
Livestock and Wildlife Species” held in Ames, IA, July 17-18, 2003.  
 
Participated as a member of the Sheep Health Committee of the National Institute for Animal Agriculture. 
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PROJECT OBJECTIVES: 
Pasteurella spp. are part of the normal nasal flora in cattle and are also present in lower numbers in the trachea.  
As a consequence of shipping and feedlot stresses, Mannheimia haemolytica (Pasteurella haemolytica) 1 
increase on upper respiratory tract mucosa and upon establishment in lungs result in pneumonia.  M. 
haemolytica produces several virulence factors, foremost of which is leukotoxin, a member of the related 
family of toxins designated as RTX (repeated toxins).  Other bacteria associated with bovine respiratory 
disease include Pasteurella multocida, Haemophilus somnus, and Mycoplasma spp. 
 
We have developed the tools (temperature-sensitive plasmids) and acquired the requisite genetic understanding 
(characterized restriction-modification systems) to genetically engineer members of the Pasteurellaceae, a 
diverse group of bacteria causing a wide range of diseases in animals and man.  The replication-conditional 
plasmids, pBB192 and pBBD80, have allowed us to construct 'clean' deletion mutant vaccine candidates of M. 
haemolytica, P. multocida, and Haemophilus somnus.  Such mutants are devoid of exogenous DNA and 
considered by NIH guidelines to be non-recombinant organisms. 
 
OVERALL PROJECT ACCOMPLISHMENTS: 
A new mucosal vaccine was developed and tested, in cooperation with New Mexico State University, which 
protected cattle from pneumonic Pasteurellosis within 3 days of administration.  The vaccine was effective 
either by top-dressing on feed or by intranasal administration at the point of first assembly.  The vaccine offers 
hope to many cattle producers who need a fast and effective vaccine and to the cattle industry which needs to 
avoid adverse reactions to injected vaccines. 
 
IMPACT: 
 
TECHNOLOGY TRANSFERS: 
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Avian Disease and Oncology Laboratory 
 
Project Title:   Genomics and Immunogenetics of Economically Important 
Traits of Poultry 
CRIS Number:   3635-31320-007-00D 
Scientists:        Cheng, H., Zhang, H., Hunt, H. 
Location:      East Lansing, MI, Avian Disease and Oncology Research 
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PROJECT OBJECTIVES: 
Poultry is the third largest agricultural commodity and at 41%, the main meat consumed in the U.S. The 
utilization of advanced breeding methods and large-scale industrialization of animal production have enabled 
tremendous progress in economic efficiency. The development of large-scale hatcheries and poultry farms has 
prompted increased efforts in disease control. Combinations of disease agent eradication, chemoprophylaxis, 
vaccination, and sanitation have helped to control but not eliminate losses due to disease. Virus-induced tumor 
diseases of particular concern and importance to the poultry industry are being studied at this location. Marek's 
disease (MD) is a lymphoproliferative disease (T cell cancer) caused by a member of the herpesvirus family. B 
cell cancers are found in avian leukosis virus (ALV)-infected chickens. These diseases cost poultry producers 
millions of dollars each year due to condemnation of the birds and reduced egg production. Control of MD has 
been achieved through the use of vaccines that prevent tumor development but do not block MDV infection. 
Control of ALV is conducted by eliminating virus-positive individuals to eradicate future infections. With 
regard to MD, the constant presence of the pathogen, periodic outbreaks in vaccinated flocks, the emergence of 
new and highly virulent strains, and the lack of new vaccines all point to the need for continued research on 
alternative methods for disease control. One attractive solution is breeding for resistance and/or improved 
vaccinal response. Although genetic resistance to MD is complex and controlled by many genes, genetic 
selection for high levels of resistance can be obtained. Our goal is to understand the molecular, biochemical 
and immunological basis of genetic resistance and vaccinal response to MD. Our multidisciplinary approach is 
to develop tools and reagents that can identify all the genes, proteins and pathways involved. Once obtained, 
this information will be useful to select chickens with superior disease resistance and response to vaccines, 
thereby, increasing animal health, making producers more competitive, and reducing the costs to consumers. In 
the case of ALV, besides eliminating virus-positive individuals to stop virus spread in infected flocks, two 
other measures should be considered to prevent future outbreaks: 1) use marker-assisted selection to increase 
the frequency of resistant birds, and. 2) periodic surveillance to monitor for new disease causing variants. Our 
aims are to define genes and alleles that confer viral resistance, understand the mechanisms for generating new 
ALV disease-causing variants, and develop chicken strains or selection schemes that would minimize the 
potential for producing new highly-virulent ALV strains. 
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OVERALL PROJECT ACCOMPLISHMENTS: 
Since the inception of this project, the resources to identify agricultural important genes and the results from 
the application of these tools have grown rapidly. Using a White Leghorn by Jungle Fowl cross, over 1,200 
genetic markers or genes have been placed that cover the entire chicken genome. This genetic map is the most 
comprehensive and widely used in the world. The map has been integrated with the other two chicken genetic 
maps to make a consensus map containing close to 2,000 markers as well as physical maps. The integrated 
genetic and physical maps formed the framework of the whole genome sequence that was released on March 
2004. In addition, the genetic map was used to identify many regions containing genes that confer resistance to 
MD in both experimental and commercial animals. Unique lines have been developed at our location, which 
will greatly aid in the identification and biological characterization of the actual genes. New methods that look 
at gene expression variation and viral-chicken protein-protein interactions have been implemented that will 
complement our existing efforts. Using a screen to identify virus-chicken protein interactions, it was 
determined that chicken growth hormone and stem cell antigen 2 interacts with viral proteins to modulate the 
immune response, and both confer disease resistance. These are the first MD resistance genes identified. With 
respect to immunology, the molecular characterization of MHC genes in eight B congenic strain was 
completed. A new method was developed to make reagents that identify MHC markers on cells. These 
reagents helped to demonstrate that MHC gene expression is reduced in MD virus-infected cells. An antiserum 
known as R2 was developed that detects endogenous virus (EV) expression, which is valuable since EV 
expression has been correlated with decreased egg and meat production, susceptibility to viral-induced tumors, 
and possibly the generation of ALV variants. Furthermore, a genetic assay was developed that identifies 
chickens resistant to ALV, which enables assessing genetic risk of susceptibility to subgroup B, D, and E ALV 
in chicken flocks without involving actual viral challenge. More importantly, it drastically simplifies and 
accelerates selection for genetically resistant (or susceptible) lines of chickens to the ALV subgroups. Finally, 
a new method has been developed to culture early embryonic cells, which following genetic manipulations, are 
still able to properly populate the sex organs of chimeric chickens. 
 
IMPACT: 
Our genetic map provided the framework for the chicken genome sequence. With our genetic map, 
investigators have been able to identify genomic regions containing genes of agricultural importance. Our 
efforts have also demonstrated how combining functional genomic screens can identify the causative genes, 
which allows for more accurate breeding using molecular markers and the elucidation of biological pathways. 
Our unique reagents and chicken lines also empower scientists, especially with respect to immunological 
characterization. 
 
TECHNOLOGY TRANSFER: 
The majority of genetic markers were developed by our location and are being used throughout the world. 
Markers for specific Marek’s disease resistance genes are being evaluated in commercial layers. 
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PROJECT OBJECTIVES: 
Marek's disease (MD) is a lymphoproliferative and immunodepressive disease of chickens caused by a 
herpesvirus. Infection with the causative virus is nearly universal among commercial chicken flocks 
worldwide. The virus is relatively stable in the environment, is spread through the air and is unlikely to be 
eradicated from commercial flocks. Despite widespread use of vaccines, economic losses from mortality of 
layers and breeders and condemnation of broilers continue to plague producers. Losses tend to be sporadic and 
unpredictable. Moreover, the virus continues to mutate to greater virulence, reducing the effectiveness of many 
existing vaccines and causing concerns that vaccines currently considered effective will not protect in the 
future. Also, the host range of the virus has apparently expanded to include adult chickens and turkeys. The 
major problem is the need for practical and cost-efficient technology that will better control losses, both now 
and in the future. This research project addresses the problem through a comprehensive program dealing with 
basic mechanisms of the disease process, characterization of the virus, and development of better vaccines. 
Much of this work is also designed to complement and improve the genetic resistance of chickens to this 
disease. 
 
OVERALL PROJECT ACCOMPLISHMENTS: 
We confirmed that recent MDV isolates are more virulent than earlier isolates and that there are some changes 
in the MDV genome that may be indicative of different pathotypes. We also compared some highly attenuated, 
moderately attenuated and some low virulent strains for their ability to protect against an MDV challenge. We 
found that partly attenuated, slightly virulent strains provided the best protection. These findings will help us to 
better design new vaccines. We also demonstrated that the putative oncogene of MDV (meq), could be deleted 
and that meq is essential for transformation of lymphocytes in infected chickens. Using mutational analysis, we 
demonstrated that the pp38 gene of the vaccine virus, Rispens, functions identically to the pp38 gene in the 
very virulent Md5 virus. This knowledge helps us to understand the mechanisms by which the virus replicates, 
causes disease, and may be useful in developing a new class of recombinant DNA vaccines. 
 
IMPACT: 
Research conducted on various aspects of Mareks’ disease will undoubtedly lead to development of better 
methods for its control. Successful control of Marek’s will insure the viability of the United States poultry 
industry and insure a supply of inexpensive meat and egg products of high quality for consumers in the U.S.  
and in other countries. 
 
TECHNOLOGY TRANSFER: 
We developed a set of PCR primers that will specifically detect MDV in infected birds. These primers and the 
technology to use the primers have been sent to numerous state diagnostic labs, private poultry companies, and 
scientists at academic institutes. We have shared specific MD viral sequences with other scientists to enhance 
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the global effort to elucidate the function of various viral genes. We have also supplied characterized MD viral 
field strains to poultry companies for use in challenge experiments to test the susceptibility of different chicken 
strains and the efficacy of different vaccines. An MDV with a pp38 deletion was sent to a scientist to study the 
role of pp38 on cytotoxic lymphocytes. We sent the MDV cosmid clones to other laboratories to transfer the 
technology of MDV mutants to the scientific community.  
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PROJECT OBJECTIVES: 
Avian leukosis virus (ALV) and reticuloendotheliosis virus (REV) are the most common naturally occurring 
retroviruses associated with neoplastic (cancer-like) diseases in poultry. In addition to causing tumors and 
other production problems, both ALV and REV are potential contaminants of live-virus vaccines of poultry. 
Control of retroviruses in poultry is complicated by lack of specific diagnostics and vaccines as well as a high 
frequency of antigenic and molecular variation among strains of virus. In recent years, the broiler breeder 
industry has identified an ALV-induced disease termed myeloid leukosis as its highest disease priority. This 
disease has the potential to negatively influence the economic viability of the entire broiler industry. On the 
other hand, the principal economic concerns of REV infection are as contaminants of biologic products 
produced in chicken embryo cells or tissues or as a barrier to export of breeding stock to certain countries.  
However, sporadic outbreaks of neoplastic disease have been observed in turkeys and infected breeders can, in 
some cases, transmit the virus to progeny. Understanding the basic mechanisms involved in virus-host 
interaction, transmission of virus as well as the development of improved diagnostic technology for viruses and 
tumors are integral components of any successful program for control of retrovirus infection in poultry. The 
research emphasizes studies on influence of virus-, host-, and environment- related factors on retrovirus-
induced diseases in poultry. Using current information on molecular and antigenic characteristics of the virus, 
more sensitive and specific procedures for detection of virus and antibody will be developed. Currently 
available technology will also be explored to develop vaccines for use as an adjunct to eradication programs, 
the principal means for controlling retrovirus infection in poultry. The research will provide the necessary tools 
for better diagnosis and control of this economically important virus infection of retrovirus infection in poultry.  
 
OVERALL PROJECT ACCOMPLISHMENTS: 
This project was initiated in fiscal year 2002. During the last five years (the life of the previous project), 
infection with subgroup J ALV (ALV-J) and tumors previously thought to be not present in flocks in the U.S. 
were diagnosed in broiler breeder flocks in various regions of the U.S. Two new tools were developed that 
aided in the diagnosis of ALV-J: 1) a PCR test (a DNA-based test); and 2) a genetically engineered cell line 
that is resistant to infection with ALV-J (C/J). Various industry and other diagnostic laboratories have 
successfully used these new tools in the diagnosis of ALV-J infection in field samples. Also, the envelope gene 
of the U.S. prototype of ALV-J termed ADOL-Hc1 was identified, sequenced and used as an excellent source 
of antigen (protein) that is now being used in commercial diagnostic kits for detection of antibody to ALV-J. 
Scientists at ADOL were first to isolate natural recombinant ALVs with an envelope of subgroup B and LTR 
of subgroup J (ALV-B/J) from commercial layers flocks suffering from myeloid leukosis. This confirmed that: 
a) natural recombination between two subgroups of ALV can occur, and b) a recombinant ALV-J was 
associated with an outbreak of myeloid leukosis in commercial layer flocks; commercial layers are thought to 
be relatively resistant to ALV-J-induced myeloid leukosis. Preliminary data suggest an influence of age at 
exposure of embryos and dose of virus on the development of ALV tolerant infection (consistent viremia and 
lack of antibody). 
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IMPACT: 
Research on avian retroviruses at ADOL, particularly avian leukosis viruses has contributed significantly to the 
success of programs, currently used by most if not all of primary poultry breeder companies, to reduce or 
eradicated this important virus infection from their breeding stocks. As vaccines to control avian retroviruses 
are not available, eradication of virus infection at the primary breeder level is the method of choice for 
controlling this economically important disease. Successful control of retrovirus infection will reduce 
economic losses associated with retrovirus-induced tumor mortality and lower productivity. Therefore, 
successful control of retrovirus infection in poultry will also insure the viability of the United States poultry 
industry and will also insure a supply of inexpensive meat and egg products of high quality for consumers in 
the U.S. and in other countries 
 
TECHNOLOGY TRANSFER: 
Important new tools were developed that aided industry and diagnostic laboratories in the diagnosis of ALV: 1) 
a polymerase chain reaction (PCR) test (a DNA-based test); 2) a genetically engineered cell line that is 
resistant to infection with ALV-J (C/J), and 3) a set of monoclonal antibodies. Also, the envelope gene of the 
U.S. prototype of ALV-J termed ADOL-Hc1 was identified, sequenced and used as an excellent source of 
antigen (protein) that is now being used in commercial diagnostic kits for detection of antibody to ALV-J. 
Most recently, Scientists at ADOL transferred to their counterparts at USDA-APHIS-CVB and industry the 
protocol used at ADOL for detection of ALV in vaccines and other samples. 
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Foodborne Contaminants Research 
 
Project Title: Development of New Technologies for Detection of Prions in Animal Feed and 
Environmental Samples 
CRIS Number:   5325-32000-003-00D 
Scientists:  M. Carter, R. Wong (30%), Vacant, Vacant 
Location:     Western Regional Research Center (Albany, CA) 
Contact: Carter, M., phone 510.559.6053, mcarter@pw.usda.gov 
 
 
PROJECT OBJECTIVES: 
The primary focus of this CRIS is investigation and development of novel technologies for detection, 
quantitation, and strain characterization of both normal and abnormally-folded prion proteins. The methods 
investigated are suitable for use with environmental samples as well as animal feed and feed additives. Because 
the food industry will not tolerate false positive or false negative test results, the new detection methods must 
be highly sensitive and specific. In addition, they must be rapid, cost effect, and easily interpreted. Major goals 
include 1) significant improvements in sensitivity for prion assays, including methods for strain-specific 
detection. In addition to immunochemistry and traditional analytical chemistry, hybrid methods combining the 
best features of both approaches are being investigated. Strain-specific detection is likely to require further 
orthogonal assay technologies. Additional goals include 2) effective sampling methods for capturing, 
concentrating, and detecting prions, other animal proteins, and surrogates from samples of air, water, soil, feed, 
and feed additives; and 3) development of inactivation/destruction of prions for decontamination. The methods 
investigated must be appropriate for sampling and decontamination of food processing surfaces and animal 
holding pens. Thus they must be: free from chemical or physical extremes; safe, with no generally toxic 
residue; and relatively inexpensive, for use on large areas. The objectives of this CRIS overlap somewhat with 
those of CRIS 5325-42000-027-00D, Development of New Technologies for Rapid Identification of 
Pathogen/Pathogen Products. 
 
OVERALL PROJECT ACCOMPLISHMENTS: 
• A method for detecting meat and bone in animal feed has been developed based on a GC/MS system that 
detects the presence of cholesterol. A linear response from 0.5 ng (~ 2 picomole) to 60 ng (~ 150 
picomole) is observed. This method can be used to detect MBM contamination at levels between 0.1 
and 5 %. The assay is being converted into a rapid, field portable immunoassay that can be applied to 
feed or meal samples. 
• Significant advances have been made in the development of a mass spectrometric method for 
quantitation of prions at low levels. Model peptides similar to those expected from PrPSc digests have 
been analyzed by linear ion trap technology using nanoLC and electrospray technology. Limits of 
detection in the low attomolar level have been obtained. If this can be achieved with PrPSc peptides, an 
assay that is several orders of magnitude more sensitive than extant antibody-based methods should be 
possible. Digests of hamster prions have been completed and analyzed by qualitative mass 
spectrometry to identify peptide targets for quantitative work in the future. A patent disclosure has been 
written which has been approved for patent filing within the next 6 months. 
• New monoclonal antibodies that bind PrP have been developed by immunization of PrP ablated mice and 
a modified cell fusion protocol. These antibodies have broad specificity and extend the detection range 
for PrPSc in a Conformation Dependent Immunoassay. 
                                                                                      153 
 
• In an effort to produce better PrP antibodies, PrP ablated BALB/c mice and PrP ablated BALB/c mouse 
derived myeloma cells are being produced. PrP ablated animals with greater than 90% BALB/c 
background already have been produced and myeloma induction is underway. 
 
IMPACT: 
More sensitive tests for prions are essential in order to develop a live-animal test. Such tests would greatly 
simplify cattle management for BSE and management of cervid populations for CWD. These assays will 
extend our ability to track prions in environmental samples, and they will be useful tools for evaluating prion 
inactivation methods, and for pathogenesis studies. 
 
TECHNOLOGY TRANSFER: 
The mass spectrometric method for detecting prions and prion strains has been approved for a patent 
application. Once issued, this approach can be licensed, making the method readily available to producers and 
regulators. 
 
PUBLICATIONS: 
 
None 
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Animal Diseases Research Unit 
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Animal Diseases Research Unit 
 
Project Title:   Anaplasmosis:  A Genomic Approach to Vaccine Development 
CRIS Number:     5348-32000-016-00D 
Scientists:             Scoles, G., Suarez, C., Goff, W., Knowles, D.                       
Location:        Pullman, WA, Animal Diseases Research Unit 
Contact:  Scoles, G. 509-335-6337 (VOICE) scoles@vetmed.wsu.edu 
  
PROJECT OBJECTIVES: 
Anaplasmosis is one of the most prevalent arthropod-borne hemoparasitic diseases that continue to constrain 
the production, movement and utilization of cattle worldwide. Extensive losses continue within the major cattle 
producing regions of the world. The economic losses occur through disease and export-import restrictions.  
Immunization against the causative rickettsial pathogen, Anaplasma marginale, with a safe and effective 
vaccine is not yet feasible on a practical basis.  There are three main research objectives.  These objectives are 
the development of accurate method(s) of diagnosis, the development of a safe and efficacious vaccine and 
acquisition of a detailed understanding of vector transmission with a goal of improved control methods.  We 
have completed the first objective.  Our approach to vaccine development (objective 2) has three components.  
The first component is dissection of the bovine immune response, which develops in response to infection and 
is protective in the chronic (persistent) phase.  The second component is dissection of the interface between 
Anaplasma marginale and the tick vectors, which transmit this organism.  This component has the unique 
advantage of identifying components of the organism, which are exposed only during development in the 
vector and therefore may be targets for vaccine development. Our final component, completed within this past 
year is genomic sequencing and annotation of the A. marginale genome. 
  
OVERALL PROJECT ACCOMPLISHMENTS: 
The development and commercialization of our diagnostic test for Anaplasma marginale infection is 
completed.  This test is now commercially available and has been adopted by Canada as their official test.  This 
test will have major impact internationally on the control of anaplasmosis.  This test will allow, for the first 
time, accurate epidemiological studies to be conducted. During recent months we've complete a collaborative 
project with CEAH, APHIS in conducting a serologic survey, using our cELISA, for detection of A. marginale 
infection in cattle within the United States.  Also, producers will be able to test and segregate infected cattle in 
areas in which ticks are present, or adopt new management tools in handling infected cattle, such as assuring 
the same needle isn't used to process both infected and uninfected cattle.  Accurate diagnosis will now allow 
for the possibility of opening export markets to countries which were previously thought to be free of 
anaplasmosis, but upon testing with accurate methodology are found to have infected cattle, sheep or goats.  
This recently occurred in Canada when through collaboration with our Unit it was discovered that bison within 
Canada are infected with A. marginale. 
 
IMPACT:   
The competitive ELISA for identification of cattle persistently infected with Anaplasma marginale has been 
transferred to industry and its final approval for distribution as a kit was approved in 2002.  We provide to 
APHIS on continual basis information to aid in vector control at the southern U.S. border.  We have also aided 
Canada in providing diagnostic expertise in a recent discovery of Anaplasma marginale infection in bison 
within Canada.  This diagnostic kit was used in 2003 for congressional budget meetings.  Most importantly our 
diagnostic test has been used by APHIS to begin establishing the epidemiology of A. marginale within the 
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United States.  These data are being used in adjusting current A. marginale import restrictions placed on U. S. 
cattle by Canada. 
 
TECHNOLOGY TRANSFER:   
A competitive ELISA was licensed and transferred to industry.  This test is commercially available (U.S. 
Veterinary License No. 332) and has been adopted by Canada as their official import test.   
 
PUBLICATIONS: 
 
Davidson, W.R., Goff, W.L. Anaplasmosis. In: Infectious Diseases of Wild Mammals, 3rd edition (E. 
Williams and I Barker, eds.) Iowa State University Press. 2001. p. 455-466. 
 
Futse, J.E., Massaro, U.W., Knowles, D.P., Palmer, G.H. Transmission of Anaplasma marginale by Boophilus 
microplus: Retention of vector competence in the absence of vector-pathogen interaction. Journal of Clincal 
Microbiology. 2002. v. 41. p. 3829-3834. 
 
Scoles, G.A. Phylogenetic analysis of the Francisella-like endosymbionts of Dermacentor Ticks. Journal of 
Medical Entomology. 2004. v. 41 (in press). 
 
Gorham, J., and Knowles, D. 2000. Biotechnology in the diagnosis of infectious diseases and vaccine 
development.  OIE Manual of Standards for diagnostic tests and standards: biotechnology, 1.7.  
 
Bradway, D. S., Torioni de Echaide, S., Knowles, D. P., Hennager, S. G., and McElwain, T. F. 2000. 
Sensitivity and specificity of the complement fixation test for detection of Anaplasma marginale persistently 
infected cattle.  Journal of Veterinary Diagnostic Investigation. 13:77-79. 
 
Valdez, R. A., McGuire, T. C., Brown, W. C., Davis, W. C., and Knowles, D. P.  2001. Long-term in vivo 
depletion of functional CD4+ T lymphocytes from calves requires both thymectomy and anti-CD4 monoclonal 
antibody treatment. Immunology, 102:426-433. 
 
Ferreira, A. M. T., Suzart, S., Vidotto, O., Knowles, D. P., and Vidotto, M. C. 2001. Use of repetitive DNA 
elements to define genetic relationships among Anaplasma marginale isolates FEMS Microbiology Letters, 
197:139-143. 
 
Brayton, K. A., Knowles, D. P., McGuire, T. C., and Palmer, G. H. 2001. Efficient use of a small genome to 
generate antigenic diversity in tick-borne ehrlichial pathogens.    Proceedings National Academy of Science, 
USA, 98:4130-4135. 
 
Valdez, R. A., McGuire, T. C., Brown, W. C., Davis, W. C., Jordan, J. M., and Knowles, D. P. 2002. Selective 
in vivo depletion of CD4+ T lymphocytes with anti-CD4 monoclonal antibody during acute infection of calves 
with Anaplasma marginale. Clinical and Diagnostic Laboratory Immunology. 9:417-424. 
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Animal Disease Research Unit 
 
Project Title:   On farm Ecology of Listeria Monocytogenes 
CRIS Number:     5348-32000-022-00D 
Scientists:             Borucki, M., Knowles, D.P. 
Location:         Pullman, WA, Animal Diseases Research Unit 
Contact:   Borucki, M., Phone: (509) 335-7407, Fax: (509) 335-8328,  
   mborucki@vetmed.wsu.edu 
 
PROJECT OBJECTIVES: 
Listeria monocytogenes is a bacterium capable of causing serious disease in humans and animals.  L. 
monocytogenes infection of cattle and sheep can lead to disease of the central nervous system and death. 
Human listeriosis is a potentially fatal food borne disease often associated with the consumption of 
contaminated dairy products.  Because L. monocytogenes is widely distributed in the environment, a major 
problem associated with the food safety issue is the source(s) of L. monocytogenes in food borne illness. The 
role of domestic animals in dairy product contamination is not clearly understood. The focus of our research 
program is to elucidate the sources and significance of dairy farm contamination as related to human and 
animal disease.  A majority of human outbreaks are caused by just 3 of the 13 L. monocytogenes serotypes, 
therefore we will be focusing on identifying the prevalence of these serotypes on the dairy farm and developing 
methods to precisely and reliably identify genetic subtypes that are especially virulent. Specifically, our project 
has three major objectives: (1) characterize on-farm subtypes of livestock origin and compare these subtypes to 
those of food-borne disease origin; (2) develop a rapid and informative assay to identify L. monocytogenes 
serotypes, subtypes, and identify the genes that differ between epidemic and nonepidemic strains; (3) identify 
or develop an in vivo or in vitro model capable of quantifying the virulence potential of L. monocytogenes 
strains. 
 
OVERALL PROJECT ACCOMPLISHMENTS: 
Objective 1: Determine the prevalence and subtypes of L. monocytogenes present on Pacific Northwest 
dairy farms. Approximately 775 raw milk samples from 474 Pacific Northwest herds were tested at multiple 
timepoints and isolates obtained from the milk samples were serotyped, genetically characterized, and 
evaluated for unique biological properties. A vast majority of L. monocytogenes isolates obtained from the 
milk and farm samples were found to be clinically significant serotypes that persist in the dairy environment 
for an extended period of time. Research was also done to investigate whether human listeriosis cases are 
associated with the same subtypes of L. monocytogenes found in raw milk and area dairy farms by comparing 
farm-associated subtypes to human isolates. Several human isolates were genetically similar or identical to 
farm and milk strains and it was also determined that a strain responsible for a large 1985 epidemic has a 
current, local on-farm reservoir and continues to cause sporadic human disease.  This work was an important 
step in defining the on-farm ecology of L. monocytogenes and accessing the contribution of farm 
contamination as a source in human listeriosis.  
 
Objective 2: Construct and test a DNA microarray to allow rapid, accurate and discriminatory 
subtyping of L. monocytogenes isolates for the purpose of on farm molecular epidemiology and gene 
discovery.  Research was done to test the utility of a mixed genome DNA microarray analysis for genetic 
subtyping of L. monocytogenes strains and to identify the genetic differences between subtypes.  Fifty L. 
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monocytogenes isolates were subtyped using a 585-probe mixed genome microarray and genes that 
differentiate the major genetic divisions were identified.  Microarray analysis results preserved previously 
described phylogenetic relationships between major serogroups, discriminated among isolates within a 
serotype, and identified specific genes that vary between isolates including several putative virulence factors.  
Identification of serotype-specific regions allowed the development of PCR primers for rapid, accurate, and 
inexpensive identification of L. monocytogenes serotypes. 
 
To further investigate genetic regions that characterize subtypes, a subsequent 2000-probe mixed genome 
DNA microarray was constructed and used to identify 675 polymorphic (informative) probes for sequence 
analysis and construction of a condensed microarray.  Fifty-five L. monocytogenes strains were genetically 
characterized using the condensed array including strains that had been subtyped previously by Dr. Franco 
Pagotta (Health Canada) and Dr. Sandra Smole (MA State Laboratory Institute) using pulsed-field gel 
electrophoresis (PFGE), ribotyping, and multilocus sequence typing (MLST). Microarray subtyping had 
resolution equal to that of PFGE (using AscI and ApaI digests), higher resolution than ribotyping and MLST 
(using 8 housekeeping genes), and correctly grouped eleven out of twelve isolates that had an epidemiological 
link.  Additionally, a majority of epidemic strains were grouped together within phylogenetic Division I.  
Discriminant function analysis allowed identification of 22 probes from the mixed-genome array that 
distinguish serotypes and subtypes including several potential markers that were distinct for the epidemic 
cluster.  Many of the subtype-specific genes encode proteins that likely confer survival advantage in the 
environment and/or host.   
 
Objective 3: Develop in vitro and in vivo virulence models for L. monocytogenes infection that allow the 
phenotypic characterization of putative virulence genes identified by microarray analysis.  In order to 
determine if a particular subtyping method is effectively able to differentiate virulent isolates from less virulent 
“environmental” isolates one must first be able to access the virulence potential of a particular L. 
monocytogenes strain.  Isolates known to be associated with human or animal clinical cases are known to be 
virulent. However, isolates found in the environment may also be virulent given the right host and dose.  
Therefore, it is important to develop an assay that is able to predict the virulence potential of 
environmental/nonclinical strains.  Six human epidemic strains and six environmental strains were assayed for 
invasiveness using a modified intragastric inoculation A/J mouse model (Czuprynski et al., 2003).  Variation in 
strain invasiveness was observed and epidemic strains were significantly more invasive than environmental 
strains (P=0.01).  A/J strain mice purchased from one vendor were significantly more susceptible than A/J 
mice purchased from a different vendor.   
 
IMPACT: 
The prevalence of L. monocytogenes contamination in Pacific Northwest area bulk milk tanks was previously 
unknown.  The results from Objective 1 are an important initial step in defining the on-farm ecology of L. 
monocytogenes, the regional distribution of L. monocytogenes subtypes, and accessing the contribution of farm 
contamination as a source in human listeriosis. Results from Objective 2 demonstrate the applicability of 
microarray analysis to L. monocytogenes subtyping and gene discovery. These results show that a relatively 
simple microarray had resolution comparable to, or exceeding, existing methods and correctly identified strains 
associated with food poisoning outbreaks. Importantly, this method also identified the genetic regions that 
differ between strains and thus identified numerous genetic markers that are currently being used in 
epidemiological and pathogenesis studies. This microarray data also allowed development of alternative 
genetic methods to serotype isolates quickly and inexpensively.  An intragastric inoculation mouse model was 
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developed (Objective 3) that demonstrated that epidemic strains as a group are more infective than 
environmental strains. The ability to accurately assess the disease-causing potential of an isolate is essential for 
defining the genes that control strain virulence. Development of this model is a critical step towards 
understanding why some strains cause epidemics whereas others do not. 
 
TECHNOLOGY TRANSFER: 
 
PUBLICATIONS: 
 
Borucki, M.K., Krug, M.J., Muraoka, W.T., Call, D.R. Discrimination among Listeria monocytogenes isolates 
using a mixed genome DNA microarrays. Veterinary Microbiology. 2003. v. 92. p. 351-362. 
 
Call, D.R., Borucki, M.K., Besser, T E. Mixed-genome microarrays reveal multiple serotype and lineage-
specific differences among strains of Listeria monocytogenes. Journal of Clinical  Microbiology. 2003. v. 41. 
p. 632-639.  
 
Call, D.R., Borucki, M.K., Loge, F.J. Detection of bacterial pathogens in environmental samples using DNA 
microarrays. Journal of Microbiological Methods. 2003. v. 53. p. 235-243.  
 
Palumbo, J.D., Borucki, M.K., Mandrell, R.E., Gorski, L.A.  Serotyping of Listeria monocytogenes by ELISA 
and identification of mixed-serotype cultures by colony blot. Journal of Clinical  Microbiology. 2003. v. 41. p. 
564-571.  
 
Muraoka, W.T., Gay, C., Knowles, D., Borucki, M.K. Prevalence of Listeria monocytogenes in bulk milk of 
the Pacific Northwest. Journal of Food Protection. 2003. v. 66. p. 1413-1419. 
 
Borucki, M.K., Peppin, J.D., White, D., Loge, F., Call, D.R. Variation in biofilm formation among strains of 
Listeria monocytogenes. Applied Environmental Microbiology. 2003. v. 69. p. 7336-7342. 
 
Borucki, M.K., Call, D.R. Listeria monocytogenes serotype identification by PCR. Journal of Clinical  
Microbiology. 2003. v. 41. p. 5537-5540.  
 
Wesley I, Borucki M, Call D.R, Larson D, Schroeder-Tucker L. Detection and diagnosis of Listeria 
monocytogenes and listeriosis in animals. In: Torrence ME, Isaacson RE, eds. Microbial Food Safety in 
Animal Agriculture. Ames: Iowa State Press. 2003  p. 233-242. 
 
Kim, S.H., Bakko, M., Knowles, D., Borucki, M.K. Oral inoculation of A/J mice detects invasiveness 
differences between Listeria monocytogenes epidemic and environmental strains. Infection and Immunity. (In 
press). 
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Animal Disease Research Unit 
 
Project Title:   Biology of Ruminant Gammaherpesviruses Associated with Malignant Catarrhal Fever 
CRIS Number:     5348-32000-018-00D 
Scientists:             Li, H., Taus, N.S., Knowles Jr, D.P. 
Location:         Pullman, WA, Animal Diseases Research Unit 
Contact: Li, H., Phone: (509) 335-6002, Fax: (509) 335-8328, hli@vetmed.wsu.edu 
 
PROJECT OBJECTIVES: 
Malignant catarrhal fever (MCF) is a significant source of economic loss in several major ruminant species, 
including cattle, bison, and deer.  In most of the world outside of Africa, sheep are the major source of the 
virus that causes the syndrome, referred to in this instance as sheep-associated MCF.  Diagnosis of MCF, 
particularly sheep-associated MCF, historically has been problematic.  The major goals for this project are to 
develop new methods for effective diagnosis and control of MCF.  The program has resulted in several reliable 
diagnostic assays such as competitive inhibition ELISA and quantitative fluid-phase PCR.  Using these newly 
developed assays, we have been able to construct a reasonable picture of the life cycle of the virus in its natural 
host and to develop control programs to prevent transmission. 
  
OVERALL PROJECT ACCOMPLISHMENTS: 
Over the past few years this project has brought about fundamental and dramatic advances in the understanding 
of MCF and in the preferred methodologies used for diagnoses and control.  The development of the 
competitive inhibition ELISA has been the single most important accomplishment, as it allowed reliable 
serological diagnosis of infection, thereby enabling effective investigations into the epidemiology of the virus.  
We have also applied the PCR test for sheep-associated MCF virus DNA to these same questions.  The 
combination of the two technologies, aggressively applied to the problems, has enabled us to develop a 
reasonably comprehensive picture of the life cycle of this group of viruses in nature.  Recently we intensively 
examined viral shedding patterns from 6 to 9 month-old adolescent and adult sheep, showing that nasal 
shedding is the major mode for viral transmission, and adolescents are the highest risk group for viral 
shedding.  Once we understood the transmission patterns among sheep, we were able to clear up much of the 
mystery traditionally associated with MCF epidemiology, to design a management-based control program to 
prevent transmission, and to produce MCF virus-free sheep.  We have also developed a competitive PCR and 
adapted a real-time PCR for the quantitation of sheep-associated virus DNA.  These assays should prove 
instrumental in defining the temporal distribution of virus in the host, and the time-specific shedding patterns 
of both carriers and affected hosts.  A PCR assay for sheep-associated MCF was adapted for use on DNA 
extracted from formalin-fixed paraffin-embedded tissues, which enables retrospective examination of 
specimens for the virus.  An in situ PCR was also developed for detection of sheep-associated virus in MCF-
affected animals, which is in the early stages of application to pathogenesis studies.  Recently a new member 
of the MCF virus group capable of causing classic MCF in white-tailed deer was identified.  In addition, we 
also discovered that goats are endemically infected with their own strain of MCF virus that is closely related to, 
but distinct from, the classic sheep strain of virus and showed it to be capable of causing disease in deer that 
presents significantly differently from the classic MCF.  These findings illustrate the complexity of the life 
cycles of members of the MCF virus group in nature and provide additional information to guide diagnosis and 
development of control measures. 
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IMPACT: 
Development of an accurate and practical monoclonal antibody-based MCF serological test and establishment 
of various PCR assays specific for MCF viruses have significantly improved MCF diagnostics, and have 
provided essential tools for MCF research.  Our additional accomplishments in epidemiological studies 
represent a very significant milestone in the history of MCF investigation. Despite many studies by many 
investigators over the past 60 to 70 years, the etiology and epidemiology of sheep-associated MCF have 
remained a controversial enigma.  Our studies provide a basis for understanding the intriguing biological 
events that occur with this virus, and enable rational explanations for the previously enigmatic and confusing 
observations concerning transmission.  Production of virus-free sheep that pose no threat to their MCF-
susceptible neighbours could be a great benefit to limited-size cattle-sheep operations and bison owners, as 
well as petting zoos and game farms.  The studies highlight how to effectively avoid severe MCF losses in 
clinically susceptible species, particularly in bison.   
 
TECHNOLOGY TRANSFER: 
The competitive ELISA for detection of MCF viral antibody against an epitope that is conserved among MCF 
group viruses in ruminant species has been transferred to industry (VMRD, Inc, Pullman) and the kit has been 
distributed internationally since 2002.  Four additional monoclonal antibodies against MCF virus have also 
been transferred to VMRD, Inc. 
 
A diagnostic service, consisting of cELISA and various PCRs, for MCF has been established through the 
Washington Animal Disease Diagnostic Laboratory. We are now considered the reference laboratory of choice 
for MCF PCR and serology.  
 
PUBLICATIONS: 
 
Li, H., Snowder, G., O’Toole, D., Crawford, T.B. Transmission of ovine herpesvirus 2 among adult sheep. 
Veterinary Microbiology. 2000. v. 71. p. 27-35. 
 
Li, H., Dyer, N., Keller, J., Crawford, T.B. Newly recognized herpesvirus causing malignant catarrhal fever in 
white-tailed deer (Odocoileus virginianus).  Journal of Clinical Microbiology. 2000. v. 38. p. 1313-1318. 
 
Li, H., Keller, J., Knowles, D.P., Crawford T.B. Recognition of another member of the malignant catarrhal 
fever (MCF) virus group: an endemic gammaherpesvirus in domestic goats.  Journal of General Virology. 
2001. v. 82. p. 227-232.  
 
Li, H., Hua, Y., Snowder, G., Crawford T.B. Levels of malignant catarrhal fever viral DNA in nasal secretions 
and blood of sheep: implication for transmission. Veterinary Microbiology. 2001. v. 79. p. 301-310. 
 
Muller-Doblies, U.U., Egli, J., Li, H., Braun, U., Ackermann, M. Malignant catarrhal fever in Switzerland, part 
1: epidemiology.  Swiss Archives of Veterinary Medicine. 2001. v. 143. p. 173-183. 
 
Li, H., McGuire, T.C., Muller-Doblies, U.U., Crawford, T.B. A simpler, more sensitive competitive inhibition 
enzyme-linked immunosorbent assay for detection of antibody to malignant catarrhal fever viruses. Journal of 
Veterinary Diagnostic Investigation. 2001. v. 13. p. 361-364. 
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Müller-Doblies, U.U., Egli, J., Hauser, B., Li, H., Strasser, M., Ehrensperger, F., Braun, U., Ackermann, M.  
Malignant catarrhal fever in Switzerland, part 2: evaluation of diagnostics. Swiss Archives of Veterinary 
Medicine. 2001. v. 143. P. 581-591. 
 
Li, H., Snowder, G., Crawford, T.B.  2002. Effect of passive transfer of maternal immune components on 
infection with ovine herpesvirus 2 in lambs. American Journal of Veterinary Research. 2002. V. 63. P. 631-
633. 
  
O'Toole, D., Li, H., Sourk, C., Montgomery, D.L., Crawford, T.B. Malignant catarrhal fever in a bison feedlot 
1994 – 2000. Journal of Veterinary Diagnostic Investigation. 2002. v. 14. P. 183-193. 
 
Zarnke, R.L., Li, H., Crawford, T.B. Serum antibody prevalence of malignant catarrhal fever viruses in seven 
wildlife species from Alaska.  Journal of Wildlife Diseases. 2002. v. 38. p. 500-504. 
 
Crawford, T.B., Li, H., Rosenberg, S.S., Norhausen, R.W., Garner, M.M. Mural folliculitis and alopecia in 
Sika deer caused by the goat-associated malignant catarrhal fever virus. Journal of American Veterinary 
Medical Association. 2002. v. 211. p. 843-847. 
 
Albini, S., Zimmermann, W., Neff, F., Ehlers, B. Hani, H., Li, H., Hüssy, D., Engles, M., Ackermann, M. 
Identification and quantification of gammaherpesvirus 2 DNA in fresh and stored tissues of pigs with 
symptoms of porcine malignant catarrhal fever. Journal of Clinical Microbiology. 2003. v. 41. p. 900-904. 
 
Albini, S., Zimmermann, W., Neff, F., Ehlers, B., Häni, H., Li, H., Hüssy, D., Casura, C., Engels, M., 
Ackermann, M.  Diagnostic findings in pigs with porcine malignant catarrhal fever. Swiss Archives of 
Veterinary Medicine. 2003. v. 145. p. 61-68. 
 
Li, H., Wunschmann, A., Keller, J., Hall, D.G., Crawford, T.B. Caprine herpesvirus-2 associated malignant 
catarrhal fever in white-tailed deer (Odocoileus virginianus). Journal of Veterinary Diagnostic Investigation. 
2003. v. 15. p. 46-49. 
 
Simon, S., Li, H., Crawford, T.B., Oaks, L. The vascular lesions of a cow and bison with sheep-associated 
malignant catarrhal fever contain ovine herpesvirus 2-infected CD8+ T lymphocytes. Journal of General 
Virology. 2003. v. 84. p. 2009-2013. 
 
Kim, O., Li, H., Crawford, T.B. Demonstration of sheep-associated malignant catarrhal fever virions in sheep 
nasal secretions. Virus Research. 2003. v. 98. p. 117-122. 
 
Bender, L.C., Li, H., Thompson, B.C., Morrow, P.C., Valdez, R. Infectious disease survey of gemsbok in New 
Mexico.  Journal of Wildlife Diseases. 2003. v. 39. p. 772-778. 
 
Li, H., Gailbreath, K., Bender, L.C., West, K., Keller, J., Crawford, T.B. Evidence of three new members of 
malignant catarrhal fever virus group in muskox (Ovibos moschatus), Nubian ibex (Capra nubiana) and 
gemsbok (Oryx gazelle). Journal of Wildlife Diseases. 2003. v. 39. p. 875-880. 
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 Animal Diseases Research Unit 
 
 
Project Title:   Ovine Prion and Viral Infections: Scrapie and Ovine Progressive  
Pneumonia, Diagnosis and Control 
CRIS Number:     5348-32000-019-00D 
Scientists:             Alverson, J., Herrmann, L., Knowles Jr, D.P., O'Rourke, K.I. 
Location:         Pullman, WA, Animal Diseases Research Unit 
Contact:  Alverson, J., Phone: (509) 335-6312, Fax: (509) 335-8328 
janeta@vetmed.wsu.edu 
 
PROJECT OBJECTIVES: 
The economic losses to the sheep industry due to ovine scrapie can be reduced by a coordinated program of 
live animal testing, replacement with sheep of lower susceptibility, and reducing transmission within the flock.  
Scrapie is a transmissible spongiform encephalopathy associated with deposition of an abnormal isoform of a 
mammalian glycoprotein, the prion protein, in tissues throughout the sheep.  The highest level of accumulation 
is in the brain, although detectable levels are found in lymphoid tissues and placenta/fetal tissues.  Detection of 
prions in peripheral lymphoid tissue can be used to identify and cull infected animals early in infection.  
Further, the susceptibility of sheep to clinical scrapie and to accumulation of prions is under genetic control.  
Quantitative determination of the level of protection associated with commonly occurring genotypes could 
enable producers and regulatory programs to integrate protective genetics with elimination of infected stock to 
reduce the amount of disease in U.S. flocks.  Control of all domestic prion diseases is important in reducing 
trade barriers for U.S. sheep and germplasm and for assuring the present and future global markets for cattle.  
Ovine progressive pneumonia virus causes persistent viral infection and development of multi-organ 
inflammatory disease in some animals. The infection rates in US sheep flocks range from 9 to 49%.  A variable 
and unpredictable percentage of infected animals will progress to clinical disease with high viral titers and 
increased risk of transmission to flockmates.  This project has produced a serologic test for the disease.  The 
current project includes development of a vaccine to reduce infected animals and identification of genes 
associated with decreased transmission in infected sheep. 
  
OVERALL PROJECT ACCOMPLISHMENTS: 
A practical live animal test for scrapie and preclinical postmortem tests for scrapie were developed and 
transferred to the regulatory agencies for use in the US.  Monoclonal antibodies useful in assays on routinely 
formalin fixed tissue from infected sheep, deer, elk, cattle, humans, mink, domestic cats and a wide variety of 
captive wildlife potentially exposed to prion diseases were developed.  Mechanisms for preventing 
transmission of scrapie through genetic selection of sires were demonstrated.  Along with sire testing, genetic 
testing in bred ewes will ensure less transmission of scrapie from ewe to lamb.  A project investigating scrapie 
prevalence in goats and the importance of goats in the transmission of scrapie to sheep was initiated.  We have 
initiated another research project relating to transmission of OPPV at the Experimental Sheep Station in 
Dubois, ID.   We continue to test a small sheep flock (Future Farmers of America Herd) (<30) for OPPV in 
Sumner, WA, associated with Sumner High School. 
 
IMPACT: 
The development of the third eyelid test for scrapie diagnosis and prevention of scrapie transmission by 
screening for PrP diploid genotype has directly benefited the sheep industry.  In addition, investigations of 
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different transmission sources namely salivary glands, peripheral blood mononuclear cells, and placental 
tissues has resulted in an increased understanding regarding the mechanisms of scrapie transmission.  Both 
determination of the sensitivity limit of PrP(Sc) detection in immunohistochemistry and determination of the 
specific lymphoid cell types that accumulate truncated and full length PrP(Sc) have established the specificity 
and sensitivity requirements for PrP(Sc) detection and will aid future studies on detection of PrP(Sc) in blood. 
 
Development of a prime-boost vaccine strategy for caprine arthritis encephalitis virus (CAEV) resulted in 
protection in CAEV challenged goats.  Since ovine progressive pneumonia virus (OPPV) and CAEV are 
considered quasispecies, this finding will guide the future testing of this vaccine on sheep.  In addition, the 
high sensitivity and specificity of the CAEV cELISA in both goats and sheep along with the ability to 
quantitate the amount of anti-CAEV/OPPV antibody will aid accurate diagnosis and eradication of small 
ruminant lentiviruses from flocks and herds throughout the United States.  The cELISA was used in the 
National Animal Health Monitoring System (NAHMS) for seroprevalence of OPPV in U.S. sheep flocks 
which was performed by the Centers of Epidemiology and Animal Health, APHIS, Fort Collins, CO in 2001.  
 
Together, these contributions have reduced economic losses to the sheep industry.  The eventual eradication of 
scrapie and OPPV will reopen U.S. sheep exports which will increase economic gains to the sheep industry. 
 
TECHNOLOGY TRANSFER: 
Licenses: 
Two monoclonal antibodies to the prion protein and their use in combination as detection reagents for prions 
have been patented.  Both antibodies are commercially available.  Only non-exclusive licenses have been 
offered, to insure the widest possible use of these reagents in diagnostics, industry, and research.  The 
antibodies are in use internationally and collaborative programs to train personnel in Canada, Mexico, and 
China are in progress. The preclinical test for scrapie has been transferred to the National Veterinary Services 
Laboratory.  APHIS has established a national testing network, through which veterinary and state diagnostic 
laboratories will apply the technology under contract with APHIS.  CAEV cELISA is currently licensed for 
goats and will be licensed for sheep and commercially available in the U.S. in 6-12 months. 
  
PUBLICATIONS: 
 
Bender, S., Alverson, J., Herrmann, L.M, O’Rourke, K.I.  Histamine aids biopsy of third eyelid lymphoid 
tissue in sheep. Veterinary Record (in press) 
 
Caplazi, P., O’Rourke, K.I, Baszler, T.V.  Resistance to scrapie in PrP ARR/ARQ heterozygous sheep is not 
caused by preferential allelic use. Journal of Clinical Pathology (in press).  
 
Hamir, A.N, Miller, J.M, O'Rourke, K.I, Bartz, J.C, Stack, M.J, Chaplin, M.J. Transmission of transmissible 
mink encephalopathy to raccoons (Procyon lotor) by intracerebral inoculation. Journal of Veterinary 
Diagnostic Investigation. 2004. v. 16(1). p. 57-63.  
 
Herrmann, L.M., Hotzel, I., Cheevers, W.P., Pretty On Top, K.P., Lewis, G.S., Knowles, D.P. Seven new 
ovine progressive pneumonia virus (OPPV) field isolates from Dubois Idaho sheep comprise part of OPPV 
clade II based on surface envelope glycoprotein (SU) sequences. Virus Research. 2004. v. 102(2) p. 215-20. 
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Herrmann, L.M., Cheevers, W.P., Davis, W.C., Knowles, D.P., O'Rourke, K.I. CD21-positive follicular 
dendritic cells a possible source of PrPSc in lymph node macrophages of scrapie-infected sheep. American 
Journal of Pathology. 2003. v. 162(4). p. 1075-1081. 
 
Herrmann, L.M., Cheevers, W.P., McGuire, T.C., Adams, D.S., Hutton, M.M., Gavin, W.G., Knowles, D.P. 
Competitive-inhibition enzyme-linked immunosorbent assay for detection of serum antibodies to Caprine 
Arthritis-Encephalitis Virus:  diagnostic tool for successful eradication. Clinical and Diagnostic Laboratory 
Immunology. 2003. v. 10(2). p. 267-271. 
 
Herrmann, L.M., Cheevers, W.P., Marshall, K.L., McGuire, T.C., Hutton, M.M., Lewis, G.S., Knowles, D.P. 
Detection of serum antibodies to Ovine Progressive Pneumonia Virus (OPPV) in sheep using a Caprine 
Arthritis-Encephalitis Virus (CAEV) competitive-inhibition Enzyme-Linked Immunosorbent Assay (cELISA). 
Clinical and Diagnostic Laboratory Immunology.  2003. v. 10(5). p. 862-865. 
 
Maxson, L., Wong, C., Herrmann, L.M., Caughey, B., Baron, G.S. A solid-phase assay for identification of 
modulators of prion protein interactions. Analytical Biochemisty. 2003. v. 323(1). p. 54-64. 
 
Paramithiotis, E., Pinard, M., Lawton, T., LaBoissiere, S., Leathers, V.L., Zou, W-Q., Estey, L.A., 
Lamontagne, J., Lehto, M.T., Kondejewski, L.H., Francoeur, G.P., Papadopoulos, M., Haghighat, A., Spatz, 
S.J., Head, M., Will, R., Ironside, J., O'Rourke, K., Tonelli, K., Ledebur, H.C., Chakrabartty, A., Cashman, 
N.R. A prion protein epitope selective for the pathologically misfolded conformation. Nature Medicine. 2003. 
v. 9(7). p. 893-899. 
 
Valdez, R.A., Rock, M.J., Anderson, A.K., O'Rourke, K.I. Immunohistochemical detection and distribution of 
prion protein in a goat with natural scrapie. Journal of Veterinary Diagnostic Investigation. 2003. v. 15. p. 157-
162. 
 
Cheevers, W.P., Snekvik, K.R., Trujillo, J.D., Kumpula-McWhirter, N.M., Pretty On Top, K.J., Knowles, D.P. 
Prime-boost vaccination with plasmid DNA encoding caprine-arthritis encephalitis lentivirus env and viral SU 
suppresses challenge virus and development of arthritis. Virology. 2003. v. 306. p. 116-125. 
 
 
 
O'Rourke, K.I., Duncan, J.V., Logan, J.R., Anderson, A.K., Norden, D.K., Williams, E.S., Combs, B.A., 
Stobart, R.H., Moss, G.E., Sutton, D.L. Active Surveillance for scrapie by third eyelid biopsy and genetic 
susceptibility testing of flocks of sheep in Wyoming. Clinical and Diagnostic Laboratory Immunology. 2002. 
v. 9(5). p. 966-971. 
 
Herrmann L.M, Baszler T.V, Knowles D.P, Cheevers W.P.  PrP(Sc) is not detected in peripheral blood 
leukocytes of scrapie-infected sheep:  determining the limit of sensitivity by immunohistochemistry. Clinical 
and Diagnostic Laboratory Immunolology. 2002. v. 9(2). p. 499-502. 
 
Tuo, W, O’Rourke, K.I, Zhuang, D., Cheevers, W.P, Spraker, T.R, Knowles, D.P.  Pregnancy status and fetal 
prion genetics determine PrPSc accumulation in placentomes of scrapie-infected sheep. Proceeding of the 
National Academy of Science USA. 2002. v. 99. p. 6310-6315. 
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Tuo, W, Zhuang, D, Knowles, D.P, Cheevers, W.P, Sy, M-S, O’Rourke, K.I.  PrP-C and PrP-Sc at the 
maternal-fetal interface. Journal of Biological Chemistry. 2001. v. 276. p. 18229-34. 
 
O’Rourke, K.I Ovine Scrapie:  New tools for control of an old disease in veterinary clinics of North America. 
Food Animal Practice. 2001. v. 17(2) p. 283-300. 
 
Herrmann, L.H, Davis, W.C, Knowles, D.P, Wardrop, K.J., Sy, M-S., Gambetti. P., O’Rourke, K.I.    Cellular 
prion protein is expressed on PBMC but not platelets of normal and scrapie-infected sheep. Haematologica. 
2001. v. 86. p. 164-171. 
 
Kim, H, O’Rourke, K.I,  Walter, M, Purchase, H.G, Enck, J, Shin, T.K. Immunohistochemical detection of 
scrapie prion proteins in clinically normal sheep in Pennsylvania. Journal of Veterinary Diagnostic 
Investigation. 2001. v. 13. p. 89-91. 
 
Koo, H.C, Park, Y.H,  Lee, B-C, Chae, C, O’Rourke, K.I,  Baszler, T.V. Immunohistochemical detection of 
prion protein (PrP-Sc) and epidemiological study of BSE in Korea. Journal of Veterinary Science. 2001. v. 
2(1). p. 25-31. 
 
O’Rourke, K.I, Baszler, T.V, Besser, T.E, Miller, J.M, Cutlip, R.C, Wells, G.A.H, Ryder, S.J., Parish, S.M, 
Hamir, A.N, Cockett, N.E, Jenny, A. Knowles, D.P.   Preclinical diagnosis of scrapie by 
immunohistochemistry of third eyelid lymphoid tissue. Journal of Clinical Micrology. 2000. v. 38. p. 3254-
3259. 
 
Herrmann, L.M, Baszler T.V, Knowles D.P.  PrP(c) mRNA, but not PrP(Sc) is found in the salivary glands of 
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Project Title:   Functional Approaches to the Control of Babesiosis in Cattle and  
Horses 
CRIS Number:     5348-32000-020-00D 
Scientists:    Suarez, C., Knowles Jr, D., Scoles, G., Goff, W.    
Location:         Pullman, WA, Animal Diseases Research 
Contact:   Suarez, C., Phone: (509) 335-6341, Fax: (509) 335-8328 
ces@vetmed.wsu.edu 
 
 
PROJECT OBJECTIVES: 
There is a threat of reintroducing bovine babesiosis, a tick borne, hemoparasitic protozoal disease, into the U.S. 
from Mexico for the following reasons: 1) the USDA-APHIS surveillance program involves ticks only, 2) at 
least a million cattle are moved north across the Mexican border each year, a percentage of which are Babesia 
carriers, 3) acaracide resistant ticks occur in northern Mexico, 4) there is an increase in the number of wild 
ungulates along the border, and these and some cattle are not treated for ticks, and 5) there is no babesiacidal 
drug or vaccine approved for use in the U.S. Two products from research that would help alleviate the threat 
would be safe and effective vaccines for use in the U.S (and elsewhere) and diagnostic assays capable of 
handling large numbers of samples for use in surveillance. Babesia vaccine development requires the 
characterization of the protective immune mechanisms, the identification of protective antigens from the 
parasites, and the development of effective delivery systems. Given this, we have three areas of focus: 1) A 
series of immunologic assays have been developed and are now routinely used in our laboratory to characterize 
the immune response following exposure to Babesia and to assess the efficacy of immunization trials. These 
assays include, gene expression of several immunoregulatory cytokines, cytokine production and secretion 
assay by flow cytometry, lymphocyte, dendritic cell, and monocyte/macrophage activation, leukocyte 
phenotype analysis, cellular proliferation, and antibody isotype analysis. 2) In collaboration with scientists of 
the Department of Veterinary Microbiology and Pathology of WSU, we are characterizing new Babesia 
antigens as potential vaccine candidates, and investigating immunological properties of CpG containing DNA 
motifs present in the babesial genome. These CpG motifs have strong immunostimulatory activity. 3) We are 
establishing a babesial transfection system to functionally characterize genes expressing antigens of interest 
and to develop transmission-defective attenuated parasites. Reagents have also been identified for the design of 
an improved diagnostic assay for Babesia bovis and B. bigemina, and formatting and validating them are 
included in the objectives. 
 
OVERALL PROJECT ACCOMPLISHMENTS: 
Several assays used to evaluate the bovine immune response were developed and applied in studies providing a 
more complete understanding of the mechanisms operative during Babesia infection. One important 
mechanism involves the babesiacidal activity of nitric oxide and its induction by signals sent from 
immunologically activated cells. Among these signals are interferon-gamma and interleukin-12, both 
characteristic of a "Type-1 response". Other studies confirmed the importance of a Type-1 response in 
resolution of a primary Babesia infection, and suggested that the response is tightly regulated. Other molecules 
associated with a "Type-2 response", IL-4 and especially IL-10 have been shown to down-regulate the 
appropriate Type-1 response. Additional studies revealed the importance of Type-1 immunity against this 
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infection as a part of the strong innate immunity of young calves, and that the mechanisms are less effective in 
older cattle, where the disease is more severe. Natural killer (NK) cells capable of producing interferon gamma 
and that proliferate in the spleens of calves mounting a successful immune response have been identified. 
Reagents to purify both splenic dendritic cells and NK cells have recently been used to develop assays for 
examining the cooperative nature of these cells in response to babesial parasites in vitro as well as ex vivo 
during infection.  
 
Work on the elucidation of the role of CpG motifs as an immunomodulator and the identification of new 
vaccine candidate antigens has and will further contribute to the design of future vaccines. A transition from 
the previous project design to a new project with more emphasis on the tick/pathogen interface was started in 
2003. While studies concerning the immunology associated with babesial infection/immunization continue, the 
new project emphasizes the identification of babesial molecules involved in the transmission stages of the 
disease and the development of a novel babesial transfection system for genetic manipulation of the parasites. 
Recently, we developed a transient transfection system for expression of exogenous genes in Babesia bovis 
under the transcriptional control of the B. bovis rap-1 promoter. A B. bovis-specific protein that had been 
identified and characterized previously, was chosen for use as an epitope-defined diagnostic antigen, was 
formatted as a competitive ELISA assay and has resulted in good diagnostic specificity. Validation studies 
continue in efforts to establish the predictive value for the assay, and to determine conditions appropriate for 
commercialization.  The work has resulted in the identification of parasite components with attributes 
important for the design of improved diagnostics (competitive ELISAs for each parasite (Babesia equi and 
Babesia caballi).  Validation of these assays for adoption as replacements for the current official, but inferior 
assays has been accomplished. Improved diagnostics will improve and support the credibility of import 
regulatory policies. Basic immunology studies have revealed the importance of the disease agent-specific arm 
of the immune system involving T-cells in the resolution of infection whereas animals lacking T-cells suffered 
severe disease despite possessing the intact non-specific arm of the immune system. 
  
IMPACT: 
The tick-borne diseases laboratory within the ADRU has been invited to apply for OIE reference laboratory 
status acknowledging the development and standardization of diagnostic assays for equine and bovine 
babesiosis for use throughout the world.  Our diagnostic tests for Babesia equi and Babesia caballi have been 
adapted by APHIS, are replacing the inaccurate CFT for importation testing and have been adopted by OIE as 
the prescribed tests for these diseases. 
Basic immunology studies have characterized the protective innate immune response in cattle to Babesia bovis 
infection identifying critical aspects that need to be induced by new vaccines. The project has resulted in a 
battery of immunological assays with which to evaluate vaccine trials. 
 
TECHNOLOGY TRANSFER: 
Material transfer agreements: The cELISA for diagnosing B. bovis in cattle has been transferred to 
collaborators in Morocco, Australia, and Italy for validation. The improved diagnostic assays for equine 
babesiosis have been transferred to APHIS and to collaborators in Morocco in support of a FAS-supported 
epidemiology study. The equine babesiosis assays are being adopted for use by collaborators in Argentina, 
Brazil, Canada, England, Israel, Japan, and Morocco and as part of an OIE inter-laboratory validation. 
 
Five improved tick-borne disease diagnostic assays have been transferred to the Institut Agronomique et 
Veterinaire (Hassan II) in Rabat, Morocco in support of ongoing epidemiology studies to determine the 
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feasibility of renewed trade activities with the US cattle industry. Moroccan graduate students were trained 
during the course of activities. 
(Jehle, P., Goff, W.L. Scientific exchange for Moroccan technicians engaged in research on tick-borne disease 
control in North Africa. AgLink U.S.-Morocco Trade Promotion Program-1998-2003. 2003. End of Project 
Report. p. 49.) 
 
Our diagnostic tests for equine babesiosis have been transferred to industry and will be commercially available 
within 2004.  The company and APHIS are collaborating to assure standardization of test parameters and 
utilization. 
 
PUBLICATIONS: 
 
Suarez CE, Florin-Christensen M, Hines SA, Palmer GH, Brown WC, McElwain TF.  Characterization of 
allelic variation in the Babesia bovis merozoite surface antigen 1 (MSA-1) locus and identification of a cross-
reactive inhibition-sensitive MSA-1 epitope. 2000. Infection and Immunity. v. 68. p. 6865-6870. 
 
Florin-Christensen J, Suarez CE, Florin-Christensen M, Hines SA, McElwain TF, Palmer GH. 
Phosphatidylcholine formation is the predominant lipid biosynthetic event in the hemoparasite Babesia bovis. 
2000. Molecular and Biochemical Parasitology. v. 106. p. 147-156. 
 
Brown WC, Ruef BJ, Norimine J, Kegerreis KA, Suarez CE, Conley PG, Stich RW, Carson KH, Rice-Ficht 
AC.  A novel 20-kilodalton protein conserved in Babesia bovis and B. bigemina stimulates memory CD4(+) T 
lymphocyte responses in B. bovis-immune cattle. 2001. Molecular and Biochemical Parasitology. v. 118. p. 
97-109. 
 
Goff, W.L., Johnson, W.C., Parish, S.M., Barrington, G.M., Tuo, W. and Valdez, R.A. The age-related 
immunity in cattle to Babesia bovis infection involves the rapid induction of IL-12, IFN- and iNOS mRNA 
expression in the spleen. 2001. Parasite Immunology. v. 23. p. 453-461. 
 
Shoda LK, Kegerreis KA, Suarez CE, Roditi I, Corral RS, Bertot GM, Norimine J, Brown WC.  DNA from 
protozoan parasites Babesia bovis, Trypanosoma cruzi, and T. brucei is mitogenic for B lymphocytes and 
stimulates macrophage expression of interleukin-12, tumor necrosis factor alpha, and nitric oxide. 2001. 
Infection and Immunity.  v. 69. p. 2162-2171. 
 
Johnson, W.C., Lasri, S., Kappmeyer, L.S., Rhalem, A., Sahibi, H., Knowles, D.P. and Goff, W.L.  Factors 
influencing the deployment of a Babesia caballi cELISA in tropical areas. 2001. Proceedings of the10th 
International Symposium of Veterinary Laboratory Diagnosticians, Parma, Italy.  p. 322-323. 
 
Rhalem, A., Sahibi, H., Lasri, S., Johnson, W.C., Kappmeyer, L.S., Hamidouch, A., Knowles, D.P. and Goff, 
W.L.  Validation of a competitive enzyme-linked immunosorbent assay for diagnosing Babesia equi infections 
of Moroccan origin and its use in determining the seroprevalence of B. equi in Morocco.  2001. Journal of 
Veterinary Diagnostic Investigation. v. 13. p. 249-251. 
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immunologically distinct proteins. 2002. Infection and Immunity. v. 70. p. 3566-3575. 
 
Norimine J, Suarez CE, McElwain TF, Florin-Christensen M, Brown WC. Immunodominant epitopes in 
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2048. 
 
Goff, W.L., Johnson, W.C., Parish, S.M., Barrington, G.M., Elsasser, T.H., Davis, W.C., and Valdez, R.A.  IL-
4 and IL-10 inhibition of IFN gamma- and TNF alpha-dependent nitric oxide production from bovine 
mononuclear phagocytes exposed to Babesia bovis merozoites. 2002. Veterinary Immunology and 
Immunopathology.  v. 84. p. 237-251. 
 
Stiller, D., Goff, W.L., Johnson, L.W. and Knowles, D.P.  Dermacentor variabilis, Say (Acari: Ixodidae): an 
experimental vector of Babesia equi (Laveran) to ponies. 2002. Journal of Medical Entomology. v. 59.  p. 667-
670. 
 
Goff, W.L., Johnson, W.C., Tuo, W., Valdez, R.A., Parish, S.M., Barrington, G.M. and Davis, W.C.  The age-
related innate immune response in calves to Babesia bovis involves IL-12 induction and IL-10 modulation. 
2002. Annals of the New York Academy of Sciences.  v. 969.  p. 164-168. 
 
Boonchit, S., Xuan, X., Yokoyama, N., Goff, W.L., Wagner, G.G. and Igarashi, I.  Evaluation of an enzyme-
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the detection of specific antibodies in cattle.  2002. Journal of Clinical Microbiology. v. 40.  p. 3771-3775. 
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cells in the spleen. 2003. Parasite Immunology. v. 25. p. 185-188. 
 
Boonchit, S., Xuan, X., Yokoyama, N., Goff, W.L., Waghela, S.D., Wagner, G.G. and Igarashi, I.  An 
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Animal Disease Research Unit 
 
Project Title:   BSE and Other TSEs Ruminant Herbivors: Diagnosis, Transmission and Genetics 
CRIS Number:     5348-32000-021-00D 
Scientists:             O’Rourke, K.I., Knowles, D.P., Alverson, J.    
Location:         Pullman, WA, Animal Diseases Research Unit 
Contact:   O'Rourke, K. Phone: (509) 335-6020, Fax: (509) 335-8328, 
korourke@vetmed.wsu.edu 
  
 
PROJECT OBJECTIVES: 
Free ranging and farm raised deer and elk in the U.S. develop a fatal prion disorder, chronic wasting disease 
(CWD). CWD is a relatively uncharacterized TSE with novel patterns of transmission and agent distribution, 
as well as the considerable challenge of a persistent disease in free ranging wildlife. The objectives of the 
project are to develop inexpensive, high capacity live animal and postmortem diagnostic tests, prion detection 
methods for monitoring environmental contamination, and pathogenesis/transmission experiments that provide 
direction to intervention techniques and reagents. Control of all domestic prion diseases is important in 
reducing trade barriers for U.S. sheep and germplasm and for assuring the present and future global markets for 
cattle. 
 
OVERALL PROJECT ACCOMPLISHMENTS: 
Postmortem diagnostic test methodology for BSE using automated, monoclonal antibody 
immunohistochemistry was developed and transferred to USDA, APHIS, National Veterinary Services 
Laboratory.  A non-automated immunohistochemistry test for BSE was developed in conjunction with private 
industry and is marketed outside the United States, with all sales registered with USDA, APHIS, Center for 
Veterinary Biologics.  Postmortem diagnostic test methodology for CWD using automated 
immunohistochemistry was developed through a collaborative project with the Colorado State Veterinary 
Diagnostic Laboratory and transferred to USDA APHIS.  The test is conducted by the National Veterinary 
Services Laboratory and a network of 20 contract laboratories and is used as a gold standard test to confirm the 
results on rapid (ELISA) tests.    The test was modified for use in live deer using tonsil biopsies collected under 
general anesthesia.  Monoclonal antibodies useful in assays on routinely formalin fixed tissue from infected 
sheep, deer, elk, cattle, humans, mink, domestic cats and a wide variety of captive wildlife potentially exposed 
to prion diseases were developed. Prion gene variation in mule deer, white-tailed deer, and elk was examined.  
A processed prion pseudogene, the first reported in placental mammals, was discovered to occur in a large 
proportion of mule deer and a small proportion of white-tailed deer.  Genetic variants associated with relative 
susceptibility to CWD were reported in white-tailed deer and elk; no evidence of relative genetic resistance to 
CWD was found in mule deer.   
  
IMPACT:   
The development of an automated monoclonal antibody-based immunohistochemistry diagnostic assay has 
allowed the US to provide gold standard testing for BSE and CWD at NVSL and a network of 20 contract 
laboratories.  The manual version of the test is the legal diagnostic test for BSE in Canada and in 17 countries 
in Central and South America.  This standardized approach to diagnosis in the US and with our Western 
Hemisphere trading partners has allowed the cooperating nations to apply a single diagnostic standard for these 
diseases and increase the confidence of the regulatory agencies and US consumers in the validity of the 
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surveillance programs.  The finding of a processed pseudogene in some species of deer has allowed the 
regulatory and research communities to correct previous work on genetic susceptibility and sets the stage for 
large scale field studies on transmission of the disease among related and unrelated members of free ranging 
breeding groups.     
 
TECHNOLOGY TRANSFER: 
Licenses: 
VMRD, Inc., licensed the monoclonal antibody developed for this project and completed the research and 
development work on an inexpensive "dot blot ELISA" assay for early diagnosis of chronic wasting disease in 
mule deer and white tailed deer.  VMRD, in conjunction with ADRU, developed an inexpensive 
immunohistochemistry diagnostic test for BSE.  The test was validated by the Canadian Food Inspection 
Agency and the Veterinary Laboratories Agency in the United Kingdom.  The BSE test is marketed 
internationally and is a diagnostic gold standard test in Canada.  Monoclonal antibody F99/97.6.1 has been 
licensed by a number of companies attempting to develop antemortem tests and is available commercially for 
research purposes. 
  
PUBLICATIONS: 
 
O’Rourke, K.I, Spraker, T.R, Hamburg, L.K, Besser, T.E, Brayton, K.A, Knowles, D.P.  Polymorphisms in the 
prion precursor functional gene but not the pseudogene are associated with susceptibility to chronic wasting 
disease in white-tailed deer.  Journal of General Virology. 2004. v. 85.  p. 1339-1346.   
 
Spraker, T.R, Balachandran, A., Zhuang, D., O’Rourke, K.I.  Variable patterns of PrP-CWD distribution in 
obex and cranial lymphoid tissues of Rocky Mountain elk with nonclinical chronic wasting disease.  
Veterinary Record . 2004 (in press). 
 
Brayton, K.A, O’Rourke, K.I, Lyda, A.K, Miller, M.W, Knowles, D.P. A processed pseudogene contributes to 
apparent mule deer prion gene heterogeneity.  Gene.  2004. v. 326. p. 167-173. 
 
O'Rourke, K.I., Zhuang, D., Lyda, A., Gomez, G., Williams, E.S., Tuo, W., Miller, M.W. Abundant PrP-CWD 
in tonsil from mule deer with preclinical chronic wasting disease. Journal of Veterinary Diagnostic 
Investigation 2003. v. 15. p. 320-323. 
 
Spraker, T.R., Zink, R.R., Cummings, B.A., Sigurdson, C.J., Miller, M.W., O'Rourke, K.I. Distribution of 
protease-resistant prion protein and spongiform encephalopathy in free-ranging mule deer (Odocoileus 
hemionus) with chronic wasting disease. Veterinary Pathology. 2002. v. 39. p. 546-556. 
 
Wild, M.A., Spraker, T.R., Sigurdson, C.J., O'Rourke, K.I., Miller, M.W. Preclinical diagnosis of chronic 
wasting disease in captive mule deer (Odocoileus hemionus) and white-tailed deer (Odocoileus virginianus) 
using tonsillar biopsy. Journal of General Virology. 2002. v. 83. p. 2629-2634. 
 
Spraker, T.R, O’Rourke, K.I, Balachandran, A., Zink, R.R, Cummings, B.A, Miller, M.W., Powers, B.E.  
Validation of monoclonal antibody F99/97.6.1 for immunohistochemical staining of brain and tonsil in mule 
deer (Odocoileus hemionus) with chronic wasting disease.  Journal of Veterinary Diagnostic Investigation. 
2002. v. 14. p. 3-7. 
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Spraker, T.R, Zink, R.R, Cummings, B.A, Wild, M.A, Miller, M.W, O’Rourke, K.I.  Comparison of 
histological lesions and immunohistochemical staining of proteinase resistant prion protein in a naturally-
occurring spongiform encephalopathy of free-ranging mule deer (Odocoileus hemionus) with those of chronic 
wasting disease of captive mule deer. Veterinary Pathology. 2002. v. 39. p. 110-119. 
 
Raymond, G.J, Bossers, A., Raymond, L.D, O’Rourke, K.I,  McHolland, L.E, Bryant, P.K, Miller, M.W, 
Williams, E.S, Smits, M., Caughey, B.  Evidence of a molecular barrier limiting susceptibility of humans, 
cattle and sheep to chronic wasting disease.  EMBO Journal. 2000. v. 19. p. 4425-4430. 
 
Hamir, A.N, Cutlip, R.C,  Miller, J.M, Williams, E.S, Stack, M.J, Miller, M.W, O’Rourke, K.I, Chaplin, M.J.   
Preliminary findings on the experimental transmission of chronic wasting disease agent of mule deer to cattle.  
Journal of Veterinary Diagnostic Investigation. 2001. v. 13. p. 91-96. 
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Southeast Poultry Research Laboratory 
 
CRIS Title:   Poult Enteritis Mortality Syndrome 
CRIS:   6612-32000-036-00D 
Scientists:   Spackman, E.; Pantin-Jackwood, M. 
Location:   Southeast Poultry Research Laboratory, Athens, GA 
Contacts:   706-546-3617 (P); 706-546-3161 (F); espackman@seprl.usda.gov
 
 
PROJECT OBJECTIVES: 
Poult enteritis mortality syndrome (PEMS) is a highly infectious disease of young turkeys. PEMS was first 
reported in North Carolina in 1991. Since then, PEMS has been reported throughout the Southeastern United 
States and Texas. There are also reports of a PEMS-like disease in California, Arkansas, Missouri, and Israel. 
PEMS has been called one of the most devastating emergent diseases to strike the poultry industry due to 
production losses from the disease complex and in some regions of the U.S. an estimated 60-90% of all 
commercial turkey flocks will experience some poult enteritis like disease seasonally during grow-out. The 
causative agent(s) of PEMS remains unknown. The research under this CRIS seeks to identify the PEMS 
agent(s) using novel molecular techniques, develop diagnostic reagents for rapid identification, and understand 
the pathogenesis of the disease. 
 
OVERALL PROJECT ACCOMPLISHMENTS: 
Accomplishments over the life of this project have included: 1) the isolation, identification and characterization 
of a unique strain of astrovirus in turkeys with PEMS; 2) reproduction of a PEMS-like clinical disease in 
turkeys with this astrovirus; 3) reproduction of immune deficiencies in turkeys with the astrovirus which 
reduces the ability of turkeys to fight off other pathogens; 4) an evaluation of commercial disinfectants which 
demonstrated that most fail to inactivate the astrovirus, with the exception of formaldehyde and Virkon S that 
were effective for killing the virus; 5) the development of a specific and sensitive standard RT-PCR test to 
detect turkey astrovirus and transfer of the technology to veterinary diagnostic laboratories; 6) development of 
state-of-the-art molecular tests (multiplex real-time-RT-PCR) for the simultaneous detection of several PEMS 
associated viruses, including; turkey astrovirus, turkey coronavirus, classical avian reoviruses and turkey 
reoviruses, all from samples collected from PEMS affected turkeys; 7) an evaluation of turkey astrovirus, 
turkey coronavirus and turkey reovirus shed and virus presence in selected organs at different times post-
exposure in order to determine optimal sampling methods for the detection of each virus with molecular tests; 
and 8) a preliminary characterization of turkey reoviruses which are associated with poult enteritis complex. 
 
IMPACT:  
This work has directly addressed the objective of developing rapid, sensitive and accurate detection methods 
for the viruses commonly associated with PEMS (turkey coronavirus, turkey astrovirus and avian reovirus). 
Also optimal sampling methods have been determined to increase the utility of these methods in the field. The 
availability of accurate molecular diagnostic tests using state-of-the-art technology, such as real-time RT-PCR 
will also help to address the objective of isolating, identifying and characterizing viral agents associated with 
PEMS due to the difficulty in culturing these agents.  Additionally, using the improved technology we have 
been able to identify reoviruses that are genetically different from classical avian reoviruses in samples 
collected from commercial turkey flocks with poult enteritis and which otherwise may not have been detected.  
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Therefore more pathogens can be detected and more information about them can be obtained at their initial 
detection.   
 
TECHNOLOGY TRANSFER: 
Schultz-Cherry, S., L.A. Kelley, M.D. Koci and B.S. Seal. Avian Astrovirus US patent# 6,696,562 
 
A reverse-transcription-polymerase chain reaction (RT-PCR) was developed, based on the sequence produced 
at SEPRL, to identify the turkey astrovirus, and the test was transferred to the University of Guelph diagnostic 
laboratory.  The RT-PCR test was further enhanced into a multiplex format so that could identify both turkey 
astroviruses and turkey coronaviruses from the same sample.  This test was transferred for use by the Poultry 
Diagnostic Research Center at the University of  Georgia. 
 
PUBLICATIONS: 
 
Koci, M.D., Seal, B.S., Schultz-Cherry, S. Development of an RT-PCR diagnostic test for an avian astrovirus. 
2000. Journal of Virological Methods. v.90 pp. 79-83 
 
Schultz-Cherry, S., Kapczynski, D.R. Simmons, V.M. Koci, M.D., Brown, C., Barnes, H.J. Identifying 
Agent(s) associated with poult enteritis mortality syndrome; importance of the thymus. 2000. Avian Diseases. 
v.44. pp. 256-65. 
 
Schultz-Cherry, S., Kind, D.J., Koci, M.D. Inactivation of an astrovirus associated with poult enteritis 
mortality syndrome. 2001. Avian Diseases. v.45. pp. 76-82. 
 
Kapczynski, D.R., Sellers, H.S., Simmons, V., Schultz-Cherry, S. Sequence analysis of the S3 gene from a 
turkey reovirus. Virus Genes. 2002. v.25. p.95-100. 
 
Koci M.D., Kelley, L.A., Larsen, D. and S. Schult-Cherry. Astrovirus induced synthesis of nitric oxide 
contributes to virus control during infection, Journal of Virology, 78:1564-74, 2004 
 
Sellers, H.S., M.D. Koci, E. Linneman, L.A.Kelley and S. Schultz-Cherry. Development of a multiplex reverse 
transcription-polymerase chain reaction diagnostic test specific for turkey astrovirus and coronavirus. Avian 
Diseases; in Press 
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Southeast Poultry Research Laboratory 
 
CRIS Title: Identification of Virulence Determinants, Pathogenetic Mechanisms and Control 
Methods of Avian Paramyxoviruses 
CRIS:   6612-32000-038-00D 
Scientists: King DJ, Kapczynski DR, Yu Q, Swayne DE, Mitchell BW, Vacancy 
Location:  Southeast Poultry Research Laboratory, Athens, GA 
Contacts:  706-546-3407 (Phone), 706-546-3161 (FAX),  
jking@seprl.usda.gov
 
PROJECT OBJECTIVES: 
Avian paramyxoviruses are the cause of two diseases important to the U. S. poultry industry. Newcastle 
disease (ND) is a viral disease of poultry and a worldwide problem first recognized in the U. S. in the 1930s. 
Newcastle disease virus (NDV), also known as avian paramyxovirus type 1 (APMV-1), infects all known wild 
and domestic bird species. Different NDV strains vary in virulence and produce differing clinical forms of the 
disease that range from high mortality to mild or inapparent respiratory infections. Although the highly virulent 
form of the disease was diagnosed in the U.S. in 2002-2003 for the first time since 1998, the mild form of ND 
is the predominant one occurring in the U.S. and is the cause of reduced productivity from respiratory disease 
and reduced rate of gain. Avian pneumovirus (APV) infections of turkeys in the U.S., in contrast to ND, are of 
recent concern. APV, now classified as an avian metapneumovirus, was isolated from commercial turkeys in 
Colorado in 1996. The disease was reported in the United Kingdom in 1985 and prior to 1996 the disease was 
exotic to North America. The virus causes a mild, but rapidly spreading, upper respiratory disease and adverse 
effect on weight gain and feed conversion. Secondary bacterial infections increase the severity of the disease. 
The initial diagnosis of the disease in the U.S. was delayed because the U.S. isolate was of a different subtype 
than had been isolated elsewhere and serological assays to detect the new subtype had to be developed. 
Research to resolve the problems caused by these two diseases includes characterization of new isolates, 
identifying the factors responsible for their causing disease, and developing control strategies, including 
vaccination and diagnostics. 
 
OVERALL PROJECT ACCOMPLISHMENTS: 
Present methods for the detection of the causative agent of Newcastle disease (ND), Newcastle disease virus 
(NDV), are based on isolation of the virus in embryonated chicken eggs, a sensitive and reliable method but 
expensive and time consuming. ND susceptible and vaccinated chickens and turkeys were infected with the 
California 2002 END virus at Southeast Poultry Research Laboratory (SEPRL) to provide samples for 
comparative testing by virus isolation and a rapid diagnostic method developed by SEPRL scientists from the 
avian influenza and Newcastle disease rapid diagnostic development project. A comparison of results of virus 
isolation and the rapid test demonstrated the efficacy of the newly developed rapid test procedure. This 
efficacy with experimental samples was the justification for proceeding with validation testing of the new rapid 
procedure on field samples including those from the END outbreak of 2002-2003 and transfer of the test to the 
National Veterinary Services Laboratories for use in the California NDV outbreak. 
 
Last year, avian pneumovirus (APV) antibody was demonstrated in wild birds in the Southeast U.S. and 
suggests wild birds could be a source of APV virus transmission to turkeys. Southeast Poultry Research 
Laboratory scientists collected swabs from the species of wild birds previously found to have APV antibodies.  
APV was identified from 12 of the sampled wild birds and it was determined through sequence analysis of the 
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glycoprotein, matrix and fusion genes that the wild bird viruses are closely related to viruses found in domestic 
poultry. The presence of virus in wild birds and the relatedness to viruses found in domestic poultry indicate 
the potential for wild birds to spread APV infections in areas of the United States where the virus is currently 
not found in poultry. 
 
Identifying the source of the exotic Newcastle disease (END) virus that caused the END outbreak in the 
Southwestern U.S. and Texas during 2002-2003 is critical to the development of control programs to prevent 
future outbreaks. Southeast Poultry Research Laboratory scientists analyzed and compared the nucleotide 
sequence of the virus genome of isolates from the 2002-2003 outbreaks with the sequence of recent isolates of 
END virus from U.S. quarantine stations and from outbreaks in several countries in the world. The END virus 
isolates from the 2002-2003 U.S. outbreaks were found to be most similar to viruses isolated from northern 
Mexico during 1996 and 2000. Therefore, the most likely source of END virus that caused the California and 
Texas 2002-2003 END outbreaks was virus transmission from Mexico via infected birds or virus contaminated 
fomites. 
 
Genetic changes in avian pneumovirus (APV) between its initial identification as the cause of turkey 
rhinotracheitis (TRT) in Colorado during 1997 and the isolates from current outbreaks in Minnesota were 
unknown. Southeast Poultry Research Laboratory scientists analyzed the nucleotide sequence of the virus 
attachment protein gene (G) of isolates from 1997 and compared it to the G sequence of recent APV isolates. 
APV virus G gene changes were found to have occurred between 1997 and the present. These changes suggest 
selection or mutation among U.S. isolates has occurred since the first outbreak of TRT in the U.S. 
 
The embryonated chicken egg had not been examined as a model system to evaluate virulence properties of 
Newcastle disease virus (NDV) isolates and laboratory induced NDV mutations. At the Southeast Poultry 
Research Laboratory, the embryos from eggs inoculated with NDV reference and mutated reference strains 
were collected, formalin fixed, sectioned, and stained with a gene probe and NDV antibodies to detect virus 
distribution in the tissues and membranes of the embryonated egg. Low-virulence strains were detected 
exclusively in the cells of the chorioallantoic membrane, whereas more virulent NDV isolates and mutated 
strains that had been demonstrated to have acquired virulence for chickens were widely disseminated in 
chicken embryo tissues. The results demonstrate the potential value of this as a model system for evaluating 
NDV virus virulence as an alternative to chicken inoculation. 
 
Efficacious avian pneumovirus (APV) vaccines are needed by the turkey industry. At the Southeast Poultry 
Research Laboratory, a live attenuated APV vaccine (cp30) was developed by successive adaptation of the 
virus to decreasing temperatures and its efficacy in turkeys was evaluated. The results indicate the dose 
necessary for complete protection from clinical signs following APV challenge also resulted in clinical signs 
following vaccination. A cold adaptation of the vaccine strain to reduce post vaccinal reaction was ineffective 
at reducing those reactions at a dosage required to produce protection.  
 
Protection of commercial poultry from exotic Newcastle disease (END) is a constant threat to U.S. poultry 
producers. Southeast Poultry Research Laboratory scientists conducted vaccine efficacy experiments with 
END California 2002 virus in chickens.  The results indicated protection from END with either a single dose of 
live or inactivated vaccine. Current commercial ND vaccines are effective in protecting against disease 
resulting from END virus infections.  
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The capability to easily differentiate vaccinated from infected birds would enhance current Newcastle disease 
(ND) control programs. A project scientist developed a vaccine that is a shell of the whole virus which retains 
the important surface structures that induce immunity but can=t infect or be transmitted from bird to bird 
because the virus genome and internal proteins have been removed. The vaccine is known as a Newcastle 
disease virus (NDV) virosome vaccine, was administered intranasally, and protected chickens against a lethal 
NDV challenge. Because vaccinated birds can be differentiated from infected birds, this vaccine may provide 
an alternative to current live NDV vaccines. 
 
Extensive genomic data of Newcastle disease virus (NDV) is largely incomplete. To extend that data, the 
nucleocapsid (N) protein genes from twenty-four NDV isolates representing various pathotypes with different 
geographical and chronological origins were cloned and sequenced. Comparison of N protein amino acid 
sequences among members of the Paramyxoviridae resulted in NDV and avian paramyxovirus type 6 
separating as a cluster distinct from the Rubulavirus genus. This data provided further support for the recently 
updated classification of avian paramyxoviruses in their own genus Avulavirus among the Paramyxovirinae. 
 
Rapid diagnostic procedures are needed for Newcastle disease virus (NDV). Viral genomic information around 
a known virulence marker of NDV was used to develop a heteroduplex mobility assay (HMA) to differentiate 
strains that have different genome sequences in the region of that marker. Project scientists were able to 
distinguish vaccine-like viruses from other isolates potentially virulent for chickens. Use of the HMA in labs 
that do not have nucleotide sequencing facilities can provide a rapid identification of potentially virulent NDV 
that continue to threaten commercial poultry. 
 
Waterfowl have been a suspect source of avian pneumovirus (APV) that infected turkeys in Minnesota. 
University of Minnesota scientists placed APV-negative mallard ducks as sentinels on a turkey farm 
experiencing a severe APV outbreak and were able to recover APV from swab samples and detect anti-APV 
antibodies in serum of the sentinel ducks even though they did not develop clinical APV disease. Sequence 
analysis at Southeast Poultry Research Laboratory of four APV isolates recovered from the APV outbreak in 
turkeys shared 95% to 99% nucleotide sequence identity and 97% to 99% predicted amino acid sequence 
identity with the duck isolate. These results indicate that the APV isolates from turkeys and ducks shared a 
common source, and the viruses from different avian species can cross-infect. 
 
The diversity of among avian pneumovirus (APV) isolates from commercial turkeys in the north-central region 
of the U.S., particularly Minnesota had not been determined. A comparison of nucleotide and predicted amino 
acid sequences from 15 U.S. AMPV isolates were completed. The results demonstrated that these viruses were 
all closely related and distinct from European APV isolates. This further confirms that the U.S. viruses are 
closely related genetically and form a separate sub-type relative to European viruses. 
 
An effective APV vaccine is still needed to control the disease in turkeys. Turkeys were vaccinated with a 
DNA vaccine comprised of the APV fusion protein gene, a gene whose product is believed critical in 
generating an effective immune response. Vaccinated turkeys shed less challenge virus and produced higher 
neutralizing antibody titers than attained with other experimental vaccines. The results suggest that improved 
APV vaccines are feasible and provide the basis for expanding this vaccination approach. 
 
Laboratory experiments with APV fail to reproduce the severity of disease seen in the field. Southeast Poultry 
Research Laboratory (SEPRL) scientists conducted coinfection experiments with APV and low virulent 
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Newcastle disease virus (NDV) or Escherichia  coli at SEPRL. Coinfection of APV and NDV results in 
increased severity of disease. This suggests that control of field NDV or more judicious use of NDV vaccines 
are necessary to control APV. 
 
Existing avian pneumovirus (APV) diagnostic tests do not work in bird species other than chickens and 
turkeys. A competitive ELISA test developed in FY2001 at Southeast Poultry Research Laboratory was 
validated using field sera samples in conjunction with Minnesota Bureau of Animal Health. Using the 
validated test, APV positive sera samples were identified in American coots and Canada geese but not in 13 
other wild bird species. This suggests that some wild birds can be infected with APV and may be a reservoir 
for the virus. 
 
IMPACT: 
The work addresses the objectives in our OSQR Project Plan: 1) to characterize emergent Newcastle disease 
virus and avian metapneumovirus isolates to extend the capabilities for molecular epidemiology of the most 
important avian paramyxovirus infections; 2) to further characterize determinants important to avian 
paramyxovirus pathogenesis; and 3) to develop improved control strategies, including vaccination, diagnostics 
and identification of virus reservoirs based on information from avian paramyxovirus characterization and 
pathogenesis studies. The outbreak of exotic Newcastle disease (END) that was diagnosed in the U.S. during 
October 2002 served to focus and provide immediate impact for this year’s research. Project scientists 
provided support in the eradication of END by analysis and experimentation that are components of the first 
and third project objectives. 
 
TECHNOLOGY TRANSFER: 
Patents: 
ANucleotide Sequence for the Avian Metapneumovirus (Colorado) Attachment Glycoprotein Gene@ Inventors: 
Bruce S. Seal and Rene Alvarez. Docket No.: 0036.02. Serial No.: 10/285,626. Date Filed: 11/01/2002. 
 
An invention report, No. 0186.02 entitled “A Virosome Vaccine for NDV”, was submitted to the Office of 
Technology Transfer for potential patent development of the NDV virosome vaccine developed in our 
laboratory. 
 
Cooperative Research and Development Agreements (CRADA): 
CRADA #58-3K95-2-914 entitled AImproved Diagnostics for Avian Pneumovirus by Use of Peptide Antigens 
and Anti-peptide Antiserum to the Viral Nucleocapsid Protein and Phosphoprotein@ between ARS and IDEXX 
Laboratories, Inc. Principal Investigator: Bruce Seal 
 
PUBLICATIONS: 
Seal, B. S., D. J. King, and R. J. Meinersmann. Molecular evolution of the Newcastle disease virus matrix 
protein gene and phylogenetic relationships among the paramyxoviridae. 2000. Virus Research. V. 66. P.1-11. 
Seal, B. S., D. J. King, and H. S. Sellers. The avian response to Newcastle disease virus. 2000. Developmental 
and Comparative Immunology. V. 24. P. 257-268. 
                                                                                      182 
 
Seal, B.S., Sellers, H.S. and Meinersmann, R.J.  Fusion protein predicted amino acid sequence of the first U.S. 
avian pneumovirus isolate and lack of heterogeneity among other U.S. isolates.  2000.  Virus Research. V66. 
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Locke, D.P., Sellers, H.S., Crawford, J.M., Schultz-Cherry, S., King, D.J., Meinersmann, R.J., Seal, B.S.  
Newcastle disease virus phosphoprotein gene analysis and transcriptional editing in avian cells. Virus 
Research. 2000. v. 69. p. 55-68. 
Gulati, B.R., Cameron, K.T., Seal, B.S., Goyal, S.M., Halvorson, D.A., Njenga, M.K. Development of highly 
sensitive and specific enzyme-linked immunosorbent assay based on recombinant matrix protein for detection 
of avian pneumovirus antibodies. Journal of Clinical Microbiology. 2000. v.38. p. 4010-4014. 
King, D.J. Selection of Thermostable Newcastle Disease Virus from Reference and Vaccine Strains. Avian 
Diseases. 2001. v. 45. p. 512-516. 
Berinstein, A., Sellers, H.S., King, D.J., Seal, B.S. Use of a heteroduplex mobility assay to detect differences in 
the fusion protein cleavage site coding sequence among Newcastle disease virus isolates. 2001. Journal of 
Clinical Microbiology. v. 39. p. 3171-3178. 
Kommers, G.D., King, D.J., Seal, B.S., Brown, C.C. Virulence of pigeon-origin Newcastle disease virus 
isolates for domestic chickens. 2001. Avian Diseases. v. 45. p. 906-921. 
Sellers, H.S., Villegas, P.,  El-Attrache, J., Kapczynski, D.R., Brown, C.C.  Detection of infectious bursal 
disease virus in experimentally infected chickens using in situ hybridization. Avian Diseases. 2001. v.  45. p. 
26-33. 
Kommers, G.D., King, D.J., Seal, B.S., Carmichael, K.P., Brown, C.C. Pathogenesis of six pigeon-origin 
isolates of Newcastle disease virus for domestic chickens. Veterinary Pathology. 2002. v. 39. p. 353-362. 
Seal, B.S., Crawford, J.M., Locke, D.P., Sellers, H.S., King, D.J. Nucleotide sequence analysis of the 
Newcastle disease virus nucleocapsid gene and phylogenetic relationships among the Paramyxoviridae. Virus 
Research. 2002. v. 83. p. 119-129. 
Shin, H.J., Nagaraja, K.V., McComb, B., Halvorson, D.A., Jirjis, F.F., Shaw, D.P., Seal, B.S, Njenga MK. 
Isolation of avian pneumovirus from mallard ducks that is genetically similar to viruses isolated from 
neighboring commercial turkeys. Virus Research. 2002. v. 83. p. 207-212. 
Shin, H.-J., Cameron, K.T., Jacobs, J.A., Turpin, E.A., Halvorson, D.A., Goyal, S.M., Nagaraja, K.V., Kumar, 
M.C., Lauer, D.C., Seal, B.S., Njenga, M.K. Molecular epidemiology of subgroup C avian pneumoviruses 
isolated from the United States and comparison with subgroup A and B viruses. Journal of Clinical 
Microbiology. 2002. v. 40. p. 1687-1693. 
Turpin, E.A., Perkins, L.E.L., Swayne, D.E. Experimental infection of turkeys with avian pneumovirus and 
either Newcastle disease virus or Escherichia coli. Avian Diseases. 2002. v.46. p.412-422.  
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Antigenic cross-reactivity among avian pneumoviruses of subgroups A, B, and C at the matrix but not 
nucleocapsid proteins. 2002. Avian Diseases. v. 46. p. 725-729.  
Turpin, E.A., Perkins, L.E.L., Swayne, D.E. Experimental Infection of Turkeys with Avian Pneumovirus and 
Either Newcastle Disease Virus or Escherichia coli. Avian Diseases. 2002. v. 46. p. 412-422.  
Alvarez, R., Lwamba, H.M., Kapczynski, D.R., Njenga, M.K., Seal, B.S. Nucleotide and predicted amino acid 
sequence-based analysis of the avian metapneumovirus type C cell attachment glycoprotein (G) gene: 
Phylogenetic analysis and molecular epidemiology of U.S. pneumoviruses. 2003.  Journal of Clinical 
Microbiology. v. 41. p. 1730-1735.  
Jacobs, J.A., Njenga, M.K. Alvarez, R., Mawditt, K., Britton, P., Cavanagh, D., Seal, B.S. Subtype B avian 
metapneumovirus resembles subtype A more closely than subtype C or human metapneumovirus with respect 
to the phosphoprotein, second matrix and small hydrophobic proteins. Virus Research. 2003. v. 92. p. 171-178.  
Kommers, G.D., King, D.J., Seal, B.S., Brown, C.C. Pathogenesis of chicken-passaged Newcastle disease 
viruses isolated from chickens and wild, and exotic birds. 2003. Avian Diseases. v. 47. p. 319-329.  
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PROJECT OBJECTIVES:   
Avian influenza presents a major disease threat to the US poultry industry. The unpredictable 
nature of the disease and the viral agent that causes it is the same today as it was in 1983 when 
the disease struck the Northeastern United States with severe economic consequences. Because 
of research on avian influenza viruses in recent years we now know that some viruses can rapidly 
change from causing only mild disease to one that causes a deadly disease in chickens. It is likely 
that the longer a virus infects commercial poultry, the more likely it is to cause the severe form 
of the disease. The research under this CRIS unit seeks to understand the changes that are 
required for this shift in ability to cause disease. The research also seeks to control the presence 
of AI viruses in poultry by development of new and more effective vaccines and to develop tests 
to more rapidly diagnosis infection in chickens. 
 
The CRIS project proposal has four major objectives.  They include:  
1) Define the role of individual avian influenza virus (AIV) genes and the host responses in 
the pathogenesis and the host range of AIV. 
2) Conduct research in molecular epidemiology of AIV outbreaks in poultry and wild birds 
to identify sources and reservoirs of AIV. 
3) Develop and evaluate immunologic and chemotherapeutic control methods for AIV. 
4) Develop rapid diagnostic tests for AIV. 
 
The projects objectives are designed to flexible to respond to disease outbreaks, including 
outbreaks that affect poultry caused by other disease agents.  
 
 
OVERALL PROJECT ACCOMPLISHMENTS: 
In collaboration with APHIS (National Veterinary Services Laboratory, Ames, IA), a real time 
RT-PCR (RRT-PCR) test was developed that can rapidly and with high sensitivity detect both 
low pathogenic and highly pathogenic avian influenza.  This test was validated for the direct 
detection of any influenza viruses from infected birds in an outbreak situation, and was used to 
help eradicate an H7 avian influenza outbreak in Virginia in 2002. The test was adopted as an 
official test by APHIS and is being used for surveillance throughout the United States, including 
by the National Animal Health Laboratory Network, the federally supported state diagnostic 
laboratory system.  The test has continued to play a valuable role in initially diagnosing and 
helping to control avian influenza outbreaks in several different states, including Delaware, 
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Maryland and Texas.  This was the first widespread use of a real-time RT-PCR for the control of 
a animal disease outbreak in the United States.   
  
For the control of low pathogenic avian influenza outbreaks, vaccination is being more 
commonly considered, because it can potentially help control an outbreak at a lower cost than 
depopulation programs.  At the Southeast Poultry Research Laboratory (SEPRL), the use of 
currently available and new vaccination strategies are being investigated for the control of avian 
influenza. Currently only two types of vaccines are available for use for avian influenza, killed 
adjuvanted vaccines and fowlpox-vectored vaccines. Our research has shown that to get optimal 
protection from these vaccines, it is important to match the vaccine to the challenge strain.  A 
better match of vaccines allows less virus to be shed from vaccinated but infected birds.  
Additional research has shown that when vaccination is used on a widespread basis antigenic 
drift, similar to what is seen with human influenza viruses, can be a problem for decreased 
effectiveness for the vaccine.  Our laboratory was the first to show that antigenic drift can be a 
problem for vaccination use for avian influenza viruses.  Additional research has been focused 
on using viral-vectored or recombinant vaccines for avian influenza including fowlpox vectored 
vaccines, replication incompetent alphavirus vectors, and Newcastle disease virus vectored 
vaccines.  All three of these vaccines types have shown to provide protection from influenza 
challenge, and can provide the advantage of use as a DIVA (differentiate infected from 
vaccinated animals) vaccine.  These vaccines are still being evaluated to determine if they have 
significant advantages over commercially available vaccines and can be produced in a cost 
effective manner.  Additional vaccine technologies, including the reverse genetics approach to 
create avian influenza viruses that can also be used with the DIVA approach have also been 
shown to be effective.  
 
The characterization of influenza isolates in the U.S. and around the world is important to assess 
potential biological threats to the U.S. poultry industry. In collaboration with researchers at the 
National Veterinary Services Laboratory, state veterinary diagnostic laboratories, the Hong Kong 
Agriculture, Fisheries, and Conservation Department, the National Veterinary Research and 
Quarantine Service in South Korea, the Chile Ministry of Agriculture, and other countries, we 
have characterized influenza viruses from the U.S. and around the world by sequence analysis 
and animal inoculation studies. The molecular epidemiology and animal studies derived from 
this work is important for estimating the risk for each influenza outbreak and has resulted in the 
characterization of a novel way for a low pathogenic avian influenza to become highly 
pathogenic (Chile H7N3 outbreak). More recently, our characterization of H5N1 viruses from 
Southeast Asia has been valuable in demonstrating differences between viruses from other 
countries, and helping to identify risk factors for this country.  Vaccination studies were also 
conducted that showed that current vaccines could still protect from birds from clinical disease 
for these viruses.  
 
In the past several years, several countries including Mexico and Japan, have tried to block 
imports of U.S. poultry product based on the concern for virus being transmitted in poultry meat 
or egg products.  Research done at SEPRL has shown for low pathogenic avian influenza, virus 
infection of meat did not occur and the risk of spread through meat products was low.  
Additionally, work done at SEPRL showed that commonly used pasteurization or processing 
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temperatures would inactivate virus in egg products, which makes these products safe even if 
they were exposed to avian influenza viruses. This information was shared directly with trade 
officials as part of APHIS trade missions, and provided some relief from unfounded trade 
restrictions. 
 
Our laboratory has been partnering with several other laboratories in the U.S. and abroad to do 
wild bird surveillance for avian influenza.  The goal of this work is to molecularly and 
antigenically characterize viruses from throughout the world to better understand the variability 
of influenza viruses in the natural host population.  This information will prove valuable for 
preparing for disease outbreaks in the United States.  
 
The Southeast Poultry Research Laboratory has an interest in emerging diseases that might 
impact poultry, and with their Biosafety-Level 3 facilities, are in a unique position to study some 
of these emerging diseases.  Our laboratory was the first or one of the first laboratories to do 
poultry related research for both the Severe Acute Respiratory Syndrome (SARS) virus and West 
Nile virus in the U.S.  The SARS virus emerged in Southeast Asia and infected over 8400 
humans with over 800 deaths.  Early epidemiologic evidence suggested a zoonotic potential for 
the virus with animals in the live animal markets in China.  The source of the virus causing 
SARS is still unknown but animals may be the source or may be contributing to the spread of the 
virus.  The Southeast Poultry Research Laboratory conducted a study to determine if chickens, 
turkeys, ducks, geese and Japanese quail were susceptible to the SARS virus and could spread 
the virus to humans. The study failed to demonstrate that the SARS virus could grow in these 
birds. These data indicate that the common five domestic poultry species were not the reservoir 
and will not spread the SARS virus to humans.  Similar research with West Nile Virus was 
conducted that showed the common poultry species could be infected with these viruses, but 
clinical disease seldom occurred and that with low levels of viremia, these species were unlikely 
to spread the virus. 
 
IMPACT: 
Progress was made in all four major objectives of the CRIS project, and this work continues to 
have direct and indirect impact for the poultry industry.  The development of a real-time RT-
PCR for avian influenza provided an immediate benefit in helping to control the outbreak of 
avian influenza in Virginia.  This new test not only provided results much faster than 
conventional virus isolation, it was cheaper and more tests could be performed each day.  This 
test has become the official standard for surveillance by APHIS and is being used by over 20 
diagnostic labs in the U.S. and abroad.  The ongoing commitment to do molecular epidemiology 
for outbreaks in the U.S. and abroad has helped to provide the poultry industry information about 
what viruses pose risks to the U.S. poultry industry.  Through the isolation and sequence analysis 
with both commercial and wild bird influenza viruses, a large sequence repository has been 
developed that will help prepare for future outbreaks, and hopefully allow us to predict which 
viruses are the most dangerous. Our work on using reverse genetics to make new vaccines 
provides great potential for vaccines use in the future and allows the more widespread use of 
DIVA (differentiate infected from vaccinated animals) vaccines.  Several other vaccine 
technologies are being investigated to try and improve on the existing vaccines, either by making 
the vaccines more cost effective or by making them easier to administer.  Several trade 
                                                                                      188 
 
embargoes from Mexico and Japan initiated research at SEPRL to look at the risk of virus spread 
in meat and to do pasteurization studies to demonstrate that current practices mitigated any risk 
of disease spread.  These studies provided the scientific basis that was used to help lift these 
embargoes.  Efforts to examine the pathogenesis of different avian influenza viruses have 
focused on the H5N1 viruses from Southeast Asia.  These viruses are highly pathogenic for 
poultry, and some of them also pose a zoonotic threat.  Numerous pathology studies have helped 
to identify host ranges and allow better risk assessment of these rapidly changing viruses.  
 
TECHNOLOGY TRANSFER: 
The real-time RT-PCR test for avian influenza has been transferred widely to both state and 
federal diagnostic laboratories.  Additional test technology, including proficiency panels and 
neuraminidase N2 testing, have been transferred to APHIS, NVSL for their use. 
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PROJECT OBJECTIVES: 
Avian influenza (AI) viruses have been circulating periodically 
in domestic poultry over the past 100 years. Wild waterfowl 
and shorebirds are the reservoir for all identified AI virus 
subtypes and although chickens and turkeys are not natural 
host species, these viruses can routinely crossover from the 
wild-bird reservoir to poultry. Although the incidence of highly 
pathogenic AI viruses are relatively rare, less pathogenic 
strains of these viruses more often circulate through poultry 
flocks and are responsible for significant morbidity, mortality 
and production losses. The devastation of low pathogenic (LP) H7N2 avian influenza (AI) in 
chickens and turkeys has been apparent in the eastern U.S. in 2001 and 2002 resulting in 
depopulation of 4.7 million commercial turkeys and chickens and is estimated to have cost the 
poultry industry approximately $130 million. In addition, outbreaks have occurred in live poultry 
markets of New England. In 2004, a limited outbreak of highly pathogenic (HP) H5N2 AI 
occurred in Texas. 
 
Traditional parenteral vaccination has provided some success at providing protection against 
disease but is less effective in protecting against infection. This is thought to be due in part to the 
observation that systemic vaccination is a poor inducer of mucosal immunity and therefore 
organisms can invade the host before the systemic immunity can impede the infection. Because 
AI viruses invade mucosal surfaces, emphasis should be placed on vaccines that induce strong 
mucosal immunity. Thus, the main objective of this CRIS will be to develop mucosal vaccines in 
an attempt to induce greater immune protection. The development of new vaccine approaches for 
controlling such emerging/reemerging pathogens can be of great importance to the profitability 
of the poultry industry. 
 
OVERALL PROJECT ACCOMPLISHMENTS: 
Accomplishments over the life of the project included publication of techniques for the 
identification of avian immunoglobulins. These techniques have included the development of a 
monoclonal antibody (mAb) to IgA and has improved the sensitivity of measuring IgA antibody 
titers in immune samples. The mAb has also reduced the background levels observed with 
commercially available reagents. Other accomplishments for this CRIS included: (1) improved 
biological reagents needed to measure IgG antibody responses in chickens and turkeys, (2) 
development of an ELISPOT assay to measure antibody secreting cells in various tissues, (3) 
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identification of mucosal adjuvants for use in inactivated poultry vaccines, and (4) develop and 
evaluation of inactivated AI and a recombinant Newcastle disease virus vaccine with AI 
hemagglutinin gene insert. Research at Southeast Poultry Research Laboratory has also 
demonstrated that the route of vaccine influenced the optimal mucosal response in white leghorn 
chickens.  The identification of optimal mucosal vaccine routes(s) is crucial for improving 
mucosal immune response(s) to avian influenza viruses that infect poultry. Protocols were 
established for vaccines and vaccination to protect turkeys from LPAI viruses. 
 
IMPACT: 
The new assays provide a mechanism to assess the effectiveness of vaccines to protect poultry 
against AI and other respiratory and intestinal pathogens at the site of pathogen growth and 
injury. The vaccine technology improvements have produced vaccines for salmonella and AI that 
gives improved protection against their respective diseases than produced by existing 
commercial products. One of these will decrease the cost of vaccination for AI because it can be 
given by spray and not injection. This information will be used to develop efficacious vaccines 
for stimulating protective immunity against AI and possibly other respiratory pathogens that 
affect poultry. Furthermore, the identification of immune effectors mediating protection indicates 
ways to maximize protective immune responses in poultry. 
 
TECHNOLOGY TRANSFER:  
No technology transfers.   
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Southeast Poultry Research Laboratory 
 
Project Title:   Development and Validation of Rapid Diagnostic Tests for Avian  
Influenza and Newcastle Disease 
CRIS Number:     6612-32000-041-00X 
Scientists:             Swayne D., Suarez DL, King DJ, Spackman E, Kapczynski, D  
Location   Athens, Georgia                                              
                        Southeast Poultry Research Laboratory  
Contact: Swayne, D., Phone: (706) 546-3433, Fax: (706) 546-3161,  
dswayne@seprl.usda.gov
 
PROJECT OBJECTIVES: 
Highly pathogenic avian influenza (AI) and Newcastle 
disease (ND) are severe systemic, highly transmissible 
diseases of poultry that cause high mortality rates and 
severe economic losses. Traditionally, diagnosis has 
been slow, requiring virus isolation and identification. 
This delayed diagnosis has hampered efforts for early 
detection and elimination, resulting in devastating 
natural outbreaks. Complicating diagnosis is the 
existence of low virulent forms of AI and avian 
paramyxovirus type 1 (synonymous with Newcastle 
disease virus) viruses that can mutate to become highly pathogenic avian influenza and 
Newcastle disease viruses, respectively. These low virulent forms must be differentiated from 
common respiratory diseases. The sources of AI and ND viruses include domestic poultry and 
wild birds, but genetic analysis of diverse virus isolates across time, geographic location and bird 
species have not been accomplished. Genetic analysis of AI and ND viruses has been non-
systematic, leaving critical gaps on genetics in our knowledge base. 
 
To develop a rapid diagnostic test for these two diseases, real time reverse transcriptase 
polymerase chain reaction (RRT-PCR - a biotechnology test to detect genes), technology will be 
developed to detect the viruses in birds and differentiate these viral infections from "look-a-like" 
respiratory diseases. Initially, probes will be designed based on the current AI and ND virus 
sequences, and tested in an RRT-PCR test. Second, surveillance in wild and domestic birds will 
yield new genetically diverse AI and ND virus isolates to test the sensitivity and specificity of 
the RRT-PCR probes. Various genes from genetically diverse isolates will be sequenced and 
analyzed to improve probe design and the specificity and sensitivity of RRT-PCR test. 
Furthermore, the sequences of diverse viral isolates will help build molecular epidemiological 
maps for future determination of the source of outbreak viruses. Third, RRT-PCR tests will be 
validated in experimental studies. Fourth, the RRT-PCR tests will be validated in the field in the 
U.S. and foreign nations.     
 
OVERALL PROJECT ACCOMPLISHMENTS: 
Rapid RT-PCR (RRT-PCR) test were developed and validated in laboratory and the field to 
diagnosis type A influenza virus (avian influenza virus) and differentiate H5 and H7 
                                                                                      197 
 
                                                                                      198 
 
hemagglutinin subtypes in diagnostic samples. RRT-PCR tests were developed and validated in 
the laboratory and field to diagnose Newcastle disease.  
 
IMPACT: 
The AI RRT-PCR tests were used in the 2002 Virginia H7N2 AI outbreak and 2002 Live Poultry 
Markets to make AI diagnoses in less than 24 hrs. The NDV RRT-PCR test was used in 
California during 2003.  These tests have become the National Standard tests for diagnosis of AI 
and ND viruses at the National Veterinary Services Laboratories and have been distributed to 
National Animal Health Laboratory System for use at the State Veterinary Diagnostic Levels to 
get rapid diagnosis of AI and ND. 
 
TECHNOLOGY TRANSFER: 
The Southeast Poultry Research Laboratory (SEPRL) has been on the leading edge of use of real 
time PCR testing as a diagnostic test for viral pathogens of poultry with its work on avian 
influenza virus and Newcastle disease virus.  Through collaborations with APHIS, the rapid 
diagnostic test for avian influenza and Newcastle Disease was validated and adopted by APHIS 
as a principle test for the detection of these agents from field samples. These tests has already 
been adopted by many state veterinary diagnostic laboratories with interest from others, and they 
are official tests for the National Animal Health Laboratory Network.  SEPRL has been 
instrumental in the technology transfer to these laboratories by providing reference reagents, 
training, coded test panels and other resources materials for the implementation of the 
technology in each laboratory. 
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Southeast Poultry Research Laboratory 
 
Project Title:  Development of environmental and genomic strategies to control Marek’s 
disease 
CRIS Number:  6612-32000-043-00D 
Scientists:   Mitchell B., Swayne D., Vacant 
Location:   Southeast Poultry Research Laboratory, Athens, GA 
Contacts:  706-546-3433 (phone), 706-546-3161 (FAX), dswayne@seprl.usda.gov 
 
PROJECT OBJECTIVES:  
Marek’s disease is a cancer of the lymphocytes in chickens caused by a herpesvirus. Vaccines 
have been used since the 1960’s to prevent and/or control development of the cancer. Such 
vaccines have been successful but new strains of the virus have arisen through virulence shifts 
that have overcome vaccine protection. The objectives of this project are: 1) development of 
environmental control systems that will reduce field exposure of chickens to the Marek’s disease 
virus and result in reduced incidence of Marek’s disease, and 2) development of a comparative 
genomics program that will lead to the identification of predictors of virulence shifts. Initially, 
objective one will be approached by developing and testing high voltage electrostatic space 
charge systems (ESCS) for use in chick rearing areas and poultry houses to reduce feather dander 
containing the Mareks’ disease virus. ESCS systems designed at SEPRL has been shown to 
reduce dust in hatching cabinets and animal rooms. Feather dander is a major source of dust 
particles. Marek’s disease is transmitted because the virus is shed in high quantities of feather 
dander. Impact of ESCS on reducing environmental load of Marek’s disease virus and 
transmission of Marek’s disease virus will be determined. A genomics approach will be used to 
identify viral genes responsible for shifts in virulence of field MDV which will assist in vaccine 
development. 
 
OVERALL PROJECT ACCOMPLISHMENTS: 
None. New project initiated in late 2003. 
  
IMPACT:  
None. New project 
 
TECHNOLOGY TRANSFER: 
None. 
 
PUBLICATIONS:  
None. 
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PROJECTS 
 
Animal Parasitic Diseases Laboratory (APDL) 
• Genomic, Proteomic and Immunological Approaches to Control Avian Coccidian Parasites 
• Strategies to Control Swine Parasites Affecting Food Safety 
• Biosystematics and Biodiversity of Pathogens and Parasites 
• Biology and Epidemiology of Neospora Caninum and Related Protozoa 
 
Bovine Functional Genomics Laboratory (BFGL) 
• Improving Milk Quality by Reducing Mastitis in Dairy Cattle 
• Immunological and Genetic Basis of Resistance to Parasites of Cattle 
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Animal Parasitic Diseases Laboratory (APDL) 
 
Project Title:   Genomic, Proteomic and Immunological Approaches to Control Avian 
Coccidian Parasites 
CRIS Number:     1265-31320-070-00D 
Scientists:            Lillehoj, H., Fetterer, R., Allen, P., Miska, K., Jenkins, M. 
Location:        Animal and Natural Resources Institute, Animal Parasitic Diseases 
Laboratory 
Contact: Lillehoj, H., Phone: (301) 504-6170, Fax: (301) 504-5306, 
hlilleho@anri.barc.usda.gov
 
PROJECT OBJECTIVES: 
Coccidiosis is a ubiquitous intestinal protozoan infection of poultry which seriously impairs the 
growth and feed utilization of infected animals. In poultry, coccidiosis has been particularly 
problematic where annual losses of over $600 million per year have been sustained by the U.S. 
poultry industry alone.  Each of the more than 30 billion chickens raised annually worldwide is 
at risk for coccidiosis. Coccidiosis in chickens is caused by at least seven distinct species of 
obligate intracellular parasites of the genus Eimeria.  The pathology of coccidiosis is caused by 
the rapid replication of the parasite during asexual reproduction in the cells of the gut, resulting 
in diarrhea, weight loss, and anorexia.  Several notable problems currently exist for effective 
control of coccidiosis: 1) Disease resistant strains have been emerging very rapidly worldwide. 
Therefore the effectiveness of existing pharmaceutical therapeutics have been decreasing steadily 
over the last decade. This problem is compounded by our lack of understanding of the 
mechanism(s) that confer(s) drug resistance and how the drug resistant strains are propagated. 2) 
Knowledge of the nature of protective immunity elicited by natural infection is limited.  
Vaccination against Eimeria induces species-specific immunity, and is the basis for increased 
utilization of live oocyst vaccines in broiler production. However, strains of some species (a 
particular problem with E. maxima) are poorly cross-protective, reducing the effectiveness of 
live vaccines.  3) The limited number of existing recombinant vaccines do not offer cross-
protection against all seven species of Eimeria that infect chickens. 4) Additionally, there is 
worldwide consumer as well as governmental effort to reduce the use of feed additive 
pharmaceuticals for animals destined for human consumption, further driving the need for more 
efficacious vaccines.  Our long-term goal is to develop new cost-effective strategies that will 
control coccidiosis for the poultry producer.  To accomplish this, we are conducting research 
through a multidisciplinary approach using immunology, biochemistry, cellular and molecular 
biology and functional genomics and proteomics to 1) identify host genes and traits which confer 
protective immunity against all Eimeria species and use this information to develop marker-
assisted selection strategy for commercial broiler industry, 2) determine the immunological 
pathways that provide innate and acquired host resistance, and understand the early physiological 
host responses associated with the immune response and pathology,  3) develop new vaccine 
strategies for induction of protective mucosal immunity, 4) identify parasite genes and gene 
products that are related to growth and development and that may play roles in pathology and 
drug resistance. These genes may prove to be targets for new vaccines and chemotherapy. 5) 
understand the physiology of parasite development through studies of Eimeria parasites in cell 
culture, 6) modulate infections through use of non-pharmaceutical feed additives, and 7) 
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understand the genetic mechanisms which may drive antigenic diversity in the parasites.  
Successful completion of these studies will enhance our understanding of Eimeria biology and 
genetics, the development of host immunity to parasite invasion, innate disease resistance to 
coccidiosis, and will assist in the development of practical, multifaceted, effective control 
strategies against Eimeria sp. 
 
OVERALL PROJECT ACCOMPLISHMENTS: 
1. Identification of Eimeria genes and gene product which are involved in immunity and 
parasite development. We have targeted new structural, stress-related, and 
developmentally regulated parasite proteins associated with several Eimeria species as 
potential protective antigens, produced recombinant parasite proteins that have been 
tested using new methods of vaccine delivery including various viral vector systems as 
well as DNA vaccines. Subtracted cDNA libraries from E. tenella oocysts were produced 
and over 500 ESTs representing transcripts whose expression is differentially regulated 
between sporulated and unsporulated oocysts were identified. Analysis of expression of 
several of these transcripts via real-time PCR methods confirmed that these transcripts 
are differentially expressed.  The full-length sequences of some candidates are being 
obtained, and will be tested as potential targets for vaccine development. In addition, 
analysis of ESTs from E. acervulina sporozoites and merozoites has resulted in 
identification of four full-length candidate transcripts that will also be tested in vaccine 
development.  These candidates include a serine protease inhibitor, macrophage 
inhibitory factor, a member of a family of surface proteins, and peroxiredoxin.  All of 
these molecules may be essential to parasite function, and may serve as good vaccine 
targets.  Recent success in characterizing genes that are important during sporulation 
enhanced our knowledge of parasite development and will facilitate the development of 
new therapeutics that would inhibit the formation of the infectious oocyst therefore 
preventing infection of the host. A major ooccyst protein was identified and characterized 
during sporulation of E. tenella.  This protein can serve as an important marker of 
development in Eimeria species. Further studies to examine the changes in other oocyst 
proteins that occurs during sporulation using a combination of mass finger-printing 
techniques and n-terminal sequencing to identify proteins characterized on 2D gels and 
the use of real-time PCR and micro-array system to examine the quantitative changes in 
proteins during maturation of the oocysts will complement our ongoing efforts to develop 
coccidia vaccine. Investigation of enzyme changes during sporulation of E. tenella will 
also lead to the identification of key enzymes associated with sporulation and sporozoite 
invasion of host cells and determine if sporozoite proteins are synthesized de novo or are 
incorporated from unsporulated oocysts. In efforts to find Eimerian metabolic systems 
that would be suitable targets for control programs, we identified one enzyme of the 
biotin-containing acetyl coA carboxylase complex (ACC1). This complex encompasses 
the initial steps in synthesis of fatty acids, requisite components of cell membranes, and 
has been found to be susceptible to inhibition by acetoxyphenoxypropionate (“fop”) type 
herbicides in both Plasmodium sp and Toxoplasma sp. These herbicides inhibit growth of 
these parasites in vitro. ACC1 activity is present in apicoplast organelles in these two 
parasites. However, Eimeria growth and reproduction was not inhibited by two “fop” 
herbicides when fed to coccidia-infected chickens. We have found that the presence of 
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apicoplast organelles in Eimeria is questionable, and that although a genetic sequence 
similar to the acetyl coA carboxylase of Toxolasma is present in the E. tenella genetic 
data base (Sanger, UK), there does not seem to be a leader sequence that would target it 
to an apicoplast. The complex may be in the cytoplasm, or confined to Golgi vesicles. 
The presence of the ACC1 complex transcripts is being confirmed by sequencing of RT-
PCR products amplified from cDNA of E. tenella sporulated oocysts, and probes are 
being developed to facilitate its localization histologically. These findings reveal an 
exciting, fundamental metabolic difference between Eimeria sp and other apicomplexa 
that may be exploitable for new control strategies. Proteins in developmental stages of 
Eimeria species have been characterized. An important antigen of unknown function 
previously reported in E. acervulina was identified to act as an actin binding protein, 
profilin. This was the first report of profilin from apicomplexa. The structure of this 
protein was deduced from the E. tenella genomic data base.  The protein is conserved in 
all species of Eimeria studied and is unique to the Apicomplexans.  Profilin transcripts 
and the subsequent protein are expressed at all stages tested 
 
2. Provided new information on coccidia proteins, recombinant vectors, and mucosal 
delivery methods that will facilitate the development of novel vaccine strategies for avian 
coccidiosis for the poultry industry. Vaccine trials using Eimeria immunogenic 
recombinant vaccines have clearly demonstrated that subunit, recombinant, and DNA 
vaccines can elicit protective immunity. Identification of new structural and metabolic 
Eimeria proteins, other stress-related and developmentally regulated Eimeria proteins and 
development of various novel vaccination strategies using attenuated, recombinant viral 
vectors, recombinant antibody or various delivery methods such as gene gun, in ovo 
injector have demonstrated the feasibility of eliciting protective intestinal immune 
responses. A systematic proteomic approach was implemented to determine the protein 
compliment of developmental stages of Eimeria and determine the interaction of these 
proteins with the host immune system. Pure, live oocysts strains have been characterized 
for drug sensitivity and cross protection potential. Immuno-stimulatory complexes 
(ISCOMS) have been investiaged as antigen delivery systems in vaccination protocols for 
avian coccidiosis.   Saponins from plants native to Kazakstan were evaluated for low 
toxicity and ability to form ISCOMs.  The best saponins were used to prepare ISCOMs 
containing crude coccidia antigens. Immunization with these ISCOMS significantly 
stimulated cellular and humoral immunity in mice and provided significant protection to 
re-infection in immunized chicken.  Recombinant Eimeria antigens are being expressed 
and will be incorporated into ISCOMS for further vaccination trials. To address problems 
in cross protection studies, or in trials comparing efficacies of various anticoccidial 
treatments, we have developed a protective index that takes into consideration both gross 
aspects (weight gain and lesion score) and metabolic indicators (plasma carotenoids and 
NO2-+NO3-) of pathology during coccidia infections.  Recent cross protection studies 
with several E. maxima strains indicate that parasite fecundity is a major factor in 
eliciting protective immunity.  Thus, genes that regulate the reproductive capacity of 
Eimeria sp. will be important targets for control of avian coccidia infections. Further 
studies on the role of chicken cytokines as adjuvant in DNA vaccine will enhance our 
understanding of how the chicken cytokine modulate local immunity to parasites. The 
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results of our studies clearly document the role of various immunomodulators such as 
chicken cytokines, saponins as adjuvants that should provide additional impetus for 
further investigation of their biological activities at the molecular and immunological 
levels. These results provide important background information from which novel 
vaccine technology can be developed for coccidiosis control. 
 
3. Developed a large scale screening system for testing drug and vaccine sensitivities of 
field isolates of Eimeria and host immune responses to vaccination. A new method to 
conduct a large scale evaluation of current anti-coccidial vaccines and drugs, and to 
assess the protective host immune response to vaccination has been developed and is 
being evaluated as way to create efficient management of avian coccidiosis. As evidence 
of the importance of this work, several CRADAs have been initiated with poultry and 
pharmaceutical companies to evaluate drug sensitivity of field strains of avian coccidia. 
Furthermore, the lack of appropriate immunological reagents to study the poultry immune 
responses is a major limiting factor for the progress of poultry disease research.  Industry 
support was obtained to test field strains of Eimeria for sensitivity to common anti-
coccidial drugs or live oocysts vaccines from US poultry producers. To continue the 
investigation on the role of cytokine as genetic adjuvant, a National Research Initiative 
grant was awarded to characterize and clone major chicken lymphokines (IFN-γ, IL-15, 
IL-2, IL-16 and IL-17) that are associated with protective host immune responses to 
coccidiosis to develop enzyme-linked immunosorbent assays (ELISA) to evaluate the 
host immune response to vaccination on a large scale.  
 
4. Identified DNA and physiological markers that are associated with pathology and 
immune protection in commercial meat-type chickens. . Genetic mapping using 
commercial chicken strains has found quality trait loci (QTL) markers on chicken 
chromosome 1 associated for resistance to coccidia, weight gain, and oocyst production. 
The locus identified as "LEI0101" decreased parasite production 3000 times in broiler 
chicken families. This was the first description of an association of chicken genetics with 
coccidiosis resistance and this finding will be used by the poultry industry for marker 
assisted selection (MAS) of breeding stocks. This research provides the groundwork to 
develop novel strategies of improving the genetic capacity of chickens for enhanced 
resistance to coccidiosis and was the basis for a new NRI Grant to develop a practical 
marker-assisted selection strategy for avian coccidiosis in commercial broilers.  New 
knowledge concerning the genetics and physiology controlling the interaction of the host 
and parasite are required to develop markers that can be used to optimize new treatment 
strategies for avian coccidiosis. Hormonal changes associated with appetite suppression 
and reduced feed intake have been identified, linking for the first time early host 
pathology to neuroendocrine changes. Additionally 3-methylhistidine has been found to 
be a metabolic marker associated with muscle protein breakdown and with reduced feed 
intake. infections. Availability Genetic mapping (definition of DNA markers) for 
resistance to coccidiosis was initiated through the Award of a Fund for Rural America 
(FRA) and extended through a National Research Initiative grant which has also allowed 
the construction of the cDNA library. The first normalized chicken intestinal cDNA 
library containing >38,000 gene sequences has been developed. Availability of chicken 
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intestinal genome database will facilitate the identification of the nature of host genes 
controlling nutrition, immunity, physiology, growth and disease resistance which are 
important in the studies on the mechanisms of growth and development. Development of 
functional genomics technology led to the development of a Trust agreement entitled 
"Application of Functional Genomics to Develop Novel Control Strategies Against 
Poultry Diseases". Chicken intestinal cDNA microarray will lead to identification of host 
genes which control innate and acquired immune responses to coccidiosis and facilitate 
the development of novel immunological control strategies for coccidiosis. Cooperative 
work with Growth Biology Cooperative work with Growth Biology Lab showed a high 
coincidence of acute reduced feed intake and acute increase in the appetite suppressing 
hormone ghrelin at 4 days post infection with the duodenal parasite, E. acervulina.  These 
changes were also coincidental with significant reduction in plasma levels of leptin, IGF-
1 and T3, and a significant increase in pancreatic glucagon. These hormonal changes 
were followed by significant weight gain reduction. Weight gain and feed conversion are 
the most economically important production parameters to poultry producers.  These 
studies are the first to show a significant impact of coccidia infections of the chick small 
intestine on the host neuroendocrine system leading to multiple hormonal changes, and to 
reveal the direct relationship they likely have with feed intake weight gain reduction and 
muscle protein accretion. Because these hormonal effects occur before gross pathology is 
evident, a shift in research emphasis to early host-parasite interactions may uncover the 
primary biochemical and immunological host responses. This, in turn, may aid in 
defining the important genes associated with resistance and susceptibility to coccidiosis.  
We have found that this weight gain decrease is associated with muscle protein break-
down as assessed by increased levels of plasma 3-methylhistidine. The ratio of 
reduced/oxidized glutathione decreases significantly in blood, intestinal mucosa and liver 
at 6 days post infection during primary infections with both E. acervulina and E. tenella.  
Reduction in the red/ox ratio is an indicator of oxidative stress, and is reported to play an 
important signaling role in the development of cellular immunity.  
 
5. Developed molecular diagnostic method to identify Eimeria field strains and investigate 
underlying molecular mechanisms of antigenic diversity of field Eimeria species. In order 
to implement precision agriculture techniques in determining species of coccidia in the 
field, polymerase chain reaction (PCR)-based techniques have been developed and used 
to detect the seven recognized species of Eimeria.  This method proved to be useful for 
the industry as well as customers since it provides a fast and accurate detection of 
coccidian parasites.  This technique conserves time and well as resources since 
determination of species composition by microscopic examination takes no less than 3 
weeks.  Microscopic examination is also fraught with error given the similar morphology 
of these species. The PCR method is based on specific amplification of single Eimeria 
species.  The test, which can be completed in a single day, utilizes 7 different pairs of 
oligonucleotide primers that are directed to species-specific regions of ribosomal DNA.  
The validity of this technique was confirmed by the testing of several litter samples from 
nearby farms.  Additionally, elucidation of underlying molecular mechanisms responsible 
for generation of genetic diversity of Eimeria species is important and aid in development 
of recombinant vaccines. Among the 3 major species of poultry coccidia, E. tenella, E. 
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acervulina, and E. maxima, E. maxima is believed to be more antigenically diverse than 
the other two species, and immunization of chickens with one strain of E. maxima does 
not always protect against infections with other strains of the same species.  This is 
important for producers of live Eimeria oocyst vaccines which face the prospect that one 
strain of E. maxima may not be sufficient for protecting chickens against coccidiosis.  We 
have observed that while the genetic diversity of ribosomal DNA in E. tenella and E. 
acervulina is fairly small, E. maxima displays significantly greater amounts of sequence 
diversity.  The data collected so far suggests that the genetic organization of ribosomal 
DNA in E. maxima may be substantially different than in the other two species.  It is 
likely that in the genome of E. maxima multiple ribosomal DNA loci exist on different 
chromosomes, while in E. tenella and E. acervulina the more conventional organization 
of the ribosomal DNAs is seen, with all ribosomal DNA being contained in a single 
closely linked locus.  This data provides the first genetic evidence that E. maxima may be 
fundamentally different from other Eimeria species so far studied, and may lead to the 
understanding of the mechanisms behind the antigenic diversity present in this species. 
 
6. Immunoenhancement of intestinal innate immunity using dietary supplementation, 
probiotics, CpG oligodinucleotides, cytokines and recombinant antibodies.  Due to 
increasing concerns over the use of drugs in poultry production, alternative methods need 
to be developed.  Our studies have demonstrated that cytokines, probiotics, CpG 
oligodinucleotides (ODN), vitamins and recombinant antibodies can enhance intestinal 
immunity against coccidiosis.  For example, IFN-γ is an important cytokine that activates 
macrophages and is produced by activated lymphocytes in the intestine following 
coccidiosis.  Role of IFN-γ production during coccidiosis has been well studied using a 
quantitative RT-PCR and recently using gene expression profiling. In E. tenella-infected 
chickens, IFN-γ transcripts were detected in the spleens, cecal tonsils, and IEL following 
the primary and the secondary infections with E. tenella.  Multiple intramuscular 
injections of chIFN-γ on one day prior to, and two and four days after infection with E. 
acervulina, conferred significant protection as measured by body weight loss and oocyst 
shedding in white leghorn chickens.  The treatment of chicken cells with the recombinant 
chIFN-γ inhibited the intracellular development of E. tenella without affecting the 
sporozoite invasion of host cells. Another cytokine, interleukin-2 (IL-2) plays an 
important role in the function of the immune system and is a potent growth factor for a 
variety of cell types including T-cell differentiation, B-cell development and NK cell 
activation. Co-injection of the IL-2 gene with the 3-1E coccidia gene enhanced the host 
response to the recombinant vaccination.  Recently we have assessed the effects of 
directly injecting genes encoding the chicken cytokines IL-1β, IL-2, IL-8, IL-15, IFN-α, 
IFN-γ, TGF-β4, or lymphotactin on chickens vaccinated with the DNA vaccine. 
Lymphotactin gene, when given simultaneously with the pcDNA3-1E vaccine, 
significantly protected chickens against body weight loss induced by E. acervulina 
infection. Parasite replication was also significantly reduced in chickens immunized with 
the pcDNA3-1E vaccine and co-injected with IL-8, lymphotactin, IFN-γ, IL-15, TGF-β4, 
or IL-1β gene as compared to chickens given the pcDNA3-1E vaccine alone.  These 
results provide the first direct evidence that chicken cytokines exert a protective effect 
against Eimeria and provide a rational basis for the use of this cytokine as a vaccine 
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adjuvant against coccidiosis.  The effects of dietary supplements such as vitamin A and 
probiotics have been studied in coccidiosis.  Overall, dietary vitamin A levels can affect 
gut immunity in broiler chickens and its deficiency can cause immunosuppression at 
those sites resulting in increased susceptibility to coccidiosis. Probiotic supplementation 
of the intestinal microflora has been shown to enhance gut defensive mechanisms in 
poultry.  We have demonstrated that a Lactobacillus-based probiotic stimulated the local 
immune system of broiler chickens and improved resistance to coccidia. Flow cytometric 
analysis of duodenum IEL showed that chickens fed the probiotic-supplemented diet had 
a significant increase in IEL T lymphocyte subpopulations and indicated that the 
probiotic enhanced local immune defenses in the intestinal tract of broiler chickens 
resulting in better resistance to E. acervulina. A greater understanding of the mechanisms 
of enhancement of intestinal immunity using various dietary supplements would improve 
the effectiveness of using these feed additives for disease control. Short 
oligodeoxynucleotides (ODN) containing unmethylated CpG motifs have been shown to 
be effective immunoprotective agents in mammalian models, by inducing both innate and 
adaptive immune responses.  We have recently identified CpG sequences that activate 
chicken innate immunity and enhance protective immune response against Salmonella 
and coccidia. In multiple trials, CpG ODN provided great potential as vaccine adjuvants 
in chickens and enhanced disease resistance against E. acervulina infection. On the other 
hand, we found that feed supplementation with high levels of fat-soluble vitamin E (DL-
alpha-tocopheryl acetate), a natural antioxidant, does not reduce pathology of mild or 
severe E. maxima infections in chickens.  Plasma levels of Vitamin E declined by 60 to 
70% during the acute phase of infection in a manner correlated with decreases in plasma 
carotenoids regardless of the level fed.  It is postulated that ameliorative effects of 
vitamin E are not observed during E. maxima infections because the vitamin is prevented 
from access to infected tissues because of malabsorption and/or oxidation.  Producers are 
thus cautioned against wasteful use of alpha-tocopheryl acetate as a dietary supplement to 
control avian coccidiosis.  A number of plant products have immunostimulatory 
properties, and may be useful as feed additives to control coccidiosis.  Echinacea 
purpurea can enhance immunity to challenge infection when fed to chicks immunized 
with suboptimal doses of live oocysts.  Beta glucans from yeast and hops are currently 
being tested as immunostimulatory feed additives in various challenge protocols.  
 
IMPACT: 
1. The Poultry and Animal Health Industries have shown great interest in our vaccine 
research.  A patent on recombinant coccidial vaccines (U.S. Patent 5,122,471) was 
licensed to Nippon Zeon, Inc. CRADAs (two) were established with Nippon Zeon to 
develop and field test a fowlpox virus vector system for coccidia vaccine 
(Jenkins/Lillehoj). Recombinant chicken antibody technology was the basis for the U.S. 
patent 6,451,984 and this technology was transferred to IDEXX Laboratories through a 
CRADA to develop novel control strategies against other economically important poultry 
pathogens. A CRADA with Intervet was established to produce and characterize new 
vaccine strains of Eimeria for incorporation into live vaccines (Allen) that are finding 
increased industrial acceptance. 
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2. Vital information on the drug and vaccine sensitivity trials were effectively 
communicated to the poultry producers and alerted them of emerging drug resistance.  
The information allows poultry producers to select the most efficacious drugs or vaccines 
to combat avian coccidiosis. CRADAs have been initiated with Townsends, Inc., 
Solutions Biosciences, Inc., and Schering-Plough to test the sensitivity of Eimeria strains 
isolated from broiler houses in various regions of the U.S.  A highly specific and 
sensitive molecular technique based on PCR amplification of DNA coding for ribosomal 
RNA has been developed to rapidly determine the species composition of Eimeria 
oocysts in a broiler operation. In addition, the cooperative work with the commercial 
poultry operations provided new, often more virulent isolates of avian Eimeria, such that 
basic research is examining strains which are present in the field. These programs have 
led to the development of a novel and practical concept for enhancing poultry immunity 
using lymphokines. These reagents against chicken lymphokines have led to patent filing 
(Serial Number 09/534,002) and this technology led to the development of a CRADA 
with Novus International, Inc. to evaluate the efficacy of field trial data of a new coccidia 
vaccine delivery technology (Lillehoj) and a Trust agreement with Maine Biological 
Laboratories, Inc. to apply cytokines for enhanced immunity in poultry. In summary, 
these studies have set the stage for the future development of novel control strategies for 
poultry diseases. 
3. The work on the chicken genome has provided the first description of an association of 
chicken genes with coccidiosis resistance. The chicken cDNA database will facilitate the 
identification of the nature of host genes controlling immunity, growth and disease 
resistance.  These new bodies of information can be used by the poultry industry for 
marker-assisted selection of resistant breeding stocks without the need to conduct large 
numbers of experimental infections. The findings of  an early impact of coccidia infection 
on the chick neuroendocrine system  and muscle metabolism provide new foci for 
functional genetic selection of resistance and susceptibility coccidiosis disease resistance 
and development of new metabolic markers to assess the impact of coccidiosis on the 
important production parameters of growth and feed conversion.  
4. Our research findings concerning novel vaccine strategies and the assessment of vaccine 
efficacy have been used by many poultry industry in developing new commercial 
coccidia vaccines.  Through CRADA and Trust agreements, many technologies have 
been transferred to poultry industry worldwide.  
 
TECHNOLOGY TRANSFER: 
1. A contract with Intervet Inc. was established to isolate and prepare two E. maxima strains, and 
a strain of E. acervulina  and E. tennella  for use in live vaccines.  Eimeria acervulina and E. 
tenella strains have been prepared and submitted.  Eimeria maxima strains are currently 
undergoing purification and testing, including cross protection and drug sensitivity assessments. 
  
2. Over 500 E. tenella cDNAs associated with oocyst development and >10,000 EST isolated 
from chicken cDNA library have been deposited onto public gene databanks. Deposited 14,374 
chicken cDNA isolated from chicken intestine into NCBI Genbank (GenBank accession 
number:CD726833-CD740810 and CF074760-CF075157). 
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3. Developed PCR based methods to identify Eimeria species from field samples as part of a 
CRADA to develop control strategies against avian coccidiosis. 
 
4. Developed MOU on "Application of Intelliject System to enhance poultry immunity" with 
AviTech Inc., Hebron, MD. And transferred technology on in ovo vaccination. 
 
5. Contract with Phytosynthese Inc. was developed to test natural product preparations which are 
derived from a French company for anti-coccidial effectiveness. 
 
6. Genes identified through screening of cDNA libraries which are important for parasite 
functions will be tested for potential vaccine activity. 
 
7. A detailed knowledge of the genetic diversity within and between Eimeria species will be 
transferred to the poultry industry and will enable the implementation of precision agriculture 
technologies to apply treatments or combinations of treatments optimally suited to control the 
parasite variants in a particular locale.  
 
8. The results of the identification of host genes which control coccidiosis and the development 
of DNA marker based strategy for coccidiosis resistance will be transferred to the poultry 
industry community.  
 
9. New technologies enabling analysis and comparisons of multiple Eimeria species through 
genetic sequencing and analysis of gene products will allow the identification of DNA and or 
protein components that may be useful in the development of a multi-species subunit vaccine.   
 
10. Vaccine technology, vaccine delivery strategies, and immunological technologies will be 
transferred to poultry vaccine companies for commercial applications.  Poultry producers will be 
able to utilize commercially produced vaccines for the control of Eimeria in their flocks. 
Monoclonal antibodies, recombinant chicken cytokines, immunoassays for poultry health 
assessment and genetically engineered chicken antibodies will have immediate application to 
poultry studies by scientists in academia, industry and federal and state agencies. 
 
11.  Developed a highly reliable protocol for testing the drug sensitivity of field isolates of 
Eimeria obtained from commercial broiler houses.  Developed a rigorous statistical evaluation 
method that provides information on the efficacy of specific anti-coccidial drugs against isolated 
field strains of Eimeria.  This protocol was used to initiate two CRADAs with poultry 
(Townsends Inc) and pharmaceutical companies (Solutions Biosciences, Inc. and Schering-
Plough). 
 
Patents: 
1.   Kim J. K., Han, J. Y., Song, K. D., and  Lillehoj, H.S. 2002.  Recombinant ScFv 
antibodies specific to Eimeria spp. responsible for coccidiosis.  Patent Korean  (File no. 
2001-52934) and Japan (File no. 2001-266333).  
 
                                                                                      212 
 
2. Lillehoj, H. S. and Nichols, M. 2002. Chicken monoclonal antibodies specific for 
coccidial antigens involved in invasion of host lymphocytes. US Patent 6,451,984 
 
3. Allen, P. 2001. Applied a patent for the use of ground preparations of Echinacea purpurea 
feed additives to stimulate immunity elicited by live vaccination. Docket number 
0217.01,  Serial number 9/931,033   Date filed: 8/17/2001   Recordation date: 
10/25/2001. 
 
4. Lillehoj, H. 2000. Monoclonal antibodies detecting chicken IFN-gamma and 
development of in vitro assay.  Serial Number 09/534,002, Document Number 0165.99.  
Patent filed 3/24/00.    
 
5. Yasuda, et al., 2000. Novel DNA encoding Eimeria glyceroaldehyde-3-phosphate 
dehydrogenase and uses thereof.  Filed by Nippon Zeon Inc. 
 
6. Lillehoj, H.S., Dalloul, R. Nichols, M., and Chung, K. S., “Immunopotentiating effect of 
Formitella fraxinea mushroom lectin on poultry immunity to coccidiosis. Docket No. 
0161.03. 
 
7. Heckert, R. A., Xie, H. and Lillehoj, H. S., “ Immunomodulation of poultry by 
oligonucleotides”. Filed by the Office of Technology Commercialization, University of 
Maryland. November, 2003.  
 
Cooperative Research and Development Agreements (CRADA) 
58-1265-9-058 (Trust Fund Agreement with Roche Vitamins) 
Effect of dietary vitamin E supplementation on chickens infected with Eimeria maxima. 
Investigator, P.C. Allen    Funding: $23,000 
Start:  09/01/1999     Termination: 08/31/2001 
 
58-1265-2-F091 (Trust Fund Agreement with Phytosynthese Inc.) 
Anticoccidial Effects of Plant-Derived Products 
Investigator: P.C. Allen    Funding: $6,000 
Start: 02/28/ 2002     Termination: 02/28/2003 
 
1265-31320-070-13T  (Trust Fund Agreement with Intervet) 
Production of vaccine strains suitable for incorporation in a live vaccine for avian coccidiosis. 
Investigator: P.C. Allen    Funding: $59,000 
Start1: 01/01/2001     Termination: 01/01/2004  
 
333-1265-140  (ISTC Project with Former Soviet Union Countries) 
ISCOM delivery of recombinant  coccidia (Eimeria) antigens. 
Investigator: R. Fetterer                                   Funding:  $ 40,000 
Start:  01/01/01     Termination:  01/01/04 
*Renewed Start: 09/01/2003 to 09/30/2006 with new funding $ 40,000. 
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1265-32000-061-15T  (CRADA with Nippon Zeon, Japan) 
Development of a coccidiosis vaccine in recombinant fowlpox virus and HVT 
Investigator: Mark C. Jenkins    Funding: $ 100,000 
Start: 04/01/1999     Termination: 03/31/2003 
58-1265-2056 (Trust Fund Cooperative Agreement with Townsends, Inc) 
Testing of drug and vaccine sensitivity of Eimeria field isolates 
Investigator: Mark C. Jenkins    Funding: $ 15,000 
Start: 08/31/2002     Termination: 09/01/2007 
 
58-1265-2019  (Trust Fund Cooperative Agreement with Solutions Biosciences, Inc.) 
Testing of drug and vaccine sensitivity of Eimeria field isolates 
Investigator: Mark C. Jenkins    Funding: $ 25,000 
Start: 04/15/2002     Termination: 04/14/2006 
 
1265-32000-050-08T (Trust Agreement with IDEXX Corp.)  
Development of chicken hybridomas and other immunological reagents for chickens 
Investigator: Hyun Lillehoj    Funding: $ 50,000 
Start: 01/01/1997     Termination: 09/01/2002 
 
1265-32000-050-10T (CRADA with Nippon Zeon Corp.) 
Development of fowlpox virus vector system for coccidia and cytokine gene delivery to enhance 
poultry immunity  
Investigator: Hyun Lillehoj    Funding: $ 422, 600 
Start: 03/01/2001     Termination: 12/06/2002 
 
1265-20-00-11237 (Trust Agreement with Novus International Inc.) 
Development of immunological reagents for the avian system 
Investigator: Hyun Lillehoj    Funding: $ 12,000 
Start: 02/01/1997     Termination: 01/01/2000 
 
1265-32000-050-12T (CRADA with Novus International Inc.) 
Development of mucosal immunization strategy against coccidiosis 
Investigator: Hyun Lillehoj    Funding: $ 150,367 
Start: 07/01/1998     Termination: 06/01/2000 
 
1265-32000-050-14T 15R (CSREES National Research Initiative Grant)  
Interferon-gamma-mediated immune enhancement in avian coccidiosis 
Investigator: Hyun Lillehoj    Funding: $ 96,000 
Start: 09/01/1998     Termination: 08/31/2003 
 
1265-32000-050-13T (Trust Agreement with Maine Biological Laboratory) 
Application of cytokines and immunological reagents for enhanced immunity in chickens 
Investigator: Hyun Lillehoj    Funding: $ 50,000 
Start: 02/01/1998     Termination: 01/31/2003 
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1265-31320-070-01R (Fund for Rural America Grant) 
DNA marker technology in commercial broiler selection programs 
Investigator: Hyun Lillehoj    Funding: $ 320,000 
Start: 02/01/1998     Termination: 02/01/2001 
1265-32000-050-23R (Reimbursable Agreement with University of Maryland) 
Development of in vitro cytokine assays for studying mucosal immunity in chickens 
Investigator: Hyun Lillehoj    Funding: $ 148,589 
Start: 09/01/2000     Termination: 08/31/2005 
 
1265-31320-014-04T (Trust Agreement with Ghen Immunology Institute) 
Development of novel immunological control strategy using hyperimmune egg antibodies to 
prevent against coccidiosis 
Investigator: Hyun Lillehoj    Funding: $ 20,000 
Start: 03/01/2001     Termination: 02/28/2006 
 
1265-31320-014-03T (Trust Agreement with Avicore Biotechnology Institute) 
Application of functional genomics to develop novel control strategies against poultry diseases 
Investigator: Hyun Lillehoj    Funding: $ 240,000 
Start: 04/01/2001     Termination: 03/30/2006 
 
1265-31320-070-15R (CSREES National Research Initiative Grant) 
Mapping quantitative trait associated with disease resistance in commercial broiler chickens 
Investigator: Hyun Lillehoj    Funding: $ 200,000 
Start: 01/01/2003     Termination: 12/30/2005 
 
1265-31320-070- (CRADA Agreement with Zeon Corp.) 
DNA vaccination strategy through embryonic vaccination 
Investigator: Hyun Lillehoj    Funding: $ 20,000 
Start: 04/01/2003     Termination: 03/30/2008 
 
1265-31320-070-T (Trust Agreement with Novus International Inc.) 
Assessment of coccidia immune response using interferon-gamma assay 
Investigator: Hyun Lillehoj    Funding: $ 10,000 
Start: 04/01/2002     Termination: 03/30/2007 
 
Agreement No. 58-1265-4-F060 (Cooperative Research Project Between ARS and Rural 
Development Administration, South Korea) 
Study on the mechanisms of immunomodulatory phytochemicals from fruits and vegetables in 
Republic of Korea. 
Investigator: Hyun Lillehoj  Funding: $ 72,000 
Start: May, 1, 2004    Termination: April 30, 2007. 
 
193-1265-154 (CRADA with Intervet Inc.) Production of vaccine strains suitable for 
incorporation in a live vaccine for avian coccidiosis.  
Investigator : Patricia C. Allen; funding $59,000. Start 2/1/2002,; terminate 9/1/2005.  
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Other external agreement: 
A material transfer agreement was established with Transfer Point, a manufacturer of yeast beta 
glucans to test effectiveness of the product as an anticoccidial feed additive. 
 
A cooperative project with Gregory Siragusa, USDA, Russel Research Center, Athens GA, is 
under way to test anticoccidial activity of soluble beta glucans from hops. 
 
A cooperative research project was undertaken with  Bill Chobotar, Andrews University, to 
ultrastructurally locate the acetyl coA carboxylase complex in Eimeria sp.     
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PROJECT OBJECTIVES: 
Swine have two prominent foodborne parasitic disease agents: the muscle worm, Trichinella 
spiralis, and the tissue protozoan parasite, Toxoplasma gondii. Infective eggs from the large 
roundworm, Ascaris suum, represent an emerging disease where agricultural use of pig manure 
contaminated with parasite eggs may increase human infection. Outbreaks of human disease 
from swine products negatively reflect on pork as a safe source of nutritious edible tissue and 
lowers export potential. Molecular tests to evaluate parasite infections in meat products need to 
be improved so that they are very sensitive and accurately reflect the true source of the infection.  
 
Proper maintenance of herd health precludes infection but requires a large capital investment and 
breaches in procedure can readily result in new infections. No drugs are available to adequately 
cure tissue parasites, and the cost of development of new drugs by the pharmaceutical industry is 
prohibitive and unpredictable. Further, secondary bacteria disease is associated with worm 
infection in livestock and bacteria like Campylobacter is a major cause of diarrhea in humans. A 
long-term preventative control strategy is to vaccinate against swine parasites. Cooperative 
efforts between university, industry and government laboratories is directed at molecular 
regulators of immunity, receptor biology, innate protective mechanisms, and antibody responses 
targeted at the intestinal immune system of pigs. The basic nature of this work will also provide 
information for the immunological control of microbial and viral infection in swine. 
 
Consumers are now requesting safer food products, thus encouraging producers to raise animals 
without antibiotics. Thus, producers have had to reshape the methods that they employ for 
raising disease-free pigs. This will require advanced knowledge of neonatal swine immunity and 
molecular tests for activators of the swine immune system such as recombinant cytokines 
[interleukin-12 (IL-12) and IL-18]. Description of effects of these cytokines and of synthetic 
oligonucleotides (CpG) on swine immunity, and their use to enhance neonatal swine immunity 
and to stimulate appropriate protective mechanisms against food borne pathogens, will have 
commercial value. Vaccines incorporating these activators would complement existing control 
procedures and provide the benefits of long-term protection, cost efficiency and reduced drug 
residues in the food chain. Studies of toxoplasmosis have shown that strong protective immunity 
can be induced in pigs by irradiated oocysts and attenuated strains, but that immunity is not 
complete and may result in low-level infection. Novel cytokine-based procedures that activate 
porcine immunity by increasing interferon-gamma (IFN-gamma) levels have the potential to 
enhance resistance to toxoplasmosis. The underdeveloped intestinal immune system of weaned- 
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pigs provides a model to test other prospective immune enhancing agents on development of 
resistance to infection in neonatal pigs.  
 
Swine disease control is most important during the first month of a pig's life due to the immature 
immune system development in the newborn pig. Moreover there is rapid exposure of the 
newborn to infectious agents when it moves from the birthing (farrowing) unit into nursery 
facilities that house litters from numerous sows. We have asked whether administration of 
exogenous immune proteins, termed cytokines, enhances neonatal immunity and disease 
responses, and determines whether this will help protect young pigs from infections and stress-
induced immune deficiencies. Our studies are aimed at determining the role of cytokines in the 
development of the neonatal immune system of swine. Descriptions of the mucosal immune 
system and the immunobiology of gastrointestinal parasite responses in neonatal and growing 
pigs will provide useful and largely unique information that will be available to scientists in 
other federal, academic and industry (producers, vaccine and pharmaceutical companies) 
laboratories.  
 
Traditional genetic approaches have been very effectively used by the swine industry to enhance 
feed efficiency, pig meat production and reproductive traits. Recently, molecular methods have 
provided new genomic markers to actively select for specific traits such as the ESR gene for 
improved piglet number per litter. For pig health, inheritance of specific alleles within the swine 
leukocyte antigen (SLA) complex genes have been known to positively influence disease and 
vaccine responses. Broader pig health studies to determine whether defined immune markers 
could be correlated with specific resistance to disease are only now being approached. Results 
from these studies should provide producers with pigs that would require fewer antibiotic 
treatments and better disease resistance. 
 
In the last year the disease target of this CRIS have been expanded to include Porcine 
Reproductive and Respiratory Syndrome (PRRS) and other respiratory diseases of swine. 
According to the National Pork Board (NPB), PRRS costs U.S. pork producers at least $600 
million annually, and thus is the most economically significant disease facing the US industry 
today. PRRS affected 21.4% of all breeding herd operations and, importantly, 58.3% of 
operations with >500 sows (NAHMS 2000). From 16.6-50.7% of all grow/finish operations 
reported having PRRS within the previous 6 months. Losses are due not only to reduced 
reproduction capacity in gilts or sows, but to other aspects of production, poor growth and 
increased respiratory problems. Modified live virus vaccines are available for PRRS but protect 
only against homologous viral challenges. Because PRRSV is an RNA virus its genome changes 
and heterologous strains quickly arise. Thus new immune approaches are needed for prevention 
of PRRS using new biotherapeutics, improved vaccines and better adjuvants. 
 
OVERALL PROJECT ACCOMPLISHMENTS: 
Determination of the risk of foodborne transmission of Toxoplasma gondii in meat products 
requires a thorough epidemiological survey to allay consumer fears.  Such a survey is underway 
involving a large statistical sampling of market beef, pork and chicken from numerous cities in 
the United States. Monitoring the levels of the parasite in actual market samples will involve 
several approaches, including bioassays, serum and tissue juice antibody assays and a molecular 
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assay developed with the support of National Pork Board funds. Samples are now being tested 
for T. gondii and the results for each test compared. These results will assure consumers of an 
accurate risk of exposure to toxoplasmosis through the commercial meat supply.  
  
The immune system is complex and requires new tools to track the cells that respond to 
infectious organisms. Members of this laboratory participated in a major international workshop 
to determine the reactivity of ~200 monoclonal antibodies (mAb) against swine immune cells. 
The mAb were exchanged, tested for specific reactivity and the results statistically analyzed so 
that clusters of differentiation (CD) numbers could be assigned. The results are now 
internationally accepted as the standard CD designation for pig immune cells, enabling scientists 
worldwide to exchange data and determine which cells are essential in preventing infections or in 
stimulating protective vaccine responses. In 2003-2005 a screen of 386 anti-human CD mAb 
have been tested for cross-reactivity on swine cells as part of the Human Leukocyte 
Differentiation Antigens (HLDA8) workshop Animal Homologues Section. This will further 
increase availability of crucial anti-CD mAb for immune research in pigs. 
 
Molecular markers of distinct Trichinella genotypes/species have been identified and developed 
into a sensitive diagnostic test. This test will reduce the risk of undetected freeze resistant 
Trichinella strains that could undermine the frozen meat technology that is the major commercial 
and consumer-based control strategy for the inactivation of Trichinella in edible tissue. In 
addition, the epidemiology of the remaining 9 other detectable genotypes can be monitored to 
prevent their emergence in the U.S.   
 
Studies of toxoplasmosis have shown that strong protective immunity can be induced in pigs by 
irradiated oocysts and attenuated strains, but that immunity is not complete and may result in low 
level infection. Novel cytokine-based procedures that activate porcine immunity by increasing 
IFN-gamma levels have the potential to enhance resistance to toxoplasmosis. Details on the 
under developed nature of the intestinal immune system of weaned-pigs provides a model to test 
other prospective immune enhancing agents on development of resistance to infection in 
neonatal pigs.  
  
Swine disease control is most important during the first month of a pig's life due to an immature 
immune system.  ARS scientists have established methods to show how the respiratory and 
intestinal immune systems develop in the neonatal piglet and have shown that the immune 
system is under-developed in the intestine and, thus, less able to respond effectively against 
gastrointestinal infections.  Future research should determine whether treatment of these young 
piglets with immune cytokine proteins will stimulate maturation of their immune system and 
thus enable them to be more resistant to infectious diseases as they move into the nursery, thus 
preventing piglet losses and saving producers' drug and veterinary costs. 
 
ARS scientists at Beltsville, MD, with PIC/Sygen collaborators, have phenotyped hundreds of 
young piglets from PIC stock for early indicators of immune functions. This project was 
established to aid producers looking for alternatives to using antibiotics for early weaned pigs 
and researched methods to identify pigs which are genetically more disease resistant. The 
statistical analyses have indicated that some immune correlates of healthier and more productive 
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pigs do exist; further studies will determine whether healthier pigs can be identified using 
simpler genetic markers. With such markers, pigs which are more disease resistant could be 
made available so that consumers would be provided with healthier pork products that contained 
less drug residues.  
 
New approaches are being explored to determine whether pigs that are genetically resistant to 
disease can be identified as an alternate to using antibiotics to treat early weaned pigs. ARS 
scientists at Beltsville, MD, in collaboration with PIC/Sygen have evaluated piglets' blood cell 
markers associated with immune function and showed that there were significant increases in 
specific T cell subsets during the first few weeks of a piglet's life. These results may help explain 
why neonates are more susceptible to disease and may also indicate how producers can plan 
management changes to avoid immune and disease stressors. Additionally this data indicated that 
there were piglets which were genetically more resilient, based on their growth characteristics 
and increased numbers of specific immune subsets at 7 weeks of age. Thus, genetic tests could 
be developed to identify breeders with this trait. 
 
Pigs are exposed to infectious agents when they are moved to new facilities and mix with pigs 
from other areas. The use of antibiotics to control infection is limited and alternate therapeutic 
approaches are desperately needed. In collaboration with the Biotechnology Research and 
Development Corporation (BRDC) and their collaborating pharmaceutical and breeding 
company partners, ARS scientists cloned and purified a new pig therapeutic, recombinant 
porcine cytokine interleukin-12 (rPoIL-12). However, rPoIL-12 has limited activity in swine 
because of low IL-12 receptor expression [unlike other animal species] and therefore, may not, 
on its own, provide adequate stimulation of the pig immune system. This is essential information 
for pharmaceutical and vaccine companies as they search for effective immune stimulants for 
swine. 
 
Modified live virus (MLV) vaccines are only partially effective in preventing new PRRSV 
infections. With BRDC funding ARS scientists and Univ. Illinois researchers performed detailed 
examination of immune gene expression following MLV vaccination and demonstrated that 
some innate immune responses were not stimulated by PRRS MLV. To improve these responses, 
they then tested innate adjuvants (interferon-alpha, IFNA, and interferon inducer poly(inosinic 
acid)-poly(cytidylic acid) [poly(IC)]) as adjuvants for MLV resulting in improved interferon-
gamma production but limited increases in protection against PRRS. Thus, these new adjuvants 
will be helpful, but not sufficient, in improving PRRSV vaccines. 
 
IMPACT: 
A comprehensive panel of "designer" immune reagents has been developed to assess swine 
immune responses, for use in analyses of disease and vaccine studies and neonatal pig 
development. These include sensitive gene expression tests for >300 swine immune genes, mAb 
markers for swine cell subsets and immune cytokines, and biotherapeutics. Products from this 
CRIS's research will enhance an expanding base of scientific knowledge on mucosal and 
neonatal immunology of swine, techniques and reagents for veterinary application, practical 
outcomes for control of zoonotic pathogens and characterization of products with commercial 
applications.  
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Studies comparing pig immune gene expression to Toxoplasma gondii and Ascaris suum 
infections have shown that clearly distinct T helper I (Th1) and Th2 responses can be induced. 
Based on these gene expression studies swine researchers worldwide will be able to assess 
protective immunity to different infectious organisms and vaccinations. These gene expression 
assays will help determine whether novel cytokine-based procedures that activate porcine 
immunity have the potential to enhance resistance to specific infectious agents or development of 
resistance to infection in neonatal pigs.  
 
This CRIS has developed new animal models to assess the impact of mixed infections on disease 
responses and on pig health. Testing responses to secondary bacteria disease in association with 
worm infection in livestock have indicated that the Th1/Th2 balance can be altered in local 
mucosal tissues. This has led to cooperative studies with human clinicians for inflammatory 
bowel syndrome and Crohn’s disease. 
 
This project has tested biotherapeutic alternatives to using antibiotics for early weaned pigs and 
researched methods to identify pigs which are genetically more disease resistant. The 
biotherapeutic porcine IL-12 protein was proven not to be effective. The adjuvants, IFNA and 
poly(IC) were partially effective as booster of anti-PRRS vaccine immunity. Studies proved that 
the respiratory and intestinal immune systems develop in the neonatal piglet is under-developed 
and, thus, less able to respond effectively against respiratory and gastrointestinal infections.  
Some immune correlates of healthier and more productive pigs do exist; studies are underway to 
determine whether healthier pigs can be identified using simpler genetic markers. With such 
adjuvants and markers, pigs which are healthier could be made available so that consumers 
would be provided with safer pork products that contained less drug residues.  
 
Novel molecular parasite detection and diagnostic tests have been produced for swine parasites. 
Molecular markers of distinct Trichinella genotypes/species have been identified and developed 
into a sensitive diagnostic test that can be used for epidemiologic studies of the detectable 
Trichinella genotypes to prevent their emergence in the U.S. A real-time, PCR-based, sensitive 
diagnostic test to identify and quantitate Toxoplasma gondii DNA in tissues and other biological 
samples, including meat products, has been developed and a patent application.  
 
TECHNOLOGY TRANSFER: 
The results of these studies have been presented to a number of local groups at field days and 
presentations through the ARS National Visitor's Center and to scientific groups including the 
American Association of Veterinary Parasitologists, the World Association for the Advancement 
of Veterinary Parasitology, the Conference of Research Workers in Animal Disease, national and 
international animal genome meetings, and national and international immunology meetings. 
Scientists involved in this CRIS serve on the National Pork Board Toxoplasmosis Advisory 
group and assist in review of the Board's programs and grant submissions.  
 
ARS scientists are also involved in multistate projects, NC-1004 (serving in 2004 as NC-1004 
Chair) and NRSP8 for animal genome studies, and NC-229 for PRRS research. Most recently 
this has been evidenced by successful participation in the multistate USDA CSREES Animal and 
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Plant Biosecurity grant #2003-05164: “Integrated Control and Elimination of Porcine 
Reproductive and Respiratory Syndrome Virus (PRRSV) in the U.S.” 
 
Reagents generated to study immune responses in swine have been made available to the 
research community worldwide. This has included molecular probes and real-time PCR primers 
and probes for swine cytokines and immune markers that have been shared internationally. 
Numerous monoclonal antibodies (mAb) reactive with swine immune cell subsets (CD antigens) 
and cytokines are now available through commercial sources. The results of international CD 
workshops are now internationally accepted, enabling scientists worldwide to exchange data and 
determine which cells are essential in preventing infections or in stimulating protective vaccine 
responses. Now, in 2003-2005, the workshop involves testing for cross-reactivity on swine cells 
as part of the Human Leukocyte Differentiation Antigens (HLDA8) workshop Animal 
Homologues Section. This will further increase availability of crucial anti-CD mAb for immune 
research in pigs. 
 
The cloning and expression of a functional interleukin-12 (IL-12) cytokine was conducted under 
a BRDC funded grant. Sponsors from the BRDC legally reviewed the patent potential of porcine 
IL-12. No patent application was submitted. Availability of the cloned, expressed IL-12, is 
decided by BRDC.  
 
Patents: 
The patent application for the real-time, PCR-based, diagnostic test to identify Toxoplasma DNA 
in tissues and other biological samples, including meat products, was submitted to the US patent 
office. Further tests to determine usefulness on commercial pork products are underway through 
support of a new National Pork Board grant under the new CRIS project. Transfer of this 
technology to scientists at the Centers for Disease Control and other institutions has been 
ongoing . 
 
PUBLICATIONS (Listed by CRIS objectives): 
 
Objective #1: Develop reagents and assays to enable definition of cytokine-regulated 
immune mechanisms that protect pigs. 
 
Dawson HD, Royaee AR, Nishi S, Kuhar D, Schnitzlein WM, Zuckermann F, Urban JF, Lunney 
JK. 2004. Identification of Key Immune Mediators Regulating T helper 1 Responses in Swine. 
Vet. Immunol. Immunopathol. In Press. 
 
Royaee AR, Zuckermann F, Husmann R, Calzada-Nova G, Schnitzlein WM, Lunney JK. 2004. 
Cytokine response of porcine lymphoid cells in response to host vaccination with PRRS virus. 
Vet. Immunol. Immunopathol. In Press.  
 
Zarlenga DS, Dawson H, Kringel H, Solano-Aguilar G, Urban JF Jr. 2004. Molecular Cloning of 
the Swine IL-4 receptor α and IL-13 receptor α1-chains: effects of experimental Toxoplasma 
gondii, Ascaris suum and Trichuris suis infections on tissue mRNA levels. Vet. Immunol. 
Immunopathol. In press. 
                                                                                      231 
 
 
Dawson HD, Beshah E, Nishi S, Solano-Aguilar G, Morimoto M, Zhao A, Madden KB, 
Ledbetter TK, Dubey JP, Shea-Donohue T, Lunney JK, Urban, JF Jr. 2004. Localized multi-gene 
expression patterns support an evolving Th1/Th2-like paradigm in response to infections with 
Toxoplasma gondii and Ascaris suum in pigs. Infection and Immunity. In Revision. 
 
Martens GW, Lunney JK, Baker JE, Smith DM. 2003. Rapid Assignment of Swine Leukocyte 
Antigen (SLA) Haplotypes in Pedigreed Herds using a Polymerase Chain Reaction Based Assay. 
2003. Immunogenetics. 55: 395-401. 
 
Lunney JK, Fossum C, Alm GV, Steinbach F, Wattrang E. 2002. Veterinary immunology: 
opportunities and challenges. Trends in Immunology. 23: 4-6. 
 
Solano-Aguilar G, Zarlenga D, Beshah E, Gasbarre L, Junker D, Cochran M, Dawson H, Urban 
J, Lunney J. 2002. Limited effect of Recombinant porcine Interleukin 12 on porcine lymphocytes 
due to a low level of IL-12 Beta 2 receptor. Vet. Immunol. Immunopathology. 89: 133-148.  
 
Thacker E, Summerfield A, McCullough K, Ezquerra A, Dominguez J, Alonso F, Lunney J, 
Sinkora J, Haverson K. 2001. Summary of workshop findings for porcine myelomonocytic 
markers. Vet. Immunol. Immunopathology. 80:, 93-109. 
 
Davis WC, Haverson K, Saalmüller A, Yang H, Lunney JK, Hamilton MJ, Pescovitz MD. 2001. 
Analysis of monoclonal antibodies reacting with molecules expressed on T cells. Vet. Immunol. 
Immunopathology. 80: 53-62. 
 
Haverson K, Saalmüller A, Alvarez B, Alonso F, Bailey M, Bianchi ATJ, Boersma WJA, Chen 
Z, Davis WC, Dominguez J, Engelhardt H, Ezquerra A, Grosmaire LS, Hamilton MJ, 
Hollemweguer E, Huang C, Khanna KV, Kuebart G, Lackovic G, Ledbetter JA, Lee R, Llanes 
D, Lunney JK, McCullough KC, Molitor T, Nielsen J, Niewold TA, Pescovitz MD, Perez de la 
Lastra J, Rehakova Z, Salmon H, Schnitzlein WM, Seebach J, Simon A, Sinkora J, Sinkora M, 
Stocks CR, Summerfield A, Sver L, Thacker E, Valpotic I, Yang H, Zuckermann FA, Zwart R. 
2001. Overview of the Third International Workshop on Swine Leukocyte Differentiation 
Antigens. Vet. Immunol. Immunopathol. 80: 5-23. 
 
Johnson P, Keen NT, Lunney JK, Sadowsky MJ. 2001. Conference Editorial: Agricultural 
Microbes Genome 2. Comparative and Functional Genomics. v. 2. p. 10-13.  
 
Objective #2: Determine if parasite-induced polarization of swine immunity effects pig 
health and susceptibility to zoonotic agents. 
(Pig) 
Kringel H, Dubey JP, Beshah E, Hecker R, Urban JF Jr. 2004. Effect of CpG 
oligodeoxynucleotide (ODN)-induced immune activation on porcine immunity to infection with 
Toxoplasma gondii. Vet. Parasitol. (in press). 
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Mansfield LS, Gauthier DT, Abner SR, Jones KM, Wilder SR Urban JF Jr. 2003. Enhancement 
of disease and pathology by synergy of Trichuris suis and Campylobacter jejuni in the colon of 
immunologically naive swine. Am J Trop Med Hyg. 68:70-80. 
 
Abner SR, Hill DE, Turner JR, Black ED, Bartlett P, Urban JF Jr, Mansfield LS. 2002. Response 
of intestinal epithelial cells to Trichuris suis excretory-secretory products and the influence on 
Campylobacter jejuni invasion under in vitro conditions. J. Parasitol. 88: 738-745. 
 
Solano-Aguilar GI, Beshah E, Vengroski K, Zarlenga D, Jauregui L, Cosio M, Douglass LW, 
Dubey JP, Lunney, JK. 2001. Cytokine and lymphocyte profile in miniature swine after oral 
infection with Toxoplasma gondii oocysts. Intnl J Parasitology. 31: 187-195. 
 
Solano-Aguilar GI, Beshah E, Vengroski K, Zarlenga D, Jauregui L, Cosio M, Douglass LW, 
Dubey JP, Lunney JK. 2001. Cytokine and lymphocyte profile after oral infection with 
Toxoplasma gondii oocysts. Scandinavian J. Immunology. 54: 93. 
 
(Mouse) 
Ekkens M, Liu Z, Liu Q, Whitmire J, Xiao S, Foster A, Pesce J, VanNoy J, Sharpe A, Urban JF 
Jr., Gause WC. 2003. The role of OX40L interactions in the development of the Th2 response to 
the gastrointestinal nematode parasite Heligmosomoides polygyrus. J. Immunol 170:384-93. 
 
Zhao A, McDermott J, Urban JF, Gause W, Madden KB, Au Yeung K, Morris SB, Finkelman 
FD, Shea-Donohue T. 2003. Dependence of IL-4, IL-13 or Nematode-Induced Alterations in 
Murine Small Intestinal Smooth Muscle Contractility on Stat6 and Enteric Nerves. J Immunol 
171:948-954. 
 
Strait RT, Morris SC, Smiley K, Urban JF Jr.,, Finkelman RD. 2003. IL-4 exacerbates 
anaphylaxis. J. Immunology. 170: 3835-3842. 
 
Gause WC, Urban JF Jr., Stadecker MJ. 2003. The immune response to parasitic helminths: 
insights from murine models. Trends in Immunology. 24: 269-277. 
 
Schopf LR, Hoffmann KF, Cheever AW, Urban JF Jr., Wynn TA. 2002. IL-10 is critical for 
resistance and survival during gastrointestinal helminth infection.  J. Immunol. 168: 2383-2392. 
 
Ekkens M, Liu Z, Liu Q, Foster A, Whitmire J, Pesce J, Urban JF Jr, Gause WC. 2002. Memory 
Th2 effector cells can develop in the absence of B7-1/B7-2, CD28 interactions, and effector Th 
cells after priming with an intestinal nematode parasite. J. Immunol. 168: 6344- 6351. 
 
Madden KB, Whitman L, Sullivan C, Gause WC, Donaldson DD, Urban JF Jr., Katona IM, 
Finkelman FD, Shea-Donohue T. 2002.  Role of Stat6 and mast cells in IL-4 and IL-13-induced 
alterations in murine intestinal epithelial cell function. J. Immunol. 169: 4417-4422.  
 
Liu Z, Liu, Q., Pesce, J, Whitmire J, Ekkens M, Foster, A, VanNoy, J, Sharpe A, Urban JF Jr, 
Gause WC. 2002. Nippostrongylus brasiliensis can induce B7-independent Ag-specific 
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development of IL-4-producing T cells from naïve CD4 T cells in vivo.  J. Immunol. 169: 6959-
6968, 2002. 
 
Finkelman FD, Urban JF Jr.. 2001. The other side of the coin: The protective role of the type 2 
(Th2) cytokines. J. Allergy and Clinical Immunology. v.107. p.772-780. 
 
Shea-Donohue T, Sullivan C, Finkelman FD, Madden KB, Morris SC, Goldhill J, Piñeiro-
Carrero V, Urban JF Jr. 2001. The Role of Interleukin-4 in Heligmosomoides polygyrus induced 
alterations in murine intestinal epithelial cell function. J. Immunol. 167: 2234-2239. 
 
Urban JF Jr., Noben-Trauth N, Schopf L, Madden K, Finkelman FD. 2001. Cutting edge: IL-4 
receptor expression by non-bone marrow-derived cells is required to expel gastrointestinal 
nematode parasites.  J. Immunol. 167: 6078-6081. 
 
(Human) 
Elliott DE, Li J, Blum A, Metwali A, Qadir K, Urban JF Jr, Weinstock JV. 2003. Exposure to 
Schistosome Eggs Protects Mice from TNBS-induced Colitis. Am J Physiol Gastrointest Liver 
Physiol. 284: G385-91. 
 
Summers RW, Elliott DE, Qadir K, Urban JF Jr., Thompson R, Weinstock JV. 2003. Trichuris 
suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease. Am. 
J. Gastroenterol. 98: 2034-2041. 
 
Weinstock JV, Summers RW, Elliott DE, Qadir K, Urban JF Jr, Thompson R. 2002: The 
possible link between de-worming and the emergence of immunological disease. J Lab Clin 
Med. 139: 334-38.  
 
Objective #3: Assess development of mucosal immune responses in pigs and the effect on 
neonatal pig health and transmission of foodborne pathogens using state-of-the-art 
immunological methods and cDNA microarray technology. 
 
Zarlenga DS, La Rosa G, Pozio E, Rosenthal B. 2004. Identification and classification within the 
genus, Trichinella, with special emphasis on non-encapsulated species. Vet. Parasitol. (In press). 
 
Morimoto M, Morimoto M, Whitmire J, Xiao S, Star RA, Urban JF Jr., Gause WC.  2004. 
Peripheral CD4 T cells rapidly accumulate at the host: parasite interface during an inflammatory 
Th2 memory response. J. Immunol. 172(4):2424-30. 
 
Bannerman D, Paape MJ, Lunney JK. 2004. Immunity: Innate. In Encyclopedia of Animal 
Science; Pond WG, Bell AW Eds.; Marcel Dekker, Inc., New York. In Press. 
 
Lunney JK, Paape MJ, Bannerman D. 2004.Immunity: Acquired. In Encyclopedia of Animal 
Science; Pond WG, Bell AW Eds.; Marcel Dekker, Inc., New York. In Press. 
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Gerrits RJ, Lunney JK,  Johnson LA, Pursel VG, Rohrer GA, Dobrinsky JR. 2004. A vision for 
artificial insemination and genomics to improve the global swine population. Theriogenology. In 
Press. 
 
La Rosa G, Marucci G, Zarlenga DS, Casulli A, Zarnke RL, Pozio E.  2003. A study of the ITS-2 
locus in laboratory and natural isolates of Trichinella nativa and Trichinella T6 suggests an 
incipient genetic divergence between the two genotypes. Int. J. Parasitol. 33; 209-216.  
 
Morimoto M, Zarlenga DS, Beard H, Alkharouf N, Matthews BF, Urban JF Jr. 2003. Ascaris 
suum: cDNA microarray analysis of 4th stage larvae (L4) during self-cure from the intestine. 
Exp. Parasitol. 104: 113-121.  
 
Lunney, J.K. 2003. In Search of Disease-Resistant Pigs. National Hog Farmer, Apr 15, 2003, 
pp.30-34. 
 
Lunney JK 2003. Are there immune gene alleles that determine whether a pig will be healthy? 
Genetics of Pig Health Symposium, M Boggess, Ed.; National Pork Board Press, DesMoines, 
IA. p.63-72. 
 
Solano-Aguilar GI, Galina L, Douglass LW, Lunney JK. 2002. Developmental immunity in 
neonatal pigs monitored by the function of peripheral blood mononuclear cells.  Proc. 17th Cong. 
Intnl. Pig Vet. Soc., Iowa. Vol. 1, p.259. 
 
Dawson H, Nishi S, Beshah E, Solano-Aguilar G, Zarlenga D, Urban JF, Lunney JK. 2002. 
Functional genomic assessment of porcine disease resistance: real time assays of porcine 
immune gene expression. Proceedings 7th World Congress on Genetics Applied to Livestock 
Production. #13-41. 
 
Pozio E, Zarlenga DS. La Rosa G. 2002. The detection of encapsulated and non-encapsulated 
species of Trichinella suggests the existence of two evolute lines in the genus. Parasite 8; 27-29. 
 
Zarlenga DS, Boyd P, Lichtenfels JR, Hill D, Gamble HR. 2002. Identification and 
characterization of a cDNA sequence encoding a glutamic acid-rich protein specifically 
transcribed in Trichinella spiralis newborn larvae and recognized by infected swine serum. Int. J. 
Parasitol. 32; 1361-1370. 
 
Solano-Aguilar GI, Vengroski K, Beshah E, Douglass LW, Lunney JK. 2001. Characterization 
of lymphocyte subsets from mucosal tissues in neonatal swine. Dev. Comp. Immunol. 25: 245-
263. 
 
Jauregui LH, Higgins J, Zarlenga D, Dubey JP, Lunney JK. 2001. Development of a Real-Time 
PCR Assay for Detection of Toxoplasma gondii in Pig and Mouse Tissues. J. Clin. Microbiol. 
39: 2065-2071. 
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Zarlenga DS, La Rosa G. 2001. Traditional and Molecular methods for parasite differentiation 
within the genus Trichinella. Vet. Parasitol. 93; 279-292.    
 
La Rosa G, Marucci G, Zarlenga DS, Pozio E. 2001. Trichinella pseudospiralis populations from 
the Palearctic region and their relationship with populations of Nearctic and Australian regions. 
Int. J. Parasitol. 31; 297-305. 
 
Zarlenga DS, Higgins JA. 2001. PCR as a diagnostic and quantitative technique in veterinary 
parasitology. Vet. Parasitol. 101; 215-230. 
 
Zarlenga DS, Chute MB, Martin A, Kapel CMO. 2001. A single multiplex PCR for 
differentiating all species of Trichinella with special application to the newly described T. 
papuae. Parasite 8; 24-26. 
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Animal Parasitic Diseases Laboratory (APDL) 
 
 
 
Project Title:   Biosystematics and Biodiversity of Pathogens and Parasites 
CRIS Number:     1265-32000-068-00D 
Scientists:             Hoberg, E.P., Lichtenfels, J.R. 
 Location:        Animal and Natural Resources Institute  
Animal Parasitic Diseases Laboratory 
United States National Parasite Collection 
Contact:  Hoberg, E.P. Phone: (301) 504-8588, Fax: (301) 504-8979, 
ehoberg@anri.barc.usda.gov
 
PROJECT OBJECTIVES: 
Helminth parasites are economically significant pathogens in ruminants, other food animals and 
equines, contributing to over $2 billion in losses annually in the United States. Efforts to 
understand epidemiology, distribution and disease and the most efficacious basis for control have 
often been hampered by difficulties in identification of pathogens and parasites. A paucity of 
knowledge about the species and populations involved and often limited information on 
geographic and host-distribution hinders our ability to predict the outcome of host-parasite 
interactions. Long-term challenges are evident that require resolution even as we develop more 
refined morphological and molecular capabilities for parasite identification. Identity and 
phylogenetic relationship are baseline information for defining host and geographic distribution 
and patterns of parasite diversity. Recognition of cryptic, emergent, exotic and invasive 
pathogens, determination of the importance of reservoir hosts such as wildlife, and elucidation of 
the influence of interfaces between agricultural and wild ecosystems on the structure of helminth 
faunas follow from biodiversity research. Additionally, among ruminants, the mosaic nature of 
the helminth fauna, particularly hidden species diversity, impacts our abilities to recognize 
emerging pathogens and invasive species or those increasingly influenced by anthropogenic and 
climatological global change. Consequently, continued strategic biodiversity survey and 
inventory in conjunction with phylogenetic systematic studies of parasitic groups are necessary 
to provide for accurate identification, diagnostics and definition of the parasitic fauna. Ecological 
perturbation linked to global change and its influence on the distribution of pathogens and 
emergence of disease can only be understood with a context provided by systematics. These 
issues form the framework of the current program for a series of integrated studies in systematics 
and parasite biodiversity among the crown clades of the strongylate nematodes primarily in 
ruminants and equines. Concurrently we will expand, and curate the specimens-collections of the 
US National Parasite Collection (USNPC). An infrastructure for Biodiversity Bioinformatics will 
link interactive information systems and diagnostic identification keys, with phylogenetic and 
epidemiological information for dissemination on the internet. We also provide a resource for 
reference specimens and information to support parasitology and animal health nationwide and 
globally. 
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OVERALL PROJECT ACCOMPLISHMENTS: 
(1) Phylogenetic Studies Indicate That The Occurrence of Taenia Tapeworms in humans pre-
dates the development of agriculture, animal husbandry and the domestication of cattle or swine. 
Taeniid tapeworms in African carnivores twice independently colonized hominids and the genus 
Homo, prior to the origin of modern humans coincidental with dietary and behavioral shifts from 
herbivory to scavenging and carnivory. Parasitological data provide a unique means of 
elucidating historical ecology, foraging behavior, and food habits of hominids during their 
evolution.  
 
(2) Comprehensive Taxonomic and Systematic Studies of Haemonchinae- revealed 2 new species 
in Haemonchus and a new species of Ashworthius. The phylogeny for Haemonchus is the 
foundation for a comprehensive reference system for diagnostic criteria and development of 
interactive identification keys; historically, coevolutionary and biogeographic analyses 
demonstrate the pervasive role of host translocation, and parasite introduction/ emergence in the 
global distributions of H. contortus, H. placei and H. similis the dominant pathogenic species in 
domestic stock.   
 
(3.) Phylogeny for Nematodirinae Nematodes- Nematodirinae are trichostrongyloid nematodes 
that globally include serious pathogens of ruminants, particularly caprines; completed the first 
phylogenetic analyses to reveal relationships among the 5 genera of nematodirines, and resolved 
historical biogeographic and host associations in the diversification of this parasite group.  
 
(4.) Mosaic Structure for Nematode Faunas in Ruminants from North America- Phylogenetic and 
historical studies of the trichostrongyloids including Ostertagiinae, Nematodirinae, and 
Haemonchinae indicate dual origins for major components of the Nearctic fauna. The Arctic-
boreal fauna and specifically the nematodrines, and many ostertagiines are endemic to North 
America, whereas the Haemonchines and Cooperiines have a history of introduction following 
Euopean contact in the 1500’s. Empirical and theoretical studies designed to examine the role of 
dispersal and translocation on faunal structure indicate a complex history.  
 
(5.) Development and Application of Epizootiological Probes- Protostrongylid muscleworms in 
the genus Parelaphostrongylus are emergent parasites among wild ruminant hosts in the 
continental United States. As requested by APHIS, and in collaboration with the College of 
Veterinary Medicine, Oregon State University, and the Western College of Veterinary Medicine, 
University of Saskatchewan, scientists of the US National Parasite Collection used comparative 
morphology, and multi-locus sequencing to identify larval parasites in feces of infected hosts and 
determine the geographic and host range for P. odocoilei. These studies indicated that a single 
species, P. odocoilei has a geographic distribution extending from California to south-central 
Alaska and the Mackenzie Mountains of the Northwest Territories and occurs in both Caprine 
and Cervid hosts; the parasite was identified for the first time in Oregon.  
 
(6.) Resources for Biodiversity Bioinformatics-  represents an effective and synergistic 
foundation to develop, utilize and present diverse knowledge about the distribution, host 
associations, and history for parasites represented by specimens-based collections such as the US 
National Parasite Collection. The Curator of the US National Parasite Collection in collaboration 
with colleagues at the Southwestern Museum of Vertebrate Biology, University of New Mexico, 
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the Western College of Veterinary Medicine, University of Saskatchewan, Department of 
Ecology and Evolutionary Biology, Cornell University, and the Vantaa Forest Research Centre, 
Rovaniemi, Finland developed protocols for comparative biodiversity studies focusing on 
parasite-host assemblages in high latitude ecosystems of the Holarctic. Studies serve as models  
for expansion of specimens-based collections as information systems integrating strategic field 
collections and databasing for development of comparative baselines for biodiversity in a 
contemporary and historical context.  
 
(7.) Molecular Diagnostics for Equine Strongyles-in collaboration with scientists in Scotland, 
Australia, and Ukraine, methods for improved diagnostics, based on morphology and DNA 
probes, were developed for nematode pathogens in horses. 
 
(8.) Diagnostic Keys for Definitive Identification of Equine Strongyles- in collaboration with V. 
Kharchenko of the Ukraine Academy of Science, and with support of a research grant from the 
CRDF (Civilian Research and Development Foundation), comparative morphological keys were 
prepared based on redescriptions of the 70 species of equine strongyles. Included were complete 
line figures and photomicrographs depiciting all significant diagnostic characters for 
identification. This work will remain the benchmark for all diagnostic work on the small 
strongyles, and is the foundation for any development of molecular-based probes for 
identification.    
 
IMPACT: 
 
(1.) The typical parasite fauna in humans is far older than previously considered and indicates a 
very prolonged association between humans and their characteristic food-borne pathogens. These 
insights provided a new focus in comparative epidemiological studies of T. saginata, T. asiatica 
and T. solium in humans and food animals for veterinarians and parasitolotigists in North 
America and globally. 
 
(2.) Improved knowledge of the species composition of this economically important genus 
provides information critical to understanding patterns of host association and geographic 
distribution and contributes to the development of methods and agents for controlling these 
nematodes. This is the foundation for a synoptic on-line and interactive key for identification.  
 
(3.) Information from these studies contributes to species-level analyses of Nematodirus and 
Nematodirella, including species known as serious pathogens in domestic sheep and cattle, and 
to improved diagnostics for these Holarctic nematodes. These studies are baselines in developing 
predictive hypotheses about the response of nematodes to changing climate and ecological 
perturbation. Essential and base-line information is disseminated to extension services, state 
departments of agriculture ands wildlife, and to the veterinary community. 
 
(4.) Disparate origins and adaptations to climate reveal different capacities and responses are 
expected across the spectrum of nematode pathogens in ruminants within the context of global 
climate change. Expansion and population increases for temperate faunas including the highly 
pathogenic haemonchines is predicted. These insights are critical to any strategic planning 
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process for prediction of impacts linked to global climate change and the responses of complex 
host-parasite systems.  
 
(5.) The investigation was the first to demonstrate the utility of “epizootiological probes” to 
elucidate the geographic and host associations for a pathogenic parasite; a baseline is provided to 
begin to understand the potential for emergence of such elaphostrongyline nematodes as a 
consequence of global change and the potential for host switching to domestic stock. These 
methods have broad applicability in both veterinary medicine and conservation biology, 
particularly where hosts cannot be collected for complete necropsy.  
 
(6.) Specimens collections become portals for access to critical information linking interactive 
keys, phylogenetic, biological and epidemiological data through species homepages for helminth 
parasites in Holarctic mammals, including those that circulate among domestic and wild 
ruminants. Essentially for the veterinary and wildlife conservation communities  this will 
represent “one-stop shopping”  for access to definitive information to identify parasites, 
understand their host associations and geographic rtanges, and to predict the outcomes of 
interactions among wild and domestic hosts at the interface of natural and managed ecosystems. 
 
(7.) Improved diagnostics provides essential working tools for the identification of species 
responsible for an emerging disease (larval cyathostomiasis), the development and testing of new 
antiparasitic compounds required by widespread nematode resistance to current drugs, and the 
testing of biological agents needed to control the more than 50 species of nematode pathogens in 
horses. The control of nematodes will greatly improve the health, well being and productivity of 
horses worldwide used for farming, recreation and in many countries for food.   
 
(8.) Keys will be made available on line for access on the web. Such access will broadly 
disseminate the results of this research to the veterinary and equine communities and serve to 
standardize the basis for identifications of these pathogens. 
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TECHNOLOGY TRANSFER NP 103 (FY 2000-2004): 
(1.)  US National Parasite Collection- database, informatics & specimens resources.  
Internet website at: www.lpsi.barc.usda.gov/bnpcu. Serves as a primary resource for national and 
global parasitology.  The USNPC is the largest specimens-based collection in the world. It serves 
a global constituency providing critical resources for systematics research, identification and 
diagnostics. It is a foundation for a network that provides proactive and predictive data for 
exotic, invasive and emergent pathogens and parasites.  
BNPCU scientists provided a National Reference Collection of specimens of parasites in 
animals, through development of the US National Parasite Collection, and an associated database 
of specimen records to researchers worldwide via the Internet and the loan of specimens.  
Impact: Parasitologists in ARS, and others working in veterinary, medical, or wildlife 
parasitology, have access to the necessary specimens and database to conduct studies in 
identification, classification and distribution that impact all efforts to control parasites of  
agricultural or medical importance.  The unique specimens, collected over a period of 150 years, 
provide a storehouse of genetic information that serves as a primary resource for biodiversity 
research.  Outcome:  The efficiency and prospects for success of all research worldwide on 
parasites of animals are enhanced.  The identification and control of parasites that contaminate 
fish, shellfish, or red meat and/or increase the cost of its production is more accurate and 
efficient, resulting in food that is safer and less expensive.  Prospects are enhanced for 
preventing the importation of exotic parasites that threaten American agriculture. 
 
(2.) NSF Grant- Beringian Coevolution Project. (BS&I 0196095). 1999-2003. $240,000. 
 
(3.) CRDF Grant, Cooperative Grants Program- Biological and Biomedical Engineering. 
Comparative morphology, phylogenetic analyses and classification of Strongyloid Nematode 
Parasites of Equidae. December 2001-2003. $80,000. (USNPC with Ukraine Academy of 
Sciences). 
 
(4.) ARS-former Soviet Union Scientific Cooperation Program- Collaborative Grant. Population  
ecology, and systematics of the Family Protostrongylidae. February 2002-2005. (USNPC and 
Uzbekistan Academy of Sciences). 
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PUBLICATIONS- according to category in NP 103 (FY 2000-2004): 
 
Diagnostics (including systematics, phylogeny, coevolution; empirical & theoretical studies; 
resources for systematics research; biodiversity) 
 
BrooksDR, Dowling APG, van Veller MGP, Hoberg EP. Ending a decade of deception: A 
valiant failure, a not so valiant failure and a success story. Cladistics. 2004; 20: 32-46. 
 
Brooks DR, Hoberg EP. Triage for the biosphere: The need and rationale for taxonomic 
inventories and phylogenetic studies of parasites. Comparative Parasitology. 2000; 67: 1-25. 
(order of authorship is arbitrary) 
 
Brooks DR, Hoberg EP. Parasite systematics in the 21st Century: Opportunities and obstacles.  
Trends in Parasitology. 2001; 17: 273-275. 
 
Dowling APG, van Veller MGP, Hoberg EP, Brooks, DR. A priori and a posteriori methods in 
comparative evolutionary studies of host-parasite associations. Cladistics. 2003; 19: 240-253. 
 
Hoberg EP. Foundations for an integrative parasitology: collections archives and biodiversity 
informatics. Comparative Parasitology. 2002. v.69. p.124-131. 
 
Hoberg EP. Colonization and diversification: Historical and coevolutionary trajectories among 
cestodes, pinnipeds and cetaceans. Proceedings International Congress of Parasitology X. 
Monduzzi Editore, Bologna. 2002. p. 65-69. 
 
Hoberg EP. Coevolution in marine systems. In Marine Parasites, K. Rohde (ed.). CSIRO, 
Sydney, Australia. In Press. 
 
Hoberg EP. Marine birds and their helminth parasites. In Marine Parasites, K. Rohde (ed.). 
CSIRO, Sydney, Australia. In Press. 
 
Hoberg EP, Abrams A. Synlophe in Ostertagia cf. kasakhstanica (Nematoda: Ostertagiinae), the 
minor morphotype of O. bisonis in western North America. Journal of Parasitology. 2001; 87: 
1181-1184. 
 
Hoberg, E.P., Abrams, A., Carreno, R., Lichtenfels, J.R. Ashworthius patriciapilittae n. sp. 
(Trichostrongyloidea: Haemonchinae), an abomasal nematode in Odocoileus virginianus from 
Costa Rica, and a first record for the genus in the Western Hemisphere. Journal of Parasitology. 
2002; 88: 1187-1199. 
 
Hoberg EP, Adams A. Phylogeny, history and biodiversity: Understanding faunal structure and 
biogeography in the marine realm. Bulletin of the Scandinavian Society of Parasitology. 2000; 
10: 19-37. 
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Hoberg, E.P., Klassen, G.J. Revealing the faunal tapestry: Coevolution and historical 
biogeography of hosts and parasites in marine systems. Parasitology. 2002; Supplement 124: S3-
S22. 
 
Hoberg EP, Lichtenfels JR, Gibbons LM. Phylogeny for species of the genus Haemonchus 
(Nematoda: Trichostrongyloidea):  Considerations of their evolutionary history and global 
biogeography among Camelidae and Pecora (Artiodactyla). Journal of Parasitology; 2004; 90: In 
Press. 
 
Hoberg EP, Mariaux J, Brooks DR.  Phylogeny among orders of the Eucestoda 
(Cercomeromorphae): Integrating morphology, molecules and total evidence.  In: 
Interrelationships of the Platyhelminthes.  DTJ Littlewood and RA Bray (eds).  Taylor and 
Francis. 2001; pp. 112-126. 
 
Hoberg EP, Rickard L, Lichtenfels JR. Phylogeny for the Nematodirinae (Nematoda: 
Trichostrongyloidea): Coevolution and historical biogeography among Lagomorpha and 
Artiodactyla.  Journal of Parasitology. 2004; 90: In Press. 
 
Hodgkinson, J.E., Love, S., Lichtenfels, J.R., Palfreman, S., Ramsey, Y.H., and Matthews, J.B. 
Evaluation of the specificity of five oligoprobes for identification of cyathostomin species from 
horses. International Journal of  Parasitology. 2001; 31:197-204. 
 
Kharchenko, V.A., Lichtenfels, J.R. and Krecek, R.C.  Cyathostomum montgomeryi and its place 
in the Cyathostominae (Nematoda: Strongylidae).  Comparative Parasitology. 2001. 68:97-102. 
 
Lichtenfels, J.R., Gibbons, L.M., Krecek, R.C. Recommended terminology and advances in the 
systematics of the Cyathostominea (Nematoda; Strongyloidea) of horses. Veterinary 
Parasitology. 2003; 107: 337-342. 
 
Lichtenfels, J.R., McDonnell, A., Love, S. and Matthews, J.B.  Nematodes of the Tribe 
Cyathostominea (Strongylidae) collected from horses in Scotland.  Comparative Parasitology. 
2001; 68: 265-269.  
 
Lichtenfels, J.R. and Pilitt, P.A. Synlophe patterns of the Haemonchinae of ruminants 
(Nematoda: Trichostrongyloidea).  Journal of Parasitology. 2000. 86:1093-1098.  
 
Lichtenfels, J.R., Pilitt, P.A., Gibbons, L.M.and Boomker, J.D.F.  Haemonchus horaki n. sp. 
(Nematoda: Trichostrongyloidea) from the rhebok, Pelea capreolus, in South Africa.  Journal of 
Parasitology. 2001; 87: 1095-1103. 
 
Lichtenfels, J.R., Pilitt, P.A., Gibbons, L.M., Hoberg, E.P. Redescriptions of Haemonchus 
mitchelli and Haemonchus okapiae (Nematoda: Trichostrongyloidea) and descriptions of a 
unique synlophe for the Haemonchinae. Journal of Parasitology. 2002; 88: 947-960.  
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McDonnell, A., Love, S., Tait, A., Lichtenfels, J.R. and Matthews, J.B.  Phylogenetic analysis of 
partial mitochondrial cytochrome oxidase C subunit I and large ribosomal RNA sequences and 
nuclear internal transcribed spacer 1 sequences from species of  Cyathostominae and 
Strongylinae (Nematoda, Order Strongylida) parasites of the horse.  Parasitology. 2000; 121: 
649-659.  
 
Murrell, K.D., Lichtenfels, J.R., Zarlenga, D.S. and Pozio, E.  The systematics of the genus 
Trichinella with a key to species. Veterinary Parasitology. 2000; 93: 293-307. 
 
Nadler SA, Hoberg EP, Hudspeth DSS, Rickard LG. Relationships of Nematodirus species and 
Nematodirus battus isolates (Nematoda: Trichostrongyloidea) based on nuclear ribosomal DNA 
sequences. Journal of Parasitology. 2000; 86: 588-601. 
 
Rickard L, Hoberg EP. Reassignment of the genus Lamanema (Nematoda: Trichostrongyloidea) 
from Nematodirinae to Molineinae. Journal of Parasitology. 2000; 86: 647-650. 
 
Santin-Duran M, Alunda JM, de la Fuente C, Rosenthal B, Hoberg EP. Identical ITS-1 and ITS-2 
sequences indicate that Spiculopteragia asymmetrica and S. quadrispiculata (Nematoda: 
Trichostrongylidae) constitute morphologically distinct variants of a single species. Journal of 
Parasitology. 2002; 88: 417-418. 
 
Zamparo D, Brooks DR, Hoberg EP, McLennan, DA. Phylogenetic analysis of the Rhabdoceola 
(Platyhelminthes) with emphasis on the Neodermata and relatives.  Zoologica Scripta. 2001; 30: 
59-77. 
 
Zoonotic Pathogens 
 
Andersen, E.M. and Lichtenfels, J.R. Anisakiasis. In: W.M. Meyers, ed., Pathology of Infectious 
Diseases. Volume I Helminthiases. Armed Forces Inst. Pathology, Washington, DC. 2000. 
529pp.  
 
Hoberg, E.P. Taenia tapeworms: biology, evolution and socioeconomic significance. Microbes 
and Infection. 2002; 4: 859-866. 
 
Hoberg EP, Alkire NL, de Queiroz A, Jones A.  Out of Africa: Origins of the Taenia tapeworms 
in humans. Proceedings Royal Society of London, Series B. 2001; 268: 781-787. 
 
Hoberg EP, Jones A,  Rausch RL, Eom KS, Gardner SL. A Phylogenetic hypothesis for species 
of the genus Taenia (Eucestoda: Cyclophyllidea).  Journal of Parasitology. 2000; 86: 89-98. 
 
Wünschmann A, Garlie V, Averbeck G, Kurtz H, Hoberg EP. Cerebral cysticercosis by Taenia 
crassiceps in a domestic cat. Journal of Veterinary Diagnostic Investigation. 2003; 15: 484-488. 
 
Epidemiology of Disease & Global Climate Change 
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Hoberg EP, Kocan A, Rickard LG. Gastrointestinal strongyles in wild ruminants. In: Parasitic 
Diseases of Wild Mammals. W Samuel, M Pybus and A Kocan (eds). Iowa State University 
Press. 2001; pp. 193-227. 
 
Hoberg, E.P., Kutz, S.J., Cook, J., Galbreath, K. Arctic biodiversity: From discovery to faunal 
baselines - revealing the history of a dynamic ecosystem.Journal of Parasitology. 2003; 89: S84-
S95.  
 
Hoberg EP, Kutz S, Nagy J, Jenkins E, Elkin B, Branigan M, Cooley D. Protostrongylus stilesi 
(Protostrongylidae): Ecological isolation and putative host switching between muskoxen and 
Dall's sheep in a contact zone. Comparative Parasitology. 2002; 69: 1-9. 
 
Kutz SJ, Hoberg EP, Polley L. Emergence of third stage larvae of Umingmakstrongylus 
pallikuukensis from three gastropod intermediate host species. Journal of Parasitology. 2000; 86: 
743-749. 
 
Kutz SJ, Hoberg EP, Polley L. Umingmakstrongylus pallikuukensis (Nematoda: 
Protostrongylidae) in gastropods: Larval morphology, morphometrics, and development rates.  
Journal of Parasitology. 2001; 87: 527-535.  
 
Kutz S, Hoberg EP, Polley L. A new lungworm in muskoxen: An exploration in Arctic 
parasitology. Trends in Parasitology. 2001; 17: 276-280. 
 
Kutz SJ, Hoberg EP, Polley L. Development of Umingmakstrongylus pallikuukensis in a 
gastropod intermediate host under Arctic field conditions. Canadian Journal of Zoology. 2002; 
80: 1977-1985. 
 
Santin-Duran M, Alunda JM, de la Fuente C, Hoberg EP. Onchocercosis in red deer (Cervus 
elaphus) from Spain. Journal of Parasitology. 2001; 87: 1213-1215. 
 
Santin-Duran M, Alunda JM, San Miguel JM, Hoberg EP, de la Fuente C. Elaeophorosis 
in red deer (Cervus elaphus) from central Spain. Journal of Wildlife Diseases. 2000; 36: 
779-782. 
 
Santin-Duran M, Alunda JM, Hoberg EP, de la Fuente C. Abomasal parasites in wild sympatric 
cervids, red deer Cervus elaphus and fallow deer Dama dama, at three locations from Central 
and Western Spain. Journal of Parasitology 2004; 90: In Press. 
 
Emerging, Exotic, Invasive Pathogens 
 
Carreno R, Durden L, Brooks DR, Abrams A, Hoberg EP. Parelaphostrongylus tenuis 
(Nematoda: Protostrongylidae) and other parasites of white-tailed deer (Odocoileus virginianus) 
in Costa Rica. Comparative Parasitology. 2001; 68: 177-184. 
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Kutz SJ, Hoberg EP, Nagy J, Polley L. Emerging parasitic infections in Arctic ungulates. 
American Zoologist. 2004; 44: In Press. 
 
Kutz SJ, Veitch A, Hoberg EP, Elkin B,  Jenkins EJ, Polley L. New host and geographic records 
for the protostrongylid nematodes Protostrongylus stilesi and Parelaphostrongylus odocoilei in 
Dall’s sheep (Ovis dalli dalli). Journal of Wildlife Diseases. 2001; 37: 761-774.  
 
Immunology 
 
Zarlenga, D.S., Boyd, P., Lichtenfels, J.R., Hill, D., Gamble, H.R. Identification and 
characterization of a cDNA sequence encoding a glutamic acid rich protein specifically 
transcribed in Trichinella spiralis newborn larvae and recognized by infected swine serum. 
International Journal for Parasitology. 2002; 32.1361-1370.  
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ABSTRACTS- NP 103 (FY 2000-2004): 
 
(invited abstracts)  
 
Hoberg EP, Schauff M. USDA Collections at the interface of agriculture and the environment. 
Association of Systematics Collections, National Conference. Symposium, Information, 
Technology, and Partnerships: Natural History Collections in the New Millennium. Baltimore, 
Maryland. 13-15 May 2000. 
 
Hoberg EP. Phylogeny, history and biodiversity: Understanding faunal structure and 
biogeography in the marine realm. In: Ecological Parasitology on the Turn of the Millennium. 
Zoological Institute, Russian Academy of Sciences & Scandinavian Society for Parasitology, St. 
Petersburg, Russia. July 2000. 
 
Hoberg EP. Biodiversity and Biogeography: Establishing the context and keystones for Arctic 
parasitology. General Introduction. International Workshop for Arctic Parasitology, Prince 
Albert National Park, Saskatchewan, Canada. October 2000. 
 
Kutz S, Hoberg EP, Polley L. Global warming and host-parasite systems in the Arctic: Should 
we be concerned?  Issues Presentation. International Workshop for Arctic Parasitology, Prince 
Albert National Park, Saskatchewan, Canada. October 2000. 
 
Jenkins E, Hoberg EP, Kutz S, Veitch A, Polley L. Challenges in investigating protostrongylids 
in northern hosts: Parelaphostrongylus odocoilei in Dall’s sheep (Ovis dalli dalli) of northern 
North America. Issues Presentation. International Workshop for Arctic Parasitology, Prince 
Albert National Park, Saskatchewan, Canada. October 2000.  
 
Hoberg EP. Foundations for an integrative parasitology: collections archives and biodiversity 
informatics. In: Symposium- Parasitology in Science and Society. Helminthological Society of 
Washington, 676th Meeting, and Smithsonian Institution, Washington D.C. 27 October 2001. 
 
Cook J, Galbreath K, Runck A, Fedorov V, Hoberg EP. Beringian Coevolution Project: An 
interface between mammalogy and parasitology.  In: Biogeography and Evolution in Northern 
Host-Parasite Systems: A Symposium Honoring Robert L. Rausch and Virginia R. Rausch. 
International Congress of Parasitology X. Vancouver, Canada. 4-9 August 2002. 
 
Hoberg EP. Colonization and diversification: Historical and coevolutionary trajectories among 
cestodes, cetaceans and pinnipeds. In: Symposium for Parasites of Marine Mammals. 
International Congress of Parasitology X. Vancouver, Canada. 4-9 August 2002. 
 
Hoberg EP, Kutz SJ, Cook J. Arctic biodiversity: From discovery to faunal baselines- revealing 
the history of a dynamic ecosystem. SubPlenary Lecture, In: Parasitology and Biodiversity in an 
Age of Discovery. International Congress of Parasitology X. Vancouver, Canada. 4-9 August 
2002. 
 
                                                                                      247 
 
Hoberg EP.  Robert and Virginia Rausch: Fifty years on the frontiers of northern parasitology. 
In: Biogeography and Evolution in Northern Host-Parasite Systems: A Symposium Honoring 
Robert L. Rausch and Virginia R. Rausch. International Congress of Parasitology X. Vancouver, 
Canada. 4-9 August 2002. 
 
Hoberg EP, Alkire N, de Queiroz A, Jones A. Phylogeny of Taenia tapeworms: Insights about 
the origins of species in humans. In: Symposium on Taenia asiatica and cysticercosis. 
International Congress of Parasitology X. Vancouver, Canada. 4-9 August 2002. 
 
Hoberg EP. Hominids, carnivores and Taenia tapeworms: Revealing historical associations for 
parasites and pathogens in humans.In: Biologie des cestodes: recherches actuelles. IIIe Cycle 
Romand en Sciences Biologiques. Muséum d’Histoire naturelle de Geneve. 1-3 October 2002.  
 
Hoberg EP. Old worms in new hosts? Radiation of the Tetrabothriidea in marine birds and 
mammals. In: Biologie des cestodes: recherches actuelles. IIIe Cycle Romand en Sciences 
Biologiques. Muséum d’Histoire naturelle de Geneve. 1-3 October 2002.  
 
Kutz SJ, Hoberg EP.  Stress in the Arctic- Emerging parasitic infections of arctic ungulates. In: 
Biology of the Canadian Arctic: A crucible for change in the 21st Century. Society of Integrative 
and Comparative Biology. Toronto, Canada. 4-9 January 2003. 
 
Jenkins E, Veitch AM, Appleyard GD, Hoberg EP, Kutz SJ, Polley L. Geographic distribution 
and seasonal patterns of larval shedding of the muscle-dwelling nematode Parelaphostrongylus 
odocoilei in thinhorn sheep from northern North America. 15th Annual Arctic Forum, Arctic 
Research Consortium of the United States. 28-29 April 2003. (ARCUS Award for Research 
Excellence- Life Sciences). 
 
Hoberg EP. Collections, archives and informatics: A new synergy for tracking history and 
biodiversity from species to populations. International Workshop for Arctic Parasitology II. 
Arctic Centre, University of Lapland, Rovaniemi, Finland. 1-7 September 2003. 
 
Kutz SJ, Hoberg EP, Nagy J, Elkin B, Veitch A, Jenkins E,  Polley L. Emerging parasitic 
infections and diseases of Arctic ungulates. International Workshop for Arctic Parasitology II. 
Arctic Centre, University of Lapland, Rovaniemi, Finland. 1-7 September 2003. 
Hoberg EP. Tapeworm evolution: Insights on phylogeny and history in the global biosphere. 
Plenary Lecture. International Science Conference, Dedicated to Academician Konstantin 
Ivanovich Skrjabin on the Occasion of His 125th Anniversary. Laboratory of Helminthology, 
Institute of Parasitology, Russian Academy of Sciences. Moscow, 14-16 April 2004. (Abstract 
published; visa denied). 
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(contributed abstracts)  
 
Hoberg EP. Invasive and emerging pathogens: Biodiversity at the interface of agricultural and 
natural ecosystems. Invasive Species Symposium. Agricultural Research Service, Beltsville, 
Maryland. 15 February 2000. 
 
Kutz S, Hoberg EP, Polley L. Parasite biodiversity, development and transmission: An 
integrative model for monitoring climate change at northern latitudes.  12th Northern Wild Sheep 
and Goat Conference, Whitehorse, Yukon Territory, Canada. May 2000. 
 
Kutz S, Veitch A, Hoberg EP, Elkin B, Jenkins E, Polley L. New host and geographic records for 
Protostrongylus stilesi and Parelaphostrongylus odocoilei in Dall’s sheep from the Mackenzie 
Mountains, NWT.  12th Northern Wild Sheep and Goat Conference, Whitehorse, Yukon 
Territory, Canada. May 2000. 
 
Kutz SJ, Hoberg EP, Polley L. A model for investigating the development, transmission, and 
response to climate change of protostrongylid parasites on the Arctic tundra. Wildlife Disease 
Association, Annual Meeting. Jackson, Wyoming. 4-8 June 2000. 
 
Kutz SJ, Veitch A, Jenkins E, Elkin B, Chirino-Trejo M, Hoberg E, Polley L. 
Parelaphostrongylus odocoilei and Protostrongylus stilesi in Dall’s sheep: Predisposing factors 
for mortality? Wildlife Disease Association, Annual Meeting. Jackson, Wyoming. 4-8 June 
2000.  
 
Hoberg EP, Rosenthal B. Biosystematics and faunal assessment of parasites in Holarctic Bovidae 
and Cervidae. International Workshop for Arctic Parasitology, Prince Albert National Park, 
Saskatchewan, Canada. 1-4 October 2000. 
 
Galbreath K, Hoberg EP, Telford S, Cherniavsky F, Kutz S, Duszynski D, Waltari E, Cook J. 
Current status of the Beringian Coevolution Project. International Workshop for Arctic 
Parasitology, Prince Albert National Park, Saskatchewan, Canada. October 2000.  
 
Hoberg EP, Kutz SJ. Arctic biodiversity: baselines, archives and host-parasite systems as a 
window on faunal change. Taxonomy, Systematics, Phylogeny. American Society of 
Parasitologists, 76th Annual Meeting, Albuquerque, New Mexico. June 2001.  
 
Lichtenfels JR, Pilitt PA, Gibbons LM, Hoberg EP. Synlophe pattern differences among species 
of Haemonchus (Nematoda: Trichostrongyloidea).Taxonomy, Systematics, Phylogeny. 
American Society of Parasitologists, 76th Annual Meeting, Albuquerque, New Mexico. June 
2001.  
 
Kutz SJ, Veitch A, Nagy J, Elkin B, Hoberg EP, Jenkins E, Polley L. Contact zones between 
expanding muskoxen populations and Dall’s sheep- An emerging disease issue.13th Biennial 
Northern Wild Sheep and Goat Council Symposium.  Rapid City, South Dakota. April 2002.  
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Jenkins E, Veitch A, Hoberg EP, Kutz SJ, Elkin B, Polley L. Distribution, life cycle and 
significance of Parelaphostrongylus odocoilei in a new host- Thinhorn sheep. 13th Biennial 
Northern Wild Sheep and Goat Council Symposium.  Rapid City, South Dakota. April 2002. 
 
Kutz SJ, Veitch A, Simmons N, Hoberg EP, Elkin B, Jenkins E, Polley L. Parasites in Dall’s 
sheep: What can we learn from historical and contemporary collections (Or: Putting together the 
pieces).13th Biennial Northern Wild Sheep and Goat Council Symposium.  Rapid City, South 
Dakota. April 2002. 
 
Jenkins E, Veitch A, Hoberg EP, Kutz S, Elkin B, Polley L. Life cycle, distribution and 
significance of Parelaphostrongylus odocoilei in thinhorn sheep (Ovis dalli).World Conference 
on Mountain Ungulates III. Zaragosa, Spain. June 2002. 
 
Kutz SJ, Nagy J, Elkin B, Hoberg EP, Wagner B, Polley L. Epidemiology of abomasal parasites 
of muskoxen on Banks Island, Northwest Territories. World Conference on Mountain Ungulates 
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PROJECT OBJECTIVES: 
Neosporosis, caused by Neospora caninum, is a major cause of abortion in cattle, and it also 
causes paralysis in other animals. It is distributed worldwide. Sarcocystis neurona is the most 
important cause of neurologic illness in horses in the United States. The objective of research 
conducted on these parasites include preventing transmission of Neospora to dairy and beef 
cattle, and preventing transmission of S. neurona from opossums to horses. For each parasite, 
understanding their biology and epidemiology will lead to improved control. 
A conservative estimate for losses associated with Neospora-induced abortion in dairy cattle in 
California alone is approximately 35 million dollars annually, not accounting for the cost of 
culling the cows, re-breeding the cows, and loss of milk production. Sarcocystis neurona is the 
most important cause of neurologic disease in horses. It causes over 100 million dollars in annual 
losses to the equine industry. Basic information is needed on the biology and epidemiology of 
these parasites so that control programs based on management or vaccine strategies may be 
designed. This project is related to Animal Health NP 103, Component 2-Pathogen Detection 
and Diagnostics, Component 4-Animal Immunology, Component 5-Mechanisms of Disease, 
Component 7-Epidemiology of Disease, and Component 8-Strategies to Control Infectious and 
Non-infectious Disease. Neospora and Sarcocystis neurona are newly recognized and emerging 
pathogens. This research supports national program priorities for parasites including improved 
pathogen detection, monitoring and surveillance of disease, mechanisms of disease and disease 
prevention and control. 
  
OVERALL PROJECT ACCOMPLISHMENTS: 
Neospora caninum, a major cause of abortion in cattle, was identified and named. Epidemiology 
of N. caninum in dogs and bovines was investigated. Molecular methods have been developed to 
differentiate N. caninum oocysts from oocysts of other coccidian parasites that utilize dogs as the 
definitive host.  This will allow for specific detection of dogs infected with N. caninum and will 
advance the elucidation of the life cycle of the parasite within the dog definitive host.  Molecular 
studies have been conducted to identify strain differences between tissue cysts and tachyzoites of 
N. caninum isolated from different geographic regions.  These studies will determine if 
immunization protocols and detection assays developed from one geographic isolate will be 
useful for isolates from other regions.  Neospora caninum infection was found in dogs even in 
remote areas of the world such as the Amazon, Brazil. Studies have been conducted to determine 
the life cycle and identify stages of the parasite in naturally congenitally infected puppies.  
Neospora caninum was isolated for the first time from an aborted bovine fetus in Portugal and 
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neosporosis was documented as the most important cause of bovine abortion in Portugal. The 
pathogenesis of N. caninum infection and abortion is largely unknown.  Initial studies were 
conducted in pregnant cows inoculated with N. caninum at 110 day of gestation. Studies have 
demonstrated placental invasion of the parasite in infected, pregnant cows.  The placental 
invasion by the parasite and down regulation of cytokines appears to be an important pathogenic 
mechanism.   
 
Diagnostic tests and animal models were developed to screen drugs and vaccines. A reproducible 
model of congenital neosporosis was developed in mice such that female mice infected with the 
parasite during gestation produce offspring that are infected with N. caninum. This mouse model 
reproduces one major clinical feature of neosporosis in cattle and now provides a means of 
testing vaccines against the parasite that may be used to prevent the disease in cattle. Another 
important accomplishment was the complete protection against neosporosis afforded by 
immunization of mice with N. caninum tachyzoite antigen. Complete protection was obtained 
against congenital transfer of Neospora caninum in mice by immunization with plasmid DNA 
coding for a tachyzoite dense granule protein. This result points to studies that may be conducted 
in cattle and possibly reveal individual antigens that may elicit a protective response.  Significant 
protection was elicited against N. caninum-induced abortion in sheep by immunization of ewes 
with native N. caninum tachyzoite antigen emulsified in a proprietary adjuvant. 
 
Sarcocystis neurona, the cause of neurologic diseases in horses and other animals and fatal 
encephalomyelitis in horses was named, cultured, diagnostic tests were developed, and its source 
of infection (the opossum) was identified. The complete life cycle of S. neurona was documented 
in a natural intermediate host, the raccoon. Fatal neurologic S. neurona infection was 
documented in a cat following a routine surgical operation to remove claws suggesting that stress 
can reactivate this disease. The equine model of S. neurona infection in horses was refined which 
results in production of clinical sarcocystosis in the horse.  The development of this model will 
allow studies to determine the biology and progression of infection leading to disease in the 
horse. As few as 100 sporocysts caused clinical sarcocystosis in horses. Methods to kill S. 
neurona sporocysts in the environment were studied and moist heat at 60oC killed sporocysts. 
 
Besnoitiosis is a disease related to sarcocystosis. It causes morbidity and mortality in livestock. 
A new species of Besnoitia oryctofelisi was discovered and its life cycle completed in the 
laboratory. The ultrastructure of Besnoitia stages was studied to aid diagnosis. 
 
IMPACT: 
 
TECHNOLOGY TRANSFER:  
The results of these studies have been presented to a number of local, national, and international 
scientific and industry groups including the American Association of Veterinary Parasitologists, 
the World Association of Veterinary Parasitologists, ARPAS, and other groups. 
 
Reagents and information supplied to drug companies formed the basis for development and 
successful marketing of diagnostic kits and vaccines for neosporosis (for example, Iddex ELISA 
kit for Neospora). 
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Bovine Functional Genomics Laboratory (BFGL) 
 
 
Project Title:   Improving Milk Quality by Reducing Mastitis in Dairy Cattle 
CRIS Number:     1265-32000-065-00D 
Scientists:             Paape, M., Bannerman, D.  
Location:        Animal and Natural Resources Institute, Bovine FunctionaL Genomics 
Laboratory 
Contact:  Paape, M., Phone: (301) 504-8302, Fax: (301) 504-9498, 
mpaape@anri.barc.usda.gov 
 
PROJECT OBJECTIVES: 
Economic loss to the dairy industry due to mastitis can be reduced by enhancing the cow's 
natural defenses to bacterial infection of the mammary gland.  Thus, means of improving the 
cow's natural defenses are urgently needed to minimize the use of antibiotics in preventing 
mammary gland infections.  Widespread use of antibiotics has resulted in the development of 
resistant strains of bacteria which has necessitated periodic development of new more potent 
antibiotics.  This poses the awesome possibility that the time is rapidly approaching when strains 
of bacteria will be produced that are resistant to any and all antibiotics.  The use of antibiotics 
also poses the ever present problem of antibiotic contamination of the milk supply.   
 
The bacteria causing the greatest loss to the dairy industry are Staphylococcus aureus and Gram-
negative species.  Staphylococcus aureus and gram-negative bacteria are ubiquitous in the 
environment and result in 85% of all cases of mastitis.  More importantly once inside the gland 
S. aureus adhere to and penetrate tissues lining the gland to form abscesses that are impervious to 
antibiotics and host defense mechanisms.  This results in chronic cases of mastitis that 
necessitate culling of valuable milking stock.   
 
Infections by Gram-negative bacteria are especially debilitating if contracted soon after calving, 
usually resulting in death of the cow.  Death is due to the failure of the udder to control the 
inflammation caused by endotoxin produced by the rapidly multiplying coliform organisms in 
the milk. It is estimated that 300,000 dairy cows either die or are culled from the herd because of 
acute coliform mastitis.  
 
Current investigations are focused on determining the nature of S. aureus and Gram-negative 
bacteria virulence factors and means of shoring up the animal's defenses to combat them. 
Virulence factors under investigation are: 1) means of entrance of the bacteria into the gland, 2) 
mechanism(s) of avoiding host cellular and humoral defenses and 3) mechanism(s) of adherence 
and penetration into the tissue.  Means of shoring up the animal's defenses to combat bacterial 
infection and neutralization of bacterial toxins under current investigation include: 1) strain 
variation in the various virulence factors, 2) strain distribution in the national herd, 3) 
incorporation of the predominant virulence factors in a vaccine(s), 4) methods of delivery of the 
vaccine(s), 5) immunomodulators to enhance the immune defenses, 6) nutritional factors 
effecting immune function and 7) cloning of genes responsible for neutralization of endotoxin.   
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OVERALL PROJECT ACCOMPLISHMENTS: 
Staphylococcus aureus vaccines currently available are of limited effectiveness because they 
include only 40% of the serotypes identified in the national dairy herd.  A trivalent S. aureus 
vaccine, that covers 100% of the serotypes in the national dairy herd, was used to immunize first 
calf heifers to prevent S. aureus mastitis and was used in conjunction with antibiotics to treat 
chronic S. aureus mastitis infections.  The vaccine was 100% effective in protecting heifers from 
S. aureus infections and 70% effective in curing chronic infections, thus, preventing at the very 
beginning of the cow's productive life.  This vaccine could significantly decrease dairyman's 
losses due to mastitis; to that end it is being tested in commercial herds in Michigan, Maryland 
and North Carolina to cure existing chronic S. aureus infections. 
 
IMPACT: 
 
TECHNOLOGY TRANSFER: 
A phenolic teat dip was developed and shown to be effective in preventing new intramammary 
infections.  This teat dip will be made available to dairymen.  We have shown that treatment of 
beef cows at weaning by intramammary infusion of antibiotics will reduce incidence of mastitis 
and improve calf weaning weights.  Adoption of this technology will increase beef cattlemen's 
profits. 
 
Patents: 
A patent, No. 0108.01, "Use of recombinant bovine CD14 in the treatment and prevention of 
coliform mastitis in dairy cows" was prepared and submitted to the Patent Office through the 
USDA Office of Technology Transfer. 
  
PUBLICATIONS: 
 
Lee, J.-W., Paape, M.J., Elsasser, T.H., Zhao, X. Elevated milk soluble CD14 in bovine 
mammary glands challenged with Escherichia coli Lipopolysaccharide,  Journal of Dairy 
Science. 2003. v. 86. p.2382-2389. 
 
Lee, J.-W., Paape, M.J., Zhao, X. Recombinent bovine soluble CD14 reduces severity of 
experimental Escherichia coli mastitis in mice. Veterinary Research. 2003. v. 34, p. 306-316. 
 
Lee, J.-W., Paape, M.J., Elsasser, T.H., Zhao, X. Recombinant soluble CD14 reduces severity of 
mammary intection by Escherichia coli.  Infection and Immunity. 2003. v. 71. p. 4034-4039 
 
Bannerman, D.D., Goldblum, S.E. Mechanisms of bacterial lipopolysaccharide-induced 
endothelial apoptosis. American Journal of Physiology. 2003. v. 284. p.L899-L914. 
 
Li, X., Tupper, J.C., Bannerman, D.D., Win, R.K., Rhodes, C.J., Harlan, J.M. Phosphoinositide 3 
kinase mediates toll-like receptor 4-induced activation of NF-OB in endothelial cells. Infection 
and Immunity. 2003. v. 71, p. 4414-4420. 
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endothelial apoptosis. Microbial Pathogenesis. 2003. v. 35. p. 87-93. 
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Animal Endocrinology. 2003. v. 22. p. 37-50. 
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Escherichia coli. FASEB Journal. 2003. v. 17. p. A670. 
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Bovine Functional Genomics Laboratory (BFGL) 
 
 
Project Title:   Immunological and Genetic Basis of Resistance to Parasites of Cattle 
CRIS Number:     1265-32000-072-00D 
Scientists:             Gasbarre, L., Zarlenga, D. 
Location:        Animal and Natural Resources Institute,Bovine Functional Genomics 
Laboratory 
Contact:  Gasbarre, L., Phone: (301) 504-8509, Fax: (301) 504-8414, 
lgasbarr@anri.barc.usda.gov 
 
 
PROJECT OBJECTIVES: 
Gastrointestinal (GI) nematode infections cause major losses to the American cattle industry due 
to decreased productivity of infected animals.  Current control procedures are based on the 
repeated administration of anthelmintic drugs to a large proportion of the cattle herd.  Attempts 
to control parasites by pasture management are either ineffective, or are economically unfeasible. 
The alternative to these measures is to use the host immune system to control the intensity of 
parasite infection. Until recently there was little evidence that the bovine immune system was 
capable of limiting the magnitude of infection by GI nematodes.  Studies in our laboratory have 
demonstrated that for most of the nematode species, even a short period of exposure is very 
effective in inducing the bovine immune system to reduce the number of parasites that become 
established in the host.  The major exception to this is Ostertagia ostertagi, but even with this 
species, the immune system effectively reduces parasite transmission by reducing egg output by 
the female worms.  These studies indicate that it is feasible to control nematode infections by 
using the host immune system.  Before this method of control can be implemented a number of 
basic questions must be answered.  At the present time nothing is known concerning the exact 
mechanism that results in resistance to infection.  Similarly, there is a lack of information 
concerning the ability of Ostertagia to evade an immune response that appears to function very 
effectively against the other nematode species.  Recently we have proven that host genetics play 
an important role in determining if individual cattle become immune or not, but as of this date 
little information concerning the genes involved is available.  Finally, there is a complete lack of 
information available concerning the practical use of immunity-based systems in a modern 
production system.  Information in these four areas is necessary for the integration of 
immunologically based control programs into a profitable and sustainable livestock management 
system. 
 
Neosporosis is a parasitic disease primarily of dairy cattle that is caused by the protozoan 
parasite Neospora caninum.  Although the parasite was first described as causing hind-limb 
paralysis in dogs, it is now recognized as a major cause of reproductive failure in cattle 
worldwide.  This research program has the goal of understanding the immunological response to 
N. caninum so that ways of preventing neosporosis in cattle using vaccines or passive 
immunotherapy may be developed. 
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OVERALL PROJECTS ACCOMPLISHMENTS: 
This project began in November of 2001, as such this is the second year of the project.  
Reference to the time line of the project indicates that : 1. QTL for parasite resistance have been 
identified, 2. the microarrays have been at least partially developed ( i.e. more than 400 genes) 
and are being used to define resistant and susceptible cattle, and 3. cDNA libraries from 
Ostertagia have been prepared and are being screen for activity on the host immune system.  
 
IMPACT: 
 
TECHNOLOGY TRANSFER: 
Presented talks to the Ambassador and Secretary of Agriculture of, Brazil on the identification of 
genes affecting disease resistance in cattle.  Presented talk to selected international Veterinary 
students from the Cornell University Leadership program on modern concepts of parasite 
control. 
 
Developed instructional aids for parasite control for beginning dairy and beef grazers .The PCR 
based diagnostic test continues to be used to assess parasite infection in local herds and validate 
the purity of local laboratory strains of parasites. Scientists from Montana have contacted us to 
evaluate the types of parasite infections present on local farms using this test. 
 
PUBLICATIONS: 
 
Wang, Y., Zarlenga, D.S., Paape, M.J., Dahl, G.E. Recombinant bovine CD-14 sensitizes the 
mammary gland to lipopolysaccharide. Journal of Veterinary Immunology and 
Immunopathology. 2002. v. 86. p. 115-124. 
 
Gasbarre, L. C., Stout, W., Soder, K.  Parasites. Beginning Grazier's Notebook, 2002, pp. 32-34. 
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Animal Health Research 
 
Project Title:   Genetic Predisposition of Livestock to Infection by Mucosal Pathogens 
CRIS Number:     5438-32000-023-00D 
Scientists:             Heaton, M., Laegreid, W., Clawson, M.  
Location:        Clay Center, NE, U.S. Meat Animal Research Center, Animal Health 
Research 
Contact:  Heaton,  M., Phone: (402) 762-4362, Fax: (402) 762-4375, 
heaton@email.marc.usda.gov 
 
PROJECT OBJECTIVES: 
Infectious diseases in livestock are a significant source of economic loss and represent a potential 
risk to human health.  Removing animals with the highest risk of disease from the production 
cycle will lead to improved herd health and food safety.  The ultimate goal of livestock genomics 
with regard to animal health is to read an animal's DNA sequence and estimate its risk of 
acquiring or maintaining infections.  Our immediate aim is to evaluate natural genetic variation 
in diverse populations and identify alleles that predispose livestock to infectious diseases.   
Before this can be accomplished, two key issues need to be addressed:  1) the identification of 
nucleotide sequence variation in host genes that play a fundamental role in the infection process 
2) the identification of gene haplotypes that are associated with susceptibility or resistance to 
infectious disease.  Health traits of interest include:  failure of passive transfer in cattle, ovine 
progressive pneumonia, prion disease in cattle sheep and deer, and bovine respiratory disease 
complex.  Our research is designed to address these issues in commercial populations of 
livestock.  As these objectives are achieved for selected candidate genes, new information and 
technology will be developed that will facilitate reading an animal's DNA sequence for 
estimating its risk of acquiring or maintaining infections. 
 
OVERALL PROJECT ACCOMPLISHMENTS: 
Discovery of genetic markers associated with failure of passive transfer (FPT) in new born 
calves.  FPT is a condition in which neonates do not acquire protective serum levels of maternal 
antibodies from their mothers via colostrum.  Calves with FPT are at significant risk for 
morbidity and mortality from infectious disease. The neonatal receptor for the Fc portion of 
immunoglobin, FcRn, is a heterodimer of MHC-1 alpha-chain homolog (encoded by the FCGRT 
locus) and beta-2-microglobulin (encoded by the B2M locus).  This receptor functions both in 
uptake of IgG1 from the neonatal intestine as well as regulating the concentration of 
immunoglobin in the colostrum.  Nucleotide sequence diversity was identified in these gene loci 
in U.S. beef cattle and evaluated for correlation with FPT in neonatal calves.  Specific alleles of 
both FCGRT and B2M genes were found to have significant correlation with low serum levels of 
IgG (odds ratios of 3.8 and 10.6, respectively).  One combination of alleles was found only in 
calves that failed passive transfer.  Moreover, the two markers together accounted for 50% of the 
FPT cases in the study.  Thus, these alleles represent potentially useful DNA markers for 
managing genetic risk of FPT. 
 
Identification of new prion gene variation in cattle, sheep, and deer and development of accurate 
DNA tests for scrapie resistance.  Prion gene (PRNP) variation has been well correlated with 
susceptibility to TSEs in humans, sheep, and rodents.  Similar correlations have not yet been 
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reported in cattle or deer;  however characterization of PRNP nucleotide diversity in those 
species is incomplete.  We hypothesized that there is unrecognized and important nucleotide 
variation in the prion genes of cattle and deer that may influence TSE susceptibility.  To test this, 
the complete PRNP coding region and a portion of PRNP promoter were sequenced in diverse 
groups of U.S. beef cattle, white-tailed and mule deer, and U.S. sheep.  Sequence comparisons 
identified a total of 54 new  polymorphisms.  This allowed us to design the most accurate and 
efficient DNA tests for scrapie resistance in sheep. 
 
Developed the first set of bovine single nucleotide polymorphism (SNP) markers for animal 
identification, parentage, and traceback in cattle.  To identify SNP markers that would be 
appropriate for genetic testing in commercial populations, we designed and assembled two 
panels of genomic DNA:  one from 96 sires from 17 breeds that represent the breadth and 
composition of cattle germ plasm used in the U.S. beef industry, and another from a panel of 192 
purebred American Angus from seven herds in four Midwestern states.  These two panels were 
used to identify and test SNP markers for determining the genetic identity and kinship of an 
animal.  We identified a select set of 32 highly informative SNP markers distributed among 18 
autosomes and both sex chromosomes.  These DNA markers were used in confirming the 
country of origin for the Holstein cow in Washington State that tested positive for BSE on 
December 23, 2003.   There are now more than 45 SNPs in this collection. 
 
Development of essential tools and information for large-scale automated SNP discovery and 
genotyping in beef cattle.  Dissection of complex traits in cattle from commercial populations 
will require the ability to genotype large numbers of animals and an abundant supply of validated 
DNA markers specific for candidate genes.  SNP markers are a potential resource for analyzing 
complex traits because of their high frequency, low mutation rates, and amenability to automated 
analysis.  We reported more than 45 SNPs markers and 40 haplotype structures in 9 bovine 
cytokine genes.  Moreover, matrix-assisted laser desorption/ionization time-of-flight mass 
spectrometry (MALDI-TOF MS) was demonstrated as a leading technology for livestock SNP 
genotyping.    
 
Expression, genetic mapping, and haplotyping of bovine genes induced by Escherichia coli 
O157H7.   A potential method for reducing the impact of infectious disease in livestock is to 
increase the host genetic resistance to infection.  The first line of defense against enteric 
infections are the epithelial mucosa and the immune mechanisms activated by contact with 
bacterial envelopes.  This contact initiates responses leading to local inflamation and the eventual 
clearance of infection.  We identified and mapped two bovine genes that were differentially 
expressed in bovine epithelial cells during an inflammatory response to E. coli O157H7.  These 
genes, interleukin (IL) 8 and epithelial cell inflammatory protein (ECIP)-1, were both members 
of the C-X-C chemokine family, a group of proteins that play a pivotal role in mobilizing 
inflammatory cells in response to infectious challenges.  The ECIP1 gene had not previously 
been identified in any species and is thought to represent a novel chemokine induced by E. coli 
O157:H7.  In subsequent research, we defined the IL8 haplotype structure in U.S. beef cattle and 
estimated the ancestral allele. 
IMPACT: 
An important application of disease research and DNA marker technology is the identification of 
individuals with the highest risk for infectious disease and traceback of diseased animals.  Our 
research has provided more than 300 single nucleotide polymorphisms (SNP) markers and assays 
to distinguish between nucleotide sequence variants of candidate genes in popular breeds of U.S. 
cattle, sheep, and deer.  These DNA markers have been placed in the public domain and 
transferred to more than 40 companies and institutions in more than 19 countries.  The markers 
have facilitated the identification of genotype/phenotype associations and ultimately allowed 
prediction of an individual’s genetic predisposition for infection from its DNA sequence.  All of 
these markers are available for use without restriction. 
 
During the Washington State BSE, a collection of these DNA markers were used to confirm the 
Canadian origin of the BSE index case.  This DNA testing result coincided with the recovery of 
live cattle markets.  During the market drop, losses due to BSE was estimated at $10 M per day.  
 
FPT is a serious problem in beef and dairy cattle and has both environmental and genetic 
influences.  The two publications resulting from this research represent the first use of SNP 
markers and genetic epidemiology in cattle health traits and provide a road map for future 
execution of related studies.  
 
TECHNOLOGY TRANSFER:  
Bovine SNP markers and assay designs for determining identity and parentage have been 
transferred to several commercial entities for general use in the cattle industry. This has been 
accomplished through peer-reviewed scientific publications, deposition of information in 
GenBank at NCBI, a Specific Cooperative Agreement (SCA), and a Cooperative Research and 
Development Agreement (CRADA). At least two privately held companies have already placed 
their version of these cattle DNA tests in the hands of their customers. At least one large 
commercial ranch in Texas has already made use of these tests for animal ID and parentage. At 
least four European and Asian countries have requested the publically available SNP markers 
and assay design. 
 
SNP markers and assay design for prions genes in U.S. sheep, cattle, and deer have also been 
transferred to several commercial genotyping companies and diagnostic labs for general use. Our 
sheep prion genoytping assays are being used commercially in the national scrapie eradication 
program. The cattle and deer information will likely be used in the epidemiology of bovine 
spongiform encephalopathy (BSE) and chronic wasting disease (CWD), respectively.  
 
PUBLICATIONS: 
 
Clawson, M. L., M. P. Heaton, C. G. Chitko-McKown, J. M. Fox, T. P. L. Smith, W. M. 
Snelling, J. W. Keele, and W. W. Laegreid.  2004.  Male-specific SRY and ZFY haplotypes in 
U.S. beef cattle.  Animal Genetics 35:246-249. 
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Clawson, M. L., M. P. Heaton, C. G. Chitko-McKown, J. M. Fox, T. P. L. Smith, W. M. 
Snelling, J. W. Keele, and W. W. Laegreid.  2004.  Beta-2-microglobulin haplotypes in U.S. beef 
cattle and association with failure of passive transfer in newborn calves.  Mamm. Genome. 
15:227-236. 
 
Heaton MP, Leymaster KA, Freking BA, Hawk DA, Smith TPL, Keele JW, Snelling WM, Fox 
JM, Chitko-McKown CG, Laegreid WW.  2003.  Prion gene sequence variation within diverse 
groups of U.S. sheep, beef cattle, and deer.  Mamm. Genome 14:765-777. 
 
Laegreid WW, Heaton MP, Keen JE, Grosse WM, Chitko-McKown CG, Smith TPL, Keele JW, 
Bennett GL, Besser TE.  2002.  Association of bovine neonatal Fc receptor alpha-chain gene 
(FCGRT) haplotypes with serum IgG concentration in newborn calves.  Mamm. Genome 13:1-7. 
 
M. P. Heaton, G.  P. Harhay, G. L. Bennett, R. T. Stone, W. M Grosse, E. Casas, J. W. Keele, T. 
P.L. Smith, C. G. Chitko-McKown, W. W. Laegreid.  2002.   Selection and use of SNP markers 
for identification and paternity analysis in U.S. beef cattle.  Mamm. Genome 13:272-281. 
 
Page, B. T., E. Casas, M. P. Heaton, N. G. Cullen, D. L. Hyndman, C. A. Morris, A. M. 
Crawford, T. L. Wheeler, M. Koohmaraie, J. W. Keele, and T. P. L. Smith.  2002.  Evaluation of 
single-necleotide polymorphisms in CAPN1 for association with meat tenderness in cattle.  J. 
Anim. Sci. 80:3077-3085. 
 
Heaton, M.P., C.G. McKown, W.M. Grosse, J.E. Keen, and W.W. Laegreid. 2001.  Interleukin-8 
haplotype structure from nucleotide sequence variation in commercial populations of US cattle.  
Mamm. Genome.  12:219-225. 
 
Smith, T.P.L., W.M. Grosse, B.A. Freking, A.J. Roberts, R.T. Stone, E. Casas, J.E. Wray, J. 
White, J. Cho, S.C. Fahrenkrug, G.A. Bennett, M. P. Heaton, W.W. Laegreid, G.A. Rohrer, C.G. 
Chitko-McKown, G. Pertea, I. Holt, S. Karamycheva, F. Liang, J. Quackenbush, J.W. Keele. 
2001. Sequence evaluation of four pooled-tissue normalized bovine cDNA libraries and 
construction of a gene index for cattle.  Genome Res. 11:626-630. 
 
Heaton, M.P., W.M. Grosse, S.M. Kappes, J.W. Keele, C.G. Chitko-McKown, L.V. Cundiff, A. 
Braun, D.P. Little and W.W. Laegreid.  2001. Estimation of DNA sequence diversity in bovine 
cytokine genes.  Mamm. Genome.  12:32-37. 
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Animal Health Research 
 
Project Title:   Host Response and Antigenic Variation of Respiratory Viral  
Agents of Livestock 
CRIS Number:     5438-32000-024-00D 
Scientists:             Fox, J., Heaton, M., Vacant 
Location:        Clay Center, NE, U.S. Meat Animal Research Center, Animal Health 
Research 
Contact: Fox, J., Phone: (402) 762-4392, Fax: (402) 762-4375, 
fox@email.marc.usda.gov 
 
 
PROJECT OBJECTIVES: 
Respiratory viral infections caused by arteriviruses and paramyxoviruses result in significant 
economic losses in the livestock industry worldwide. For example, Porcine Reproductive and 
Respiratory Syndrome Virus (PRRSV) infections within the U.S. account for up to 15-20% of 
the economic losses yearly in the swine industry. Such economic losses from respiratory viral 
infections result from direct mortality, reduced production efficiency, and treatment/prevention 
costs to combat infection. In addition, many of the respiratory bacterial infections present in 
livestock result from impairment of pulmonary defense mechanisms by respiratory viral 
infections. Bacterial pneumonias can result in severe losses in production, be costly to treat, and, 
in some cases, persist for long periods of time. Reducing the incidence of respiratory viral 
infections will not only improve production efficiency normally lost to the viral diseases, but will 
also significantly reduce the incidence of bacterial pneumonia and losses that result from these 
infections. There is limited information known about the host cell response to infection by these 
viral agents. Examining this response is necessary to gain a better understanding of the dynamics 
of the virus-to-cell interactions. The development of better vaccines will be dependent upon a 
more comprehensive understanding of the virus-to-host interactions and how they effect disease 
expression. 
  
OVERALL PROJECT ACCOMPLISHMENTS: 
The development of the MARC-145 cells line is perhaps the single largest accomplishment of 
this project.  This cell line is currently utilized world-wide for the in vitro propagation of 
PRRSV.  In addition, significant progress has been made on analysis of PRRSV in populations 
of swine.  Recombinant antigens have been developed and immunity to individual PRRSV 
proteins evaluated in sera from naturally infected swine from around the country.  Furthermore, 
these antigens have been used to investigate the differences in immune responses over time in 
swine persistently infected with PRRSV.  In combination with sequence analysis of a number of 
PRRSV isolates, this work will result in an understanding of the host-virus interaction in the 
field.  Preliminary data from these studies has indicated which viral genes are responsible for 
induction of a protective immune response to PRRSV and the relevant genes cloned into vectors 
for use as vaccine candidates.  In addition, we have demonstrated that antibody alone is 
sufficient to protect against PRRSv infection in the pregnant sow model.  Using molecular 
genomic approaches we have examined the host cell response to infection.  Over 100 genes have 
been identified whose mRNA abundance is altered as a result of PRRSV infection.  Interestingly, 
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as important as those responsive genes identified, are a number of genes that are not responsive 
to PRRSV infection but would be expected to respond.  Within these genes are those belonging 
to the Type I interferon response to infection.  We have shown that PRRSV specifically 
interferes with the Type I interferon response resulting in little to no change in Type I interferon 
levels produced by infected cells.  This may have broad implications on the delayed immune 
response to PRRSV infection.  Further understanding and characterization of this phenomenon 
may lead to the design of vaccine delivery systems that will better trigger the innate immune 
response. 
 
IMPACT: 
 
TECHNOLOGY TRANSFER: 
PRRSV sequence data has been submitted to GenBank for public access. Cultures of MARC-145 
cells were distributed to several investigators. 
 
PUBLICATIONS: 
 
Allende R., Laegreid W.W., Kutish G.F., Galeota J.A., Wills R.W., Osorio F.A. (2000) Porcine 
reproductive and respiratory syndrome virus: description of persistence in individual pigs upon 
experimental infection. J Virol 74: 10834-7. 
 
Allende R., Kutish G.F., Laegreid W.W., Lu Z., Lewis T.L., Rock D.L., Friesen J., Galeota J.A., 
Doster A.R., Osorio FA. (2000) Mutations in the genome of porcine reproductive and respiratory 
syndrome virus responsible for the attenuation phenotype. Arch Virol 145: 1149-61. 
 
Osorio F.A., Galeota J.A., Nelson E., Brodersen B., Doster A., Wills R., Zuckermann F., 
Laegreid W.W.  (2002) Passive transfer of virus-specific antibodies confers protection against 
reproductive failure induced by a virulent strain of porcine reproductive and respiratory 
syndrome virus and establishes sterilizing immunity. Virology 302: 9-20. 
 
Miller, L. C., Laegreid, W. W., Bono, J. L., Chitko-McKown, C. G., and Fox, J. M. (2004) 
Interferon Type I response in porcine reproductive and respiratory syndrome virus-infected 
MARC-145 cells. Arch Virol (in press). 
 
Miller, L. C. and Fox, J. M. (2004) Apoptosis and porcine reproductive and respiratory syndrome 
virus. Vet. Immunol. and Immunopath. (in press).  
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PROJECTS 
 
Arthropod-Borne Animal Diseases Research 
• Vector Competence and Protection of U.S. Livestock and Wildlife from Arthropod-Borne 
Diseases 
• Molecular Biology and Pathogenesis of Arboviruses 
• Development and Validation of Rapid Field Deployable Genetic Tests for Vesicular 
Stomatitis Virus 
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Arthropod-Borne Animal Diseases Research Projects 
 
Project Title:   Vector Competence and Protection of U.S. Livestock and  
Wildlife from Arthropod-Borne Diseases 
CRIS Number:     5410-32000-010-00D 
Scientists:             Schmidtmann, E., Drolet, B., Mecham, J., Wilson, W., Letchworth III, G., 
Mayer, R. 
Location:         Laramie, WY, Arthropod-Borne Animal Diseases Research 
Contact: Schmidtmann, E., Phone: (307) 766-3630, Fax: (307) 766-3500, 
eschm@uwyo.edu 
 
PROJECT OBJECTIVES: 
Project 5410-3200-010-00D.  
 
Certain blood-feeding insects efficiently transmit several indigenous and exotic disease-causing 
viruses that adversely affect the economy of the U.S. livestock industry.  The emergence of West 
Nile virus (WNV) in the U.S. clearly demonstrates that exotic insect-transmitted pathogens can 
be imported and become established.  The intentional or un-intentional importation of mosquito-
transmitted Rift Valley Fever Virus would cause far more catastrophic human and animal loses 
than did WNV.  Therefore, the overall goal of this project is to develop knowledge and tools to 
protect US livestock from current and potential insect-transmitted pathogens. 
 
Bluetongue, epizootic hemorrhagic disease, vesicular stomatitis, and West Nile viruses account 
for acute and chronic production-related losses among U.S. livestock. Of greater economic 
concern in the global economy of the 21st Century, these insect-transmitted diseases trigger non-
tariff trade barrier restrictions that limit export sales of U.S. livestock and their germplasm. The 
key role that insects play as vectors of viral pathogens is a product of: 1) insect blood-feeding on 
host animals as the primary mode of arbovirus transmission in nature; 2) insects as a source of 
virus amplification and maintenance; and 3) the seasonal incidence and geographical distribution 
of risk for host exposure.  
 
Research conducted under this CRIS project will benefit U.S. agriculture by providing a better 
understanding of: 1) the molecular mechanisms that regulate the competence of insects that 
transmit pathogenic viruses, and 2) the environmental factors that determine vector population 
distribution and abundance.  This research opportunity is optimised by the availability of recent 
molecular and computer-aided data processing and methods that provide insights and capabilities 
that were previously unavailable. Information developed through this research will benefit U.S. 
livestock commodities by strengthening the rural economy, providing a continued supply of 
inexpensive, wholesome food products for the American consumer, as well as promoting the 
profitability and international competitiveness of livestock products.  Proposed research will 
support the development of novel strategies for controlling the vector, or its vector competence, 
as well as provide a basis for scientifically-based domestic and international trade regulations 
that protect U.S. livestock from the continuous threat of indigenous, exotic, and emerging insect-
borne diseases. 
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OVERALL PROJECT ACCOMPLISHMENTS: 
On the basis of ABADRL field and laboratory research, the biting midge, Culicoides sonorensis, 
has been implicated as the primary, proven vector of bluetongue viruses in the U. S.   
 
Evidence developed by the ABADRL also established that the northeast U.S. is bluetongue-free 
because it is outside the range of C. sonorensis.  The population genetics of the C. variipennis 
complex in North America was investigated, and resulted in a taxonomic revision (i.e. current 
subspecies were elevated to three species).  It was demonstrated that levels and types of 
dissolved salts in larval habitats differ among aquatic habitats occupied by the three species of 
the complex. This finding opens the way for large-scale mapping and prediction of C. sonorensis 
using computer-based GIS methods.  The demonstration of bluetongue-free regions of the U.S. 
has resulted in a relaxation of export regulations, thus improving the competitiveness of U.S. 
livestock and livestock germplasm in world markets.  Research that utilizes the genetic markers 
and cloned genes produced by the ABADRL will increase our understanding at the molecular 
level of the vector competence of C. sonorensis for bluetongue and epizootic hemorrhagic 
disease viruses.  Reducing the impact of existing arthropod-borne pathogens and protecting U.S. 
animal agriculture from new and emerging animal pathogens is dependent on this research.   
 
Recent ABADRL research identified a non-hematophagous insect (grasshopper) as a potential 
source of infection and maintenance reservoir of vesicular stomatitis virus.  This study 
demonstrated that VSV replicates in grasshoppers and can spread between grasshoppers and 
cattle, which may lead to better understanding the epidemiology of sporadic outbreaks of VSV 
among western livestock. Analysis of the distribution of the sand fly, Lutzomyia apache, in the 
mid-Rio Grande River Valley, New Mexico, using geographic information system methods 
indicates a potential role for this sand fly in the epidemiology of VS viruses in the southwestern 
U.S. 
  
IMPACT: 
ABADRL research has established the northeast US as a bluetongue-free region, resulting in a 
relaxation of export regulations, thus improving the competitiveness of U.S. livestock and 
livestock germplasm in world markets.  
  
The ABADRL has established an Insect Vector Genomics program that has increased  
understanding of the genetic components that affect the ability of insects to be disease vectors 
(vector capacity) and will help predict the risk of pathogen transmission.  
 
ABADRL’s investigations of the role of the potential of VSV transmission by several insect 
species have suggested new paradigms for the epidemiology of VSV. 
 
TECHNOLOGY TRANSFER: 
Technology transfer may be expected of the VSV-specific IHC assay in the future.  If a VSV 
outbreak occurs, the clinical similarity between VSV and foot and mouth disease will require 
rapid virus specific assays that can differentiate the two viruses.  In some cases, the incriminating 
positive cell culture results will have already been fixed and stained, destroying the live sample. 
The IHC assay can confirm CPE as VSV-specific after live samples have been destroyed, and 
therefore will be a valuable tool.  The assay is ready for use in VSV-infected cell cultures. The 
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use of synthetic pyrethroid insecticides as repellents for application to livestock has been 
transferred via verbal and written communication to horse owners, veterinarians and 
entomologists concerned about protecting animals from West Nile virus. Control methods for 
larval stages of C. sonorensis have been transferred to white-tailed deer farmers who have used 
the recommendations to prevent annual deer die-offs from biting midge-transmitted viruses. The 
results of the multi-state Bluetongue Surveillance Pilot study have been reported to participating 
producers and veterinary associations; this information will be useful in the formulation of 
regulations concerning export of U.S. cattle to bluetongue-free countries. Information concerning 
the presence and seasonal abundance of Culex tarsalis, the primary vector of West Nile virus in 
the western U.S., has been transferred to state and county level personnel concerned with public 
health and mosquito control, as well as coal bed methane gas developers whose well drilling 
activities produce impoundments that support mosquito larval development. 
 
Cooperative Research Projects have been initiated with the Department of Molecular Biology, 
University of Wyoming; and the Department of Microbiology, Immunology and Pathology, 
Colorado State University. 
  
ABSTRACTS: 
Nunamaker, R.A., Lockwood, J.A., Stith, C.E., Campbell, C.L., Schell, S.P., Drolet, B.S., Wilson, 
W.C., White, D.M. and Letchworth. G.J.  Are grasshoppers a source for vesicular stomatitis virus?  
The ESA Annual Meeting: An Entomological Odyssey of ESA San Diego, CA December, 2001. 
 
Lockwood, J.A., Nunamaker, R.A., Stith, C. E., Campbell, C.L., Schell, S.P., Drolet, B.S., Wilson, 
W.C., White, D.M. and Letchworth. G.J.  Grasshoppers as vectors and reservoirs of vesicular 
stomatitis. The ESA Annual Meeting: An Entomological Odyssey of ESA, November, 2002. 
   
Campbell, C.L., McNulty, M.J., Letchworth, G.J. and Wilson, W.C.  Molecular Investigations of 
virus/vector interactions. OIE Symposium on Bluetongue Virus. Taormina, Italy, 2003. Abs. #B37, 
pg 77. October, 2004 
 
Letchworth, G.J., Nunamaker, R.A., Stith, C.E., Campbell, C.L., Schell, S.P., Drolet, B.S., Wilson, 
W.C. and White, D.M.  Grasshoppers as vectors and reservoirs of vesicular stomatitis. Poster. Rocky 
Mountain Virology Club Meeting, Pingree Park, CO, September, 2003. 
 
Campbell, C.L., VanDyke, K.A., Mummey, D.L., McNulty, M.J., Letchworth, G.J. and Wilson, 
W.C. Functional genomics of vector competence in the arbovirus vector, Culicoides. Keystone 
Symposium, “Genetic Manipulations of Insects”, February, 2004, Taos, NM. 
 
Campbell, C.L., Vandyke, K.A., Letchworth, G.J., Drolet, B.S. and Wilson, W.C. Culicoides gene 
discovery project reveals putative pharmacological factors in midge saliva. Entomological Society of 
America annual meeting, Salt Lake City, UT, November, 2004. 
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PUBLICATIONS: 
 
Campbell, C.L. and Wilson, W.C.  2002. Differentially expressed midgut transcripts in 
Culicoides sonorensis (Diptera: Ceratopogonidae) following Orbivirus (Reoviridae) oral feeding. 
Insect Mol. Biol. 11:595-604. 
 
O'Toole, D., Perez de Leon, A.A., Hearne, C., McHolland, L., Yun, L. Tabachnick. W.J. 2003. 
Papular dermatitis induced in guinea pigs by the biting midge Culicoides sonorensis (Diptera:  
Ceratopogonidae). J.Vet. Diagn. Invest. 15:67-71. 
 
Drolet, B.S., Campbell, C.L. and Mecham, J.O.  2003. Protect yourself and your sample: Processing 
arbovirus infected biting midges for viral detection assays and differential expression studies. In, J. 
Richmond (ed.), Anthology of Biosafety: Arthropod-Borne Diseases, Chapter 5, pp. 53-62. 
 
Nunamaker, R.A., Lockwood, J.A., Stith, C.E., Campbell, C.L., Schell, S.P., Drolet, B.S., Wilson, 
W.C., White, D.M. and Letchworth, G.J.  2003.  Grasshoppers can serve as reservoirs and vectors of 
vesicular stomatitis virus. J. Med. Ent. 40:957-963. 
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Arthropod-Borne Animal Diseases Research 
 
Project Title:   Molecular Biology and Pathogenesis of Arboviruses 
CRIS Number:     5410-32000-011-00D 
Scientists:             Mecham, J., Drolet, B., Wilson, W. Letchworth III, G., Schmidtmann, E., 
Mayer, R. 
Location:         Laramie, WY, Arthropod-Borne Animal Diseases Research 
Contact:  Mecham, J., Phone: (307) 766-3620, Fax: (307) 766-3500, 
jmecham@uwyo.edu 
 
PROJECT OBJECTIVES: 
Project 5410-32000-011-00D. 
 
Arthropod-borne viruses (arboviruses) are important pathogens of livestock and have a 
significant impact on the U.S. livestock industry.  These viruses have a complex life cycle and 
infect both vertebrate and invertebrate hosts.  The proposed research will delineate viral and host 
characteristics important in the infection cycle, epidemiology, and pathogenesis of these viruses.  
This information will provide the basis for the development of more effective diagnostics and 
novel control strategies. The Arthropod-Borne Animal Diseases Research Laboratory is 
developing the tools necessary to diagnose, control and asses risk of insect-transmitted pathogens 
of current concern to US livestock industry; however, the technology developed could be rapidly 
adapted to respond to emerging disease concerns. 
 
Specifically, the differences in replication of BTV and EHDV in vertebrate and invertebrate 
hosts are not well understood.  Research to determine the mechanisms of replication of these 
viruses in these different hosts may reveal weaknesses that can be used to develop unique control 
strategies or improved vaccines.  BTV and EHDV undergo genetic mutation and reassortment to 
give rise to new viral strains.  Investigating the genetic relationships and evolution of these 
orbiviruses will provide more information on the epidemiology of disease and assist with 
development of improved diagnostics and control strategies.  Such information will aid the 
development of rapid, field deployable diagnostic tests for the detection of viral antibody, viral 
particles, viral antigens, and viral nucleic acids.  The pathogenesis of epizootic hemorrhagic 
disease virus (EHDV) infection in cattle is not well understood.  Research will determine if the 
difference in EHDV virulence between cattle and deer is related to endothelial cell tropism and 
the effect on the fetus of EHDV infection in pregnant cattle.  Effective control of infections 
caused by BTV and EHDV requires sensitive and specific diagnostics.  Epizootics caused by 
West Nile and vesicular stomatitis viruses have resulted in significant morbidity and mortality in 
the equine and bovine industries. At present there is no vaccine for VSV and only a provisionally 
licensed killed vaccine for WNV.  The development and evaluation of vaccines for both these 
viruses is proposed.  Monitoring of West Nile Virus infected mosquitoes is necessary for 
effective vector control.  Current WNV surveillance measures are time consuming and costly due 
to manual mosquito sorting and a two-step diagnostic procedure (RNA isolation and RT-PCR).  
This laboratory is developing a diagnostic procedure, based on RNA capture that will eliminate 
the above steps and can be coupled with mosquito species-specific markers.  The dual 
determination of mosquito species and presence or absence of WNV should expedite WNV 
surveillance and also serve as a model system for other arboviruses. 
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OVERALL PROJECT ACCOMPLISHMENTS: 
Project 5410-32000-011-00D.  
 
ABADRL research has laid the foundation for the development of diagnostic tests and control 
strategies for arboviruses.  Prior research yielded information on the molecular characteristics of 
BTV, EHDV, WNV and VSV and a greater understanding of the evolutionary relationships of 
members of these virus groups, viral characteristics associated with virulence and pathogenesis, 
replication in both invertebrate vectors and vertebrate hosts, and the immune response of the 
vertebrate host following viral infection. Genetic studies produced epidemiological information 
relating to the evolution and movement of the BTV and EHDV serogroups.  Genetic and protein 
characterization of BTV and EHDV led to the identification and characterization of the BTV 
protein (VP7) that is important in infection of the Culicoides vector and the development of both 
gene-based and antibody-based diagnostic procedures with increased sensitivity and specificity. 
The function of different viral proteins in neutralization, virulence and pathogenesis was 
investigated and described.  Genes from BTV, EHDV, VSV, and WNV were cloned into 
expression vectors capable of infecting various cells.  Methods were developed to increase the 
expression of specific viral proteins.  These vectors and the expressed proteins will be used in 
DNA vaccine trials, as recombinant vaccines as a source of antigen for the development of 
diagnostic assays, and as tools to analyze steps in viral replication in both vertebrate and 
invertebrate hosts.  A number of cell lines were developed and identified for studying BTV, 
EHDV and VSV replication.   Culicoides sonorensis cell lines from colony and field populations 
were developed and characterized.  Vector cell lines are essential tools in dissection of vector-
virus interactions.  Cell lines were identified that do not support productive infection of BTV, 
and are being used to elucidate the steps of virus replication in vertebrate cells.  Genes from an 
equine isolate of WNV have been cloned and are being used as standards for the development of 
diagnostic reagents and for recombinant vaccines.  The ABADRL participated in a collaborative 
study with Colorado State University and the Centers for Disease Control in Fort Collins that 
indicated there is little risk that horses infected with West Nile virus can transmit virus back to 
mosquitoes. 
 
The role of C. sonorensis as a vector of VSV has been examined in the laboratory using 
procedures, such as immunohistochemistry, which show that VSV passes through both the 
midgut and salivary barriers, and thus infected insects may be competent biologic vectors.  The 
presence of VSV in the eggs suggests that VSV may transfer vertically from females to their 
offspring.  Both RT-PCR and in situ hybridization assays were used to confirm VSV replication 
in the virus fed insects.   
 
The role of Culicoides saliva in arboviral infections is not known.  ABADRL scientists initiated 
experiments to determine whether Culicoides saliva had an effect on the ability of VSV to 
establish an infection in horse skin cells. Viral infection increased with increasing amounts of 
insect saliva, potentiating the infection. 
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IMPACT: 
ABADRL has developed several immunological or genetic based diagnostic tests or 
modifications of these assays that are used worldwide.  Some of these assays are available 
commercially.  These test are rapid, sensitive and have been used to set the diagnostic standards 
for international trade requirements. 
 
Information produced by the ABADRL on the pathogensis of arboviral diseases has been used in 
risk assessment and in international trade negotiations. 
 
ABADRL scientists are sought nationally and internationally for scientific advice on diagnosis, 
control and monitoring of emerging and indigenous insect-transmitted pathogens.  
 
TECHNOLOGY TRANSFER (Recent): 
Antibodies, PCR reagents and diagnostic protocols have been provided to researchers and 
diagnosticians in the U.S. and in several foreign countries. 
 
A competitive enzyme-linked immunosorbent assay for detection of antibody to epizootic 
hemorrhagic disease virus developed at the ABADRL has been transferred to the NVSL, Ames, 
IA for further testing and validation. 
 
Culicoides sonorensis cell lines were distributed to researchers in the U.S. for isolation and 
characterization of arboviruses. 
  
Cooperative agreements were established with the Wyoming Agriculture Department, the 
Wyoming Game and Fish Department, the Wyoming Public Health Department were 
established, the University of Wyoming School of Pharmacy, the University of Wyoming GIS 
center, and  with Dow Agrosciences. 
 
Collaborations continued or were developed with the University of Wyoming, the University of 
California, Davis, and with Louisiana State University. 
 
Reviews of research at the ABADRL and modern detection methods for bluetongue, epizootic 
hemorrhagic and vesicular stomatitis disease viruses was presented to National Cattlemen, 
Wyoming Stockgrowers Association/Wyoming Woolgrowers Association Wyoming Wool 
Growers representatives, National Quarantine Instititute, Qindao China, and the U.S. Armed 
Forces Research Institute for Infectious Diseases.  Most of this technology is available to 
industry partners and new methods are currently being validated. 
 
Research information was presented at meetings of the OIE Symposium for bluetongue virus, 
U.S. Animal Health Association Meeting, American Society for Virology Meeting, Keystone 
symposium, Colorado State University’s Infectious Diseases Colloquium and the Rocky 
Mountain Virology Club Meeting. 
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Arthropod-Borne Animal Diseases Research 
 
Project Title:   Development and Validation of Rapid Field Deployable Genetic Tests for  
Vesicular Stomatitis Virus 
CRIS Number:     5410-32000-012-00X 
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                        Arthropod-Borne Animal Diseases Research 
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wcwilson@uwyo.edu 
 
PROJECT OBJECTIVES: 
The objectives of this research project are to: 1) generate basic epidemiological information 
about vesicular stomatitis virus (VSV) occurrence in endemic areas in southern Mexico and 
Costa Rica for development and design of field validation study; 2) perform field validation of 
VSV rapid diagnostic tests in well-documented infected and non-infected cattle herds in Mexico 
and Costa Rica. 
 
The approach will include the establishment of sentinel herds in selected areas of southern 
Mexico and Costa Rica with various levels of documented clinical VS activity.  Basic 
information about previous history of clinical disease will be collected at the beginning of the 
study in order to determine the historical occurrence of VSV at each farm.  Rapid diagnostic tests 
developed at Plum Island Animal Disease Center (PIADC) and Arthropod-borne Animal 
Diseases Research Laboratory (ABADRL) will be evaluated in laboratory.  The most promising 
tests will then be validated in the field.  Collaborative teams will carry out rapid diagnostic tests 
in the field during periods of high VSV activity previously identified by this study.  Viruses from 
clinical cases as well as environmental or arthropod samples will be genetically characterized at 
PIADC and ABADRL. 
 
OVERALL PROJECT ACCOMPLISHMENTS: 
This project was supported by one-time funding from Homeland Security and was initiated in 
2003.  Clinical samples were collect from endemic area in Mexico and Central America.  Over 
600 of these samples were processed for VI with immuno-histochemistry verification and rapid 
real-time PCR.  One group of samples was missed by the real-time PCR.  Sequence analysis of 
the virus from these samples was used to modify the real-time PCR.  The final validation has 
been delayed due to facilities failures at the ABADRL. 
  
IMPACT: 
The potential for introduction or emergence of indigenous insect transmitted diseases 
necessitates rapid and accurate methods to detect and measure the severity of infection by 
arborviruses.  The ABADRL with Plum Island Animal Disease Center collaborators have 
developed a rapid real-time nucleic acid amplification assay (RT-PCR) VSV.  Laboratory 
diagnostic validation of the VSV test was favourable and will differentiate VSV infection from 
Foot and Mouth Disease Virus, however, field validation resulted is some false negative results.  
The test has been modified based on these samples and the new test is currently being evaluated 
and was utilized to investigate the outbreak of VSV in Texas, New Mexico and Colorado the 
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summer of 2004..  This test will enhance certification of animals and germplasm for international 
trade and the ability to monitor the extent of a disease outbreak.  This technology could rapidly 
be developed in case of an outbreak of an emerging arboviral pathogen, an intentional or un-
intentional introduction or random evolutionary change in an indigenous virus. 
 
TECHNOLOGY TRANSFER: 
Provided training on real-time PCR for detection of vesicular stomatitis virus  
to Escuela de Medicina Veterinaria, Universidad Nacional, Heredia, Costa Rica and Laboratorio 
de Diagnóstico de Enfermedades Vesiculares, Panama City, Panama, May 2004. 
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Poisonous Plant Research Projects, Logan, UT 
 
Project Title:   Investigation of Lupine-Induced Crooked Calf Disease in the Northwest 
CRIS Number:     5428-32000-011-01S 
Scientists:             James, L., Pfister, J., Ralphs, M., Panter, K. 
Location:         Logan, Utah 
                        Poisonous Plant Research 
Contact: James, L., Phone: (435) 752-2941, Fax: (435) 753-5681 
lfjpprl@cc.usu.edu 
  
PROJECT OBJECTIVES: 
Lupines continue to cause significant losses to the livestock industry in the western U.S. from 
induced 'crooked calf syndrome'. In the spring of 2003, large losses were reported in California, 
Oregon, Idaho, Western Canada and Washington State. We have done extensive research over 
the last 3 years in the Scabland region of eastern Washington where lupines are widespread and 
cause large losses every year to cattle producers. The teratogenic lupine identified was L. 
leucophyllus which contains relatively large concentrations of the teratogenic alkaloid anagyrine. 
Lupine-induced  'crooked calf disease' is responsible for significant losses to cattle producers in 
the western U.S. every year. In the last five years increasing incidences of the disease have been 
reported. In 1997, a massive loss occurred in the scablands of Washington State.  Three studies 
have been initiated to answer significant questions. (1) what factors contribute to the increased 
consumption of lupine plants resulting in large losses; (2) what animal factors contribute to the 
increased incidence of 'crooked calf disease'; (3) which range areas are high risk for large losses. 
A combination of cows native to the Scabland region and naive cows have been used in the 
grazing studies. 
  
OVERALL PROJECT ACCOMPLISHMENTS: 
Lactating cows were fed Lupinus leucophyllus at Washington State University.  Extraction and 
analytical protocols were developed in our laboratory for analysis of lupine alkaloids in milk. 
Significant levels of teratogenic alkaloids were detected in the blood and milk of cows fed L. 
leucophyllus and absorption and elimination profiles were determined in blood and milk.  
 
Analyses were completed from grazing trials in Washington State with fat and thin cows. There 
was a significant correlation between body condition and when cattle started to graze lupines and 
how long they grazed lupine plants. Eventually all animals ate substantial quantities of lupine, 
but thin animals ate more lupine at times, thus we believe the risk of intoxication is particularly 
high for thin cows compared to cattle with higher body condition scores. Data analyses were 
completed and published from an earlier cooperative research project with the University of 
Idaho at the Dubois Sheep Experiment Station that demonstrated that thin sheep more rapidly 
absorbed toxic alkaloids than did fat sheep, and conversely thin sheep showed slower elimination 
of alkaloids compared to fat animals. This strongly suggests that toxicokinetics of the teratogenic 
alkaloids may be significantly altered based on animal body condition. 
 
In grazing seasons 2001-2003 cows started eating lupine around the first of July after annual 
cheatgrass had matured and dried out, and other forbs were grazed out or matured (Lupine 
consumption ranged from 17 to 25% of diets). This period of consumption overlaped the critical 
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period of gestation (40-70 day of pregnancy) if the traditional breeding season begins May 1. 
Cattle should be removed from lupine areas during this period. 
  
IMPACT: 
 
TECHNOLOGY TRANSFER: 
Information about alkaloid content, susceptible stages of gestation and relative risk of grazing in 
specific pastures has been transferred to extension agents and ranchers through meetings, phone 
conversations and written recommendations. Many management options are currently available  
based on available knowledge about which alkaloids in the plant are a threat, susceptible stages 
of gestation, effective herbicides and management techniques to reduce losses.   
 
Management to reduce livestock losses from poisonous plants.  Influence of drought on losses to 
toxic plants. Presented at the Arizona Strip Workshop, March 26, 2003, Kanab Utah, and March 
27, 2003, St. George, Utah. Sponsored by Arizona and Utah Extension Services. The information 
presented at these workshop is available to ranchers and is being implemented in many grazing 
programs. 
  
List your most important publications in the popular press and presentations to organizations and 
articles written about your work. (NOTE:  This does not replace your peer-reviewed publications 
listed in Question 9). 
  
by Michael Ralphs, Kip Panter, Jim Pfister, Clive Gay and Ernie Motteram.  2003.  Cattle 
Consumption of lupine in the scablands of Eastern Washington, Presented at Society for Range 
Management annual meeting, Feb 2, Casper WY. 
 
Panter, K.E.  2003.  Presented seminar on toxic and teratogenic plants at 'Plant Interactions and 
the Effect of Global Warming on Alpine Biodiversity' workshop in Kazbegi, Republic of 
Georgia, June 30-July 6. 
 
Pfister, J.A.  2003.  Presented two workshops at the Arizona Strip, March 26, 2003, Kanab Utah, 
and March 27,  St. George, Utah.  Sponsored by Arizona and Utah Extension Services. 
 
PUBLICATIONS: 
 
Panter, K.E., James, L.F., Wang, S., Gardner, D.R., Waffield, W., Molyneux, R.J., Stegelmeier, 
B.L. and Bunch, T.D.  2003.  Use of Bovine Embryos Produced by In Vitro Fertilization 
Techniques to Screen Poisonous Plant Toxins for Cytotoxicity, In: T. Acamovic, C.S. Stewart 
and T.W. Pennycott, eds.  CABI Publishing, Oxon, UT. 
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Poisonous Plant Research, Logan, UT 
 
Project Title:  Poisoning of Livestock by Various Larkspur Species(Delphinium) 
CRIS Number:     5428-32630-009-00D 
Scientists:             James, L., Lee, S., Gardner, D., Pfister, J.,ralphs, M., Stegelmeier, B. 
Panter, K., Vacant   
Location:         Logan, UT, Poisonous Plant Research 
Contact: James, L, Phone: (435) 752-2941, Fax: (435) 753-5681, 
lfjpprl@cc.usu.edu 
 
PROJECT OBJECTIVES: 
Larkspur (Delphinium spp.) poisoning causes serious economic loss to  livestock producers 
grazing cattle on many western ranges.  The  objectives of the multidisciplinary research are: (1) 
isolate and  identify individual alkaloids from Delphinium species; test these  alkaloids for 
toxicity; confirm structure activity relationships for new  alkaloids; (2) develop analytical and 
diagnostic methods for larkspur  alkaloids, including development of immunogenic alkaloid 
protein conjugates and antibody based detection methods and potential vaccine  development; (3) 
investigate mechanisms of intoxication, including toxin  metabolism and clearance, and 
treatment of intoxicated animals; and (4)  determine plant, animal, or environmental factors 
influencing larkspur  consumption and continue development of management strategies to reduce  
losses for all classes of larkspur. 
 
OVERALL PROJECT ACCOMPLISHMENTS: 
Developed the Fourier transform infrared spectroscopic method of analysis of toxic and total 
alkaloid levels in tall larkspur, thus allowing for rapid analysis of thousands of samples. 
 
Elucidated the comparative toxicity of 24 alkaloids from larkspurs and structure activity 
relationships. Understanding toxicity has important implications for developing rational 
treatments to reduce losses. 
 
Developed grazing strategies to reduce losses to tall larkspurs.  Continued implementation of 
early- and late-season grazing strategies has resulted in reduced cattle losses for ranchers grazing 
on tall larkspur-infested pastures.  
 
Determined that cattle eat tall larkspur in a cyclic "toxification-detoxification" pattern after 
ingesting a daily threshold of 14-18 mg toxic alkaloid/kg b.w.  This research helps to understand 
patterns of consumption and how much larkspur is necessary to poison cattle. 
 
Determined that when cattle eat larkspur, adverse postingestive consequences regulate 
consumption, not plant flavor (i.e., taste and smell).  Increases in the toxic alkaloid concentration 
deter consumption by sheep, but have little impact on short-term consumption by cattle.  This 
research provides fundamental information about when and why cattle eat larkspurs. 
 
Determined that mineral supplementation does not affect the amount of larkspur consumed by 
grazing cattle, indicating that producers can save money by providing mineral supplements as 
necessary for nutritional needs, rather than using minerals to alter larkspur consumption. 
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Developed aversive conditioning as a potentially viable tool for ranchers.  This practice could 
potentially greatly reduce the risk of cattle losses for those livestock producers that implement 
aversive conditioning. 
 
Developed herbicidal control recommendations for tall larkspurs.  Ranchers with dense 
populations of larkspur can greatly reduce losses and enhance economic returns through the use 
of herbicides. 
 
Verified that sheep grazing before cattle can reduce larkspur availability and acceptability to 
cattle grazing afterward. 
 
Collaborative work with Colorado State University investigated the mechanism of action of 
MLA, nudicauline, 12-deacetylnudicauline, barbanine, and deltaline.  It was determined that the 
alkaloids block nicotinic acetylcholine (nAch) receptors postsynaptically.  The potency of 
deltaline is much lower, indicating that deltaline does not bind as tightly as do the other alkaloids 
at nAch receptors. 
  
IMPACT: 
 
TECHNOLOGY TRANSFER: 
Toxic larkspur alkaloid analyses done on a number of plant samples for ranchers and extension 
personnel. This is a useful tool for ranchers to help determine if they can begin grazing with low 
risk, or continue to graze, a particular pasture or allotment. 
 
The management concepts referred to as "primary toxic window" and "early season grazing" 
have been developed and transmitted to numerous ranchers and USFS personnel.  These 
concepts are based on plant chemistry and cattle diet selection patterns, and are being used to 
reduce losses on summer-grazed Forest Service allotments where tall larkspur is problematic.   
  
PUBLICATIONS: 
 
Gardner, D.R., Ralphs, M.H., Turner, D., Welsh, S. Taxonomic Implications of Diterpene 
Alkaloids in Three Toxic Tall Larkspur Species (Delphinium SPP.). Biochemical Systematics 
and Ecology. 2002. 
 
Li, X., Gardner, D.R., Ralphs, M.H., Wang, R. Development of STS and CAPS Markers for 
Identification Three Tall          Larkspurs (Delphinium SPP.). Genome. 2002. 
 
Pfister, J.A., Ralphs, M.H. Gardner, D.R., Stegelmeier, B.L., Manners, G.D., Panter, K.E. and 
Lee, S.T.  2002.  Management of three toxic Delphinium species based on alkaloid 
concentrations.  Biochemical Systematics Ecology 30:129-138 
 
Panter, K.E., Manners, G.D., James, L.F., Gardner, D.R., Ralphs, M.H., Pfister, J.A., 
Stegelmeier, B.L., Lee, S.T. Larkspur Poisoning: Toxicology and Alkaloid Structure Activity             
Relationships. Biochemical Systematics and Ecology. 2002. 
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Panter, K.E., James, L.F., Gardner, D.R., Ralphs, M.H., Pfister, J.A., Stegelmeier, B.L., Lee, S.T. 
Reproductive Losses to Poisonous Plants: Influence of Management Strategies. Journal of Range 
Management. 2002. 
 
Pfister, J.A., Gardner, D.R., Stegelmeier, B.L., Knight, A.P., Waggoner, Jr., J.W. and Hall, J.O.  
2002.  Plains larkspur (Delphinium geyerii) grazing by cattle in Wyoming. Journal of Range 
Management 55:350-359. 
 
Li, X., Ralphs, M.H., Gardner, D.R., Wang, R.R.-C.  2002.  Genetic variation within and among 
22 accessions of three tall larkspur species (Delphinium spp.) based RAPD markers.  
Biochemical Systematics Ecology, 30:91-102. 
 
Welch, S.L. and M.H. Ralphs.  2002.  Some tall larkspurs (Delphinium-Ranunculaceae), a 
taxonomic review.  Biochemical Systematics Ecology 30:103-112. 
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Poultry Research Projects 
 
Project Title:   Diagnosis and Control of Mycoplasmosis in Poultry 
CRIS Number:     6406-32000-006-00D 
Scientists:             Branton, S., Vacant, Vacant, Vacant 
Location:         Mississippi State, MS, Poultry Research 
Contact:  Branton, S., Phone: (662) 320-7608, x. 7608, Fax: (662) 320-7589 
slbranton@ars.usda.gov 
 
PROJECT OBJECTIVES: 
Mycoplasmas negatively impact both interstate movement and international export of poultry 
and are a major factor in limiting production in both meat-type and layer-type chickens. This 
research seeks to define the impact of the various poultry mycoplasmas, to develop test 
procedures to identify infected flocks, and to develop new vaccines against the organism. 
 
OVERALL PROJECT ACCOMPLISHMENTS: 
Major accomplishments over the life of the project include: 1) the finding that Mycoplasma 
gallisepticum isolation occurs more frequently (300% increase) and with greater ease from the 
palatine fissure in the roof of the chicken¿s mouth as compared to traditional tracheal isolation, 
impact - fewer swabs are required to isolate the organism and swabs are easier to obtain with less 
stress to the chicken, 2) the finding that the chicken remains infected over its life and that neither 
isolation nor disinfection of its environment will rid the chicken of the organism, impact - unless 
you can depopulate an infected farm, you cannot get rid of the organism from the flock, 3) that 
the cellular profile of the chicken's blood reflects an acute infection with mycoplasma; however, 
the cellular blood profile of the chronically infected chicken is similar to control hens, despite the 
fact that the organism can still be isolated from the chronically infected hen, impact - the 
chicken's immune system is apparently "tricked" by the organism into believing there is no need 
to continue mounting an immune response, 4) that the addition of the commonly used therapeutic 
agent ammonium chloride in layer chickens hinders the bacteriological recovery of Mycoplasma 
gallisepticum from chickens, impact - a diagnostician needs to know that a flock is being treated 
with ammonium chloride when he is attempting to isolate the organism and therefore take a 
greater number of swabs in order to assure the organism's isolation when the flock is actually 
infected, and 5) that vaccination of chickens at 10 weeks of age with the F strain of Mycoplasma 
gallisepticum does not reduce egg production over a 44-week laying cycle, impact - since 1979, 
flock managers have used the F strain of Mycoplasma gallisepticum with the understanding that 
the vaccine reduces egg production by approximately 7 eggs/hen over a 45-week laying cycle. 
  
IMPACT: 
The work addresses these objectives under our OSQR Project Plan: optimization of current MG 
vaccination protocols for layer hens; the design and production of an efficacious recombinant 
MG vaccine by molecular technologies for use in egg-type (layer hen) and potentially meat-type 
(broiler and turkey) production systems; and to determine the mechanisms by which MG 
vaccinations induce immunological change.  New and improved regimens for use with currently 
available vaccines will be the initial products of this research.  Concurrently, a recombinant 
vaccine(s) effective against MG will be developed.  The molecular technologies used to develop 
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the recombinant vaccine are also anticipated to provide information regarding the pathogenicity 
of MG. 
 
TECHNOLOGY TRANSFER: 
A self-propelled poultry vaccinating machine was developed which delivers Mycoplasma 
gallisepticum vaccines uniformly and consistently and was transferred to commercial table-egg 
producers.  The technology is undergoing field trials which should end in August 2003, at which 
time, the technology will be delivered to the poultry industry in both refereed journal and popular 
press article.  There are no constraints to the adoption durability of this technology. 
  
PUBLICATIONS: 
 
Peebles, E.D., Parker, T.A., Branton, S.L., Willeford, K.O., Jones, M.S., Gerard, P.D., Pharr, 
G.T., Maslin, W.R.  Effects of an S6 Strain of Mycoplasma gallisepticum inoculation before 
beginning of lay on the Leukocytic characteristics of commercial layers.  Avian Diseases. 2004. 
v. 48. p. 196-201. 
 
Wan, X., Branton, S.L., Hanson, L.A., Pharr, G.T.  Identification and initial characterization of a 
putative Mycoplasma gallinarum leucine aminopeptidase gene.  Current Microbiology. 2004. v. 
48. p. 32-38. 
 
Wan, X., Branton, S.L., Hughlett, M.B., Hanson, L.A., Pharr, G.T.  Expression and subcellular 
location of a leucine aminopeptidase of Mycoplasma gallinarum.  International Journal of 
Poultry Science. 2004. v. 3(1). p. 70-74. 
 
Burnham, M.R., Peebles, E.D., Branton, S.L., Jones, M.S., Gerard, P.D. Effects of F-Strain 
Mycoplasma gallisepticum inoculation at twelve weeks of age on the blood characteristics of 
commercial egg laying hens. Poultry Science. 2003. v. 82. p. 1397-1402. 
 
Burnham, M.R., Peebles, E.D., Branton, S.L., Walzem, R.L., Gerhard, P.D. Effects of F-Strain 
Mycoplasma gallisepticum inoculation on serum very low density lipoprotein diameter and 
fractionation of cholesterol among lipoproteins in commercial egg-laying hens. Poultry Science. 
2003. v. 82. p. 1630-1636. 
 
Branton, S.L., Bearson, S.M.D., Bearson, B.L., Maslin, W.R., Collier, S.D., Evans, J.D., Miles, 
D.M., Pharr, G.T. Mycoplasma gallinarum infection in commercial layers and onset of fatty liver 
hemorrhagic syndrome. Avian Diseases. 2003. v. 47. p. 458-462. 
 
Burnham, M.R., Peebles, E.D., Branton, S.L., Maurice, D.V., Gerard, P.D.  Effects of F-strain 
Mycoplasma gallisepticum inoculation at twelve weeks of age on egg yolk composition in 
commercial egg laying hens.  Poultry Science. 2003. v. 82. p. 577-584. 
 
Parker, T.A., Branton, S.L., Jones, M.S., Peebles, E.D., Gerard, P.D., Willeford, K.O., Burnham, 
M.R., Maslin, W.R.  Effects of an S6 strain of Mycoplasma gallisepticum challenge before 
beginning of lay on various egg characteristics in commercial layers.  Avian Diseases. 2002. v. 
46. p. 593-597. 
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Pharr, G.T., Branton, S.L., Hanson, L.A., Minion, F.C., Hughlett, M.B., Wan, X. 
Characterization of the pMGA genes from the F-Strain (vaccine strain) of Mycoplasma 
gallisepticum.  International Journal of Poultry Science. 2002. v. 1(4). p. 63-73. 
 
Peebles, E.D., Branton, S.L., Burnham, M.R., Gerard, P.D.  2003.  Influences of supplemental 
dietary poultry fat and F-Strain Mycoplasma gallisepticum infection on the early performance of 
commercial egg laying hens.  Poultry Science. 2003. v. 82. p. 596-602. 
 
Branton, S.L., Bearson, S.M.D., Bearson, B., Lott, B.D., Maslin, W.R., Pharr, G.T., Collier, 
S.D., Boykin, D.L. The effects of 6/85 live Mycoplasma gallisepticum vaccine 6/85 in 
commercial layer hens over a 13-week laying cycle on egg production and selected egg quality 
parameters and egg size distribution when challenged before beginning of lay. Avian Diseases. 
2002. v. 6. p. 423-428. 
 
Burnham, M.R., Branton, S.L., Peebles, E.D., Jones, M.S., Lott, B.D., Yeatman, J.B., 
Whitmarsh, S.K., Gerard, P.D. Digestive and reproductive organ characteristics in commercial 
laying hens as affected by F-strain Mycoplasma gallisepticum. Poultry Science. 2001. v. 80. 
(Suppl. 1) p. 136.  
 
Burnham, M.R., Branton, S.L., Peebles, E.D., Walzem, R.C., Whitmarch, S.K., Gerard, P.D. 
Effects of F-strain Mycoplasma gallisepticum on serum lipids and lipoprotein profiles in 
commercial laying hens. Poultry Science. 2001. v. 80. (Suppl. 1) p. 15. 
 
Burnham, M.R., Walzem, R.L., Peebles, E.D., Branton, S.L., Whitmarsh, S.K., Gerard, P.D. 
Effects of fasting on serum lipids and lipoprotein profiles in commercial laying hens. Poultry 
Science. 2001. v. 80. (Suppl. 1) p. 19. 
 
Jones, M.S., Peebles, E.D., Branton, S.L., Willeford, K.O., Pharr, G.T., Montgomery, R.D., 
Parker, T.A., Whitmarsh, S.K., Maslin, W.R. Effects of an immunodulator and phasic challenges 
of S6 strain Mycoplasma gallisepticum and escherichia coli on egg production and egg 
characteristics of commercial laying hens during peak and post-peak lay. Poultry Science. 2001. 
v. 80. (Suppl. 1) p. 16. 
 
 -300- 
Poultry Production and Products Safety 
Research 
Fayetteville, AR 
 
 
 
 
 
 
 
 
 
 
 
 
 
Poultry Production and Products Safety Research, Fayetteville, AR 
Ann M. Donoghue, Research Leader 
(479) 575-2413 
USDA, ARS, SPA, PPPSRU  
UNIV ARK, O-303 POSC 
Fayetteville AR 72701 
 
PROJECTS 
 
Poultry Production and Products Safety Research 
• Evaluation of Ascites in Poultry 
• Decreasing Production Related Bone Diseases in Poultry 
 
 
 
 
 -301- 
Poultry Production and Products Safety Research Projects 
 
Project Title:   Evaluation of Ascites in Poultry 
CRIS Number:     6226-32000-004-00D 
Scientists:             Balog, J., Donoghue, A. 
Location:         Fayetteville, AR, Poultry Production and Products Safety Research 
Contact:  Balog, J., Phone: (479) 575-6299, Fax: (479) 575-4202, jbalog@uark.edu  
 
PROJECT OBJECTIVES: 
Ascites is an often fatal metabolic disease thought to be caused by the birds' heart and lungs not 
being able to support the rapid growth of modern commercial broilers.  The disease is 
characterized as congestive heart failure, with a build up of fluid in the abdominal cavity of the 
bird.  Ascites can be experimentally induced by rearing poultry in hypobaric (low pressure) 
chambers that simulate high altitude by reducing available oxygen.  ARS has the only large-scale 
hypobaric chamber (holds up to 480 birds) in the world to study ascites.  This model is being 
used to evaluate the etiology of ascites and methods to reduce the natural occurrence of ascites in 
the poultry industry.  Our research has demonstrated a genetic basis for ascites.  Our current 
research effort is to identify the gene or gene products associated with the syndrome.  
 
OVERALL PROJECT ACCOMPLISHMENTS: 
Our past work on ascites syndrome in broilers is directly related to Animal Health National 
Program, NP 103 by virtue of the disease aspect, and since it is generally accepted that ascites 
syndrome has a large genetic component our work is also related to the Genetic Improvement 
component of Food Animal Production National Program, NP 101. While the influence of 
genetics in the etiology of the disease has been recognized for years, lines of broilers that can 
serve as experimental models were not available.  Our most significant accomplishment over the 
life of this project is that we, along with our collaborator Dr. Nicholas B. Anthony of the 
University of Arkansas, have developed two lines of birds that vary in their ascites response to 
high altitude (low oxygen pressure) and have collected tissue samples from both lines of birds.  
Genetic selection has resulted in divergent line responses, with the ascites-resistant line 
exhibiting 26% ascites mortality, while the ascites-susceptible line exhibits 98.5% ascites 
mortality.  These lines of birds and their tissue samples will be used to determine if genetic 
markers exist that could be used to improve breeder selection for ascites resistance. 
 
Over the past several years, we have fine-tuned the hypobaric chamber experimental model for 
inducing ascites.  Previous hypobaric 
chambers were only able to accommodate 
15 birds at a time.  Our chamber can hold 
480 birds to six weeks of age, thereby 
greatly increasing the sensitivity of our 
experiments.  Additionally, results of recent 
studies show that birds need not be 
maintained at high altitude for the entire 6 
weeks grow-out to produce a high incidence 
of ascites mortality and that bird numbers 
can be maximized and equipment failure can 
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be compensated for by moving birds out of the chamber.  Once the experimental model was 
established, we investigated several ways to reduce ascites mortality in broilers.  We have found 
that dietary aspirin at fairly low levels can reduce ascites.  Since dietary aspirin would be an 
inexpensive and relatively easy method to use in commercial poultry operations, there is great 
potential to impact broiler production.  We have determined that correct timing of feed 
restriction can reduce ascites mortality, without sacrificing final body weight.  This finding was 
particularly important because feed restriction is commonly used in the poultry industry, yet 
frequently the timing is incorrect, which results in birds being delayed going to market. 
 
Our recent investigations of the molecular basis of ascites syndrome have resulted in several 
major accomplishments.  We were awarded a grant from the U.S. Poultry and Egg Association 
(#58-6226-2-0002) for our proposal titled 'Molecular Genetics of Ascites Syndrome (Pulmonary 
Hypertension Syndrome) in Broilers' to conduct research to determine if mutations in the coding 
region of the bone morphogenetic protein receptor 2 (BMPR2) were linked to ascites 
susceptibility in broilers.  Utilizing commercial broiler crosses and the ascites-susceptible and 
ascites-resistant lines, we sequenced the BMPR2 messenger RNA (mRNAs) of ascitic and non-
ascitic birds and then compared these sequences with the published BMPR2 gene.  No mutations 
were found in the mRNA that altered the BMPR-II protein, but 13 single nucleotide 
polymorphisms (SNPs) were detected, and we determined that BMPR-II protein levels are 
increased in ascitic birds.  Although it appears that ascites is not caused by the same mutation 
that causes FPPH, regulation of BMPR2 expression is different in birds that develop ascites and 
we now have 13 SNPs that can be useful in gene mapping. 
 
IMPACT: 
Utilizing the world’s largest capacity hypobaric chamber for poultry, we, along with our 
collaborator Dr. Nicholas B. Anthony of the University of Arkansas, have developed two lines of 
birds that vary in their ascites response to high altitude (low oxygen pressure) and have collected 
tissue samples from both lines of birds.  Genetic selection has resulted in divergent line 
responses with the ascites-resistant line exhibiting 26% ascites mortality, while the ascites-
susceptible line exhibits 98.5% ascites mortality.  These lines of birds and their tissue samples 
are being used to evaluate the molecular etiology of ascites and to determine if genetic markers 
exist that could be used to improve breeder selection for ascites resistance.  Continued molecular 
work into the etiology of ascites syndrome led us to report that there are significant differences in 
the levels of seven electron transport proteins in ascitic birds compared with non-ascitic birds.  
We also identified 14 single nucleotide polymorphisms in the coding region of chicken bone 
morphogenetic protein receptor II and mapped this gene to the chicken chromosome 7.  We also 
determined that mutations in the chicken bone morphogenetic protein receptor II gene of the 
chicken are not responsible for ascites susceptibility. 
 
TECHNOLOGY TRANSFERS: 
The molecular genetic component of ascites syndrome is of great interest to the poultry industry, 
particularly the primary poultry breeding companies, because of this a Cooperative Research and 
Development Agreement (CRADA) was established with Cobb-Vantress, Inc.  This CRADA 
'Characterization of the Genetic Basis for Ascites Syndrome' supports an in-depth investigation 
of the molecular aspects of ascites susceptibility by utilizing the ascites susceptible and resistant 
lines of broilers.  This CRADA allows for greater interaction between ARS scientists and Cobb-
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Vantress, Inc., a primary poultry breeding company, and has potential to benefit the poultry 
industry as a whole. 
 
PUBLICATIONS: 
 
Balog, J. M., Anthony, N. B., Cooper, M. A., Kidd, B. D., Huff, G. R., Huff, W. E.  and Rath, N. 
C.  Ascites syndrome and related pathologies in feed restricted broilers raised in a hypobaric 
chamber.  Poultry Sci.79:318-323. 2000. 
 
Balog, J.M., Huff, G. R., Rath, N. C., and Huff, W. E.  Effect of dietary aspirin on ascites in 
broilers raised in a hypobaric chamber.  Poultry Sci.  79:1101-1105. 2000. 
 
Balog, J.M., Anthony, N. B., Kidd, B. D., Liu, X., Cooper, M. A., Huff, G. R., Huff, W. E.,  
Wideman, R. F., and Rath, N. C.  Genetic selection of broiler lines that differ in their ascites 
susceptibility.  2. Response of the ascites lines to cold stress and bronchus occlusion.  13th World 
Poultry Science Association European Symposium on Poultry Nutrition.  Blankenberge, 
Belgium.  pp. 329-330. 2001.  (Proceedings) 
 
Anthony, N.B., Balog, J. M., Hughes, J. D., Stamps, L., Cooper, M. A., Kidd, B. D., Liu, X., 
Huff, G. R., Huff, W. E., and Rath, N. C.  Genetic selection of broiler lines that differ in their 
ascites susceptibility.  1. Selection under hypobaric conditions.  13th World Poultry Science 
Association European Symposium on Poultry Nutrition.  Blankenberge, Belgium. pp. 327-328.  
2001.  (Proceedings) 
 
Cisar, C. R., Balog, J. M., Anthony, N. B., and Donoghue, A. M. Genetic selection of broiler 
lines that differ in their ascites susceptibility 3. Progress on identification of differentially 
expressed genes in ascitic and non-ascitic birds. 13th World Poultry Science Association 
European Symposium on Poultry Nutrition, Blankenberge, Belgium. pp. 331-332. 2001. 
(Proceedings) 
 
Balog, J. M., Kidd, B. D., Huff, W. E., Huff, G. R., Rath, N. C., and Anthony, N. B.  Effect of 
cold stress on broilers selected for resistance or susceptibility to ascites syndrome.  Poultry Sci. 
81:1383-87. 2003. 
 
Balog, J. M.  Ascites syndrome (pulmonary hypertension) in broiler chickens: Are we seeing the 
light at the end of the tunnel?  Avian and Poultry Biology Reviews, 14(3):99–126. 2003. 
 
Cisar, C. R., Balog, J. M., Anthony, N. B., and Donoghue, A. M.  Sequence analysis of bone 
morphogenetic protein receptor type II mRNA from ascitic and non-ascitic commercial broilers.  
Poultry Sci. 82:1494-99. 2003. 
 
Cisar, C. R., Balog, J. M., and Donoghue, A. M.  The chicken bone morphogenetic protein 
receptor type II (BMPR2) gene maps to chromosome 7.  Animal Genetics 34:475-476. 2003.   
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Project Title:   Decreasing Production Related Bone Diseases in Poultry 
CRIS Number:     6226-32000-002-00D 
Scientists:             Rath, N., Donoghue, A. 
Location:         Fayetteville, AR, Poultry Production and Products Safety Research 
Contact:  Rath, N., Phone: (479) 575-6189, Fax: (479) 575-4202,  nrath@uark.edu
 
PROJECT OBJECTIVES: 
Leg problems are major metabolic skeletal problems in meat-type poultry often affecting fast-
growing chickens and turkeys.  Tibial dyschondroplasia (TD) is a common growth plate problem 
in which the proper development cartilage is impaired, preventing bone development at the 
growing end of leg bones.  Consequently the growth plate and bone become fragile, prone to 
deformities and infections.  The etiology of TD is unknown but it is a complex disease since it 
can be related to a chondrocyte development, vascularization, cartilage modeling, cell survival, 
and differentiation that are regulated by a number of nutritional, physiological, and 
environmental factors. We are trying to understand the cellular and biochemical basis of TD so 
that it can be controlled by appropriate dietary interventions. We are developing experimental 
models of TD that can be used to understand the mechanisms of the disease and screen the 
dietary supplements that can prevent the problem in growing poultry.  
 
OVERALL PROJECT ACCOMPLISHMENTS: 
Over the past several years we have studied poultry leg problem and their causes particularly 
relating to tibial dyschondroplasia (TD).  We have also done some work on the aspects of poultry 
immunity, particularly on the role of certain blood proteins called 'acute phase protein' that 
modify immunity and affect disease resistance.  We have demonstrated that TD is caused by an 
unusual cell death in the growth plate, which affects cartilage replacement by bone in healthy 
animals. In investigating the causes of poultry skeletal problems, we also described a 
phenomenon of subchondral infarct in turkeys that may lead to an initial infection of bone 
leading to turkey osteomyelitis. Because bacteria tend to colonize dead tissues, dead cartilage in 
TD-affected bones may facilitate infection, resulting in diseases, such as osteomyelitis.  Our 
research also showed that a commonly used pestiicide (thiram) known to increase the incidence 
of TD does so by causing chondrocyte death.  To understand the physiological sequences of TD, 
we have currently developed a model with which we can induce TD in susceptible birds with 
only two days of feeding with thiram, which we hope will lead to a better understanding of the 
mechanisms of TD and design methods for its prevention.  Prevention of unusual cell death in 
the growth plate which appears to be a key factor in the mechanisms TD, may lead to the 
reduction of the incidence of TD in the future.  We also showed that bone strength is better 
related to the content of bone collagen cross-links than to bone minerals, and that younger birds 
have substantially lower content of collagen cross-links.  This gives us the opportunity to 
improve bone strength by manipulating collagen cross-link content of bone.  We also developed 
a novel staining procedure for avian heterophils, which facilitates their fluorescent localization in 
tissues. A bioassay of avian interleukin-6 was developed in our lab. We identified ovotransferrin 
as an avian acute phase protein.  We developed an ELISA for its measurements in blood and 
showed its immunomodulating properties. This research provides a tool for the diagnosis of 
health problems and stress in poultry. It also provides opportunity to investigate the role of 
ovotransferrin as an immunomodulating agent. We identified the presence of matrix 
metalloproteinase (MMP) in bile as an exocrine product and hypothesized its possible function in 
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digestive physiology.  Currently, we have developed a new chicken macrophage cell line that can 
be used to better understand the innate immune process in poultry. 
 
IMPACT: 
Comparing age dependent changes in different bone constituents to bone strength we found that 
pyridinium crosslinks of collagen are better related to bone strength raising the possibility that 
improving collagen crosslinks will improve bone strength.  We showed that tibial 
dyschondroplasia (TD), a metabolic cartilage defect is caused by a premature cell death in the 
maturing zone cartilage which is a basis of this problem. We have developed an experimental 
model of TD using a pesticide thiram, which induces the disease in young chickens following a 
brief exposure to this agent. This model will enable to explore the cellular and molecular 
mechanisms of TD and can be used to determine if certain nutrients can protect against the 
disease. Leg problems cost poultry industry an economic loss in excess of $200 million dollars 
annually in USA.  By understanding the mechanism and the etiology of these problems it will be 
possible not only prevent economic losses but also improve production efficiency and welfare. 
We developed a bioassay method for avian interleukin-6, a novel fluorescent staining method for 
avian heterophils, and a new chicken macrophage cell line HTC.  We identified serum 
ovotransferrin as a major avian acute phase protein that has immunomodulatory effects and can 
be used as a diagnostic indicator of poultry health problems. These studies provide basic tools to 
understand the basis of poultry health and disease resistance that will improve health and well 
being. 
 
TECHNOLOGY TRANSFERS: 
Our research is made available to the public through publications in journals, news magazines, 
presentations in meetings and conferences, and personal communications with other scientists 
and poultry growers.  We have provided the macrophage cell line HTC to researchers in 
universities and government labs. We have trained students (both graduates and undergraduates) 
from the Poultry Science, Animal Science, and Food Science Departments at the University of 
Arkansas.  We have provided our knowledge of bone disease, the analytical methods to 
academicians and representatives of poultry industries. 
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